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Abstract  
Biomaterials have gained significant importance in the field of tissue engineering.                  
For example, these biomaterials have been considered for the reconstruction of tissues for 
structural applications where the tissue morphology is of paramount importance such as 
bone, cartilage, blood vessels and skin etc. (Ameer et al., 2002). Often these biomaterials 
are used for tissue regeneration when the surrounding defective tissue exhibits the 
inherent potential for tissue regeneration. However, in situations where the tissue lacks 
this ability of regeneration, relevant cells as well as growth factors have been used to 
accelerate tissue regeneration. In addition, these biomaterials have also been combined 
with drugs and used as drug delivery systems, thereby reducing the microbial infections 
while maximising tissue regeneration (Gomes et al., 2004). 
There are several factors that make polyhydroxyalkanoates (PHAs) excellent materials 
for use in TE, however, when used as scaffolds in bone TE, PHAs fail to actively bind to 
the living tissue by means of a biologically active apatite layer or meet the mechanical 
demands in load-bearing applications. Therefore, these polymers are combined with 
inorganic bioactive materials, such as bioactive glass, to increase their applicability in 
bone TE. Also, there is a growing need to apply these scaffolds for applications such as 
drug delivery. 
For the first part of this study, a solid-in-oil-water (s/o/w) technique was used in an 
attempt to produce tailored poly(3-hydroxybutyrate) P(3HB) microspheres. The effects of 
different parameters used for microsphere production on the microsphere size, porosity, 
and drug distribution were investigated. The P(3HB) microspheres were encapsulated 
with the drugs such as gentamicin and tetracycline and their in vitro release kinetics 
studied.                                
A multifunctional P(3HB)/45S5Bioglass
®
 composite system for bone tissue engineering 
was also developed which could exhibit topographical features to increase cell 
attachment and can also act as a carrier for controlled drug delivery via the 
immobilization of P(3HB) microspheres on the scaffold surfaces. Thus a microsphere 
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coating was created on the 45S5Bioglass
®
 scaffolds resulting in a composite scaffold 
with increased compressive strength, surface nanotopography and bioactivity as 
compared to the original 45S5Bioglass
®
 scaffold. The multifunctional scaffold was also 
successfully used as a drug delivery vehicle. Hence, this multifunctional scaffold can be 
used to deliver drugs, proteins or growth factors to treat bone related diseases. This is the 
first time such a multifunctional scaffold has been developed. P(3HB) were also used to 
prepare composite films with a combination of nanoscale bioactive glass (n-BG) for 
wound healing applications. The various analyses done showed that the addition of n-BG 
particles had increased the surface roughness of the films and improved the surface 
wettability. Surface mediated reactions such as clot formation was also found to decrease 
linearly with the increase in the amount of n-BG particles.  
The microspheres were encapsulated with three model proteins BSA, Lucentis
®
 and 
RNase A to understand the effect of morphology, drug distribution on the in vitro release 
profiles. The microspheres produced were of an average size of 2µm. P(3HB) 
microspheres investigated for use as drug delivery vehicles in the intraocular 
environment exhibited a gradual release of BSA over a period of time and the 
encapsulation process did not lead to any degradation of BSA. The % cumulative release 
of Lucentis
®
 from both PBS and contact lens solution was for an extended period of 75 
days. The microencapsulation process also did not lead to any degradation of Lucentis
®
. 
Finally the effects of solvent treatment encountered by the model protein Ribonuclease A 
(RNase A) during microencapsulation in P(3HB) microspheres were investigated. From 
the results, structural integrity of RNase A was maintained. A gradual decrease in the 
enzyme activity of RNase A was observed over a period of time.  
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1.1 Biodegradable polymers used for biomedical applications 
1.1.0 Synthetic polymers 
Synthetic polymers represent the largest group of biodegradable polymers, which have 
been used for a number of biomedical applications (Langer et al., 2004). These synthetic 
polymers are known to exhibit certain positive features such as tailorable degradation 
rate, which make them suitable for biomedical applications. For example poly(lactic acid) 
PLA, a linear aliphatic polyester is produced from renewable resources such as corn 
starch or sugar cane and has attracted a lot of attention for biomedical applications due to 
its mechanical, thermal and biodegradable properties. PLA exists in two stereoisomeric 
forms i.e D-PLA and L-PLA as well as the racemic polymer, Poly(D,L-Lactic acid) 
PDLLA. PDLLA, a well known high molecular amorphous polymer, known for its 
biocompatibility, biodegradability and flexibility, has been considered suitable for 
various biomedical applications such as orthopaedic applications, stents, staples and 
sutures. These biodegradable polymers however have a risk of toxicity and 
immunogenicity due to their acidic by-products. Other properties such as high price lack 
of tailorability, presence of chemical catalysts and fast degradation rate has challenged 
their commercialization (Bhatia et al., 2007). Nevertheless researchers like Sodian et al., 
and Kose et al., have utilised these polymers for tissue engineering applications for nerve, 
skin, vascular and bone tissue engineering. They have also been used as stents, staples 
and sutures (Sodian et al., 2000, Kose et al., 2003).  
1.1.1 Natural polymers  
Natural polymers such as polysaccharides and proteins have also been considered for 
various biomedical applications due to their lack of toxicity and inflammatory reactions 
when compared to the synthetic polymers. Cells adhered onto natural polymers are 
known to interact with the surrounding environment via integrins and focal adhesion 
proteins thereby regulating the development of various tissues. Recently collagen was 
used as an implant in bovine discs (Chan et al., 2008). From the ex-vivo studies it was 
observed that although the disc height was restored due to the collagen implant, however 
after a few mechanical loadings an extrusion of the implant was observed. Thus collagen 
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did not possess the intrinsic mechanical properties that were required for implant in 
bovine discs (Chan et al., 2008). Alginate, a polysaccharide derived from brown 
seaweed, has been used for applications such as wound healing and drug delivery due to 
its ability to mould into any desirable shape. Injectable alginate gel can be moulded into 
any shape by controlling the speed of gelation. However, the applications of these 
alginate gels are limited only for soft tissue engineering applications as they do not 
possess the mechanical strength or the osteoconductivity required for bone tissue 
engineering applications (Sotome et al., 2004). Although these polymers have still been 
used for a number of biomedical applications such as cardiovascular applications, 
peripheral nerve regeneration and drug delivery systems, the need for 
polyhydroxyalkanoates has risen due to their varied mechanical properties, 
biocompatibility and biodegradability (Dang et al., 2006). 
1.1.2 Polyhydroxyalkanoates  
Polyhydroxyalkanoates (PHAs) are water insoluble biodegradable, biocompatible 
polyesters that are accumulated in a large number of Gram-positive and Gram-negative 
bacteria.  PHAs are usually produced during the stationary phase of growth under nutrient 
limiting conditions such as excess carbon and limited nutrients such as oxygen, nitrogen, 
sulphur, magnesium and phosphorous (Anderson et al., 1990). PHAs accumulate as 
cytoplasmic inclusions in different species and these vary in the number per cell and their 
size (Anderson et al., 1990).  Polyhydroxyalkanoates (PHAs) represent a complex class 
of bacterial polyesters consisting of 3-, 4-, 5- and 6-hydroxyalkanoic acids, as represented 
in Figure 1. 
 
 
 
 
Figure 1: The general structure of polyhydroxyalkanoates (R1/R2 = H, alkyl groups C1-C13,  x = 1-4 
and n = 100-30000).  
 
  Chapter1:Introduction 
4 
 
Polyhydroxyalkanoates are linear polyesters of 3-,4-,5-,6-hydroxyalkanoic acids. The 
hydroxyl group of each monomer is bonded to the carboxyl group of another monomer 
using an ester linkage. Often the variations in the length of the pendant groups extending 
from the polymer backbones or the distance between the ester linkages in the polymer 
backbones are known to cause the changes in the chemical structure of the PHAs. Due to 
the variations in the chemical structure, the physical properties (such as mechanical and 
thermal) of the polymers are affected (Valappil et al., 2007).  
1.1.2.1 Types of PHAs 
PHAs are classified as short-chain length (scl) and medium chain length (mcl) PHAs 
depending on the number of carbon atoms in the monomeric unit. They are also classified 
as homopolymers and heteropolymers depending on whether one or more than one type 
of hydroxyalkanoate is found as the monomer unit.  
1.1.2.1.1  Scl-PHAs 
Scl-PHAs such as poly(3-hydroxybutyrate); P(3HB),  poly(4-hydroxybutyrate);  P(4HB) 
and P(3HB-co-3HV) have 3-5 carbon atoms in the monomer units. The types of PHAs 
synthesised are dependent on the microbes and the carbon source used. These carbon 
sources are classified into structurally related carbon sources, which give rise to 
monomers structurally similar the carbon source and structurally unrelated carbon source, 
which are known to generate monomers completely different to the carbon source used 
(Pouton et al., 1996).  Glucose has been found to be the most efficient substrate for the 
production of the homopolymer P(3HB) using Alcaligenes eutrophus, however other 
substrates such as sucrose, methanol and acetic acid have also been used to produce this 
homopolymer using the same organism. Comamonas acidovorans is also known to 
accumulate PHAs such as P(4HB) efficiently when fed with related carbon sources such 
as 1,4-butanediol and γ-butyrolactone (Pouton et al., 1996). When the substrate (carbon 
source) is changed, organisms such as Alcaligenes eutrophus are capable of producing 
other PHAs. For examplewhen a combination of glucose and propionate are used as 
carbon sources, poly(3-hydroxybutyrate-co-3-hydroxyvalerate), P(3HB-co-3HV), with 
varying mol% HV content could be produced. The HV content can be varied depending 
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on the concentration of propionate. Similarly the mol% of 4HB units in P(3HB-co-4HB) 
can be varied depending on the concentration of the 4-hydroxybutyric acid added in the 
growth medium (Saito et al., 1996).  PHAs have also been produced using Bacillus 
cereus SPV. Bacillus cereus SPV has been known to utilise a wide range of carbon 
sources including glucose, fructose, sucrose, various fatty acids and gluconate for the 
production of PHAs. This particular strain of Bacillus spp. was also able to synthesize 
various PHAs with 3-hydroxybutyrate (3HB), 3-hydroxyvalerate (3HV) and 4-
hydroxybutyrate (4HB)-like monomer units from structurally unrelated carbon sources 
such as fructose, sucrose and gluconate (Valappil et al., 2007).  
1.1.2.1.2  Mcl-PHAs 
Mcl-PHAs such as poly(3-hydroxyhexanoate); P(3HHx) and poly(3-hydroxyoctonoate); 
P(3HO) have 6-14 carbon atom containing monomer units. Pseudomonas sp, can be 
grown on structurally related carbon sources such as alkenes, alkanes and aldehydes 
which act as precursor substrates that exhibit structures related to the constituents of the 
mcl-PHAs. For example, Pseudomonas oleovorans when grown in hexane produced a 
copolymer containing 83 mol% of 3(HHx), 12 mol% of P(3HO) and 4.9 mol% of poly(3-
hydroxydecanoate) P(3HD). However, when grown in heptane the same organism was 
able to produce 97.5 mol% of 3-hydroxyheptanoate, P(3HHp), 2.5 mol% of poly(3-
hydroxyvalerate), P(3HV) (Preusting et al., 1990). Structurally unrelated carbon sources 
such as glucose and glucanoate have also been used for the production of mcl-PHAs. For 
example, Pseudomonas putida KT2442 when grown in the presence of glucose, 3-
hydroxydecanoate, 3HD was produced predominantly as the major constituent and other 
minor constituents such as 3HHx, 3HO and 3-hydroxydodecanoate, 3HDD were also 
incorporated into the polymer (Kim et al., 2007).  
1.1.2.2 Microorganisms involved in the production of Polyhydroxyalkanoates (PHAs) 
and their copolymers   
PHA producing bacteria accumulate PHA when their cell growth is inhibited by the 
limitation of essential nutrients such as nitrogen, carbon, phosphorous, magnesium, 
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potassium and oxygen and have excess carbon. Therefore, several fermentation strategies 
have been designed to enhance the production of PHAs based on this knowledge.  
1.1.2.2.1 Scl-PHA production  
Poly(3-hydroxybutyrate) P(3HB), is the most common and simplest member of the group 
of PHAs, which has been extensively characterised. A number of Gram-positive, Gram-
negative, photosynthetic species, lithotrophs and organotrophs have been used for the 
production of P(3HB).  Bacillus cereus SPV have been known to accumulate a variety of 
different PHAs using different carbon sources. For example when grown in Kannan and 
Rehacek medium containing a structurally unrelated carbon source such as gluconate 
(20% w/v), a tercopolymer containing 3HB, 3HV and 4HB-like monomer was produced. 
The dry cell weight (dcw) was 1.943 g/L and a PHA concentration of 0.814 g/L. 
Similarly when grown in Kannan and Rehacek medium containing fructose or sucrose 
(20% w/v) as the sole carbon source, a copolymer similar to P(3HB-co-4HB) was 
produced. The dcw was 1.6 g/L and PHA concentration of 0.640 g/L was produced when 
sucrose was used as the sole carbon source; a dcw of 1.2 g/L and a PHA concentration of 
0.5g/L was produced when fructose was used as a sole carbon source. Bacillus cereus 
SPV have also been grown in a medium containing different n-alkanoates (30mM final 
concentration) for the introduction of a different monomer. In this study, as expected the 
even-chain fatty acids such as acetate, hexanoate, decanoate and dodecanoate produced 
P(3HB). A maximum dcw 0.59g/L and a PHA concentration of 0.44g/L were produced 
when decanoate was used as the carbon source. However in the presence of odd chain 
fatty acids such as propionate, heptanoate and nonanoate, P(3HB-co-3HV) was produced. 
The highest dcw of 0.496 g/L and PHA concentration of 0.234g/L was observed in the 
presence of nonanoate (Valappil et al., 2006). An increase in the carbon to nitrogen ratio 
in the growth medium has been found to increase the PHA accumulation in the cells 
(Wilkinson et al., 1958). Suzuki et al., determined that only a minimum concentration of 
nitrogen source was required for the production of P(3HB) (Suzuki et al., 1988).                  
For example, Zinn et al., carried out an efficient production of P(3HB) in a two-step fed 
batch process using Alcaligenes latus, a Gram-negative bacteria. In this study the cells 
were grown to a desired concentration and then transferred in a nutrient-limiting medium 
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in the second phase. The cell growth and PHA accumulation were dependent on the ratio 
of the concentration of the carbon source to the limiting nutrient concentration and the 
dilution rate. In this study a cell concentration of 111.7 g/L
-1
 and a P(3HB) productivity 
of 4.94 g/L
-1 
was successfully achieved (Zinn et al., 2005). Although, P(3HB) production 
has been successfully carried out from Gram-negative bacteria, the presence of 
lipopolysaccharides (LPS), known to act as endotoxins, that co- purify with the P(3HB) 
are known to induce a strong immunogenic reaction, thus proving to be a disadvantage.  
Therefore, efforts are now focussed on the production of P(3HB) from Gram-positive 
bacteria, which can be used for biomedical applications. P(3HB) was first isolated from 
the Gram positive genus Bacillus by Lemoigne in 1923. Since then several strains of 
Bacillus have been used to produce a range of different PHAs (Valappil et al., 2007).     
For example, Bacillus cereus INT005 has been found to produce P(3HB), P(3HB-co-
3HV),  poly(3-hydroxybutyrate-co-3-hydroxyhexanote) P(3HB-co-3HHx) and poly(3-
hydroxybutyrate-co-6-hydroxyhexanote-3-hydroxyhexanoate).P(3HB-co-6HHx-co-
3HHx) when grown in a medium containing different carbon sources (Tajima et al., 
2003). Similarly, when fed with -caprolactone as the main carbon source Bacillus cereus 
UW85 produced a tercopolymer containing 3-hydroxybutyrate (3HB), 3-hydroxyvalerate 
(3HV) and 3-hydroxyhexanoate (3HHx) (Labuzek et al., 2001).  
Poly(3-hydroxybutyrate-co-4-hydroxybutyrate), P(3HB-co-4HB), copolymer has been 
produced using a number of different Gram-negative and  Gram positive organisms such 
as Bacillus cereus SPV, Alcaligenes latus, Comamonas acidovorans, and Cupriavidus sp. 
Several carbon sources such as 4-hydroxybutyric acid, -butyrolactone, 1,4-butanediol, 
1,6-hexanediol and 4-chlorobutyric acids have been used for the production of this 
copolymer (Caballero et al., 2005). Copolyesters of 3-hydroxybutyrate and                     
4-hydroxybutyrate, P(3HB-co-4HB) have been synthesised by Ralstonia metallidurans  
in a two step fermentation. When grown under aerobic conditions at 30 C in a medium 
containing butyric acid as the sole carbon source and additives such as ammonium 
sulphate and potassium dihydrogen citrate, for 120 hours, was observed to synthesise 
copolymers with a wide range of compositions (70 to 100 mol% 4HB) (Doi et al., 1995).  
Biosynthesis of P(3HB-co-4HB) was also carried out using a Cupriavidus sp 
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(USMAA24), isolated from a soil sample. In this study, a two-step cultivation process 
was employed which was similar to methods described by other researchers (Sudesh et 
al., 2000). Cupriavidus sp (USMAA24) was initially grown in a nutrient broth medium 
for 24h and then transferred to a mineral medium containing different concentrations of 
1,4-butanediol and -butyrolactone. A linear increase in the 4HB composition was 
observed when the concentration of -butyrolactone in the medium was increased. 
Similarly, with an increase in 1, 4-butanediol concentration in the medium, the 3HB 
content was found to increase (Chee et al., 2008).  Gram-positive strains such as Bacillus 
cereus SPV were also observed to produce P(3HB-co-4HB) when grown in a media 
containing either glucose or fructose as the sole carbon source. The polymer yield in this 
study was observed to be 40.3% dry cell weight with a 75 mol% of 3HB and 25 mol% of 
4HB when fructose was used as a sole carbon source. Similarly the polymer yield was 
observed to be 38.4% dry cell weight with a 90 mol% 3HB and 10 mol% 4HB when 
sucrose was used a sole carbon source (Valappil et al., 2006).  
1.1.2.2.2 Mcl-PHA production  
Mcl-PHAs synthesised by Pseudomonas sp are almost always a copolymer, where             
3-hydroxyoctonoate is produced as the main monomer when grown in a medium 
containing even number of carbon atoms and 3-hydroxynonanoate is produced when 
grown in a medium containing odd number of carbon atoms (Kim et al., 2007). To date 
more than 150 units of mcl-PHA monomers have been produced by culturing various 
Pseudomonas sps on different carbon sources Some microorganisms such as 
Pseudomonas putida, Pseudomonas oleovorans and Pseudomonas fluorescens have been 
known to accumulate both aromatic and aliphatic mcl-PHAs from aromatic 
hydrocarbons. Pseudomonas putida CA-3 is known to accumulate a copolymer of mcl-
PHAs containing 3-hydroxyhexanoic acid, 3-hydroxyoctanoic acid and                                   
3-hydroxydecanoic acid monomers when grown in a medium containing styrene and 
phenyl acetic acid (Ward et al., 2005).   
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1.2.2.2.3 Scl-Mcl PHA production 
Pseudomonas sps can be grown on both structurally related and unrelated carbon sources 
to produce PHAs. The low substrate specificity of the mcl-PHA synthase, the key 
enzyme involved in the polymerization of the medium chain length hydroxyl CoA into 
mcl-PHA is mainly responsible for the diversity of the mcl-PHA monomers (Kim et al., 
2007). Scl-Mcl PHAs such as Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate), P(3HB-
co-3HHx), have been produced using a two-stage batch fermentation at 30 C. Amongst 
the range of alkanoic acids used; the highest production of P(3HB-co-3HHx) (33 wt%) 
was seen in a medium containing lauric acid. The 3-hydroxyhexanoate fraction of the 
copolymer was increased from 11-20 mol% when the concentration of lauric acid was 
increased from 5-30 g/L (Doi et al., 1995).  
1.1.2.3 Properties of Scl-PHAs 
Scl-PHAs such as P(3HB), P(3HB-co-3HV) and P(4HB) have been fully characterised 
for various biomedical applications (Williams et al., 1999; Misra et al., 2006, Chen et al., 
2005). The physical and mechanical properties of the polymers described below highlight 
the importance of these properties for use in biomedical applications.  
1.1.2.3.1 Poly (3-hydroxybutyrate) P(3HB) 
P(3HB) is a stereo-regular, isotactic polyester which has been extracted from bacteria 
with a high degree of purity. In addition to its biocompatible and biodegradable 
properties, P(3HB) is also known to exhibit piezoelectric properties which can stimulate 
bone growth and healing (Misra et al., 2006, Knowles et al., 1991). The relatively high 
crystallinity and rigidity of P(3HB) is due to its  short methyl side chain.  P(3HB) is a 
semi-crystalline thermoplastic with a degree of crystallinity ranging from 60-80 %. It has 
a regular structure due to its biological origin.  It also has an ortho-rhombic structure with 
a right-handed helix, a fibre repeat of 5.95 Å and two parallel chain molecules that pass 
through the sub-cell. The crystallization of the polymer occurs as soon it is extracted 
from the cells using non-polar solvents therefore it is amorphous in nature in its native 
state. Depending on the crystallization rate and the molecular weight of P(3HB), the 
polymer chains form „spherulites‟ when crystallised from the melt (Kumagai et al., 
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1992a). P(3HB) also undergoes crystallization upon storage at room temperature 
(Kumagai et al., 1992a). P(3HB) is known to exhibit a melting temperature (Tm) of 160 
to 177°C and a glass transition temperature (Tg)  of -4 to 15°C. However, the thermal 
properties of P(3HB) is known to vary from each sample largely due to the extraction 
techniques used and the variations in the molecular weight and polydispersity index of 
the extracted polymers (Misra et al., 2006). P(3HB) has mechanical properties which are 
comparable to those of degradable polyesters such as polylactides. The Young‟s modulus 
exhibited by P(3HB) is 400 MPa and compressive elastic modulus of 317 MPa (Misra et 
al., 2006). Although P(3HB) has a relatively high brittleness, the mechanical properties 
can be improved by blending with other degradable polymers or inorganic materials. For 
exampleP(3HB)/10 vol% hydroxyapatite exhibited a  higher tensile Young‟s modulus of 
500 MPa and compressive elastic modulus of 419 MPa when compared to P(3HB) alone 
(Wang et al., 2005a).  
1.1.2.3.2 Poly(3-hydroxybutyrate-co-3-hydroxyvalerate; P(3HB-co-3HV) 
 P(3HB-co-3HV) is a copolymer of P(3HB) with a possible variability in the mol% of 3-
hydroxyvalerate (3HV) units. Copolymers such as P(3HB-co-3HV) have been found to 
be less crystalline than P(3HB).  The degree of crystallinity can be controlled by 
increasing/decreasing the HV content. Often, the previous thermal history of the polymer 
and the conditions used to fabricate the polymer affect the crystallinity.  When higher 
than 40 mol% of 3HV is used, the 3HB units are known to crystallise within the P(3HV) 
lattice. This ability of 3HB and 3HV units to co-crystallize has been termed as 
„isodimorphism‟ (Bluhm et al., 1986; Scandola et al., 1992, Pouton et al., 1996). The 
increasing HV content is also known to effect thermal properties of P(3HB-co-3HV). The 
melting points of the copolymers vary depending on the HV and HB content as shown in 
Table 1. Similarly, the addition of HV increases the flexibility and reduces the 
mechanical strength of the polymer. This makes the polymer more processable than 
P(3HB) (Galego et al., 2000). The increase in the 3HV content is also known to reduce 
the water contact angle of the P(3HB-co-3HV) films, thereby increasing the 
hydrophilicity of the films (Misra et al., 2006). 
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Table 1:- The thermal properties of the copolymer P(3HB-co-3HV) with varying 3HB and 3HV 
contents (Scandola et al., 1992). 
3HB 
mol% 
3HV 
mol%  
Tm C Hf J/g 
100 0 176 95 
92 8 170 70 
81 19 117 62 
66 34 96 48 
59 41 83 48 
45 55 83 57 
29 71 86 71 
18 82 104 83 
5 95 106 87 
 
1.1.2.3.3 Poly-4-hydroxybutyrate (P(4HB)) 
A single P(4HB) crystal has an orthorhombic structure and is semi-crystalline in nature.  
Each of these crystals has stacks of lamellae that are both transparent and opaque in 
nature. The P(4HB) molecular chains  have been folded within the lamella in a highly 
folded and twisted condition (Martin et al., 2003). The thermal properties of P(4HB) are 
characterised as Tg of -50 C, the crystallization temperature (Tc) of 15 C, Tm of 54 C 
and the enthalpy of fusion Hf as 11.0 cal/g. An increase in the Hf value indicates the 
higher crystallinity of a polymer. Due to its high melt viscosity, 4HB remains fairly stable 
at temperatures of 200 C and there is an insignificant reduction in the molecular weight 
(Martin et al., 2003). The mechanical properties of P(4HB) films with varying porosity 
processed using different conditions (melt-processing/salt leaching conditions) is 
represented in Table 2 (Martin et al., 2003).  A decrease in the elastic modulus and 
increase in the tensile strength and elongation at break were observed at lower porosity 
when compared to the films with higher porosity. It is a strong thermoplastic pliable 
polymer with mechanical properties comparable to other high molecular weight polymers 
such as polyethylene. It is incredibly flexible with an elongation to break at around 
1000% (Doi et al., 1990; Martin et al., 2003).  
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Table 2: - Mechanical properties of P(4HB) films with varying porosity processed using different 
conditions (melt-processing/salt leaching conditions) (Martin et al., 2003). 
 
PHA  Elastic modulus 
(MPa) 
Tensile strength 
(MPa) 
Elongation at 
Break (%) 
4HB crude polymer  230    36                                     1140 
Dense film  64.8 51.7 1000 
4HB (50%) porous 14.9 6.2 164 
4HB (80%) porous 1.8 1.2 100 
 
1.1.2.3.4 Poly(3-hydroxybutyrate-co-Poly-4-hydroxybutyrate) P(3HB-co-4HB) 
The crystallinity of the copolymer P(3HB-co-4HB) is known to decrease with the 
increase in the amount of 4HB units in the copolymer. During the synthesis of the 
copolymer P(3HB-co-4HB), the bulky 4HB units do not get incorporated into the 3HB 
crystal lattice. Therefore, the copolymer with 0-29 mol% 4HB fraction exhibits only one 
3HB crystal lattice indicating that the 4HB content does not get incorporated into the 
crystal lattice (Saito et al., 1996; Chee et al., 2008). However, with the increase in the 
4HB fraction from 85-100 mol%, 4HB units get incorporated within the P(3HB) crystal 
lattice. Thus with the increase the 4HB fraction a decrease in the Tm of the copolymer 
was observed which indicated a reduction in the crystallinity. With the increase in the 
4HB content (0-100 mol%) of the copolymer, P(3HB-co-4HB), synthesised from  
A. eutrophus, the Tg of the copolymer showed a significant reduction from 4 to -50 C  as 
shown in Table 3 (Nakamura et al., 1992). The tensile strength of the copolymer also 
decreased from 43MPa to 26MPa in the presence of 16 mol% 4HB content (Martin et al., 
2003).  
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Table 3: - The thermal properties of P(3HB-co-4HB) with varying 3HB and 4HB compositions 
(Nakamura et al., 1992). 
 
 
 
 
 
1.1.2.4 Properties of Mcl-PHA and Scl-Mcl PHAs 
Mcl-PHAs such as P(3HO) and Scl-Mcl PHAs such as P(3HB-co-3HHx) have been used 
for various biomedical applications (Sanchez et al., 2003). The physical and mechanical 
properties of the polymers described below highlight the importance of these properties 
for use in biomedical applications.  
1.1.2.4.1 P(3HO) 
P(3HO) is less crystalline than the scl polymers and this difference is due to the presence 
of irregular pendant side chain group/alkyl groups which is responsible for the formation 
of a crystalline array as opposed to the formation of a closely packed 3-dimensional 
structure. The isotactic and syndiotactic structure sequences/configuration of these 
polymers are the determining factors in the formation of a crystallite.  Gagnon et al., 
observed a 30% crystallinity in P(3HO) from 
13
C NMR results. For this study, the 
authors‟ proposed that the lower crystallinity was due to a two phase morphology of 
P(3HO) such as the amorphous and crystalline phase (Gagnon et al., 1992). Mcl-PHAs 
are highly elastomeric in nature due to their low Tm (42 to 61 C) and low glass transition 
temperature (with a range between -25 to 62 C) (Steinbuchel et al., 2003).                                 
At temperatures higher than its Tm, the polymer appears sticky and amorphous. P(3HO) is 
known to exhibit a Tg of -35 °C which is associated to the glass-rubber transition and a 
Tm of 60 °C. A low Tg and Tm value for P(3HO) was observed due its lower crystallinity 
of the polymer when compared to the crystallinity of P(3HB) (Dufresne et al., 2000).           
3HB  mol%  4HB mol%              Tm C Hf J/g Tg C 
100              0  177 20.8 4 
94                6 162 13.5 -1 
90               10 159 13.0 -3 
72               28 - - -15 
15               85 48 8.6 -41 
10               90 50 10.2 -44 
6                 94 51 11.0 -46 
0               100 54 11.0 -50 
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The crystalline parts of the mcl-PHAs are known to act as physical crosslinks due to 
which their mechanical properties are very different from those of scl-PHAs and its 
copolymers. In a study conducted by Marchessault et al., the stress-strain curve for 
P(3HO) exhibited no yield stress which was typical to that observed for elastomers. 
Similarly a Young‟s modulus of 17MPa and an elongation to break of 250-350% was 
observed (Marchessault et al.,1990).  
1.1.2.4.2 P(3HB-co-3HHx) 
In the case of the mcl copolymers there is no crystallinity seen due to the presence of 
functional groups, which prevent the regular arrangement of the polymer chain. Some 
mcl copolymers do not crystallise at all due to which no Tm value is observed. For 
exampleP(3HB-co-3HHx) is semi-crystalline in nature with crystallinity similar to that of 
P(3HB). However, the crystallinity is contributed by the 3HB units and not by 3HHx 
(Van der Walle et al., 2001). An increase in the average length of the pendant group in 
the polymer has a significant effect on the thermal properties of the polymer, such as a 
decrease in the Tg when the mobility of the polymer chains is increased and the degree of 
crystallinity is reduced (Van der Walle et al., 2001). For example, when Pseudomonas 
oleovorans was grown in a medium containing hexanoate, the Tg of the P(3HB-co-3HHx) 
was -25 C when compared to the Tg of the polymer grown in decanoate which was -40 C 
(Gross et al.,1989). The introduction of a comonomer into the P(3HB-co-3HHx) 
backbone is also known to increase the flexibility (elongation to break) and toughness of 
the polymer thereby decreasing the Young‟s modulus. For example, P(3HB-co-3HHx) 
containing 2.5 mol% of 3HHx exhibited a tensile strength of 27.5MPa when compared to 
8.8MPa exhibited by P(3HB-co-3HHx)  when the 3HHx content was increased to                 
9.5 mol% (Asrar et al., 2002).  
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1.2 Bioactive ceramics  
Ceramics have been classified as either bioinert or bioactive depending on the type of 
interaction with the host tissues (Marti et al., 2000). Bioactive glass ceramics or 
silicates/phosphate glasses have been widely used in medicine and dentistry (Misra et al., 
2006). Bioactive glass is also known for its excellent properties such as high 
osteoconductivity (Chen et al., 2006). When immersed in simulated body fluid (SBF) 
they form a microcrystalline hydroxyapatite (HA). Dissolution of the Bioactive glass 
products is also known to initiate angiogenesis (Chen et al., 2006) .  
1.2.1 45S5Bioglass
®
 
This is one of the well studied bioceramic in the field of hard tissue engineering. A high 
degree of bioactivity is the most significant property of 45S5Bioglass
®
 which facilitates 
the attachment of living bone tissue, leading to successful applications in vivo (Hench et 
al., 1998a). Researchers like Hench et al., have reported that upon immersion of 
45S5Bioglass
®
 in body fluids the dissolution of 45S5Bioglass
®
 takes place forming a 
crystalline silica-hydrated gel layer (Na2Ca2Si3O9). Following this, an amorphous 
calcium phosphate layer from the hydrated silica gel layer is formed. The formation of a 
highly crystalline Na2Ca2Si3O9 layer is often dependent on the sintering conditions of the 
45S5Bioglass
®
 which controls the crystallinity of the Na2Ca2Si3O9 layer (Chen et al., 
2006). Finally, on prolonged immersion of the 45S5Bioglass
®
 scaffold in a simulated 
body fluid (SBF), the transformation from a crystalline silica-gel layer (Na2Ca2Si3O9) to 
an amorphous Ca-P layer takes place. Due to this transformation, the degradability of the 
45S5Bioglass
®
 scaffold occurs at a much faster rate when compared to tricalcium 
phosphate or wollastonite (Chen et al., 2006). Moreover, studies have shown that upon 
dissolution of 45S5Bioglass
®
 the released ions can activate the complex gene 
transduction pathways in cells, thereby enhancing cell differentiation and osteogenesis 
(Xynos et al., 2001). Microarray analysis of osteoblast gene expression has shown that 
genes with known roles in processes relevant to osteoblast metabolism and bone 
homeostasis can be induced by the ionic products of bioactive glass dissolution treatment 
and integrin, which promotes cell-cell and cell-matrix attachment (Xynos et al., 2001).  
 
 
  Chapter1:Introduction 
16 
 
1.2.2 Hydroxyapatite (HA) 
 
Hydroxyapatite is a principal constituent of bone. Hydroxyapatite is considered as a 
suitable bioactive ceramic due to its thermodynamic stability and its ability to form 
strong chemical bonds with the surrounding bone. HA are known to show good bioactive 
properties, however the resorbability of HA is reduced in comparison to tricalcium 
phosphate. For example, HA is known to remain integrated into the regenerated bone 
tissue even after implantation whereas tricalcium phosphate is completely resorbed after 
regeneration of the new bone tissue (Navarro et al., 2008). Apart from its ability to 
support bone in growth and osteointegration, hydroxyapatite has also been used for dental 
and maxillofacial applications (Misra et al., 2006). Although hydroxyapatite does not 
have the mechanical strength for long term load bearing applications, it has led to an 
increase in the elastic modulus of composites with PHAs. Hydroxyapatite has also been 
used as coatings on metallic implants (Misra et al., 2006).  
1.3 Composite materials  
Bioactive ceramics are known to have poor mechanical properties and non-uniform pore 
size distributions due to which they pose a problem for applications in hard tissue 
engineering.  Similarly polymers are also known to lack the mechanical strength needed 
for hard tissue engineering as they are too flexible and weak (Misra et al., 2006, Bonfield 
et al., 1981). Thus composites made using a combination of biodegradable polymers and 
bioactive ceramics can provide the inherent strength necessary for the inorganic part of 
the bone. In the presence of the bioactive ceramic, a tenacious bond with the surrounding 
tissue via the hydroxyapatite (HA) formation can be achieved. Also, the biocompatibility 
of the scaffolds can also be enhanced due to the changes in the surface characteristics in 
the presence of the ceramic, which will be favourable for protein adhesion as well as cell 
attachment (Misra et al., 2006). A combination of P(3HB), P(3HB-co-3HV) and P(3HB-
co-3HHx) and ceramics used as fillers and coatings have been extensively studied. The 
different composite systems developed over the recent years are described below.  
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1.3.1 P(3HB)/bioactive ceramics composites 
Hydroxyapatite (HA) is the most extensively used bioactive ceramic that is used in 
combination with polymers to form composites. Apart from imparting a positive effect on 
the mechanical properties of the composite systems, HA is also known to induce a high 
rate of bioactivity i.e. the formation of additional hydroxyapatite when immersed in 
physiological fluids. Bone apposition was reported to occur within one month of 
implantation in an in vivo study at the P(3HB)/hydroxyapatite interface, this was 
followed by the formation of bone after 6 months (Lunkinska et al., 1997). Therefore, 
these studies proved that the addition of HA had a positive effect on the composite 
systems.  
Highly porous 45S5Bioglass
®
 scaffolds were coated with a biodegradable polymer, 
P(3HB) and the in vitro bioactivity test was evaluated by soaking in a simulated body 
fluid (SBF). Compression strength tests were performed before and after immersion in 
SBF exhibited higher values than that of the uncoated samples. An increase in the 
compression strength was observed due to the polymer coating which filled the 
microcracks and struts thus having an effect on the mechanical properties of the scaffold. 
The scaffolds coated with the polymer also proved to be highly bioactive, as after a few 
days of immersion in SBF a hydroxyapatite-like layer was formed on the scaffold‟s 
surface (Bretcanu et al., 2007). P(3HB)/45S5Bioglass
®
 composite films were also 
fabricated in the form of solvent cast films to study the effect of  45S5Bioglass
®
  addition 
on the mechanical properties of the P(3HB)/45S5Bioglass
®
 composite films.  The 
presence of 45S5Bioglass
®
 led to a reduction in the crystallinity of the polymer along 
with increasing the hardness of the P(3HB)/45S5Bioglass
®
 composite films. However a 
decrease in the Young‟s modulus of the P(3HB)/45S5Bioglass® composite films from 
1.1GPa to 0.84 GPa were observed with the increase in the 45S5Bioglass
®
 addition.             
For example, at 20 wt% 45S5Bioglass
® 
concentration the interfacial strength between the 
polymer and the 45S5Bioglass
®
 particles reduced due to which the Young‟s modulus was 
reduced (Misra et al., 2007).  
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1.3.2 P(3HB-co-3HV)/bioactive ceramics composites 
P(3HB-co-3HV) has been widely used in combination with ceramics such as HA, 
tricalcium phosphate (TCP) and wollastonite (Chen et al., 2002). The addition of HA to 
P(3HB-co-3HV) has been known to have an influence on the mechanical properties of 
the composites when compared to ceramics such as TCP. In the presence of HA, the 
micro-hardness, Young‟s modulus and the dynamic modulus of the composite systems 
increased (Li et al., 2004). Researchers like Galego et al., observed that at 40wt% of HA, 
a sharp decline in the elastic modulus was observed. At a higher concentration of HA, the 
interfacial strength between the HA particles and the polymer was found to decrease due 
to this the propagation of cracks can occur under mechanical stress (Boeree et al., 1993).  
1.3.3 P(3HB-co-3HHx)/bioactive ceramics composites 
Scl-Mcl PHAs are known for their high flexibility and low stiffness therefore they are 
more suitable for soft tissue regeneration applications such as heart valves, nerves and 
skin. However they lack the mechanical strength needed for hard tissue engineering and 
their inability to form a strong interfacial bonding with the surrounding bone tissue by 
means of a biologically active layer on the implant surface. Due to these limitations 
research is now carried out using a combination of bioactive and biodegradable 
composite materials. For example in a study conducted by Xi et al., composite of P(3HB-
co-3HHx) and hydroxyapatite (HA) were fabricated using a phase separation and 
subsequent sublimation technique. The composite scaffolds obtained by this technique 
had a porosity of more than 88% and the compressive modulus and the compressive 
stress were significantly increased. A good adhesion between the P(3HB-co-3HHx) 
matrix and HA was observed, where most of the HA were attached onto the surfaces of 
the solid walls of the pores of the matrix (Xi et al., 2008). However different techniques 
used to fabricate P(3HB-co-3HHx)/bioactive ceramics have been observed to have an 
influence on the mechanical properties of the composite systems. For example in a study 
conducted by Wang et al., a decrease in the compressive elastic modulus from 1.73 GPa 
to 0.068 GPa was observed when hydroxyapatite particles (HA) were blended into the 
P(3HB-co-3HHx) scaffolds using a salt leaching technique (Wang et al., 2005). 
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1.4 Biomedical Applications of PHAs, inorganic bioactive materials and composite 
bioactive materials  
1.4.1 Drug delivery applications of biodegradable polymers, inorganic bioactive materials  
and composite bioactive materials  
Drug delivery systems used for controlled drug delivery is gradually replacing the 
conventional methods of drug administration. The common problems encountered while 
administering conventional dosage forms is the inability to deliver the drug at a 
concentration that can trigger a pharmacological response (Pouton et al., 1996). 
Therefore, the dosage frequency has to be increased thereby increasing the risks of side-
effects.  In a controlled release study, the slow drug release rate reduces the fluctuations 
seen in the plasma drug levels, therefore a lower incidence of toxicity is observed.              
The understanding of both the physical and biocompatible properties of the polymer and 
the drug is paramount for the success of drug delivery (Pouton et al., 1996). Furthermore, 
the biodegradable polymer properties and structure can be designed according to the 
environment of the release. Composites of biodegradable polymers and ceramics such as 
Bioactive glass and hydroxyapatite have also been used for drug delivery for treating 
bone diseases such as osteomyelitis while acting as a scaffold for hard tissue engineering.   
1.4.2 Types of drug delivery structures 
The type of drug delivery structure and its influence on the drug release is an important 
aspect for therapeutic applications. For example the mechanism and extent of 
degradation, drug distribution or entrapment of drugs, the mechanism of drug release and 
its kinetics can be influenced by the type of drug delivery structures. For example in a 
study conducted by Korsatko et al., the in vitro and in vivo release of the drug 7-
hydroxyetheophylline (HET) compressed in P(3HB) tablets implanted subcutaneously 
into the neck folds of female mice was investigated. From the results the authors‟ 
observed a difference in the in vitro release which was dependent on the drug loading.  A 
higher drug release was observed within a period of 24 hours with an increased drug 
loading of 60-80%. The compaction pressures used to make the tablets did not influence 
the HET release (Korsatko et al., 1984). However, in another study conducted by Gould 
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et al., a much slower release of the drug was observed when P(3HB-co-3HV) compressed 
tablets were used when compared  to the P(3HB) compressed tablets. The differences in 
the drug release between the two polymers were largely attributed to the matrix porosity, 
structure and the copolymer composition (Gould et al., 1987). P(3HB) microspheres have 
been used to study the release of several anti-cancer drugs (Juni et al., 1987). The 
authors‟ observed that the release of these anti-cancer drugs occurred in a slow and 
sustained manner. For example13% of the drug aclarubicin hydrochloride released only 
10% of the drug after a period of 5 days. Increased release rates of the drug 
sulphamethizole was observed when irregularly shaped P(3HB) microspheres were used 
(Juni et al., 1987). In vitro release of the crude extract mitragynine from P(3HB-co-4HB) 
solvent cast films were investigated by Chee et al., 2008. From the results the authors‟ 
observed a constant release rate which was attributed to the polymer degradation rate. 
The polymer degradation rate was in turn dependent on the molecular weight, 
crystallinity, thermal properties and water permeability of the solvent cast films (Chee et 
al., 2008).  
1.4.3 Mechanisms of action for controlled release 
 In order to achieve a desired drug release rate, three common mechanisms of action, 
diffusion, osmosis and degradation are considered.  
1.4.3.1 Diffusion release mechanism 
 In this type of mechanism there are two main types of devices used. 
a) Monolithic device  
b) Reservoir device 
In the monolithic device, the active pharmaceutical ingredient (API) is mixed with the 
polymeric solution or dispersed uniformly within the polymer.  Here, the API is slowly 
released into the physiological fluid by dissolution followed by diffusion. Although, a 
complete zero-order release may not be achieved it is considered as the simplest method 
of delivery. In the reservoir device, the API is placed in the core of the polymer film. The 
dissolution of the drug from the core of the film is dependent on the thickness of the film 
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and the porosity of the film (Paul et al., 1976). However, if the drug has low aqueous 
solubility then the drug diffusion could be stopped. Similarly, a highly soluble drug can 
cause a burst release increasing the drug concentration in the surrounding area (Dash et 
al., 1992). 
1.4.3.2 Osmotic Release 
Osmotic systems for controlled drug delivery employs osmotic pressure gradient as the 
driving force for drug delivery. In this type of delivery, the API is present in the core of 
the tablet, which is then coated by a semi-permeable material. This type of drug delivery 
system is mostly suitable for oral administration where a compressed tablet is coated with 
a semi-permeable membrane. For example cellulose acetate has been used as a cellulosic 
membrane. The permeability of this membrane is largely dependent on the degree of 
acetylation where an increase in the permeability is observed when the acetyl content is 
increased. Upon immersion in an aqueous media, the hydrostatic pressure within 
compressed tablets is known to increase due to the increased diffusion of water through 
the semi-permeable membrane. The thickness of this material which is around 200-
300µm is able to resist the hydrostatic pressure when the water penetrates the material. 
However, once the internal osmotic pressure is raised sufficiently, the drug solution is 
expelled through the membrane. Initially 60-80% of the drug is released at a zero-order 
rate, which is then followed by a slower release rate where the residual dissolved drug is 
released (Park et al., 1994).  
 
1.4.3.3 Degradation Release/Polymer erosion 
 One of the key properties of biodegradable polymers used in drug delivery is their 
biodegradability. This property is advantageous when compared to the surgical 
intervention required to remove the non-degradable matrix (Hasirci et al., 2000). 
Degradation occurs via two main mechanisms such as surface or bulk erosion. Surface 
erosion is known to occur when the rate of erosion exceeds the rate of water penetration 
into the bulk of the polymer. Bulk erosion is known to occur when the water molecules 
penetrate within the polymer matrix at a rate faster than erosion. Drug release from 
biodegradable polymers occurs in three main mechanisms. In the first mechanism the 
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drug is covalently attached to the polymer backbone and is concomitantly released when 
the polymer backbone is hydrolytically cleaved. In the second mechanism, the drug is 
embedded within the core of the biodegradable polymer and is released when the 
polymer eventually undergoes degradation. In this mechanism the rate of drug release is 
dependent on the rate of polymer degradation. In the third mechanism, the drug release is 
dependent on rate of diffusion from the polymeric device and a combination diffusion 
and erosion of the polymer (Dash et al., 1992).  
1.4.4 PHAs used for drug delivery  
The properties of PHAs such as biocompatibility, biodegradability and the ability to 
control the drug release kinetics by suitably engineering the chemical composition of the 
PHA matrix, have made PHAs an excellent matrix material for controlled drug delivery. 
Both scl and mcl-PHAs have been used for drug delivery. Since scl-PHAs are degraded 
by surface erosion, scl-PHAs are considered ideal for drug delivery. However the rate of 
drug release from some of these matrices can be quicker, as the number of pores on the 
surface is increased due to polymer crystallinity and hydrophobicity (Pouton et al., 1996). 
Mcl-PHAs on the other hand can be used to provide a more controlled drug delivery, due 
to their lower melting point and crystallinity. However the inability to produce mcl-PHAs 
in large quantities has limited research on mcl-PHAs.  
1.4.4.1 Physical and mechanical properties of PHAs affecting the drug release rate  
1.4.4.1.1 Crystallinity  
 The degree of crystallinity of a polymer is an important parameter that affects drug 
release kinetics. Crystalline regions of a polymer are considered to be tougher 
mechanically than their amorphous counterparts. In this region the intermolecular 
interactions of the polymer are increased, thus a more compact structure is formed. The 
compact structure of the polymer becomes impermeable to the diffusing molecules, thus 
affecting the permeability. Therefore, the reduced permeability affects the drug 
dissolution and the hydrolysis of the crystalline region of the polymer, finally affecting 
the drug release kinetics. The drug release rate from P(3HB-co-3HV) is comparatively 
faster than the homopolymer P(3HB). Researchers like Bissery et al., have used 
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homopolymers like P(3HB) to deliver anti-cancer drugs like Imoustine® in vitro. In this 
published study a continuous release of the drug was observed for a period of 7 days. 
However, the drug distribution was affected by the irregularities in the spherical nature of 
the microspheres due to the crystallinity of the polymer; as a result, large aggregates of 
the microspheres were formed (Bissery et al., 1985). However, in order to alter the 
crystalline properties of the polymer and the drug release rates, some researchers have 
blended P(3HB) with additives such as ethyl and butyl esters of fatty acids into the 
microspheres. The authors‟ noticed that although the crystalline properties of the polymer 
could not be altered, the drug release rates were enhanced due to the release of the 
additives, which facilitated the diffusion of the drugs from within the microspheres 
(Kubota et al., 1988; Kawaguchi et al., 1992). 
1.4.4.1.2 Thermal Properties 
The presence of drugs within the polymer can act as an impurity thereby affecting the 
thermal properties of the drug. Potent contraceptive drugs such as levo-norgestrol (LNG) 
have been encapsulated in P(3HB) microspheres to be used as a long acting delivery 
system. DSC reports showed no characteristic peak such as Tm for LNG in the 
thermograms of LNG encapsulated P(3HB) microspheres, thus indicating that the drug 
was present in such low concentrations relative to the polymer that the drug Tm was 
unobservable. (Lu et al., 2001). Copolymers like P(3HB-co-3HV) have Tg values ranging 
from -5 to 20 ºC, the  varying mol% of 3HV in the polymer chain has an impact on the 
crystallinity and the thermal properties of the polymer. Akthar and Pouton conducted 
experiments to identify the interactions of the P(3HB-co-3HV) with methyl red used as a 
model drug and its influence on the Tg values. X-ray diffraction studies of the methyl red 
loaded copolymer showed no difference in the rate of crystallization. However, the shape 
and the breadth of the melt endotherm broadened suggesting that the drug had the effect 
of an impurity (Akthar et al., 1991).  
1.4.4.1.3 Molecular weight 
The molecular weight of the polymer is an important factor as it affects the drug release 
kinetics (Pouton et al., 1996).  The molecular weight of a polymer extracted is affected 
by a number of factors such as the fermentation conditions used, the type of 
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microorganism, concentration of the carbon and the pH of the media. In addition to the 
these factors, conditions like the solvents used to extract the polymer and the subsequent 
steps for the purification of the polymer can also affect the molecular weight of the 
polymer (Pouton et al., 1996). The varying chain lengths of the polymer affect the 
hydrophobicity of the polymer, thus affecting the drug release kinetics both in vivo and in 
vitro. Microspheres prepared using higher molecular weight polymers have been 
observed to be irregularly shaped and coalesced together, due to which the  surface area 
of the drug-loaded particles is reduced affecting the drug release rate (Pouton et al., 
1996). In a study conducted by Khang et al., the in vitro release of the anti-cancer drug  
5-fluoro-2′-deoxyuridine from P(3HB) microspheres with different molecular weights 
(65000, 135000 and 450000Da) were studied. The authors‟ observed that the drug release 
rate from the P(3HB) microspheres with the lowest molecular weight of 65000Da was 
higher when compared to the P(3HB) microspheres with a higher molecular weight of 
135000 and 450000Da (Khang et al., 1992). Higher molecular weight polymers are 
compact in nature and sometimes these molecular weight chains can get entangled which 
can prevent the surrounding media from entering into the polymeric vehicle, thereby 
preventing the drug release, resulting in a slower drug release (Pouton et al., 1996). 
1.4.4.1.4 Processing conditions that affect the drug release rate 
 The processing conditions used to fabricate the biodegradable polymers as drug delivery 
vehicles also affect the drug release rate. For example factors such as porosity, particle 
size, viscosity and drug distribution vary under the different processing conditions 
(Berkland et al., 2003). Microsphere preparation using the emulsion technique is the most 
common method used to encapsulate the drugs. Microsphere preparation using the 
solvent evaporation method to encapsulate the drug is affected by the types of solvents 
used, surfactants used and the viscosity of the emulsion phase due to the polymer and 
surfactant concentration. 
The types of solvents used for microsphere preparation are known to affect the surface 
morphology of the microspheres. For example progesterone encapsulation in P(3HB) and 
P(3HB-co-3HV) microspheres were significantly affected by the solvents used for the 
solvent evaporation technique. When chloroform was used, a very porous and irregular 
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surface was formed but when the solvent was replaced with methylene chloride, a smooth 
surface with high encapsulation efficiency of 80% was observed. The in vitro release of 
progesterone was the slowest using the P(3HB-co-3HV) microspheres as it was less 
porous when compared to the P(3HB) microspheres (Nobes et al., 1998). 
The surfactants used in the solvent evaporation technique during microsphere preparation 
are known to affect the encapsulation efficiency of the drugs. For example polyvinyl 
alcohol (PVA), an emulsifier used in the emulsion phase during microsphere preparation, 
is known to influence the drug distribution within the microspheres, thereby having an 
influence on the in vitro drug release profile.  Yang et al., observed the uniform drug 
distribution and slower BSA release from PCL (polycaprolactone) and PLGA (poly DL-
lactic-co-glycolic acid) 65:35 microspheres when PVA was used an emulsifier (Yang et 
al., 2001). Similarly in another study conducted by Bouissou et al., the encapsulation 
efficiencies of fibronectin FIII9V-10 in PLGA microspheres using different surfactants 
such as PVA, Tween 20 and Tween 80 were compared. In this study a higher 
encapsulation efficiency of 25% was observed when PVA was used as a surfactant when 
compared to 15% and 11% encapsulation efficiency when Tween 20 and Tween 80 were 
used respectively. The microspheres fabricated using Tween 20 and Tween 80 exhibited 
surface minor ridges with hollow structures which contributed to the lower encapsulation 
efficiency. However the microspheres fabricated using PVA retained the FIII9V-10 thus 
exhibiting higher encapsulation efficiency (Bouissou et al., 2004).  
 
Other factors such as viscosity of the emulsion phase used for fabricating the 
microspheres have an effect on the microsphere size. For example the increase in the 
polymer concentration leads to an increase in the viscosity of the solution due to which 
the smaller microspheres are not broken down. In a study conducted by Bonarstev et al., 
it was observed that the P(3HB) microspheres fabricated by the oil-emulsion technique 
encapsulating the antibiotic dipyridamole (DPD) produced microspheres which were 
larger in size. The largest microparticle sizes were 92µm (Bonarstev et al., 2007). The in 
vitro release profiles of the drugs also vary considerably due to the variations in the 
microsphere sizes (Nobes et al., 1998). The in vitro release rate of various drugs from 
microspheres with various sizes is listed in Table 4. 
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Table 4:- Anti-drugs encapsulated in P(3HB) microspheres using the solvent evaporation technique. 
*CCNU is 1-(2 chloroethyl)-3-cyclohexylnitrosourea.  
 
1.4.5  Inorganic scaffolds used as drug carriers  
Bioactive ceramic scaffolds such as bioactive glass ceramics or silicates/phosphates, 
hydroxyapatite and calcium phosphates have been used for hard tissue engineering. 
However, in addition to being used to provide structural integrity required for hard tissue 
engineering they can also serve as a drug delivery vehicle by controlling the kinetics of 
the therapeutic drug without the requirement of an additional drug carrier. These 
bioactive glasses have the advantage of being easily shaped into different forms such as 
pellets, films and powders, therefore these scaffolds when used as implants have also 
been considered for drug delivery applications. For example, in order to diminish the 
infections associated with the scaffold, researchers like Domingues et al., have 
incorporated antibiotics such as tetracycline within the bioactive glass scaffold as a 
carrier for the drug. In this study the authors‟ observed that the tetracycline release from 
the bioactive glass lasted for a period of 80 days. Although a burst release of 12% was 
observed in the first 8h, a cumulative release of 22% at the end of the study was 
observed. From this study it was concluded that the bioactive glasses could be used as an 
efficient system for slow release of the drug (Domingues et al., 2004). Hydroxyapatite 
(HA) is another inorganic material, which is a major component of the bone. Porous HA 
has largely been used as a filling material for bone defects and augmentation (Wang et 
al., 2007). This porous morphology of HA has been used a fundamental feature while 
using HA as a potential drug release agent. For example in a study conducted by Palazzo 
et al., ibuprofen-lysine and hydrocortisone sodium-succinate from two cylindrical 
hydroxyapatitic grafts with the same porosity were used as drug delivery matrices. The 
authors had observed that the drug hydrocortisone sodium-succinate was released at 
Drugs  Type of 
PHA 
Particle size 
m) 
Release rate References 
*CCNU P(3HB) 1-15 90% in 10h  Bissery et al., 1985 
Alcarubicin P(3HB) 158-214 10% in 120h Juni et al., 1986 
Tetracaine P(3HB) 20-40  50% in 2h Akthar et al., 1989 
Rifampicin P(3HB) 120-200 40% in 24h Kassab et al., 1997 
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much slower rate when compared to ibuprofen-lysine during the first 40 minutes (Palazzo 
et al., 2005).  
1.4.5.1 Factors affecting the drug release rate from inorganic scaffolds  
1.4.5.1.1 Processing conditions 
Several techniques have already been developed to fabricate these scaffolds with added 
advantage of a drug delivery capability. However the methods that were employed to 
fabricate these scaffolds have a considerable effect on the drug release rate. In the 
template technique, the scaffolds are prepared by dissolving the polyurethane sponge in 
ceramic particles where the surplus slurry is then removed and sintered at a high 
temperature to obtain a porous three-dimensional scaffold (Chen et al., 2006). In order to 
impregnate the drugs within the scaffolds, they are further immersed in drug containing 
phosphate-buffered saline solution (PBS). In a study conducted by Zhu et al., the in vitro 
release study of gentamicin from both mesoporous bioactive glass (MBG) and the 
bioactive glass (BG) ceramics fabricated using the polyurethane sponge technique were 
compared.  The authors‟ observed that in the MBG scaffold the drug uptake capacity was 
two-fold higher than that of the BG scaffold due to its increased surface area and pore 
volume. Although BG and MBG scaffolds exhibited an initial burst release followed by a 
relatively slower release, the in vitro release of gentamicin from the MBG scaffolds was 
much slower when compared to the drug release from the BG scaffolds. For the MBG 
scaffolds an initial burst release of 52% was observed in the first 12h followed by a 
sustained release of 66% of the initial drug loaded for a period of 7 days. While for the 
BG scaffolds a higher initial burst release of 73% was observed in the first 12h, followed 
by 96% cumulative release of gentamicin after 7 days. It was observed that the 
gentamicin molecules were hosted deep inside the mesoporous channels in the MBG 
scaffolds which contributed towards its slower release. The BG scaffolds on the other 
hand were dense with the presence of some disordered pores on the surface. A higher 
percentage of the gentamicin molecules were located on the surface of the BG scaffolds, 
which had explained the faster release of gentamicin. Thus from this study it was 
concluded that MBG scaffolds were a better system for local drug delivery (Zhu et al., 
2009).  
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1.4.6 Composites used for drug delivery 
Although numerous techniques have been developed to fabricate inorganic scaffolds 
incorporating the drug there are some disadvantages that render them unsuitable for drug 
delivery. For example the drug release rate in the template technique cannot be controlled 
as the ceramic scaffolds are loaded with the drug by simply immersing in the drug 
containing solution (Habraken et al., 2007). In the thermal technique which involves the 
sintering of the scaffold at temperatures around >800°C, the drugs incorporated within 
these scaffolds are often degraded at high temperatures (Vallet-Regi et al., 2008). 
Scaffolds with high porosity and large interconnectivity do not have the capacity to retain 
the drug at the required site for a longer period of time (Murino et al., 2009). Thus 
several studies are now focused on the combination of biodegradable polymers and 
bioactive ceramics such as fibres or particles as composite scaffolds for drug delivery 
studies. Composite scaffolds offer a convenient alternative as they combine the 
advantages of both the biodegradable polymers and bioactive ceramics. For example 
biodegradable polymers can be used to control the drug release rate due to their 
degradation rate (Hutmacher 2000). On the other hand the presence of the bioactive 
ceramics in the composites can improve the mechanical strength and the structural 
integrity of the composite scaffolds.  
1.4.6.1 Polyhydroxyalkanoates and bioactive ceramics in drug delivery 
Although synthetic biodegradable polymers and bioactive ceramic scaffolds have been 
used as drug delivery vehicles, some synthetic polymers such as poly(methyl 
methacrylate) and poly(propylene glycol-fumarate) could not be used in vivo as they 
provoked an adverse tissue response due to their acidic degradation products (Murino et 
al., 2009). Therefore, the need to fabricate biocompatible composite scaffolds has been in 
demand (Murino et al., 2009). Polyhydroxyalkanoates (PHAs) exhibit biocompatible 
properties as well as support cell growth. They can be easily fabricated into any complex 
shape and structure. PHAs have been combined with bioactive ceramics, thus in addition 
to improving the mechanical properties of the composite scaffolds, this combination of 
polymers and ceramics also lead to formation of multi-functional scaffolds with a drug 
delivery capability (Misra et al ., 2008). For example, Wang et al., fabricated P(3HB-co-
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3HV) and HA nanoparticles encapsulating gentamicin for a controlled release study. 
Although, an initial burst release of gentamicin from these composite nanoparticles was 
observed, the total drug release period lasted for 10 weeks. With an equal weight ratio of 
HA and P(3HB-co-3HV) (1:1),  a higher encapsulation efficiency compared to HA alone 
was observed due to the formation of a strong bond between the drug and HA. Thus, this 
composite system proved to be promising for a long-term release system (Wang et al., 
2007). Other drugs such as alendronate (AL) used to prevent osteoporosis have been 
incorporated into HA and P(3HB-co-3HV) microspheres (Huang et al., 2009). 
Composites of Wollstanite and P(3HB-co-3HV) microspheres encapsulating the drug 
gentamicin have been used in a powder form as bone fillings and as an effective bioactive 
drug delivery system The drug was incorporated into the composites by a solid-in-oil-in-
water technique. These microspheres were later lyophilized and stored under vacuum. By 
this method a high encapsulation efficiency of 65.2% was observed for the composite 
scaffolds when compared to the P(3HB-co-3HV) microspheres, which was 51.8% (Li et 
al., 2005). 
1.4.6.2 Factors affecting the drug release rate from composite scaffolds 
1.4.6.2.1 Processing conditions  
One of the simplest approaches of incorporating a drug in the composite scaffolds is by 
coating the drug containing polymer solution onto the three-dimensional structure of the 
bioceramic scaffolds. This is achieved by immersing the scaffold in the drug containing 
solution. In this method the sustained release of the drug is dependent on the thickness of 
the polymer coating, initial drug loading and the percentage of porosity. For example in a 
study conducted by Kim et al., tetracycline hydrochloride was incorporated within porous 
HA scaffolds by dip coating the scaffolds in poly( caprolactone solution. The drug 
release from the composite scaffolds increased sharply when compared to the HA 
scaffolds alone during the first 2h, after which a sustained release of the drug was 
observed. In this study the initial burst release was attributed to the unbound drug 
particles present on the surface of the scaffolds. However, with the increase in the 
immersion time, the drug release was largely dependent on the hydrolytic degradation of 
the PCL layer as well as release of those drugs embedded within the porous matrix of the 
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scaffolds. Therefore, it was observed that the drug release in this system was largely 
dependent on the thickness of the polymeric coating and internal porosity (Kim et al., 
2004).  
1.4.7 Application routes of controlled release systems 
Several types of controlled release systems carrying drugs or other bioactive agents have 
been formulated with the aim of a desired controlled release at the site of action. Targeted 
drug delivery reduces the amount of dosage thus reducing the toxic side effects on 
healthy cells.  
1.4.7.1 Oral drug delivery 
 Delivery of larger macromolecules orally has always been a challenge. Some larger 
protein and peptide based drugs have stringent demand on the way they are delivered in 
the body (Yang et al., 2001). It is important for these molecules to retain their structure 
until they reach the delivery site. However, the enzyme activity in the stomach 
significantly affects the bioactivity, stability, pharmacodynamics and the 
pharmacokinetics of these molecules. In addition, the mucosal lining of the stomach 
prevents the successful penetration of the drugs, thus proving to be an obstacle                  
(Elridge et al., 1990). P(3HB) compressed tablets containing  anti-hypersensitive drugs 
were used for slow drug delivery.  The slow and sustained releases of drugs from these 
tablets were dependant on the molecular weight of the polymer. The drug release rate 
increased when molecular weight was increased from 3000kDa to 6000kDa (Korsatko et 
al., 1984). P(3HB) compression moulded compact discs were used to deliver tetracycline 
for the treatment of periodontal disease. In the presence of the tablets a significant 
improvement in the reduction of the gingival infection was seen over a period of 10 days.  
Adequate therapeutic levels of tetracycline were also maintained in the saliva (Collins et 
al., 1989; Deasy et al., 1989). P(3HB) microspheres encapsulating 50% sulphamethizole 
was orally administered in greyhound dogs. A good correlation in the in vitro release 
profile and in vivo absorption was observed (Pouton et al., 1991). Diltrazem, a 
vasodilator was compressed in P(3HB) tablets  and the construct was used to study the in 
vitro release rate (Kharenko et al., 1999). In this study, a higher/faster release rate was 
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seen with higher drug loadings. At 45% drug loading a complete release of the drug was 
seen (Kharenko et al., 1999).  
1.4.7.2 Subcutaneous Implants 
Transdermal delivery provides the opportunity to deliver small lipophillic drugs, which 
are usually destroyed by the liver when taken orally. The skin however is an impenetrable 
barrier consisting of corneocytes and a hydrophobic lipid layer which provides a highly 
tortuous pathway for the diffusion of most drugs, therefore many novel approaches have 
been applied to achieve a practical transdermal delivery (Metcalf et al., 2006).  Due to the 
skin‟s innate impermeability both passive and active methods have been employed.                  
In the passive method, a range of formulations are applied to enhance drug delivery 
without applying any physical force whereas in the active method physical forces such as 
heat, electrical current, laser light or ultrasound is employed to deliver the drug (Merino 
et al., 1997). Mcleod et al., in 1988 compressed gonadotropin releasing hormone (GnRH) 
in P(3HB) tablets and placed subcutaneously in sheep. This hormone is used to stimulate 
the luteinizing hormone (LH), which is used to promote the preovulatory follicle growth 
and induce ovulation in sheep. P(3HB) containing this hormone was able to release about 
40-50 pg of GnRH consistently for a period of 2-4h, thereby maintaining a constant 
elevated plasma level of LH. This study proved to be successful and a high incidence of 
ovulation was seen when two implants per animal was used (Mcleod et al., 1988). Mcl-
PHA with a polyamidoamine dendrimer was considered for transdermal drug delivery 
(Wang et al., 2003). In this study the model drug Tamsulosin was efficiently delivered by 
permeating through a snake skin model. The clinically required amount of drug was 
delivered due to the presence of the dendrimer (Wang et al., 2003).  
1.4.7.3 Intravenous administration 
P(3HB) microspheres (1-12 µm in size) encapsulating the anti-cancer drug „Imoustine‟ 
was intravenously injected into Lewis lung carcinoma mice (Bissery et al., 1985). The 
drug release from the P(3HB) microspheres lasted for a period of 24h when compared to 
the release rate from poly(lactic acid) (PLA) which lasted only for a period of 90 hours 
(Bissery et al., 1985). Saito et al., intravenously injected 
14
C labelled P(3HB) 
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microspheres in both mice and rat. The microspheres of an average size of 1-12µm when 
administered in mice were found to be 47% in the lungs, 14% in the liver and 2.1% in the 
spleen. However, when microspheres of 0.3-0.5 µm were injected in the tail vein of rats, 
86% of the radioactivity from the microspheres was found in the liver, 2.5% in the spleen 
and 2.4% in the lungs. Here, the difference in the radioactive distribution was due to the 
variation or irregularity in the particle size (Saito et al., 1991). 
 1.5 Biomedical applications of PHAs 
 
1.5.1 PHAs used for wound healing applications  
Skin comprises a major part of the body, any damage due to injury, burns and disease can 
have a major physiological or functional consequence. Therefore, several tissue 
engineered skin substitutes are being designed to treat acute and chronic skin wounds 
(Metcalfe et al., 2007; Macneil et al., 2008).  In tissue engineering, a biomaterial is 
designed that can be used to replace the damaged organ or tissue. However for skin tissue 
regeneration or wound healing, the biomaterial should possess the strength to promote the 
growth of skin cells such as keratinocytes, melanocytes and fibroblasts.  They should be 
non-toxic, non-antigenic and facilitate angiogenesis while being incorporated with 
minimal scarring and pain. In addition to this, biomaterials are also required to act as an 
artificial extracellular matrix (ECM) for the cells to attach. Therefore, natural polymers 
such as polypeptides, hyaluronan, glycosaminoglycans and synthetic materials such as 
polylactide (PLA), polylactide-co-glycolide (PLGA) were used as skin substitutes. 
Although these materials have been successfully used as skin substitutes, some 
disadvantages that prohibited their use were their inability to support appropriate cellular 
activity such as the molecular signalling cascades which prevented the clinicians from 
manipulating it in a surgical setting. Therefore other replacements such as biodegradable 
polyhydroxyalkanoates are being considered for skin tissue engineering/regeneration 
(Metcalfe et al., 2006). Techniques such as electrospinning and three-dimensional 
printing are being considered to provide an accurate pore size and porosity so that the 
internal architecture of the scaffold can support cell attachment (Metcalfe et al., 2006).  
Biocompatibility of the scaffolds is one of the pre-requisites for skin replacement. For in 
vitro studies, keratinocytes are used. These cells are known to have the same behaviour 
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both in vitro and in vivo. The disaggregated autologous keratinocytes when added on a 
scaffold are known to create a stratified epithelial layer. When large numbers of 
keratinocytes are grown over a period of two to three weeks, they organise themselves 
within the substitute and recreate the anatomical composition of a skin (Metcalfe et al., 
2006). Copolymers of poly(3-hydroxybutyrate-co-5mol%-hydroxyhexanoate), poly(3HB-
co-5mol%-3HHx) and poly(3-hydroxybutyrate-co-7mol%-4-hydroxybutyrate), 
poly(3HB-co-7mol%-4HB) and poly(3HB-co-97mol%-4HB) were electrospun into 
scaffolds and then subcutaneously implanted in rats to study their bioabsorption 
behaviour and tissue response. The scaffolds were observed to be well tolerated with 
minimal inflammatory response as seen from the histological evaluations (Ying et al., 
2008).  P(3HB) and P(3HB-co-3HV) sutures have also been used for healing myofascial 
wounds (Valappil et al., 2006). These sutures did not cause any necrosis, inflammation or 
carcinogenesis when implanted in vivo in female wistar rats for a period of 1 year.                 
No adverse reactions were seen in comparison to the controls and the reactions exhibited 
were characteristic of the wound process and of a reaction to a foreign body invasion. 
The presence of the HV content in the copolymer films also did not induce any changes 
in the intensity or duration of the inflammatory reactions or fibrous capsule formation 
around the sutures (Valappil et al., 2006).  P(3HB) fibres used as wound dressings were 
pre-treated with a strong acid or base to improve the surface properties for cell 
attachment. Human epithelial cells when added on the pre-treated fibres appeared well 
spread with good adhesion (Valappil et al., 2006).   
1.5.2  PHAs used for Hard tissue engineering applications  
Natural and synthetic polymers for examplecollagen, poly(ethyleneglycol), 
polyhydroxyalkanoates and poly(lactide-co-glycolide) have been considered for bone 
tissue engineering applications due to their favourable properties such as biocompatibility 
(cell attachment and differentiation) and tailorable mechanical and degradable properties 
(Yang et al., 2001). Although the above mentioned polymers have been used for load 
bearing applications such as fracture fixation devices, one of the main disadvantages that 
limit their applicability in hard tissue engineering is their fast degradability. Due to this, 
polyhydroxyalkanoates such as poly(3-hydroxybutyrate) P(3HB) and poly(3-
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hydroxybutyrate-co-3-hydroxyvalerate) P(3HB-co-3HV) with long term degradation 
profiles have been considered. P(3HB) also has the capacity to induce osteogenesis and 
healing due to its piezoelectric properties. Therefore P(3HB) has the ability to strengthen 
and repair bone which is an added feature comparable to that of natural bone (Ferrier et 
al., 2002). P(3HB) implants when used in vivo for connecting osteotomies whereby a 
bone is cut to shorten, in the tibia of rats, completely resorbed after 24 weeks. Similarly, 
when used as osteosynthetic patches anchored with two P(3HB) bolts to repair the 
zygomatic arches of rabbits, they were able to successfully cover the defects of osseous 
skull and the fracture of the visceral cranium (Misra et al., 2006). Other 
polyhydroxyalkanoates such as poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) P(3HB-
3HHx) have also been used as a scaffold material in bone tissue engineering.  In vitro cell 
attachment studies using osteoblast cells have shown high alkaline phosphatase (ALP) 
activity, strong calcium deposition and fibrillar collagen synthesis when compared to 
films of P(3HB) and PLA (Wang et al., 2005). The alkaline phosphatase activity of the  
of the cells grown on P(3HB-co-3HHx) scaffolds was up to about 65 U/g scaffolds, 50% 
higher than that of P(3HB) and PLA, respectively (Wang et al., 2005). In another study 
conducted by Deng et al., chondrocytes isolated from rabbit articular cartilage were 
seeded onto P(3HB-co-3HHx), P(3HB) and the blend of P(3HB-co-3HHx)/P(3HB) 
scaffolds for a period of 28 days. From the results it was observed that a higher 
chondrocyte proliferation was observed on the P(3HB-HHx)/P(3HB) scaffolds rather 
than the P(3HB) scaffolds alone. Thus from this study it was proven that P(3HB-co-
3HHx) films exhibited higher affinity for chondrocyte attachment, proliferation and 
differentiation when compared to the other films (Deng et al., 2002). 
1.5.3 PHAs used for other biomedical applications  
P(3HB) has also been used as pericardial patches, anastomoses tubes, separating films, 
repair of peripheral nerves and as a substitute for covering damaged tissue of 
gastrointestinal tract (Ljungberg et al., 1999; Novikov et al., 2002; Freier et al., 2002). 
Mcl-PHAs on the other hand are more applicable for soft tissue engineering such as heart 
valve tissue engineering and skin tissue engineering due to their soft and elastomeric 
properties. Mcl-PHAs such as P(3HO-co-3HHx) have been used in soft tissue 
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engineering as substitutes to repair heart valves, blood vessels and vascular grafts (Sodian 
et al., 2000a; Stock et al., 2000). Whereas P(3HB-co-3HHx) has been used in hard tissue 
engineering for the repair of cartilage and bone (Deng et al., 2002; Wang et al., 2004).  
Although, mcl-PHAs exhibit a higher structural diversity when compared to the scl-
PHAs, their main limitation lies in the inability to produce these polymers in large 
quantities. A detailed summary of the use of PHAs in tissue regeneration is shown in 
Table 5. 
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 Table 5:- Summary of common PHAs used for various biomedical applications 
Applications of 
PHAs 
Types of PHAs used Site of implantation Remarks References 
 
 
Nerve 
regeneration  
 
 
 
 
 
 
P(3HB) 
 
 
 
P(3HB) conduits to bridge the 
gap in the rat sciatic nerve  
Successful migration of Schwann cells and 
axonal regeneration was identified  
Mosahebi et 
al., 2002  
P(3HB) nerve conduits to 
support rabbit common nerve 
injury  
 
P(3HB) conduits take a long time to undergo 
degradation therefore they provide the 
mechanical support required during 
regeneration. Lesser risk of accumulating large 
amount of acidic degradation products 
Wu et al., 
2009 
 
P(4HB) 
Tubular constructs of P(4HB) 
was seeded with ovine vascular 
smooth muscle cells  
Provided mechanical support. The constructs 
supported cell adhesion   
Martin et al., 
2003  
Cardiovascular 
Patches/Heart 
valves  
 
P(3HB) 
Non-woven patches used as 
pericardial substitutions, 
enlargement of pulmonary artery 
and the repair of arterial septal 
defects 
In the presence of the pericardial patches, the 
coronary artery was well preserved even after 30 
days of implantation. The mechanical strength 
was retained. The constructs supported cell 
adhesion and prevented the dilation of the 
regenerating tissue. 
Freier et al., 
2002 
Skin regeneration  Terpolyesters of 3-
hydroxybutyrate 3HB, 4-
hydroxybutyrate (4HB) 
and  3-hydroxy-hexanoate 
(3HHx); P(3HB-co-4HB-
co-3HHx), 
 Films used as skin implants  
were seeded with L929 mouse 
fibroblasts, human keratinocyte 
(HaCaT) cells  
The cell morphology and viability analyzed 
using SEM and methylthiazol tetrazolium 
(MTT) assay proved that all the three cell types 
exhibited higher cellular activity on the P(3HB-
co-4HB-co-3HHx) films.  SEM images revealed 
well spread cell shape with large number of 
pseudopods indicating strong cell-to-cell and 
cell to material interactions 
Liu et al., 
2008 
 P(3HB-co-3HV-co-
3HHx), novel 
terpolyesters of poly(3-
hydroxybutyrate-co-3-
hydroxyvalerate-co-3-
hydroxyhexanoate),  
human keratinocyte (HaCaT) 
cells 
Films made of  P(3HB-co-3HV-co-3HHx), were 
soft and exhibited the flexibility that was 
required for skin tissue engineering,  P(3HB-co-
3HV-co-3HHx), films seeded with HaCaT 
exhibited the highest cell density and viability 
Ji et al., 2008 
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1.6 Biomedical applications of Bioceramics 
 
1.6.1 Bioceramics used for other hard tissue engineering applications  
Alumina, a bioinert ceramic has a higher Young‟s modulus of 380GPa and lower wear 
rates therefore it is used for dental implants. HA has been used as dental implants and 
coatings for chemical bonding. 45S5Bioglass
®
 has also been used as dental implants, 
coatings for chemical bonding and as maxillofacial reconstruction devices. Phosphate 
glasses have been used as vertebral prosthesis and orthopaedic fixation devices (Hench et 
al., 2004 and Huang et al., 2008). The advantages, disadvantages of bioceramics 
highlighted for various applications in tissue engineering have been listed in Table 6.  
 
Table 6:- The advantages and disadvantages of bioceramics highlighted for various applications in 
tissue engineering (Misra et al., 2006; Chen et al., 2006). 
Types of Material  Shape of 
materials  
Advantages   Disadvantages  
Inorganic calcium 
phosphates example HA,               
ß-tricalcium phosphate,                
α- tricalcium phosphate 
Films   
3D scaffolds 
Biocompatibility, and 
osteoconductivity  
Slow degradation 
rate and brittle  
 
Bioactive glasses and glass 
ceramics  
Films  
3D scaffolds  
Foams  
Biocompatibility, 
osteoconductivity 
angiogenic and tailorable 
resorption  
Inflammatory 
response 
lack of 
compression 
strength and poor 
stiffness  
 
1.6.2 Bioceramics used for Bone tissue engineering  
Bone tissue regeneration or repair has been the most common yet complicated problem in 
the field orthopaedic surgery. Often the main problems associated with treating bone 
defects were biocompatibility and its immunological response (Goldberg et al., 1987).             
In addition, the size of the bone defects caused due to trauma or disease pose 
considerable difficulty as they cannot be repaired by the natural growth of the host tissue. 
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There is the need to fill these defects with a porous material, usually known as a scaffold, 
which in addition to bridging the gap, can also promote the regeneration of a new bone 
tissue (Hench et al., 1998). Those biomaterials which exhibit bioactive properties i.e, the 
ability to form a biologically active hydroxyapatite layer when immersed in physiological 
fluids is used for bone tissue engineering applications. The bioactive property of these 
biomaterials, allow the formation of tenacious bonds to bone or ossteointegration thereby 
transferring the load to and from the living bone (Chen et al., 2006). In addition, other 
properties such as porosity and mechanical strength are also required for bone tissue 
engineering applications. For example the average porosity required for bone tissue 
engineering is 90% with a pore size of >100 m. This high porosity is known to facilitate 
the proliferation of cells for new tissue regeneration while also enabling the mass 
transport of oxygen and nutrition (Rezwan et al., 2006). These biomaterials are classified 
as either conductive i.e. the ability to provide physical support to facilitate tissue 
regeneration or inductive i.e. the ability to induce specific biological responses (Rezwan 
et al., 2006). The most commonly used biomaterials are bioceramics such as silicate 
glasses, glass-ceramics, and hydroxyapatites as well amorphous or crystalline calcium 
phosphates (Rezwan et al., 2006). For example alumina bioinert ceramics have lower 
wear rates and higher Young‟s modulus, therefore can be used for load bearing 
orthopaedic applications. Bioactive glasses such as 45S5Bioglass
®
 have exhibited higher 
bioactivity through the formation of a biologically active hydroxycarbonate apatite layer. 
It has been used as orthopaedic fixation devices. Calcium phosphates such as tricalcium 
phosphates have been used as temporary bone space fillers due to their higher dissolution 
rate, as a result they are replaced by bone during implantation. Glass ceramics such as 
phosphate glasses and wollastonite have also been extensively used as bone substitutes 
and vertebral prosthesis (Hench et al., 2004; Huang et al., 2008; Rezwan et al., 2006). 
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1.7 Biomedical applications of composite scaffolds 
 
1.7.1 Composite scaffolds used for hard tissue engineering applications  
Composite films of P(3HB-co-3HV)/TCP and P(3HB-co-3HV)/HA manufactured using 
the compression moulding technique have been used for maxillofacial reconstruction. 
The addition of TCP enhanced the mechanical properties of the films, while the presence 
of HA increased the storage modulus and bioactivity of the composite films (Misra et al., 
2006; Chen et al., 2006). 
1.7.2 Composite scaffolds used for Bone tissue engineering  
Bioactive ceramics are often known to lack the mechanical properties (fracture 
toughness) needed for bone tissue engineering due to their relatively high stiffness. In 
contrast, lack of mechanical strength is the disadvantage of using polyhydroxyalkanoates 
for load bearing applications. In addition, although some polymers have been moulded 
into complex shapes and structures, they generally lack the bioactive function which is 
imperative for bone tissue engineering applications. Due to their inability to form a strong 
bond to the natural bone they become too weak to meet the physical demands in surgery 
(Bonfield et al., 1981). Therefore, in order to achieve the optimal mechanical and 
biological property, both degradable polymers and inorganic bioactive particles have 
been combined to form composite materials (Misra et al., 2006). These composite 
materials are known to possess several advantages such as improved mechanical 
properties including higher stiffness, tailorable degradation behaviour and increased 
bioactivity due to the formation of a tenacious bond with bone. Finally, the surface 
characteristics of the composite materials such as surface roughness and wettability were 
observed to be improved due to the presence of the bioactive inorganic phases in the 
composite materials leading to better adsorption of proteins and cell growth (Li et al., 
2005; Wei et al., 2004). The bioactive inorganic ceramics as well as 
polyhydroxyalkanoates are often incorporated in the form of fibres. Mechanical and 
bioactive properties of the composite materials are often affected by the size and 
distribution of the particles within the composite materials. For example the higher 
specific surface area of the nanoparticles are known to contribute towards an increased 
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bioactivity when compared to the microparticles (Li et al., 2005; Wei et al., 2004). The 
host tissue response to nanostructure surfaces is also different when compared to the 
other surfaces. Some examples of the common composites used in bone tissue 
engineering are discussed below.  
Polyhydroxyalkanoates such as P(3HB-co-3HV) have been used in combination with HA 
and TCP in the form of films. The presence of HA in the composite films increased the 
storage modulus and bioactivity of the films (Ni et al., 2002). P(3HB) composite films 
incorporating 45S5Bioglass
® 
particles in different concentrations such as 5 and 20wt% 
were fabricated by Misra et al., to study the effects of 45S5Bioglass
®
 particles on the 
thermal and mechanical properties of the composite films. The authors observed that with 
the increase in the 45S5Bioglass
®
 concentrations, the crystallinity of the polymer matrix 
was reduced and an increase in the glass transition temperature was observed. The 
storage modulus of the composite films had increased to 2.4 x 10
9
 Pa in the presence of 
20wt% of the 45S5Bioglass
®
 particles as compared to 1.8 x 10
9
 Pa in the case of P(3HB) 
(Misra et al., 2007). P(3HB)/bioactive glass composite films with three different 
concentrations of m-BG and n-BG (10, 20 and 30 wt%, respectively) prepared by a 
solvent casting technique were examined for changes in the mechanical and structural 
properties. From the results it was observed that the addition of n-BG particles had a 
significant stiffening effect on the composites, modulus when compared with m-BG. The 
nanometric size of the n-BG particles contributed to a 50% increase in the stiffness of the 
composites (up to a 50% increase). Similarly an increase in the Young's modulus in the 
PHA/n-BG composites was also observed which related to the higher interfacial surface 
area was provided by the nanoparticles, which enhanced the load transfer between the 
matrix and the stiff inclusions when compared to the m-BG particles. Thus the results 
from this confirmed that the addition of nanosized bioactive glass particles had a more 
significant effect on the mechanical and structural properties of a composite system in 
comparison with microparticles (Misra et al., 2008). 
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1.8 Factors affecting material performance  
1.8.1  In vitro degradation  
In vitro degradation studies are performed in simple aqueous solutions so it would be 
possible to predict the in vivo degradation behaviour of an implant. It is normally carried 
out in phosphate buffered saline (PBS) solution, cell growth media such as Dulbecco‟s 
Modified Eagle Medium (DMEM) or in human serum containing inflammatory cells at 
37 C, under static or dynamic condition. After the incubation period, the samples were 
analysed for changes in mechanical properties, molecular mass and surface morphology 
(Freier et al., 2002a). PHAs have also been known to undergo both in vitro as well as in 
vivo degradation, in the context of biocompatibility, as discussed below (Freier et al., 
2002a, Jendrossek et al., 2002). A summary of some of the important results obtained 
from in vitro degradation of PHAs is given in Table 7.  In vitro degradation of P(3HB) in 
buffer solutions resulted in a decrease in the molecular weight after 80 days of incubation 
(Doi et al., 1989). The degradation of P(3HB) is observed to take place through random 
scission in both the amorphous and crystalline regions of the polymer matrix (Freier et 
al., 2002). This study concludes that P(3HB) undergoes slow in vitro degradation where 
the mass loss half life in the buffer solution occurs in the range of 56 to 152 weeks (Freier 
et al., 2002). The in vitro degradation rate of P(3HB-co-3HV) is dependent on the 
varying HV content which  has a significant effect on the molecular weight, crystallinity 
and porosity of the P(3HB-co-3HV) polymers. In order to accelerate the rate of 
degradation, P(3HB-co-3HV) films have been blended with alginate, dextrin, amylose 
and talcum powder (Table 7) (Yasin et al., 1989). The highly crystalline regions of the 
polymer P(3HO-co-3HHx) films are responsible for the slow degradation process when 
immersed in the buffer solution (pH 7.4 and 37 C). In order to accelerate the degradation, 
the P(3HO-co-3HHx) films have been blended with gelatin (Wang et al., 2005). The rate 
of degradation of the films had increased because the crystallinity of the blended films 
had reduced due to the blending of gelatin. Furthermore, the blending of gelatin had also 
created a porous surface in the films, which had increased the surface area of the films for 
hydrolytic attack (Wang et al., 2005). Hydrophilic polymers such as poly(lactic acid) 
PLA and poly-ethylene glycol (PEG) have also been grafted onto the reactive backbone 
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of polymers such as poly(3-hydroxyoctanoate-co-3-hydroxyundecenoate) P(3HO-co-
3HU), to increase the hydrophilicity of the polymers by incorporating hydrophilic 
molecules in the polymer chains. Such surface modifications improved the water uptake 
and swelling of the polymer matrix, leading to an improved hydrolysis or degradation of 
the polymer (Renard et al., 2003).  
Wollastonite has been used as a filler in P(3HB-co-3HV) film as an aid in the degradation 
of the composites.  In a study conducted by Li et al., the in vitro degradation of three-
dimensional composite scaffolds made of P(3HB-co-3HV) and wollastonite were 
investigated for a period of 15 weeks in PBS. The results of this study revealed that with 
the addition of wollastonite in the composite films, an increase in the water absorption 
capacity and weight loss of the films were observed. The addition of wollastonite in the 
range of 0-40 wt% had decreased the water contact angle from 66  to 16 .  The weight 
loss of the composite scaffolds with 10 wt% and 20 wt% wollastonite had increased from 
27% to 35% during the first 3 weeks of incubation when compared to P(3HB-co-3HV) 
scaffolds where a weight loss of only 12% was observed at the end of 15 weeks. Thus 
from these results it was observed that the degradation rate of the composite films could 
be adjusted with the addition of wollastonite (Li et al., 2005). The addition of 
45S5Bioglass
®
 glass is also known to improve the water uptake of the P(3HB) composite 
films when compared to the P(3HB) films alone (Misra et al., 2008). In a study 
conducted by Misra et al., an increase in the water uptake of P(3HB)/45S5Bioglass
® 
films 
was observed when the concentration of the 45S5Bioglass
® 
was increased from 10 wt% 
to 30 wt%. For example, at end of the one month period, an increase in the water uptake 
capacity to 25% was observed when 30 wt% of 45S5Bioglass
®
 particles were 
incorporated whereas 10wt % of 45S5Bioglass
®
 exhibited only 10% of water uptake 
capacity (Misra et al.,2008). 
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Table 7: Summary of the factors influencing in vitro degradation of PHAs 
Types of 
PHAs  
Influences on the rate of 
degradation  
                               Remarks           References  
P(3HB) Glycerin was incorporated 
into the films  
The porous surface created by glycerine increased the surface area 
of the polymer matrix exposing it to degradation after the glycerine 
was leached out from the film 
Abe et al., 1994,  
Kurcok et al., 1995   
lipase, amylase, trypsin 
and protease  
The degradation rate of P(3HB) increased three-fold in comparison 
to the films that were subject to simple hydrolysis  
Freier et al., 2002 
P(HB-co-
HV) 
Gama-irradiation and 
steam sterilization  
A significant loss in the molecular weight and mechanical 
properties were observed when the films were exposed to different 
sterilization methods 
Shishatskaya et al., 2004 
alginate, dextrin, amylose 
and talcum powder  
The rate of degradation of the films were accelerated after leaching 
of the additives out from the films  
Yasin et al., 1999  
PLA, PEG  A change in the rate of weight loss of the films was observed after 
rapid dissolution of PEG and hydrolysis of PLA 
Renard et al., 2003  
P(3HO) Monoacrylate–
poly(ethylene glycol)-
grafted poly(3-
hydroxyoctonate) 
(PEGMA-g-PHO)  
The hydrolytic degradation of the blends was dependent on the 
number of PEGMA groups on the P(3HO) chain, with an increase 
in the concentration of the  PEGMA group, the degradation rate 
increased 
Kim et al., 2005  
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1.8.2  In vivo degradation 
The host reaction to an implant/biomaterial is often dependent on the degradation 
products released by the biomaterial. Several biologically active species such as enzymes 
and lipids are known to influence the degradation kinetics of the biomaterial after 
implantation. The physicochemical characteristics of the biomaterial may also trigger the 
inflammatory system thus creating an aggressive environment for the biomaterial. Often, 
the in vivo degradation of an implant is governed by the enzymatic action of the 
phagocytic cells (Ali et al., 1994). In response to the degradation products the host body 
releases either pro- or anti-inflammatory mediators, which can cause initial acute 
inflammation, which is followed by a chronic inflammation and possible ultimate 
rejection of the biomaterial.  In vivo degradation rates of various PHAs and the animal 
models used are summarised in Table 8. Malm et al., have shown  that P(3HB) degrades 
at a much slower rate in vivo when compared to other polylactides such as  poly(D,L 
lactic acid) PDLLA and poly(L-lactic acid) PLLA. It was also observed that these films 
were completely absorbed in vivo in 24 to 30 months, where a reduction in the 
crystallinity was observed at 4 weeks with a steady reduction in the Young‟s modulus 
and microhardness (Malm et al., 1992). Similarly Williams et al., observed that mcl-
PHAs such as poly(3-hydroxyoctonoate-co-3-hydroxyhexanoate) P(3HO-co-3HHx), 
when implanted subcutaneously as films in mice, led to a reduction in the molecular 
weight from 137,000Da to 65,000Da  over a period of 40 weeks (Williams et al., 1999).  
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Table 8: - Summary of the in vivo degradation characteristics of PHAs 
Types of PHA   site of implantation for 
the study of in vivo 
degradation   
Degradation results References 
P(3HB)  Tibial osteotomies of 
rabbits 
Complete degradation after 6  months  of 
implantation 
Vainionpää   et al., 1986  
Intermedullary region of 
sheep  
Slight reduction in the hardness after 24  
months of implantation 
Herold et al., 2002  
 Mandibular region of rats  Complete degradation after 6  months Kostopoulous et al., 1994  
Condyles of rabbits  Degradation until 6 months of implantation Luklinska et al., 1997  
P(3HB-co-HV) Subfascial region of sheep  Complete resorption after 3  months Sadowski et al., 1998 
Rabbits (subcutaneous)  4 mol% reduction- 5  months Jones et al., 2000 
P(3HB-co-10% 4HB)  Rats (Intraperitoneal)  80 mol% reduction-4  months Sudesh et al., 2000 
Rats  (subcutaneous) 55 mol% reduction-1 year Ishikawa et al., 1996 
P(3H0-co-3HHx) Mice (subcutaneous) 30 mol% reduction -6  months Marois et al., 1999 
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1.8.3  Biocompatibility  
1.8.3.1  Biocompatibility of PHAs  
Biocompatibility of an implant or biomaterial is an important factor in tissue engineering. 
The purity of the biomaterial, the shape, size of the implant and the chemical nature can 
affect the biocompatibility. Biocompatibilities of PHAs are also affected by factors like 
the porosity, surface hydrophilicity and the surface energy of the material (Zhao et al., 
2003). The natural occurrence of the PHA degradation products in the human body is the 
primary reason for the lack of toxicity (Williams et al., 1999). 3-hydroxybutyric acid is a 
natural/common metabolite that is found in all higher living beings at concentrations of 
3-10 mg per 100 mL (Hocking et al., 2004). It has also been used as an irrigation solution 
after an ocular surgery. Several toxicity tests done on P(3HB) have revealed that it can be 
safely administered subcutaneously, intravenously and intraperitoneally. 
Histocompatibility tests and in vivo studies have revealed minimal inflammatory 
reactions. The degradation product of P(4HB), 4-hydroxybutyric acid, is a natural 
constituent found in human brain, lung, liver, kidney and muscle. After a series of 
cytoxicity, sensitization, intracutaneous activity and haemocompatibility tests, the FDA 
proved that P(4HB) is non toxic and biocompatible (Nelson et al., 1981). Owing to this, 
PHAs have been used for a number of biomedical applications such as wound 
management, orthopaedics, drug delivery and vascular system applications (Williams et 
al., 1999; Chen et al., 2005; Pouton et al., 1996 and Sodian et al., 2000b).   
Several cell lines such as osteoblasts, fibroblasts and chondrocytes have been used to 
study the biocompatibility of P(3HB). These studies have proven excellent 
biocompatibility and lack of toxicity of P(3HB) towards these cell lines                               
(Kose et al., 2003).  For example Shishatskaya et al., studied the effect of P(3HB) 
microspheres on the cell morphology and viability of mouse fibroblast cells. From this 
study it was concluded that the cell proliferation rate, cell viability and the morphological 
changes remained unaffected, thus proving that the microspheres were highly 
biocompatible (Shishatskaya et al., 2004). Similarly, the in vitro biocompatibility of                  
P(3HB-co-3HV) has also been tested using several cell lines. For example the effect on 
the growth of fibroblasts and its cytotoxicity was studied by Chaput et al., It was 
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observed that with the increase in the HV content a slight cytotoxic effect was recorded. 
Other researchers like Rivard et al., observed no characteristic change in the morphology 
or cell proliferation of cell lines like osteoblasts and fibroblasts when grown on P(3HB-
HV) films (Rivard et al., 1995). 
Several attempts have also been made to improve the biocompatibility of the PHA 
implants.  Kai et al., showed that the introduction of P(3HHx) in the P(3HB-co-3HHx) 
blend had improved the biocompatibility of the blend. Due to the low degree of 
crystallization of the blend, less stress due to the molecular chain arrangement was 
produced. Thus a fairly regular and smooth surface with small pores was formed for the 
blend. This surface morphology had provided a regular surface for the cells to attach and 
grow (Kai et al., 2002). The P(3HB) films however were more irregular and had a lesser 
surface area for the cells to attach (Kai et al., 2002). Researchers like Wei et al., have 
synthesised novel polyesters such as P(3HB-4HB-3HHx) from Aeromonas hydrophila. 
These authors observed that this novel polyester had exhibited a high biocompatibility 
when compared to poly(L-lactic acid) (PLLA) or P(3HB-co-3HHx) films. The 3HHx 
content in the films had remarkably reduced the crystallinity of the film. This change in 
the crystallinity of the films had affected the surface physicochemical properties of the 
film. Similarly, the increase of 4HB content also contributed to the surface roughness and 
hydrophilicity of the film. Therefore, the increased hydrophilicity, reduced crystallinity 
and increased surface roughness had contributed to the better attachment of the human 
mesenchymal cell (MSC) and increased the proliferation rate when compared to the 
tissue culture plate (TCP) (Wei et al., 2008).  A sample of the different in vitro cell 
culture studies carried out using a number of cell lines have been listed in Table 9. 
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Table 9: - In vitro cell culture studies carried out on some PHAs using various cell lines.  
Type of application  Cell lines used for           
in vitro studies  
                     Observations  References  
P(3HB) microspheres  
 
Mouse fibroblast cells 
(L929) 
Cell proliferation rate, cell viability and the morphological 
changes remained unaffected therefore proving that the 
microspheres were highly biocompatible  
Shishatskaya 
et al., 2007 
P(3HB) films (treated 
with lipase)  
 
Mouse fibroblast cells 
(L929) 
Better adherence when compared to untreated films Wang et al., 
2005  
P(3HB) films (treated 
with ammonia and 
fibronectin coating)  
Due to an appropriate balance maintained between the 
hydrophobic and hydrophilic surface properties, an increasing 
protein adsorption and cell adhesion was observed 
Wang et al., 
2003 
Blends of P(3HB-co-
4HB)/P(3HB-co-
3HHx) as films 
Rabbit chondrocytes The blend showed a fairly rough surface (average roughness 
0.8 m). Other factors that contributed to the cell attachment 
was the surface charge,  where the higher concentration of the 
polar component had increased the fibronectin adsorption 
Luo  et al., 
2009 
Films of P(3HB-co-
3HV)  
 
Human retinal 
pigment epithelial 
cells  
Cell proliferation and good cell spreading observed.  Tezcaner et al., 
2003 
P(3HO)Films  Chinese hamster 
ovary cells (CHO) 
Plasma treatment was carried out to surface modify the 
P(3HO) films. The surface modified P(3HO) films exhibited 
increased hydrophilicity and an improved cell attachment  
Kim et al., 
2002 
Films of 
(P(3HB-co-3HV-co-
4HB) 
Mesenchymal stem 
cells (MSC) 
Higher surface roughness, hydrophobicity had rendered it 
suitable for cell differentiation and cell proliferation into 
osteoblasts 
Wei et al., 
2008 
Films of 
P(3HB-co-3HHx) 
Human Bone marrow  Exhibited good biocompatibility and cells differentiated into 
osteoblasts 
Yang et al., 
2004 
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Unverdorben et al., observed mild inflammatory reactions when P(3HB) stents were 
implanted in vivo. P(3HB-co-3HV) films have been surface functionalised to promote 
biocompatibility by inducing cell adhesion and proliferation. Several methods such as 
grafting polymethacrylic acid (PMMA) or radiation on P(3HB-co-3HV) films have 
been attempted to improve cell adhesion on the films (Tesema et al., 2004). In vivo 
biocompatibility of mcl-PHAs such as P(3HO-co-3HHx) in the form of tubes, 
microspheres and pellets have been studied by Williams et al., 2005. These implants like 
the scl-PHAs also showed mild inflammatory response with the formation of a fibrous 
capsule around the samples. The samples showed no evidence of macrophages and the 
tissue response continued to be mild even after 40 weeks of implantation. Histological 
analysis revealed a thin layer of fibroblasts surrounded by collagen on the polymer 
samples (Williams et al., 2005). Blends of P(3HB-co-3HHx) and polyethylene glycol 
(PEG) with different weight ratios such as 1:1 and 1:5 have been implanted 
subcutaneously in rabbits. Although, this polymer appeared to be non cytotoxic, the 
degradation product of the polymer accelerated due to the presence of PEG which 
induced a strong tissue response involving the presence of lymphocytes, eosinophils and 
vascularisation (Qua et al., 2006). In contrast, P(3HB-co-HHx) shows good  
biocompatibility, with a gradual degradation rate of only 10% weight loss after six 
months of implantation. There were no neutrophils observed in the fibrous capsule 
surrounding the polymer sample thus indicating that the tested materials were non-
cytotoxic (Qua et al., 2006). A summary of some of the in vivo cell culture studies carried 
out on some PHAs using various cell lines are represented in Table 10. 
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Table10: - In vivo cell culture studies carried out using different structures of P(3HB) at various sites of implantation.  
Type of application  Site of implantation  Observations  References  
P(3HB) microspheres  
 
Intramuscular 
injection in Wistar rats 
An inflammatory response was observed during the 
first 24 hours of injection. A thin fibrous capsule 
formation at the interface of the microspheres and the 
tissue is formed- after 2 weeks of implantation, 
Shishatskaya 
et al., 2007 
P(3HB) compressed tablets  
 
Subcutaneous 
implantation in rat 
neck folds  
Neutrophil granulocytes changed to lymphocytes after 
implantation, without any formation of a necrotic 
tissue after 20 weeks of implantation 
Korsatko  
et al., 1987 
P(3HB) microspheres 
encapsulating anti-tumor drug 
rubomycin  
Injected in mice with 
ascetic Ehlrich 
carcinoma  
Drug released at a controlled rate had significantly 
inhibited the proliferative activity of cancer cells and 
improved the cell survival of mice 
Shishatskaya 
et al., 2007 
P(3HB)microspheres    
encapsulating the drug 2´, 3´-
diacyl-5-fluoro-2´-deoxyuridine  
intraperitoneal 
injection in mice with 
P388 leukemia 
Higher antitumor effects were observed for a period of 
5 consecutive days. The polymer microspheres also 
showed low toxicity and good biocompatibility  
Kawaguchi et 
al.,1992 
P(3HB) patches  Pericardial patches in 
sheep  
Minimal inflammatory response where only a small 
number of lymphocytes were produced. A dense 
collagen layer was seen on the patch, which was 
comparable to that of the native pericardium   
Malm et al., 
1992a 
P(3HB) films Subcutaneously 
implanted in mice for 
a period of 12 weeks 
During 4-6 weeks of implantation the thickness of the 
fibrous capsule was reduced from 200 µm to 60 µm. 
At 48 weeks, the capsule formation around the implant 
was minimal with no mono and polynuclear 
marcophages seen  
Volova et al., 
2003 
P(3HB-co-3HV)  rods 
incorporated with  drugs such as 
Sublactam and Cefoperazone 
Implanted in rat tibia  A limited necrotic area was observed around the 
implant at 15 days of incubation. Disappearance of 
initial inflammatory reaction around the implant was 
observed after 30 days.  
Yagmurlu et 
al., 1999 
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1.8.3.2 Biocompatibility of Composite scaffolds  
In vitro biocompatibility tests of inorganic/organic composite scaffolds such as glass-
ceramics and biodegradable polymers have also been carried out. In a study conducted by 
Bretcanu et al., the in vitro biocompatibility of 45S5Bioglass
®
 scaffolds coated with a 
P(3HB) were tested using a human osteosarcoma cell line (HOS-TE85). The 
biocompatibility tests done revealed that the HOS cells are seen to adhere and spread on 
the polymer coated scaffolds. A higher number of cells were also observed on the 
polymer coated scaffolds when compared to the uncoated scaffolds after a period of 7 
days in the cell culture media. This study further confirmed that 45S5Bioglass
®
/P(3HB) 
scaffolds have potential as osteoconductive tissue engineering substrates (Bretcanu et al., 
2009). In vivo studies using cylindrical specimens of P(3HB-co-3HV)/HA composites 
were carried out in rabbit tibias. After one month of implantation a well developed 
lamellar bone structure around the implant surface was observed. In this study it was 
observed that HA not only had the ability to bond with the surrounding tissue but it also 
provided the adequate support for cell growth and was tolerant towards the new tissue 
formation (Luklinska et al., 2003). The in vivo biocompatibility and anti-microbial 
activity of bioactive glasses (BG) with a composition of (SiO2)0.80 (P2O5)0.04 (CaO)0.16 
loaded with tetracycline was investigated. The histological analysis of the samples after 
implantation for the first 6h did not reveal any reaction. After 24h polymorphonuclear 
cells were observed around the bioactive glasses with a composition of (SiO2)0.80 
(P2O5)0.04 (CaO)0.16 scaffolds loaded with tetracycline. However, after 72h, an acute 
inflammatory reaction was observed which was characterized as moderate in intensity 
(Domingues et al., 2004). In another study, porous P(3HB-co-3HV) and calcium 
phosphate-loaded collagen (CaP-Gelfix) foams were tested for their  in vivo bone 
formation capacity and their suitability for use in bone tissue engineering. The composite 
scaffolds were seeded with rat bone marrow stromal cells and implanted into defects 
created in rat femurs. Although some initial inflammation was observed in the CaP-
Gelfix group, minimal inflammation was observed at all stages. Histological examination 
revealed higher fibrous connective tissue formation and in the CaP-Gelfix group when 
compared with the P(3HB-co-3HV) samples (Kose et al., 2004). In a study conducted by 
Misra et al., porous P(3HB) foams impregnated with 10 wt% of 45S5Bioglass
®
 particles 
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were fabricated and tested for their in vitro and in vivo bioactivity. The P(3HB)/BG 
foams exhibited a high level of total protein adsorption which was a 1000 g when 
compared to 800 g of P(3HB) scaffolds on their own. The porous microstructure of the 
composite foams was also found to be suitable for MG-63 cell attachment and 
proliferation. The composite foams when implanted subcutaneously in rats did not exhibit 
any foreign body reaction after one week of implantation, thereby proving to be non-toxic 
as well as biocompatible (Misra et al., 2010). In another study conducted by Misra et al., 
the effects of introducing micro (m-BG) and nanoscale (n-BG) bioactive glass particles 
on the biocompatibility of P(3HB)/bioactive glass composite systems were investigated. 
In this study the presence of n-BG particles improved the surface nanotopography which 
had considerably improved the total protein adsorption on the n-BG composites 
compared to the unfilled polymer and the m-BG composites. A cell proliferation study 
using MG-63 cells demonstrated the good biocompatibility of both types of 
P(3HB)/45S5Bioglass
®
 glass composite where an increase in cell proliferation during the 
7 day period, in tandem with the trend for the tissue culture plastic used as a control was 
observed (Misra et al., 2008). 
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1.9 Aims and Objectives of the present project  
The aim of this research project was to use lipopolysacchride (LPS) free P(3HB) isolated 
from Gram-positive bacteria, Bacillus cereus SPV, in combination with the bioactive 
ceramic 45S5Bioglass
®
 for various biomedical applications including drug delivery, bone 
TE and wound healing. A schematic representation of the research strategy used for this 
project is represented in Figure 2 
The specific objectives to fulfil the above aims include  
1.9.1 Large scale production of LPS-free P(3HB) - Production of LPS-free P(3HB) 
using acillus cereus SPV, in a 20L scale fermentation. LPS present on the outer layer or 
membrane of Gram-negative bacteria act as endotoxins thereby inducing a severe 
immunogenic reaction when in contact with blood. These endotoxins are known to 
contaminate the PHA during the recovery/extraction of PHAs.  
1.9.2 Production of P(3HB) microspheres - A solid-in-oil-water (s/o/w) technique will 
be used in an attempt to produce tailored poly(3-hydroxybutyrate) P(3HB) microspheres. 
The effects of different parameters used for microsphere production on the microsphere 
size, porosity and drug distribution will be investigated. Following optimization, the 
microspheres will be characterised using Scanning Electron Microscopy; SEM, thermal 
properties using Differential Scanning Calorimetry; DSC, paricle size distribution using 
particle size analyser. 
1.9.3 Application of the P(3HB) microspheres in drug delivery -The P(3HB) 
microspheres will also be encapsulated with drugs gentamicin and tetracycline to be used 
for potential drug delivery purposes. The microspheres will also be used to produce 
structures with various morphologies such as microsphere films and their in vitro drug 
release rate monitored. 
1.9.4 Use of polymer as drug delivery agents in polymer/composite scaffolds -3D 
composite scaffolds will be made using P(3HB) and 45S5Bioglass
®
 to form scaffolds for 
combined application in hard tissue regeneration and drug delivery. 
P(3HB)/45S5Bioglass
®
 composite microsphere films will also be prepared with  
nanoscale bioactive glass particles (n-BG) for potential wound healing applications. The 
effect of the n-BG particles on the thermal and biocompatible properties of the composite 
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microsphere films will be investigated.  In addition, the effect of the n-BG particles on 
the bioactivity as well as its haemostatic efficacy for applications in wound healing will 
be examined. The polymer/composite scaffolds will be analysed for their microstructural 
properties using Scanning Electron Microscopy, SEM, thermal properties using 
Differential Scanning Calorimetry; DSC, mechanical properties using Compressive 
strength Analysis, and X-Ray Diffraction; XRD.   
1.9.5 Determination of the in vitro biocompatibility and bioactivity of the drug 
delivery constructs and scaffolds -Biocompatibility of the drug delivery constructs will 
be carried out using HaCaT and MG-63 cell lines and the bioactivity of the 3D scaffolds 
will be measured in vitro using SBF.s 
1.9.6 Application of the P(3HB) microspheres in protein delivery - P(3HB) 
microspheres for protein delivery will be investigated. In this study three different 
proteins, bovine serum albumin (BSA), Lucentis
® 
and ribonucleic acid (RNase A) will be 
encapsulated within P(3HB) microspheres and their in vitro drug release rate monitored. 
P(3HB) microspheres  encapsulated with BSA and Lucentis
® 
will be used as drug 
delivery vehicles for the intraocular environment. RNase A has the same molecular 
weight as the functional agents such as bone morphogenic proteins (BMP-2) which is 
useful for inducing the formation of bone and cartilage. Thus the results obtained from 
the RNase A study can later be extrapolated to BMP-2. RNaseA activity and structural 
integrity of all the proteins during the encapsulation process will be investigated. 
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Figure 2:- Schematic representation of the research strategy used for this project. 
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Chapter 2  
Materials and Methods
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2.1 Materials  
2.1.1 Water  
Distilled and (high performance liquid chromatography) HPLC grade water were used 
where appropriate. The two types of water used for P(3HB) microsphere production and 
drug quantification were obtained from Elga Pure Lab Options distillation units.  
2.1.2 Chemicals  
All the chemicals, buffers and drugs used were purchased from Sigma-Aldrich, (Dorset 
UK). Care was taken to make sure that the chemicals used were of the best grade 
available (analytical or HPLC where appropriate) for the experiment.  
2.1.3 Proteins  
The broad range protein molecular weight marker and ribonuclease A (pancreatic RNase 
A) was purchased from Promega, UK. Bovine serum albumin fraction V (BSA) used in 
the bicinchoninic acid (BCA) assay was purchased from Sigma-Aldrich, (Dorset UK). 
Lucentis
®
 (Ranibizumab 10mg/mL) was purchased from Novartis Europharm Ltd, U.K. 
2.1.4 Plasmid 
The green fluorescent protein (GFP) containing plasmid (pTP6) used to transfect the    
MG63 osteoblast cells were obtained from Dr. Mark Clements, University of 
Westminster, London.  
2.1.5 45S5Bioglass
®
 and Nanobioglass (n-BG) particles  
The melt-derived 45S5Bioglass
®
 powder (particle size 10–20 m) purchased from 
NovaMin Technology Inc. (Florida, USA) was obtained from Professor Boccaccini, 
Department of Materials Science, Erlangen, Germany. The composition of 
45S5Bioglass
®
 is 45 wt.% SiO2, 24.5 wt.% Na2O, 24.5 wt.% CaO and 6 wt.% P2O5 
(Hench et al.,1998a). Flame spray synthesis used to prepare nanobioglass particles (n-
BG) and this was also obtained from Prof Boccaccini, Department of Materials Science, 
Erlangen, Germany. The composition of n-BG particles is 46.08 wt% SiO2, 22.96 wt% 
Na2O, 27.18 wt % CaO and 3.77 wt% P2O5. 
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2.1.6 Buffers and Reagents  
2.1.6.1 Buffers for SDS-PAGE  
2.1.6.1.1 2X sample buffer for sodium dodecyl sulphate-Polyacrylamide gel 
electrophoresis (SDS-PAGE) 
The components are 0.125 M Tris-HCl, pH 6.8, 15% glycerol (v/v), 6% SDS, and 
0.005% bromophenol blue. 50 µL of ß-mercaptoethanol was added to 1 mL of sample 
loading buffer.  
2.1.6.1.2 Resolving gel buffer  
The components are 1.5 M Tris-HCl, 0.4% SDS, (No pH adjustment was required).  
2.1.6.1.3 Stacking gel buffer 
The components are 0.5 M Tris-HCl, 0.4% SDS 
2.1.6.1.4 5X Reservoir Buffer 
The components are Tris Base 15g, 72g glycine, 5g SDS (g/L) 
2.1.6.1.5 Protein fixing solution (for fixing proteins following SDS-PAGE) 
Methanol (HPLC grade), acetic acid (100%) and water mixed in the ratio 5:1:4 
respectively.  
2.1.6.1.6 Coomassie brilliant blue stain (for staining SDS-PAGE gels) 
0.025% Brilliant Blue R stain dissolved in 10 mL acetic acid (100%) and 90 mL water.  
2.1.6.1.7 Destaining solution (for destaining SDS-PAGE) 
10% acetic acid (100%) in water. 
2.1.6.1.8 5X TBE, pH 8.0, (g/L) 
The components are Tris Base 54, Boric acid 27.5, EDTA 4.5 
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2.1.6.2 Reagents used for preparation of simulated body fluid (SBF) 
The components are ultra pure water 1500 mL, sodium chloride 15.92g, sodium 
bicarbonate, 0.72g; potassium chloride, 0.44g; potassium phosphate dibasic trihydrate 
0.45g; magnesium chloride hexahydrate, 0.61g; calcium chloride, 0.55g; sodium 
sulphate, 0.142g; TRIZMA
®
 base, 12.11g; hydrochloric acid-appropriate amount to 
adjust the pH to 7.25.  
2.1.6.3 Reagents used for the in vitro drug release and in vitro degradation studies  
2.1.6.3.1 Contact lens solution  
Bausch and Lomb, Multi-purpose contact lens solution, Kingston upon-Thames UK was 
used for the in vitro drug release studies.  
2.1.6.3.2 Phosphate buffered saline solution (PBS) 
Phosphate buffered saline solution (PBS) purchased from Sigma-Aldrich, (Dorset UK) 
was used for the in vitro drug release studies. The pH of the reagents used for the in vitro 
drug release and in vitro degradation studies is shown in Table 1. 
Table 1:- pH of the reagents used for the in vitro drug release and in vitro degradation studies. 
Reagents pH 
Contact Lens solution 7.17 
Phosphate buffered saline solution (PBS) 7.4 
 
2.1.7 Cell line and cell culture materials  
The human keratinocyte cell line (HaCaT) was obtained from Dr. I. C. Locke, University 
of Westminster London, UK. MG63 human osteosarcoma cell line for in vitro cell culture 
studies on 45S5Bioglass
®
 samples were obtained from Dr. Mark Clements, University of 
Westminster London, UK.  All chemicals, reagents, buffers and dyes for cell culture were 
purchased from Sigma-Aldrich (Poole, U.K) and VWR International (Poole, U.K) unless 
otherwise specified. Cell culture media components were purchased from Invitrogen LTD
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(Paisley, U.K) and foetal calf serum (FCS) was purchased from Biosera LTD (Ringmer, 
U.K).  Cell culture flasks were purchased from BD Biosciences (Oxford, UK) and 
penicillin and streptomycin was purchased from Invitrogen (Paisley, UK).  
2.1.8 Bacterial cultures  
P(3HB) was isolated from the Gram-positive bacteria Bacillus cereus SPV which was 
obtained from the culture collection of University of Westminster, London, U.K. All 
chemicals required for the growth of Bacillus cereus SPV and extraction of polymer from 
the bacterial cells were obtained from Sigma-Aldrich Company Ltd. and VWR 
Chemicals (England) except for nutrient broth and yeast extract, which was obtained 
from DIFCO (BD UK Ltd., Oxford, UK). Antifoam (FG-10) was purchased from Dow 
corning (Edison, NJ, USA) for fermentation study.  
2.1.8.1 Bacterial strains and its maintenance 
The Bacillus cereus SPV cells obtained from the culture collection (-80 °C) were grown 
in an incubator (New Brunswick Scientific C25KC incubator shaker, USA) at 30°C for 
24h in 30 mL of sterile nutrient broth. This 24h grown culture was then streaked on 
sterile nutrient agar plates (30 mL of sterile nutrient agar solution on petri-plates) in order 
to obtain single bacterial colonies. The plates were incubated for 48h at 30°C and then 
stored at 4°C. Glycerol (acting as a cyro-preservant) deeps of the culture were also 
prepared for long-term storage by adding 500µL of the 24h grown culture and 500µL of 
sterile 40% glycerol. The mixture was vortexed and stored in 1.5 mL eppendorfs at -20°C 
for further use (Valappil et al., 2007). 
2.1.8.2 Growth media  
The components of the nutrient broth are 1.0 g/L; yeast extract, 2.0 g/L; peptone, 5.0 g/L; 
sodium chloride, 5.0 g/L and maintained at 4 °C after growth on nutrient agar: yeast 
extract, 2.0 g/L; peptone, 5.0 g/L sodium chloride, 5.0 g/L; agar, 15.0 g/L. The 
production medium, glucose, 20 g/L; Difco yeast extract, 2.5 g/L; potassium chloride, 3 
g/L; ammonium sulphate, 5.0 g/L; 100mL of defatted soyabean dialysate (prepared from 
10g of defatted soyabean meal in 1000mL of distilled water for 24h at 4°C) was used. 
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2.2 Experimental Methods 
2.2.1  Production of P(3HB) 
P(3HB) production was carried out in 20 L fermentor with a 14 L working volume using 
Bacillus cereus SPV.  The inoculum (1.4 L) culture was prepared using a single bacterial 
colony obtained from a nutrient agar plate. This was incubated at 30°C for 24h on a 
rotary shaker at 250 rpm. The fermentors containing only the salts of the production 
medium were sterilized separately without the addition of glucose and soyabean 
dialysate. Glucose and soyabean dialysate sterilized separately were added to the 
fermentor along with the inoculum. The pH of the medium was adjusted to 6.8 using 1N 
NaOH. The dissolved oxygen tension (DOT) was set to 100% air saturation at the 
beginning of the run. The pH, DOT, glucose concentration and optical cell density were 
monitored throughout the run. The impeller speed was maintained at 250 rpm 
(revolutions per minute), airflow rate at 1.0 vvm (volumetric air flow rate) and at a 
temperature of 30°C.  
 
2.2.1.2 Optical Density (OD)  
 
OD of the culture was recorded at different time points, in order to measure the bacterial 
growth. OD readings were taken at 600 nm (absorbance) in a standard spectrophotometer 
(Novaspec II visible spectrophotometer, UK) and for all cases nutrient broth was used as 
blank. The optimal OD of 1.3 nm was used for inoculating in the production medium.  
 
2.2.1.3 Temperature, pH and dissolved oxygen tension (DOT)  
Temperature and DOT levels were monitored online using the temperature and DOT 
probes (polarographic oxygen-sensing probe (Inglold, Metler-Toledo Ltd., Beaumont 
Leys, Leicester, UK) which were connected to the fermentor vessel. The pH of the 
production medium was measured offline (Jenway pH meter 3305, UK) by collecting 
samples from the fermentor at regular intervals. 
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2.2.1.4 Dry cell weight (dcw) analysis 
15 mL of the culture from the fermentation run were taken at different time points to 
measure the dry cell weight. The culture was centrifuged at 4500 rpm for 10 mins and the 
cells were freeze-dried before recording the cell mass.         
2.2.1.5 Polymer extraction techniques  
The bacterial cells were harvested from the culture by centrifugation and stored at -80°C 
for 24h. The frozen cells were then lyophilised (Savant Modulyo D Freeze drier, Thermo 
electron Corp, UK) for up to 48h in a freeze drier at -47°C and at a pressure of 133 mbar. 
The freeze-dried cells were then weighed and designated as dry cell weight (dcw). 
Subsequently, the polymer was extracted from the cells by using the chloroform-
hypochlorite dispersion method as mentioned below.  
2.2.1.5.1 The extraction of P(3HB) using chloroform-hypochlorite dispersion method 
A dispersion solution containing 50 mL of chloroform and 50 mL of diluted (30%) 
sodium hypochlorite solution in water was used to extract P(3HB) from the freeze-dried 
cells. The freeze-dried cells (1g) were added to the dispersion solution and treated at 
37°C for 1h in an orbital shaker at 100 rpm. Three different phases were obtained from 
the solution containing the mixture after it was centrifuged at 3680g for 10 minutes. 
P(3HB) present in the bottom phase of the mixture was extracted by precipitation in 10 
volumes of ice-cold methanol (Vallappil et al., 2007).  
2.2.2 P(3HB) microsphere production  
A solid-in-oil-in-water emulsion technique was used for P(3HB) microspheres 
preparation. Quantities of 1 or 3 g of P(3HB) were dissolved in 8 mL of chloroform and 
agitated for 3 min (Table 2). This mixture was then transferred into the first water-in-oil 
emulsion (w/o) of 40 mL of 1% or 0.5% w/v aqueous polyvinyl alcohol (PVA) solution, 
and stirred at 1000 rpm for 3 min. This solution was then added to a second water-in-oil-
in water emulsion (w/o/w) of 500 mL of 0.5% or 0.05% w/v aqueous PVA solution, 
forming the second-oil-in-water emulsion. This emulsion was stirred either at 300 rpm or 
800 rpm for 4h to form P(3HB) microspheres. The resulting microspheres were isolated 
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by centrifugation at 3680 g for 5 min and then washed with distilled water three times, air 
dried and stored in a desiccator until further use.  
Table 2:- The varying processing conditions (amount of surfactant, polymer concentration and 
stirring rate) used for the synthesis of P(3HB) microspheres. 
 
 
 
 
The drug/protein loaded microspheres were also prepared using the same solid-oil-in-
water emulsion technique. For this the drug/proteins were added to the first water-in-oil 
emulsion (w/o) of 40 mL of 1% or 0.5% w/v aqueous polyvinyl alcohol (PVA) solution 
and then transferred to a second water-in-oil-in water emulsion (w/o/w) of 500 mL of 
0.5% or 0.05% w/v aqueous PVA solution. Following centrifugation the microspheres 
were lyophilised and stored at 4°C for further use.  The different drugs/proteins loaded 
during P(3HB) microsphere production is shown in  Table 3. 
Table 3:- Drugs/Proteins loaded during P(3HB) microsphere production. 
Drugs/Proteins loaded during P(3HB) 
microsphere production 
Drug/Protein Loadings  (wt%) 
Gentamicin 2 wt% 
Tetracycline 0.5 wt%, 2 wt%, 4 wt% 
Bovine Serum Albumin (BSA) 0.75 wt%, 1.5 wt% and 5 wt% 
Lucentis
®
 5 wt% 
Ribonucleic Acid A (RNase A) 50 wt% 
Samples Polymer  
concentration (g/L) 
PVA concentration 
(%) 
Stirring rate 
(rpm) 
1 1 0.5 800 
2 3 0.5 300 
3 1 1 300 
4 3 1 800 
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2.2.2.1 Production of P(3HB) microspheres including nanobioglass (n/BG) particles  
10 wt% of n-BG particles were added to the polymer solution to yield P(3HB)/n-BG 
composite microsphere films. This mixture was further sonicated for 1-2 min (Ultrasonic 
Homogenizers US200, Phillip Harris Scientific, UK) to improve the dispersion of the n-
BG particles by disaggregating possible agglomerations. The P(3HB)/n-BG was then 
transferred into 40 mL of  1% w/v aqueous polyvinyl alcohol (PVA) solution, and stirred 
at 800 rpm for 3 minutes. This solution was then added to 500 mL of 0.5% w/v aqueous 
PVA solution, forming the second-oil-in-water emulsion. This emulsion was stirred for 
4h at the same agitation speed as before to form the P(3HB) microspheres. The resulting 
microspheres were isolated by centrifugation at 3680 g for 5 min and then washed with 
distilled water three times, air dried and stored in a desiccator until further use. 
 
2.2.3 P(3HB) microsphere film preparation   
 
0.1g of the lyophilised microspheres were uniaxially compressed to form a disc using a 
hydraulic hand press and a force of 0.09 MPa to the films of (diameter=12.87mm and 
thickness=0.87mm) had a surface area of 1.13cm
2
 (Naraharisetti et al., 2005). P(3HB) 
microsphere (0.1g) loaded with 0.5 wt%, 2 wt% and 4 wt% of tetracycline was uniaxially 
compressed to form a disc. Similarly 0.1g of the lyophilised microspheres with the n-BG 
particles were uniaxially compressed to form a disc using the same protocol. 
2.2.4 45S5Bioglass
®
 scaffold production and coating with P(3HB) microspheres 
45S5Bioglass
®
-based glass-ceramic scaffolds were produced by the foam replica 
technique introduced in a previous investigation (Chen et al., 2006). Briefly, a PU foam 
cut to the desired size (the size of the foam determines the final dimensions of the 
scaffold)-nominally 10 x 10 x 10 mm
3
 was immersed in a well-mixed 45S5Bioglass
®
 
slurry made by dissolving 45S5Bioglass
®
 powder in poly (DL-lactic acid)–dimethyl 
carbonate solution, which consequently infiltrated the foam structure. Glass particles 
adhered to the surfaces of the polymer foam. The coated foam is normally squeezed 
vigorously after it has been taken out of the slurry to give a reasonably homogeneous 
coating (assessed by visual inspection). The foams were then dried under a fume hood in 
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air at room temperature for at least 12h. Finally the foams were sintered using an 
optimized heat treatment programme to eliminate the sacrificial PU template and to 
densify the struts. In this project, the polymer was slowly burned out at 550 C for 3h in 
order to minimize the damages to the glass coating. Once the polymer was removed, the 
glass foam was sintered at 1100 C for 2h. This experiment was carried at Imperial 
College, London with the assistance of Mr. Decheng Meng. 
The sintered 45S5Bioglass
®
 scaffolds were coated with P(3HB) microspheres by dipping 
the scaffolds for 2, 5 or 10 min into an aqueous slurry made with P(3HB) microspheres, 
and different approaches were investigated to achieve a high-quality P(3HB) microsphere 
coating on the scaffolds, as described below. 
 2.2.4.1 Agitation 
A 1% w/v microsphere solution was prepared using ultrapure water and agitated using a 
mechanical stirrer for 3h; this was followed by immersing the 45S5Bioglass
®
 scaffold in 
the slurry with the help of a copper wire gently entwined in the pores of the scaffold. The 
coated scaffolds were then removed and allowed to air dry in desiccators at room 
temperature.  
2.2.4.2 Sonication 
The 1% and 3% w/v microsphere slurries in water were sonicated using a USC300D 
VWR ultrasonic for 2, 5 and 10 mins to improve the dispersion of the microspheres by 
separating possible microsphere agglomerations. This was followed by immersing the 
45S5Bioglass
®
 scaffold in the slurry with the help of a copper wire gently entwined in the 
pores of the scaffold. The coated scaffolds were then removed and allowed to air dry in 
desiccators at room temperature.  
2.2.4.3 Immersion of the scaffold in the aqueous PVA solution  
In an alternative approach, the scaffolds were immersed in the PVA solution during 
microsphere preparation. It was anticipated that the microspheres, while settling down, 
could penetrate through the scaffold pores and crevices, thoroughly coating the scaffold.
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2.2.5 Coating of 45S5Bioglass
®
 scaffolds with gentamicin-loaded P(3HB) microspheres  
To coat the 45S5Bioglass
®
 scaffolds with gentamicin-loaded P(3HB) microspheres, a 
slurry of the drug-loaded microspheres was made using the highly non-polar solvent, 
hexane, because gentamicin, being hydrophilic, would diffuse into the water phase if an 
aqueous slurry was used. The coating was obtained by adding the microsphere slurry 
drops onto the scaffold using a pipette (1 mL of the suspension for every 0.05g of the 
scaffold).  
2.2.6 Gentamicin loading in the 45S5Bioglass
®
 scaffold 
In an attempt to incorporate the drug directly onto the scaffold for the purpose of 
comparison, gentamicin solution at a concentration of 2 mg/mg was added drop wise to 
the 45S5Bioglass
®
 scaffolds (5x5x10 mm
3
) using a pipette. The scaffolds were weighed 
before and after the loading process and the amount of drug loaded on the sample was 
estimated from the weight change. Upon addition of the solution, scaffolds were left to 
dry at room temperature in desiccators. 
2.3 Drug/Protein quantification methods 
2.3.1 Determination of the drugs (gentamicin and tetracycline) and proteins (BSA, 
Lucentis
®
 and RNase A) encapsulation efficiency encapsulation efficiency 
The encapsulation efficiency (EE %) of the drug/protein-loaded microsphere prepared 
under different conditions as mentioned in section 2.2.2. was determined using equation 
1. 
loadingdrugactual
loadingdrugerimental
EE
exp
% ………………..………............................... (1) 
    
                                                                          
To determine the EE values, 5mg of the drug/protein loaded microspheres were dissolved 
in 1mL of chloroform, to which 5mL of water was added after the microspheres were 
well dissolved. Drugs and proteins used in this study being hydrophilic in nature, 
separated into the water phase on vortexing. The water phase was then analysed for the 
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drug content using liquid chromatography-mass spectrometry (LC–MS) and the proteins 
in the aqueous phase was then quantified using the bicinchoninic acid (BCA assay) after 
centrifugation. 
 
2.3.2 Liquid Chromatography Mass Spectrometry (LC-MS) 
Liquid Chromatography Mass Spectrometry (LC-MS) was used for analysing the drug 
content from the release buffer. 15µL samples collected at different time points were 
injected onto the HPLC column (Dionex HPLC) coupled with an atmospheric pressure 
(AP)-electrospray ionization (ESI) mass spectrometer (Dionex). Separation was carried 
out at 50 C on a reversed-phase C18 60 RP column of dimensions 250 mm x 4 mm.  
2.3.2.1 Mobile phase used for gentamicin quantification  
The mobile phase used for gentamicin quantification was an isocratic flow of 60% 
pentafluoropropionic acid (20 mM in ultra-pure water from Fluka Chemicals, Buchs, 
Switzerland) and 40% methanol at flow rate of 0.5mL/min. The standard curve was 
plotted for gentamicin concentrations ranging between 1.0 and 2000 g mL
-1
. 
2.3.2.2 Mobile phase used for tetracycline quantification  
The mobile phase used for tetracycline quantification was an isocratic flow of a mixture 
of water, 5% formic acid, acetonitrile and methanol (23:40:25:12) at flow rate of              
0.2mL/min
 
(Zhu et al., 2001). The standard curve was plotted for tetracycline 
concentrations ranging between 1.0 and 2000μg/mL.  
2.3.3 Bicinchoninic acid assay (BCA) 
0.1 mL of each standard and unknown sample replicate was pipetted into labeled test 
tubes. To this 2.0 mL of the working reagent (50 parts of BCA Reagent A with 1 part of 
BCA Reagent B 50:1, Reagent A: B) was added. The tubes were covered with aluminum 
foil and incubated at 37°C for 30 minutes (working range = 20-2,000 μg/mL). The tubes 
with the standard and samples were covered and cooled to room temperature. The total 
protein adsorbed was quantified using a bicinchoninic acid (BCA) reagent kit (Thermo 
scientific). The optical density of the samples was measured at 562nm using a standard 
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spectrophotometer (Novaspec II Visible spectrophotometer, UK) against a calibration 
curve at  concentrations ranging from 1.0 and 2000μg/mL using bovine serum albumin 
(BSA), as per the manufacturer‟s protocol.   
 
2.4  In vitro drug release studies  
The in vitro release experiments were performed in an incubator at 37 C for different 
time points. Drug/protein loaded P(3HB) microspheres, microsphere-coated and 
45S5Bioglass
® 
uncoated scaffolds, were immersed in different release buffers and 1mL 
samples were collected at regular intervals. Each aliquot was replaced with fresh buffer 
and the tubes returned to the shaker. At each time point the samples were taken out in 
triplicates and the results averaged. The drug content was determined by injecting 15µL 
of the samples onto a high-performance liquid chromatography (HPLC) column and the 
gentamicin concentration quantified using the standard curve. The experiments were 
repeated three times. The protein concentrations in the release samples were determined 
by the BCA assay using the standard plot generated by the BSA standard. Thus based on 
the determined initial loading of the microspheres and the amount of protein detected in 
the release medium, the percentage of BSA release as a function of time was detected. 
The BCA assay does not reach a true end point as a result the colour development will 
continue even after cooling. Thus all tubes should be made within 10 mins, however if 
the rate of colour development occurs at low temperature then no error will be 
introduced. 
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A summary of the in vitro release studies of the different proteins and drugs are 
represented in the Table 4.   
Table 4:-Summary of the in vitro release studies of the different proteins and drugs. 
Drugs/Proteins loaded in P(3HB) 
microspheres, microsphere-coated 
and 45S5Bioglass
® 
uncoated 
scaffolds  
Release 
buffer  
Time points at which samples were 
taken (days)  
Gentamicin SBF 1, 2, 3, 4, 7, 12, 18, 22, 26 and 30 
days 
Tetracycline PBS 1, 2, 3, 4, 7, 12, 18, 22, 26 and 30 
days 
Bovine Serum Albumin (BSA) PBS, Contact 
lens solution  
1, 2, 3, 4, 7, 12, 18, 22, 26 and 30 
days 
Lucentis
®
 PBS, Contact 
lens solution 
1, 2, 3, 4, 7, 12, 18, 22, 26 and 30, 
35, 40, 45, 47, 50, 55, 57, 60, 65, 
70, 75 days 
Ribonucleic Acid A (RNase A) PBS 1, 2, 3, 4, 7, 12, 18, 22, 26 and 30 
days 
 
2.5 In vitro degradation and bioactivity studies  
2.5.1 Water uptake measurement 
All the samples were weighed before immersion (Mo, dry) in SBF/PBS/contact lens 
solution and incubated at 37°C. At specified time points such as (1, 3, 7, 14 and 30 days), 
the samples were collected and analysed for water uptake (%WA). For measuring the 
water adsorption (%WA), the immersed samples were removed, the surface gently wiped 
with blue roll (except for the microspheres, they were centrifuged at 3680g for 5 mins 
and the supernatant removed) and the weight was measured (Mt, wet). Similarly the weight 
losses (%WL) of the samples were also calculated after drying the samples (Mt, dry) at 
37°C overnight in an incubator.   
The water absorption and weight loss were calculated using the following equations 
dryt
drytwett
M
MM
WA
,
,,
%  .......................................................................................... (2)
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dry
drytdry
M
MM
WL
,0
,,0
% ............................................................................................(3) 
(Mo, dry) is the weight of the samples before immersion  
(Mt, wet) is the weight of the wet samples  
(Mt, dry) is the weight of the samples after drying 
2.5.1.1 In vitro degradation studies carried out in simulated body fluid (SBF) 
The in vitro degradation studies of the (P(3HB) microspheres  (gentamicin loaded and 
unloaded), 45S5Bioglass
®
 and P(3HB)/45S5Bioglass
®
 composite scaffolds were carried 
out in simulated body fluid (SBF), which has similar ionic concentration to human blood 
plasma (Kokubo et al., 1990; 1991). The reagents mentioned in section 2.1.6.2, were 
dissolved in deionised water to prepare 2L of final volume and the pH adjusted to 7.25. 
Freshly prepared SBF was used for all the analysis and when needed, was stored at 4°C 
for no more than 14 days. The samples were kept in a 37°C incubator under static 
conditions and at desired time points the samples were collected, gently washed with 
deionised water and left to dry at 37 °C in an incubator overnight for further analysis. The 
water uptake measurement of all the samples were carried out using the same protocol as 
mentioned in section 2.5.1 and the %WA and %WL of the films measured using 
equations 2 and 3. 
2.5.1.2 In vitro degradation studies carried out in 0.1M phosphate buffer saline solution 
(PBS) and contact lens solution  
The in vitro degradation studies of the P(3HB) microsphere films (tetracycline loaded and 
unloaded) were performed in 0.1M PBS.  Similarly the in vitro degradation studies of the 
P(3HB) microsphere loaded with BSA was carried out in 0.1M PBS as well as contact 
lens solution. The water uptake measurement of all the samples were carried out using the 
same protocol as mentioned in section 2.5.1 and the %WA and %WL of the films 
measured using equations 2 and 3.  
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2.5.2 In vitro bioactivity tests 
In vitro bioactivity tests such as hydroxyapatite formation were carried out using acellular 
simulated body fluid (SBF) as developed by Kukubo et al., 1990. The pH of SBF was 
adjusted to 7.25 at 37°C using HCl and it has the ionic concentrations approximately 
equal to those of human blood plasma (pH7.3). The reagents were dissolved in HPLC 
(high performance liquid chromatography) grade water. Freshly prepared SBF was used 
for all the analysis and when needed, was stored at 4°C for no more than 14 days. The 
SBF was refreshed after 48h of incubation followed by every 3 days. Hydroxyapatite is 
formed by the rapid exchange of Na
+
 and ions with H
+
 or H30
+
 ions from the solution. 
With the increase in the hydroxyl concentration formation of Si-O-Si layer occurs after 
the condensation and repolymerization of SiO2 rich layer. Amorphous CaO and P2O5 
layer is formed after the adsorption of Ca
2+ 
and PO4
3-
 groups on the surface. Finally the 
crystallization of the CaO and P2O5 layer takes place and a hydroxyapatite layer is 
formed.  
2.5.2.1 Sample preparation of the (P(3HB) and P(3HB)/n-BG composite microsphere 
films)   
The P(3HB) and P(3HB)/n-BG composite microsphere films  were collected after 1, 3 
and 7 days of incubation, washed with deionised water and vacuum-dried before further 
examination.  
2.5.2.2 Sample preparation of the (45S5Bioglass
®
 and microsphere coated composite 
scaffolds  
The 45S5Bioglass
®
 scaffolds of dimensions 10x10x10 mm
3
 coated with P(3HB) 
microspheres and sintered 45S5Bioglass
®
 tablets of dimensions 10 mm (diameter) x 0.2 
mm (thickness) were also used as controls for the SBF study. The scaffolds were 
collected after 1, 3, 7, 14 and 30 days of incubation, washed with deionised water and left 
to dry at ambient temperature in a desiccator for further examination. These samples were 
then characterised using SEM and XRD to determine the formation of hydroxyapatite on 
their surfaces.  
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2.6 Protein studies   
2.6.1 Bovine Serum Albumin (BSA) adsorption test  
In order to determine the protein adsorption onto the surface of the microspheres 25 mg 
of the microspheres prepared using different conditions, as mentioned in section 2.2.2, 
were added to 5 mL of distilled water containing 1 mg of BSA.  The microspheres were 
then removed by centrifugation and the concentration of BSA in the supernatant after 
adsorption on the surface of the microspheres was determined using UV spectroscopy 
(Eppendorf Biophotometer, U.K). The absorbance was measured at 280 nm wavelength. 
A calibration curve was prepared using known concentrations of BSA. The protein 
adsorbed (q) on the surface of the microspheres was calculated using equation 4.  
m
VCC
q
fi
        ………………….……………………………………………………...........(4) 
 
Where Ci are the initial and Cf are the final BSA concentration and the BSA 
concentration in the supernatant after adsorption studies, respectively; V is the total 
volume of the solution (5mL); and m is the weight of the microspheres added into the 
solution (Patil et al., 2007). 
2.6.2 Protein adsorption study of (P(3HB)/n-BG composite microsphere films, 
45S5Bioglass
®
 scaffolds (before and after coating with P(3HB) microspheres) and 
45S5Bioglass
®
 composite scaffolds covered with HA 
The protein adsorption study was carried out by placing the (P(3HB)/n-BG composite 
microsphere films, 45S5Bioglass
®
 scaffolds (before and after coating with P(3HB) 
microspheres) and 45S5Bioglass
®
 composite scaffolds covered with HA in 2 mL of the 
cell culture media (Dulbecco‟s Modified Eagle Medium supplemented with 10% foetal 
calf serum, 2mM L-glutamine, and 1% w/v penicillin and 1% w/v streptomycin solution 
at 37 C for 24h to determine the amount of serum protein adsorbed on the surface. The 
45S5Bioglass
®
 scaffolds (before and after coating with P(3HB) microspheres) were 
washed with Hank‟s balanced salt solution, pH 7.4 both after 1h and 24h.  The samples 
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were then treated with 1 mL of 3% Triton X-100 (Ghannam et al., 1999).  The total 
protein adsorbed was quantified using a bicinchoninic acid (BCA) reagent kit (Thermo 
scientific). The optical density of the samples was measured at 562 nm using a standard 
spectrophotometer (Novaspec II Visible spectrophotometer, UK). The total proteins 
adsorbed on the surface of the samples were normalized for the surface area.  
2.6.3 Protein profile of the adsorbed proteins observed using SDS-PAGE  
The protein profile of the protein extracted from the surface of the samples (45S5 
Bioglass
®
, 45S5Bioglass
®
 composite scaffolds (coated with microspheres), P(3HB)/ 
45S5Bioglass
®
 composite scaffolds covered with hydroxyapatite (HA) and the BSA and 
RNase A encapsulated from P(3HB) microspheres were analysed using SDS-PAGE. The 
proteins of the samples were extracted and denatured with (12% SDS and 20% ß-
mercaptoethanol) and compared with protein BSA present in the serum. The size 
estimation was carried out using the molecular weight reference markers from Promega, 
UK. Protein samples of 20µg were diluted in reducing 2X sample buffer (Section 
2.6.1.8), boiled for 5 mins and allowed to cool down to room temperature. 
Electrophoresis was carried out using a 12% and 15% polyacrylamide gel. The samples 
were run at a constant voltage of 200V in a Tris/glycine/SDS buffer using a Bio-Rad 
Mini-Protean II electrophoresis system.  After migration, the gels were stained with 
Coomassie Blue in methanol-acetic acid-water (2.5:1:6.4) to reveal protein, destained and 
dried (Igartua et al., 1998). 
2.6.4 RNase A stability evaluation  
2.6.4.1 Methylene Blue activity test  
RNA solution was prepared by dissolving 100 mg of RNA in 10 mL 3-(N-morpholino) 
propanesulfonic acid (MOPS) buffer (0.1M MOPS -HCl, pH 7.5, 2mM EDTA). 
Methylene blue buffer was prepared by dissolving 1 mg methylene blue in 100 mL 
MOPS buffer and the absorbance taken at 688 nm was adjusted to 0.5± 2% using MOPS 
buffer. Due to the light sensitivity of the dye, the methylene blue buffer was stored in the 
dark. RNA solution (2.5-100µL) was mixed with methylene blue buffer to a final volume 
of 1 mL in cuvettes. The sample requires preincubation at 25°C for 10 mins in the
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spectrophotometer in the dark. The RNase A release samples were analysed for specific 
activity and compared to the activity of free RNase A in solution (control) placed in 
contact with the unloaded microspheres and subjected to the same release medium and 
temperature.  10µL of the release samples as well as the control taken at different time 
points were added to 1mL of the preincubated RNA solution (0.8 mg mL
-1
) in methylene 
blue buffer and the change in absorbance at 688nm (Novaspec II Visible 
spectrophotometer, UK) was recorded. The absorbance change was recorded immediately 
between 1 and 3 mins. One unit of enzyme activity (EU) was defined as the amount of 
RNase that leads to an absorbance change of 0.01 min
-1
 at 25°C at a substrate 
concentration of 0.8 mg RNA mL
1
. The enzyme activity of the naktive enzyme is 61 
EU/mg of protein. (Stoeffele et al., 1996). 
RNase A is a protein whose fluorescence spectrum is mainly due to the tyrosine residues 
present in its structure therefore it has an emission maximum around 303nm (Nellore et 
al., 1997). The fluorescence emission spectra were measured using a Perkin Elmer LS50 
fluorescence spectrophotometer at an excitation wavelength of 268nm (Perkin Elmer 
Corporation, Rockville, USA).  
2.7 Biocompatibility tests  
2.7.1 Cell culture studies on P(3HB) microsphere films (with and without drugs) and 
P(3HB/n-BG composite microsphere films  
All media including buffers, trypsin and dyes were filter-sterilised prior to use and 
warmed to 37 C. The human keratinocyte cell line (HaCaT) was grown in Dulbecco‟s 
Modified Eagle Medium (DMEM), supplemented with 10% foetal calf serum, 2 mM  
L-glutamine and 1% w/v penicillin and 1% w/v streptomycin solution. The medium was 
changed every 2 days. The cell cultures were maintained at 37 C, 5% CO2 and passaged 
on confluence by trypsin treatment. Following cell detachment, fresh medium was added 
to the cell suspension, which was then centrifuged at 500g for 10 mins. The resulting cell 
pellet was resuspended in fresh medium and transferred to 75 cm
2
 tissue culture flasks as 
required (Prashar et al., 2002). 
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2.7.1.1 Sample preparation  
2.7.1.1.2 Sterilization of samples 
All the samples were sterilised using ultra-violet (UV) light. The samples were kept in 
24-well microplates and placed under UV for 30 minutes, for each side of the sample.           
Shortwave 254nm UV sterilization was used in a SI-950 UV Benchtop incubator with a 
height of 18 inches. The samples were handled using a sterilized spatula. This form of 
sterilization was employed, as it has been shown to be more effective compared to 
washing with alcohol or autoclaving (Shishatskaya et al., 2004).  
2.7.1.1.2 Cell seeding on substrates 
The semi-confluent HaCaT cells were released from the flasks by trypsinisation and 
concentrated to pellet form by centrifugation (400g, 5 min). A cell seeding density of 
20,000 cells/cm
2
 was used for the films, respectively. The samples were placed in a 
polystyrene 24 well flat bottomed tissue culture plate with the film samples placed in the 
centre of the well and 2 mL of the cell suspended media was added for attachment of the 
keratinocytes. The plates were incubated in a humidified environment (37°C, 5% CO2) 
for a period of 3 days. Standard tissue culture plastic was used as the control surface. 
Neutral Red (NR) assay was used to check the cell viability.  
2.7.1.2 Analysis of HaCaT cell culture studies  
2.7.1.2.1 Neutral Red assay 
The cell attachment study was carried out using the Neutral Red (NR) assay (Prashar et 
al., 2002). Briefly, the films were incubated with 2 mL of media containing 40 mg/mL of 
NR, which was filter-sterilised. The growth on the standard tissue culture plate was used 
as control. The 24 well plates containing the films were then further incubated for 3h at               
37 C to allow for uptake of the dye by viable, uninjured cells. The NR containing 
medium was removed after 3h and the films gently removed and placed in another                      
24 well plate. The films were then quickly washed with 200 mL of fixative (1% CaCl2-
mL of another solution containing 1% acetic acid and 
50% ethanol solution was added to each well to extract the dye. The plates were then
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 allowed to stand at room temperature for 10 minutes followed by rapid agitation on a 
microtitre plate shaker. The absorbance of the extracted dye (100 mL) was then read at 
540 nm on a Thermomax microtitre plate reader (MDS Analytical Technologies (UK) 
Ltd., Wokingham, UK). All experiments were performed at least three times. The total 
NR uptake was a measure of viability (% NR uptake is directly proportional to the 
number of live, uninjured cells). Control plates containing only cells and medium were 
run alongside every experiment (Prashar et al., 2002). The percentage viability was 
calculated using equation 5. 
% Cell viability = 
platesculturetissueoncellsofsabsorbanceMean
filmsoncellsofsabsorbanceMean
...(5) 
All NR assay values were expressed as a percentage of the growth relative to the tissue 
culture plate. The baseline of 100% viability was set as the absorbance of the test cells. 
Background absorbance due to non-specific reactions between the test materials and the 
NR dye were deducted from the exposed cell values. The difference in the surface areas 
of the tissue culture plastic (1.86 cm
2
) and the films (1.13 cm
2
) were considered and the 
correction factor was applied to determine the % cell viability on the films. The samples 
analysed for biocompatibility are listed in Table 5. 
Table 5:- Materials investigated for the biocompatibility studies using the HaCaT keratinocyte cell 
line. 
 
Chapters Samples analysed Neutral Red 
Assay (NR) 
SEM 
Chapter 5,6 P(3HB) √ √ 
Chapter 6 P(3HB)/tetracycline loaded with              
0.5 wt%, 2 wt% and 4 wt% 
√ √ 
Chapter 5 P(3HB) immersed in SBF for 1, 
3, 7 days 
√ √ 
Chapter 5 P(3HB)/n-BG √ √ 
Chapter 5 
P(3HB)/n-BG immersed in SBF 
for 1, 3, 7 days 
√ √ 
  Chapter 2:Materials and Methods 
77 
 
2.7.2 Cell culture studies on 45S5Bioglass
®
 composite scaffolds  
All media including buffers, trypsin and dyes were filter-sterilised prior to use and 
warmed to 37 C. The MG-63 osteoblast cells, human osteosarcoma cell line was grown 
in Dulbecco‟s Modified Eagle Medium (DMEM), supplemented with 10% foetal calf 
serum (FCS), 2mM L-glutamine and 1% w/v penicillin and streptomycin solution.                          
2.7.2.1 Culturing and cyro-preservation of MG-63 cells 
The osteoblast cells were resurrected from their frozen state by thawing them and 
transferring them quickly to centrifuge tubes containing 10 mL Low-glucose Dulbecco‟s 
Modified Eagle Medium (DMEM) (supplemented with 10% foetal calf serum, 100µg/mL 
penicillin and 100 µg/mL of streptomycin). The cell suspension was centrifuged at room 
temperature for 3 mins at 1000 rpm. The cell pellet was re-suspended using 5mL of 
DMEM and 2mL of the resuspended cell suspension was added to the tissue culture 
flasks (the flasks had gas permeable caps and a surface area of 80 cm
2
) followed by 8mL 
of fresh DMEM. The flasks were incubated in a humidified atmosphere, in 5% CO2 and 
at 37°C. The spent medium of the flask was changed after every 2 days and the flasks 
were also checked for contamination using an optical microscope.  Once the cells were 
grown to 70-90% confluency they were sub-cultured to maintain healthy growth.  
For sub culturing, the spent medium was removed from the flask and washed with 5 mL 
of PBS followed by adding 2-3 mL (1 mL/cm
2
) of trypsin onto the washed cell 
monolayer and incubated at 37°C for 2 mins. The cells were examined under inverted 
phase microscope to observe the detachment of the cells and 8 mL (3-4 times the volume 
of trypsin) of fresh DMEM was added to the flask. The cell suspension was then 
centrifuged for 3 mins at 1000 rpm. The cell pellet was resuspended using 5mL of fresh 
DMEM. 3mL of the resuspended cell suspension was further divided into three new 
flasks (1 mL) and 9mL of fresh DMEM was added. The cells were then further allowed 
to grow until the start of new experiments. The cells were not passaged for more than 3-4 
times and they were frozen in ampoules and stored in liquid nitrogen for further use. For 
cyro-preservation the cell lines were preserved in liquid nitrogen for long term-storage.           
The cells were subjected to trypsinisation and centrifugation as mentioned earlier. After 
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centrifugation the cell pellet was re-suspended in freezing medium (70% growth medium, 
20% foetal calf serum and 10% dimethyl sulfoxide) at a concentration of 0.5-1x10
6
 
cells/mL. 1 mL aliquots were further pipetted into cyro-protective vials and stored at              
-80°C overnight. Frozen vials were then transferred to the liquid nitrogen storage vessel 
and preserved until further use.  
2.8 P(3HB) microsphere, 45S5Bioglass
®
 and P(3HB)/45S5Bioglass
® 
composite 
scaffold physical characterization techniques 
 
2.8.1 P(3HB) microsphere characterization techniques  
 
2.8.1.1 Particle size analysis 
Malvern Mastersizer particle size analyzer (Worcestershire, UK) was used to measure the 
particle size of the microspheres at Imperial College London, UK. Microspheres were 
dispersed well in water and following a background measurement; the suspensions were 
added dropwise to the analyser until the ideal concentration was reached.  
2.8.1.2 Surface morphology and microstructure characterization using TEM  
P(3HB) microspheres were observed using a JEOL 5610LV scanning electron 
microscope at Imperial College London, UK by Mr. Decheng Meng. The samples were 
placed on 8 mm diameter aluminum stubs using a sticky tag to hold the sample. A gold 
sputtering device (EMITECH-K550) was used to coat the samples, operating at a 
pressure of 7x10
-2
 bar and deposition current of 20 mA for 2 mins; images were taken at 
various magnifications to analyze the samples. The cross-sections of single microspheres 
and the crystallinity of the polymer were analysed by transmission electron microscopy 
(TEM) using a JEOL JEM-2010 transmission electron microscope operated at 200kV.                                
The sample for TEM was prepared using the focused ion beam method (FIB; FEI 
FIB200-SIMS). The microspheres were coated first with gold, then with platinum. A Ga+ 
beam of 30 keV between 30 and 100 pA was used to cut the sample. Images were taken 
in secondary electron mode. Once the samples had been polished to the desired thickness, 
they were extracted using an ex-situ lift-out technique onto a 3 mm Formuar-coated 
copper grid for TEM analysis (Giannuzzi et al., 2005). 
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2.8.1.3 Porosity 
The porosity (ε) of the microspheres was measured according to equation 5, using the 
liquid displacement method (Chang et al., 2006). Briefly, 5 mL of ethanol was used as 
the displacement liquid in a measuring cylinder and weighed. The P(3HB) microspheres 
immersed in ethanol in the cylinder was sonicated in a water bath to assist penetration of 
ethanol within the pores. The sample porosity was calculated using equation 6. 
....(6) 
W1 is the weight of the cylinder filled with ethanol before the immersion of the 
microsphere sample, W 2 is the weight of the cylinder, the ethanol and the sample after 
removing the excess ethanol above the 5 mL mark, W 3 is the weight of the cylinder and 
ethanol after removing the microsphere sample saturated with ethanol, and Ws is the 
weight of the microsphere sample used in the measurement. 
  2.8.1.4 Density of microsphere powder 
The density of the microsphere powder ( msp) was determined at Imperial College, 
London using a 25 mL pycnometer and applying the equation 7. 
 
 
                                                                                       ……………………………... (7) 
 
Where mp2 is the mass of the microsphere sample and the measuring cylinder in grams, 
mp1 is the mass of the measuring container, mp4 is the mass of the specific amount of 
immersion liquid which was water and the measuring container, mp3 is the mass of the 
specific amount of the microsphere sample, the immersion liquid and the measuring 
container, and L is the density of the immersion on liquid at measuring temperature.
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2.8.1.5 Determination of Residual PVA content  
The % residual PVA content present on the surface of the microspheres prepared using 
different conditions were determined by the formation of a coloured complex between 
two adjacent hydroxyl groups of PVA solution and an iodine molecule (Yang et al., 
2008). Briefly, 2 mg of the lyophilized microsphere samples prepared using the different 
conditions were treated with 2mL of 0.5 M sodium hydroxide (NaOH) for 15 minutes at 
60 C. Each of the samples was then neutralized with 900µL of 1 N hydrochloric acid 
(HCl) and the volume was adjusted to 5mL with distilled water. To each of the samples, 
3mL of 0.65 M solution of boric acid, 0.5 mL of iodine solution  (I2)/Potassium iodide 
(KI) (0.05 M/0.15 M) and 1.5 mL of distilled water were added. Finally, the absorbance 
of the samples was measured at 690 nm (Novaspec II Visible spectrophotometer, UK) 
after 15 mins of incubation. A standard plot of PVA was also prepared under identical 
conditions (Sahoo et al., 2002).  
2.8.1.6 Determination of surface hydrophobicity  
1 mg microsphere samples prepared using different conditions, as mentioned in section 
2.2.2, were incubated with different concentrations of Rose Bengal dye (4-20 g/mL) for 
3h at room temperature. The samples were then centrifuged at 110000g for 30 minutes in 
a microcentrifuge (Sorvall legend RT, UK) to spin down the particles. The supernatant 
from each of the samples was analysed at 542.7nm (Novaspec II Visible 
spectrophotometer, UK) to determine the unbound dye. The dye solution without any 
microspheres were used as a control and run each time under the same condition to 
account for the dye bound to the centrifuge tubes (Sahoo et al., 2002). 
2.8.1.7 Specific surface area measurement  
The specific surface area (SSA) of the microspheres was measured according to 
Brunauer-Emmett-Teller (BET) method at Imperial College, London by Dr. Julian Jones. 
The physical adsorption of gas molecules on a solid surface were measured using a 
Micromeritics Tristar instrument after degassing for 1h at 150°C. The particle diameter 
(dBET) for P(3HB) was calculated for the SSA value, using equation 8. = density of 
P(3HB) i.e 1.26 g/cm
3
, SSA= Specific surface area. 
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dBET=
SSAx
6
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2.8.1.8 Zeta-potential analysis  
The zeta-potential analysis of the microspheres prepared using the different conditions as 
mentioned in section 2.2.2 were carried out in Poland by Mr. Decheng Meng, 2g of the 
P(3HB) microspheres mixed with water were stirred using a magnetic stirrer for 30 
minutes. Following that the microspheres were centrifuged and re-dispersed in 5mL of 
water and stirred once again for 30 minutes. Water and HEPES buffer was used as the 
dispersant for the microspheres to measure their zeta-potential. The zeta-potential 
analysis of the microspheres was measured using an Agilent 7020 Zeta Probe (Foster 
City, USA). 1N NaOH and 1N HCl solutions were added as necessary to adjust the pH 
(Patil et al., 2007).  
2.8.1.9  X-Ray photoelectron spectroscopy (XPS)  
The surface chemistry of the tetracycline and gentamicin loaded microspheres were 
analysed by Dr D J Morgan, Cardiff Catalysis Institute, Cardiff. Axis Ultra DLD system 
(Kratos Axis Ultra., Cardiff, U.K) with the following acquisition parameters; 
monochromated 120 W X-ray Power  (10 mA emission x 12 kV), 20 eV Pass energy, 
Analysis Area 700 x 300 μm2) were used to analyse the samples.  
2.8.2.0 Fourier Transform Infrared Spectroscopy (FTIR) 
Chemical characterization and molecular bonding of the drug loaded and unloaded 
P(3HB) microspheres were carried out at University College London, Eastman Dental 
Institute using the FTIR system 2000, Perkin Elmer, USA spectroscopy) with the 
following conditions: spectral range, 400-4000 cm
-1
; window material, CsI;16 scans; 
resolution 4 cm
-1
; temperature stabilised coated FR-DTGS detector.  
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2.8.2.1 Differential Scanning Calorimetry (DSC) 
The thermal properties of the samples (drug loaded and unloaded) microspheres and 
microsphere films taken out at different time points before and after the water uptake 
studies were measured at University College London, UCL using a Perkin-Elmer Pyris 
Diamond DSC (Perkin-Elmer Instruments, USA). The sample masses for each of the 
measurements were in the range of 5-7mg. The samples were encapsulated in standard 
aluminium pans and all tests performed under nitrogen atmosphere. The samples were 
heated/cooled/heated at a rate of 20°C min
-1
 between –50°C and 250°C. All 
measurements were carried out in triplicates. The crystallinity percentage was determined 
by measuring the enthalpy of fusion from the differential scanning calorimetry curve 
using equation 9.  
)%100(
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%
itycrystallinf
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H
ityCrystallin
...........................……………………………..(9)
 
 
where ΔHf (sample) is the enthalpy of fusion for the extracted P(3HB) sample and ΔHf (100% 
crystallinity) is the enthalpy of fusion of commercial P(3HB) 
 
2.8.2.2 Water contact angle study 
 
Static water contact angle measurements of the P(3HB) microsphere films (tetracycline 
loaded and unloaded; P(3HB/n-BG composite microsphere films) were carried out 
University College London, Eastman Dental Institute in order to evaluate the wettability 
of the samples. The experiment was carried out on a KSV Cam 200 optical contact angle 
meter (KSV Instruments Ltd., Finland). An equal volume of water (<12 µL) was placed 
on every sample by means of a gas light micro-syringe, forming a drop. Photos (frame 
interval-1s, number of frames-20) were taken to record the shape of the drops. The water 
contact angles on the specimens were measured by analyzing the record drop images 
(n=3) using the Windows based KSV-Cam software. An image was recorded by the 
KSV-Cam software every second for 30 s in order to monitor the contact angle as a 
function of time. The image processing software was used to determine the contact angle
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 by fitting the measured drop profile with the Young-Laplace Equation. 
 
2.8.2.3 White light interferometry 
2D and 3D plots of the surface topography was obtained by the means of white light 
interferometry (ZYGO
®
, New View 200 OMP 0407C, UK) at Imperial College London, 
London with the assistance of Mr. Decheng Meng in order to evaluate the topography and 
the surface roughness of the samples. P(3HB) and P(3HB)/n-BG microsphere films were 
analyzed at 10X magnification using a 100µm bipolar scan. Three analyses per sample 
were performed to get an average rms measurement.   
 
2.8.3 45S5Bioglass
®
 and P(3HB)/45S5Bioglass
® 
composite scaffold physical 
characterization techniques  
The physical characterization techniques employed were chosen to highlight the 
fictionalization aspect provided by the addition of P(3HB) microspheres in the 
45S5Bioglass
® 
scaffolds. The different techniques carried out on the 45S5Bioglass
®
 and 
composite scaffolds are mentioned below.  
 
2.8.3.1 Porosity measurements 
The porosities of scaffolds before (P1) and after (P2) coating with P(3HB) microspheres 
were determined using the equation 10. 
     
2
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..............................……………….....(10)                                                   
 
Where W1 and W2 are the weights of the scaffold before and after coating, and V1 and V2 
are the volumes of the scaffold before and after coating with P(3HB) microspheres, 
which were determined from measurements of scaffold dimensions using a digital
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calliper (Mitutoyo, Germany). The theoretical densities of 45S5Bioglass
®
 and P(3HB) are     
(ρBG =2.70 g c/m
3
)  (Hench et al., 1998) and (ρP(3HB)= 1.23 g/cm
3
) (Misra et al., 2006), 
respectively. 
2.8.3.2 Mechanical properties 
The compressive strength of 45S5Bioglass
®
 scaffolds before and after coating with 
P(3HB) microspheres was measured using a Zwick/Roell Z010 universal testing machine 
at Imperial College London, as described by Bretcanu et al., 2007. Five microsphere-
coated and five 45S5Bioglass
® 
uncoated scaffolds were carefully shaped to prismatic 
specimens of dimensions 5 x 5 x 10 mm
3
. A load of 1 kN was applied onto the 5 x 5 mm
2
 
face until the compressive strain reached 70%. The crosshead speed was 0.5 mm min
-1
.  
2.8.3.3 X-ray diffraction analysis (XRD)  
X-ray diffraction (XRD) analysis were performed on a Brüker D8 Advance 
diffractometer in flat geometry, using Ni filtered Cu K  radiation at Imperial College 
London, with the assistance of Mr. Decheng Meng. Data were collected from 10 to 100° 
in -  mode with a primary beam slit size of 0.6 mm. A Brüker Lynx Eye silicon strip 
detector was used and a size of 0.00196671° and a count time of 0.1s per step (Misra et 
al., 2008).  
2.8.3.4 Scanning electron microscopy/Energy Dispersive X-Ray analysis (SEM/EDX) 
Microstructural observations of uncoated and microsphere coated 45S5Bioglass
®
 
scaffolds were performed using a JEOL 5610LV scanning electron microscope at 
Imperial College London, by Mr. Decheng Meng. Scanning electron microscopy (SEM) 
was also used to characterise the changes that occurred on the scaffold surfaces upon 
immersion in SBF. The increase in the amounts of phosphorus (P) and calcium (Ca) and 
the decrease in the amounts of sodium (Na) and silicon (Si) were detected by energy-
dispersive X-ray (EDX) analysis. EDX spectra (Ka) of the composite samples were taken 
at different time points of immersion in SBF.  These measurements were carried out at 10 
kV in a field emission gun scanning electron microscope (EDX, INCA Oxford 
instruments). 
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2.8.3.5 Thromboelastograph (TEG) studies   
The haemostatic efficacies of the n-BG particles were measured using a 
thromboelastograph (TEG) haemostasis analyser 5000 at St Thomas‟ Hospital, London 
U.K.  In a TEG, the polyethylene cup containing blood is rotated ±5° around a torsion 
wire. The time until the bimodal symmetric viscoelasticity curve‟s amplitude is 2 mm is 
referred to as R (min) and represents the initial detection of clot formation. The maximum 
separation of the curves is referred to as MA and represents the maximum clot strength 
(dyn/cm2) (Ostomel et al 2006).  Kaolin a standardised reagent consisting of kaolin, 
buffered stabilizers and a blend of phospholipids was used for this study. Kaolin 
containing vials were warmed to room temperature initially. The vials were gently tapped 
and 1.0 mL of native blood was added into each vial and then gently inverted for a few 
times.  Then 340 µL of the citrated blood was added into TEG analyzer cups containing 
20µL of 0.2M calcium chloride. The lever was moved to the start position and the test 
and sample run were carried out until the MA parameter was defined. The TEG analyzer 
was attached to a computer running the TEG analytical software (Haemoscope 
Corporation).   
2.8.3.6 Scanning Electron Microscopy (SEM) to observe cell attachment 
 Samples were examined under SEM to observe the HaCaT cell attachment and spreading 
on the surface to the samples. Specimens from day 1 and day 3 were fixed in 3% 
glutraldehyde in 0.1 M cacodylate buffer for 12h at 4°C. Subsequent dehydration using a 
series of graded ethyl alcohols (50%, 70%, 90% and 100%) was performed. Samples 
were dried by immersion in hexamethyldisilazane for 2 min and left in a fume cupboard 
for 2h. The dried samples were then attached to aluminium stubs, gold coated and 
examined under SEM (JEOL 5610LV, USA) at various magnifications.  
2.9 Statistical analyses 
All data are expressed as mean ± standard deviation. The data were compared using 
Student‟s t-test and analysis of variance (ANOVA) was used to assess significant 
difference among selected factors. If the factor effect was significant a Bonferroni 
comparison Post Hoc test was done to assess for the presence of significant differences.
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The differences were considered significant when *p<0.05, very significant **p<0.01 and 
highly significant ***p<0.001, respectively. A p-value higher than 0.05 (p>0.05) was 
taken as indicating no significant difference. Statistical analysis was performed using 
Graphpad PRISM software (Graphpad Software Inc., La Jolla, USA) and PASW 18 
(SPSS) software (SPSS Inc., Chicago, Illinois).  
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Chapter 3 
Drug delivery using Poly(3-
hydroxybutyrate) microspheres 
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3.1 Introduction 
3.1.1 Polyhydroxyalkanoates and their applications in drug delivery  
Polymeric drug delivery systems are designed to deliver drugs to the local site of action 
for extended periods of time, so that the therapeutic levels of the drug with short in vivo          
half-lives can be maintained (Pouton et al., 1996).  In addition, different forms of drug 
delivery devices are used to reduce the fluctuations in the plasma drug levels, so a slower 
drug release rate can be achieved, which can then provide an effective pharmacological 
response (Pouton et al., 1996). Microencapsulation of a drug within a polymeric device is 
considered as one of the most common methods of drug delivery (Nobes et al., 1996). 
Drug encapsulated microspheres require less frequent drug administration when 
compared to the conventional dosage forms. Also, the drugs that are encapsulated within 
the microspheres are kept separate from other microspheres; as a result multiple drug 
administration in a single injection can be achieved, which would have not been possible 
otherwise owing to drug compatibility issues (Pouton et al., 1996). Apart from being 
orally administered, microspheres can  also be administered through a number of 
parenteral pathways such as intraocular, intravenous, intra-arterial, intraspinal and 
intraosseous (Edlund et al., 2002). Often the site of administration influences the 
performance of the drug delivery due to the difference in the local tissue environment 
such as pH and enzyme activity (Edlund et al., 2002).  
The solvent evaporation method is the most frequently used method to prepare polymeric 
microspheres. The characteristics of the microspheres produced are largely dependent on 
the type of polymer and drug used. Other processing parameters such as solvent type and 
concentration of the emulsifier, drug/polymer ratio and stirring rate are also known to 
affect the physicochemical properties of the microspheres (Bazzo et al., 2008). The 
surface morphology and porosity of the microspheres are known to be particularly 
affected due to which the drug release rate from the microspheres is also affected. 
However the encapsulation efficiency of drugs within the microspheres is largely 
dependent on the type of microencapsulation procedure as well as the solubility of the 
drug. For example in the single emulsion method (o/w), a predetermined quantity of the 
polymer dissolved in the solvent is added to deionized water (inner aqueous phase, w1) 
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containing polyvinyl alcohol PVA, which is used as a surfactant for the production of 
microspheres. The solvent from the microspheres are removed from the inner aqueous 
phase and evaporated through the emulsion-air interface. The polymer precipitation is 
accelerated giving rise to the final microsphere characteristic once the solvent 
evaporation is initiated. However the encapsulation efficiency of highly hydrophilic drugs 
in the o/w method is affected by the fast shrinkage of the microspheres as a result the 
encapsulated drug is drained out of the microspheres during the solvent removal. 
Therefore the o/w method is more suitable for the entrapment of less hydrophilic drugs as 
they will agglomerate toward the microsphere surface due to their hydrophobic nature. In 
the double emulsion method (w1/o/w2) the initial emulsion phase (w1) is added to a 
second aqueous phase containing PVA (w2) where during solvent evaporation, small 
microdroplets formed within the microspheres coalesce forming a honeycomb structure. 
During solvent evaporation, the precipitating polymer wall also forms holes through 
which the entrapped drug is partly removed. This honeycomb structure is considered 
most suitable for efficient entrapment of hydrophilic drugs (Rosca et al., 2004).  
Double emulsion method has been used by several researchers to entrap highly 
hydrophilic drugs such as gentamicin within biodegradable microspheres (Yang et 
al.,2001; 2007; Lecàroz et al., 2006). Gentamicin a highly water soluble drug, is an 
aminoglycoside that had been used against a wide range of Gram-positive and Gram-
negative bacteria. For example gentamicin has been used for the treatment of 
osteomyelitis, an inflammatory bone disease. Osteomyelitis is the microbial infection of 
the bone medullary cavity, cortex and periosteum that is known to occur during post-
operative sepsis after an orthopaedic procedure. However, for the treatment of 
osteomyelitis, a prolonged systemic antibiotic treatment such as the use of gentamicin, 
either oral or parenteral, for a period of 4-6 weeks, is known to cause systemic toxicity 
and patient discomfort. Therefore, localised delivery at the infected site was introduced 
by injecting drug loaded microspheres. By this method the risk of high dose 
administration and possibility of building drug resistance could be avoided (Huang et al., 
2001). In a study conducted by Huang et al., PLA microspheres containing gentamicin 
was used for the treatment of bone infection. PLA microspheres with an average size of 
178µm were entrapped with gentamicin sulphate for the treatment of osteomyelitis, 
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where 80% of gentamicin sulphate was released within 3 weeks of implantation (Sampath 
et al., 1992).  
Thus in this chapter, P(3HB) microspheres containing gentamicin for the treatment of 
bone infections such as osteomyelitis were developed since they do not possess the risk 
of toxicity and immunogenicity due to their acidic byproducts which is a disadvantage 
when PLA is used. The processing conditions that particularly affect the characteristics of 
the P(3HB) microspheres were investigated so that microspheres with a high gentamicin 
loading efficiency, controllable porosity and uniform drug distribution could be achieved. 
Firstly, the P(3HB) microsphere preparation using a double emulsion/solvent evaporation 
technique by varying the polymer concentration, emulsifier concentration and the stirring 
rate is discussed. The effects of the final characteristics of the microspheres on the 
properties of the microspheres such as surface hydrophilicity, zeta-potential analysis and 
protein adsorption were also monitored. Their surface chemistry was analysed for the 
presence of any surface bound drugs that may contribute to the initial burst release 
(Naraharisetti et al., 2005). X-ray photoelectron spectroscopy was used to analyse the 
surface chemistry of the microspheres. Infrared spectroscopy was used to evaluate the 
chemical interaction of gentamicin with the P(3HB) microspheres (Stephens et al., 2000).  
Secondly, the changes in microsphere characteristics such as surface morphology and 
porosity in the presence of the drug (gentamicin) and its effect on the drug release 
kinetics was also investigated. Also, the effect of the processing conditions and the 
presence of the drug on the thermal properties of P(3HB) was studied. Finally, the in vitro 
degradation behaviour of the gentamicin loaded P(3HB) microspheres as compared to 
unloaded P(3HB) microspheres were studied. A schematic representation of the 
microsphere preparation as well as the various characterization techniques used to 
analyse the gentamicin loaded and unloaded microspheres are shown in Figure 1. 
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Figure 1:- Schematic representation of the factors influencing the P(3HB) microsphere 
characteristics and the different characterizations described in this chapter. 
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3.2  RESULTS 
3.2.1 P(3HB) microsphere preparation  
The P(3HB) microspheres were prepared by the solid-oil-in-water (s/o/w) technique 
using different conditions presented as described in Chapter 2, section 2.2.2, Table 2.             
In order to optimise the microspheres for maximum encapsulation efficiency the 
conditions for microsphere preparation including polymer concentration, the surfactant 
concentration and the stirring rate were varied. The conditions were decided using partial 
factorial analysis (Govender et al., 2005). This allowed the determination of optimal 
processing conditions using limited experiments. 
3.2.2 P(3HB) microsphere characterization 
3.2.2.1 Particle size  
The particle size distribution curve of the P(3HB) microspheres prepared using different 
conditions shown in Chapter 2, section 2.2.2, Table 2 are represented  in Figure 2 (A, B, 
C, D). Figure 2A shows that the size range of the measured particles were around 1-
15 m, where 80% of the measured particles had a mean particle size ranging from             
1.5 to 2.0 m and 90% of the microspheres had diameters below 5 m. Figure 2B shows 
that the size range of the measured particles were around 1-10 m, where 50% of the 
measured particles had a mean particle size ranging from 1.5 to 2.0 m and 90% of the 
microspheres had diameters below 5 m, similarly Figure 2C also showed that 50% of the 
measured particles had a mean particle size ranging from 1.5 to 2.0 m and 90% of the 
microspheres had diameters below 5 m. Figure 2D shows that the size range of the 
measured particles were around 1-10 m, where 90% of the measured particles had a 
mean particle size ranging from 1.5 to 2.0 m and 80% of the microspheres had diameters 
below 5 m. 
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Figure 2:- Size distribution analysis of P(3HB) microspheres prepared using different conditions.     
A sample 1 (polymer concentration of 1g/L, PVA concentration of 0.5wt% and stirrer speed of 800 
rpm), B sample 2 (polymer concentration of 3g/L, PVA concentration of 0.5wt% and stirrer speed of 
300 rpm), C sample 3 (polymer concentration of 1g/L, PVA concentration of 1wt% and stirrer speed 
of 300 rpm), D sample 4 (polymer concentration of 3g/L, PVA concentration of 1wt% and stirrer 
speed of 800 rpm).  
 
3.2.2.1.1 The effect of polymer concentration on the particle size 
The amount of P(3HB) used per unit volume of the solvent in this study were varied from 
1g to 3g respectively. The microspheres prepared under conditions 1 (polymer 
concentration of 1g/L, PVA concentration of 0.5wt% and stirring rate of 800 rpm) and 2 
(polymer concentration of 3g/L, PVA concentration of 0.5wt% and stirring rate of                
300 rpm) (Chapter 2, section 2.2.2, Table 2) had an average size of 2 m and 1.7 m as 
shown in Figure 2A and B.  These microspheres were slightly larger than 1.58 m and 
1.54 m average microsphere size (Figure 2C and D). 
C 
A B 
D 
D 
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3.2.2.1.2 The effect of the surfactant concentration on the microsphere size 
 Polyvinyl alcohol (PVA) concentration, which was used as a surfactant, was varied from 
0.5% w/v to 1% w/v as shown in Chapter 2, section 2.2.2, Table 2. For conditions 1 
(polymer concentration of 1g/L, PVA concentration of 0.5wt% and stirring rate of 
800rpm) and 2 (polymer concentration of 3g/L and stirring rate of 300 rpm), a lower 
PVA concentration of 0.5% w/v was used and in conditions 3 (polymer concentration of 
1g/L and stirring rate of 300 rpm) and 4 (polymer concentration of 3g/L and stirring rate 
of 800 rpm), a PVA concentration of 1% w/v was used in the emulsion phase. The mean 
particle size, as seen from Figure 3, increased with the decrease in the PVA concentration 
in the emulsion phase.  
 
Figure 3: - The effect of the surfactant concentration on the P(3HB) microsphere size sample 1 
(polymer concentration of 1g/L, PVA concentration of 0.5wt% and stirrer speed of 800 rpm), sample 
2 (polymer concentration of 3g/L, PVA concentration of 0.5wt% and stirrer speed of 300 rpm), 
sample 3 (polymer concentration of 1g/L, PVA concentration of 1wt% and stirrer speed of 300 rpm), 
sample 4 (polymer concentration of 3g/L, PVA concentration of 1wt% and stirrer speed of 800 rpm), 
plotted against particle size (µm).  
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3.2.2.1.3 The effect of stirring on the microsphere size  
In order to study the effect of stirring rate on the microsphere size, the stirring rate was 
maintained at 300 rpm and 800 rpm in the final emulsification step under varying PVA 
concentrations and P(3HB) concentrations, as explained in section 3.2.2.1.2. The 
microsphere sizes were 2 m and 1.54 m when prepared under conditions 1 (polymer 
concentration of 1g/L and PVA concentration of 0.5wt %) and 4 (polymer concentration 
of 3g/L and PVA concentration of 1wt %) with a stirrer speed of 800 rpm. Similarly, the 
microspheres prepared under condition 2 (polymer concentration of 3g/L and PVA 
concentration of 0.5wt% and 3 (polymer concentration of 1g/L and PVA concentration of 
1wt%) with a stirrer speed of 300 rpm exhibited an average size of 1.7 m and 1.58 m, 
respectively.
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3.2.2.1.4 The effect of stirring on the microsphere surface area 
The specific surface area of the microspheres prepared varied depending on the different 
conditions used as represented in Figure 4. An increase in the specific surface area was 
observed when the average particle size was decreased (Figure 4). The microspheres with 
an average particle size of 1.54 m and 1.58 m in diameter (sample 3 and sample 4 
Chapter 2, section 2.2.2, Table 2) exhibited a specific surface area of 9.60 m
2
/g and            
9.52 m
2
/g. However, microspheres with slightly larger particle size of 2 m and 1.7 m in 
diameter (sample 2 and sample 1, Chapter 2, section 2.2.2, Table 2), exhibited a specific 
surface area of 6.05 m
2
/g and 9.4 m
2
/g.  
 
 
Figure 4: - The specific surface area of the P(3HB) microspheres prepared using different conditions. 
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3.2.2.2 Surface morphology 
 The surface morphology of the microspheres prepared by the solvent evaporation 
method using different conditions was viewed under scanning electron microscopy 
(SEM) (Figure 5). The microspheres prepared under the different conditions as explained 
in section Chapter 2, section 2.2.2, appeared spherical in shape with a smooth surface 
morphology.  
 
Figure 5:- Scanning electron micrographs (SEM) of the P(3HB) microspheres prepared under 
different conditions described in Table 1 sample 1 (polymer concentration of 1g/L, PVA 
concentration of 0.5wt% and stirrer speed of 800 rpm), sample 2 (polymer concentration of 3g/L, 
PVA concentration of 0.5wt% and stirrer speed of 300 rpm), sample 3 (polymer concentration of 
1g/L, PVA concentration of 1wt% and stirrer speed of 300 rpm), sample 4 (polymer concentration of 
3g/L, PVA concentration of 1wt% and stirrer speed of 800 rpm). Numbers in the insets indicate size 
at magnification x22,000. 
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3.2.2.3 Surface hydrophobicity 
 The surface hydrophobicity of the microspheres fabricated using higher and lower 
concentrations of PVA was determined by comparing the amount of Rose Bengal dye 
that was adsorbed per mg of the microspheres.  As seen in Figure 6, the amount of Rose 
Bengal bound to the surface of the microspheres decreases with the increase in the PVA 
concentration. The microspheres fabricated under conditions 3 (polymer concentration of 
1g/L, PVA concentration of 1wt% and stirrer speed of 300 rpm) and 4 (polymer 
concentration of 3g/L, PVA concentration of 1wt% and stirrer speed of 800 rpm) 
exhibited a higher % residual PVA and hence bound a lesser amount of Rose Bengal Dye 
when compared to the microspheres fabricated under conditions 1 (polymer concentration 
of 1g/L, PVA concentration of 0.5wt% and stirrer speed of 800 rpm) and 2 (polymer 
concentration of 3g/L, PVA concentration of 0.5wt% and stirrer speed of 300 rpm).  For 
example, at the highest concentration of 12 mg/mL of Rose Bengal dye, the microsphere 
samples 3 and 4 bound 0.72 mg/mg and 0.63 mg/mg of the dye when compared to                
1.03 mg/mg and 1.07 mg/mg for the microsphere samples 1 and 2.  
 
Figure 6:- Amount of Rose Bengal Dye bound onto the surface of the P(3HB) microspheres sample 1 
(polymer concentration of 1g/L, PVA concentration of 0.5wt% and stirrer speed of 800 rpm), sample 
2 (polymer concentration of 3g/L, PVA concentration of 0.5wt% and stirrer speed of 300 rpm),  
sample 3 (polymer concentration of 1g/L, PVA concentration of 1wt% and stirrer speed of 300 rpm), 
sample 4 (polymer concentration of 3g/L, PVA concentration of 1wt% and stirrer speed of 800 rpm) 
as a function of an increase in the Rose Bengal dye concentration. 
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3.2.2.4 Zeta-potential analysis   
The microspheres prepared with a higher PVA concentration in conditions 3 (polymer 
concentration of 1g/L, PVA concentration of 1wt% and stirrer speed of 300 rpm) and 4 
(polymer concentration of 3g/L, PVA concentration of 1wt% and stirrer speed of                
800 rpm) at pH 7 exhibited a much lower zeta-potential value of -14.2 mV & -14 mV 
when compared to the zeta-potential values of -32.2 mV and -33.7mV of the 
microspheres prepared under conditions 1 (polymer concentration of 1g/L, PVA 
concentration of 0.5wt% and stirrer speed of 800 rpm)  and 2 (polymer concentration of 
3g/L, PVA concentration of 0.5wt% and stirrer speed of 300 rpm),  as seen in Figure 7. 
 
Figure 7:- The zeta-potential values of the P(3HB) microspheres fabricated using different conditions 
at pH 7.  
-40
-35
-30
-25
-20
-15
-10
-5
0
Z
et
a-
P
o
te
n
ti
al
 (
m
V
)
pH 7
Sample 1
Sample 2
Sample 3
Sample 4
  Chapter 3:Results 
100 
 
3.2.2.4.1 pH/Zeta-potential  
To measure the zeta-potential of the microsphere samples as a function of pH, a 
suspension of the microsphere samples were prepared 0.001 M HEPES buffer and the pH 
adjusted either with 0.1 M HCl or 0.1 M NaOH. From the zeta-potential-pH profiles it 
was observed that all the microspheres exhibited a negative surface charge at pH 7 as 
shown in Figure 7. However at a lower pH, the microspheres exhibited a positive zeta-
potential value (Figure 8). The microspheres fabricated using conditions 3 (polymer 
concentration of 1g/L, PVA concentration of 1wt% and stirrer speed of 300 rpm) and       
4 (polymer concentration of 3g/L, PVA concentration of 1wt% and stirrer speed of                
800 rpm) exhibited lower positive zeta-potential charge when compared to the 
microspheres fabricated using conditions 1 (polymer concentration of 1g/L, PVA 
concentration of 0.5wt% and stirrer speed of 800 rpm)  and 2 (polymer concentration of 
3g/L, PVA concentration of 0.5wt% and stirrer speed of 300 rpm).  
 
Figure 8:- The zeta-potential values of the P(3HB) microspheres fabricated using different conditions 
at  different pH . 
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3.2.4.1.2 Effect of zeta-potential on protein adsorption  
The comparison of protein (BSA) adsorption and zeta-potential of the microspheres 
fabricated under the different conditions are represented in Figure 9. From the results, the 
microspheres prepared under conditions 3 (polymer concentration of 1g/L, PVA 
concentration of 1wt% and stirrer speed of 300 rpm)  and 4 (polymer concentration of 
3g/L, PVA concentration of 1wt% and stirrer speed of 800 rpm) adsorbed a slightly 
higher amount of protein which was 327 mg/g and 324.4 mg/g when compared to 
315mg/g and 240mg/g of proteins adsorbed on the microspheres prepared under 
conditions 1 (polymer concentration of 1g/L, PVA concentration of 0.5wt% and stirrer 
speed of 800 rpm)  and 2 (polymer concentration of 3g/L, PVA concentration of 0.5wt% 
and stirrer speed of 300 rpm).  
 
Figure 9:- Amount of BSA adsorbed on the surface of the P(3HB) microspheres, sample 1 (polymer 
concentration of 1g/L, PVA concentration of 0.5wt% and stirrer speed of 800 rpm), sample 2 
(polymer concentration of 3g/L, PVA concentration of 0.5wt% and stirrer speed of 300 rpm),   
sample 3 (polymer concentration of 1g/L, PVA concentration of 1wt% and stirrer speed of 300 rpm), 
sample 4 (polymer concentration of 3g/L, PVA concentration of 1wt% and stirrer speed of 800 rpm) 
as a function of its zeta-potential. 
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3.2.2.5 Internal microstructure of the microspheres  
The internal microstructure of the microspheres fabricated using condition 4 as seen in 
Table 1 was examined using TEM (Figure 10). An individual microsphere was selected 
and cut to the desired thickness. Figure 10A shows the cross-section of a typical 
microsphere inside the focused ion beam (FIB) instrument. The TEM image of the cross-
section of the microsphere, Figure 10B, indicated that there were many nanosized pores 
inside the microsphere. The pore sizes were in the range of 5 to 20 nm. As seen in 
Figure 10C, the polymer appeared well crystallised with the crystals randomly oriented.  
3.2.2.5.1 Porosity  
All the microspheres prepared under different conditions as shown in Table 1 exhibited 
internal porosity which was measured using equation 6 as described in Chapter 2, section 
2.8.1.3. The average porosity of the microspheres prepared using condition 1, 2, 3 and 4 
(sample 1, 2, 3 and 4, Table 1), was 50%, 53%, 54% and 55% respectively.  
 
Figure 10:- A) Focussed Ion Beam images (FIB) showing the cross-section of a microsphere, (B) TEM 
image of a cross section of a microsphere, (C) Randomly oriented crystalline structure of P(3HB). 
Arrows indicating the presence of nanopores within the microsphere (B).  
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3.2.3 Determination of the encapsulation efficiency of P(3HB) microspheres 
In order to achieve higher drug loadings, the effects of polymer concentration, PVA 
concentration and stirring rate on encapsulation efficiency during microsphere 
preparation was investigated. In this study, gentamicin, a model drug with an initial drug 
loading of 2 mg/g was encapsulated within the microspheres fabricated using different 
conditions described in Chapter 2, section 2.3.1. In this study although the initial drug 
loading was kept constant, the highest encapsulation efficiency (equation 1, Chapter 2, 
section 2.4.1) of 48%, 34% and 32% were observed in microspheres that were prepared 
under the conditions 4, 3 and 2 respectively, as compared to 11% for the microspheres 
prepared under the condition 1. The  total amount of gentamicin present in the final PVA 
solution and the surface associated gentamicin bound to the microspheres are represented 
in Figure 11.  
 
 
Figure 11:- The percentage encapsulation efficiency, percentage of surface associated gentamicin and 
percentage of gentamicin present in the PVA solution of the gentamicin loaded microspheres, (n=3; 
error=±s.d). 
0
10
20
30
40
50
60
70
80
1 2 3 4
P
er
ce
n
ta
g
e 
%
P(3HB) microsphere samples 
% Encapsulation efficiency 
% Gentamicin present in PVA solution 
%Surface associated gentamicin
  Chapter 3:Results 
104 
 
3.2.4 Determination of drug-polymer interaction  
In order to study the effect of the drug-polymer interaction on the in vitro release kinetics 
of the drug, analysis such as XPS analysis, Fourier Transform Infrared (FTIR) and 
Dynamic scanning analysis were carried out. 
3.2.4.1 Elemental composition of the surface of the microspheres 
 The surface chemistry of the microspheres with the highest encapsulation efficiency of 
48% was investigated using XPS analysis. As shown in Figure 12, the presence of 
carbon, nitrogen and oxygen content present on the surface of the gentamicin-loaded 
microspheres was examined using a soft X-Ray excitation. Nitrogen present in 
gentamicin was used to estimate the amount of drug entrapped during the microsphere 
fabrication procedure. The surface chemical composition of the tested sample was found 
to be 67.29% carbon, 31.25% oxygen and 1.05% of nitrogen. The binding energy of 
nitrogen N-1s is Eb=399.5 eV which corresponds to the single bonded nitrogen as shown 
in Figure 13B.
 
The binding energy of the nitrogen N-1s present on the gentamicin-loaded 
microspheres was found to be 396.13 eV, which was quite close to the value for singly 
bonded nitrogen. 
 
Figure 12:- A) XPS spectra of gentamicin loaded P(3HB) microspheres,  B) Magnification of the 
nitrogen peak with a binding energy of 396.13 eV is depicted. 
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3.2.4.2 Fourier Transform Infrared studies (FTIR)  
 FTIR spectra of the unloaded P(3HB) microspheres and gentamicin loaded P(3HB) 
microspheres were carried out to identify the possible chemical drug-polymer interaction. 
The FTIR spectra of the unloaded P(3HB) microspheres is shown in  Figure 13A,  where 
the absorption bands at 980cm
-1
, 1230cm
-1
 , 1282cm
-1
 and 1782cm
-1
 were attributed to 
the crystalline phase of the polymer and bands at 1184cm
-1
 and 1741cm
-1
 were attributed 
to the amorphous phase of the polymer. The stretching vibrations of the amorphous and 
crystalline carbonyl groups were seen at 1741cm
-1
 and 1728cm
-1
. (Vallapil et al., 2007; 
Shih et al., 2006). The characteristic peaks for the gentamicin spectrum seen at 
wavenumbers 1642cm
-1
, attributed to the secondary amide bond was not seen in the 
gentamicin loaded microspheres (Figure 13B). Due to the low concentration of 
gentamicin in the P(3HB) microspheres,  no chemical shift in the FTIR spectra of P(3HB) 
in the presence of gentamicin was observed, hence, no possible covalent bonding had 
taken place between gentamicin and P(3HB). 
 
 
Figure 13: FTIR spectrum of (A) P(3HB) microspheres (B) Gentamicin loaded P(3HB) microspheres.
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3.2.4.3 Thermal analysis of the microspheres  
 Differential Scanning Calorimetry (DSC) was used to determine the thermal properties 
of the gentamicin loaded and unloaded P(3HB) microspheres (Table 1). The melting 
temperature (Tm) of the polymer on its own was 175.76 C, the unloaded P(3HB) 
microspheres were 174.72 C and the gentamicin loaded microspheres was 174.46 C. The 
thermograms obtained from DSC for the polymers, unloaded P(3HB) microspheres and 
gentamicin loaded P(3HB) microspheres, are shown in Figure 14 (A, B & C). 
The crystallinity (%Xc) of the crude polymer P(3HB) microspheres and the gentamicin 
loaded P(3HB) microspheres were 50.44 %, 47.83 %, 44.72 % respectively as calculated 
using equation 9, Chapter 2, section 2.8.2.1. 
The Tg of the crude polymer was around 4.35 C, which was lower than that of the 
P(3HB) microspheres and the gentamicin loaded P(3HB) microspheres which were               
4.60 C and 4.98 C, respectively. The Tg value of the gentamicin loaded microspheres 
before immersion in SBF was 4.98 C which was much higher when compared to 4.60 C 
of the unloaded P(3HB) microspheres before immersion.  
Gentamicin a complex mixture made up of three major components, gentamicin C1 with a 
Tm of   94-100 C, gentamicin C1a and gentamicin C2 with a Tm of 107 C and 124 C did 
not appear as a separate peak in the DSC thermograms of the gentamicin loaded 
microspheres as seen in Figure 13C, when compared to the thermograms of the P(3HB) 
microspheres. 
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Table 1:- The thermal properties of the crude polymer, P(3HB) microspheres and gentamicin loaded 
microspheres measured using DSC (n=3). 
 
 
 
 
 
 
 
 
 
 
Figure 14:- The DSC thermograms of the A) crude P(3HB), B) unloaded P(3HB) microspheres and  
C) gentamicin loaded microspheres (n=3).   
 
 
Thermal Properties Tg (ºC ) %Xc  Tm (ºC ) 
Crude Polymer 4.35 50.44 175.76 
P(3HB) microspheres 4.6 47.83 174.72 
Gentamicin loaded 
P(3HB) microspheres 
4.98 44.72 174.46 
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3.2.5 In vitro degradation of the P(3HB) microspheres  
 The water uptake and weight loss studies of the gentamicin loaded and unloaded 
P(3HB) microspheres carried out in simulated body fluid (SBF) over a period of 30 
days are represented in Figure 15. The % water adsorption (% WA) for the gentamicin 
loaded microspheres exhibited a gradual increase from 507% to 552% over a period 
of 30 days when compared to the % WA of 228.11% to 584% from day 1 to day 30 of 
the unloaded P(3HB) microspheres (Figure 15A). Similarly, the % weight loss         
(% WL) of the gentamicin loaded microspheres also increased from 37% to 87% from 
day 1 to day 30 when compared to the %WL of 5.81% to 11.75% of the unloaded 
P(3HB) microspheres as seen in Figure 15B. 
 
Figure 15:- In vitro degradation study of A) unloaded P(3HB) microspheres and B) the 
gentamicin loaded P(3HB) microspheres immersed in simulated body fluid (SBF) showing (% 
water absorption and % weight loss) (n=3; error bars =  SD). 
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A gradual change in the pH of SBF was observed with the increase in the immersion time 
of the gentamicin loaded microspheres (Figure 16). The pH of SBF with the unloaded 
P(3HB) microspheres changed from 7.25 to 7.00 over a period of 30 days. However, the 
pH of SBF with the gentamicin loaded P(3HB) microspheres changed from 7.0 to 6.85 
over a period of 30 days as seen in Figure 16. 
 
 
 
Figure 16:- pH changes observed in the SBF solution containing unloaded P(3HB) microspheres and 
Gentamicin loaded P(3HB) microspheres on day 1, day 15 and day 30, (n=3; error bars =  SD). 
 
3.2.5.1 Effect of water adsorption on the thermal properties of the gentamicin loaded and 
unloaded P(3HB) microspheres as a function of time 
The thermal properties of the gentamicin loaded and unloaded P(3HB) microspheres after 
the in vitro degradation studies in SBF were also investigated (Figure 17). The DSC 
thermograms of the gentamicin loaded and unloaded P(3HB) microspheres are 
represented in Figure 17A, and 17B.  
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Figure 17:- A comparison of the thermal properties of the A) unloaded P(3HB) and B) gentamicin 
loaded microspheres  measured using DSC at day 1, days 15 and    day 30 (n = 3; error bars=±SD). 
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The Tg value of the unloaded P(3HB) microspheres remained almost constant after 
immersion in SBF, only a slight change from 4.60 C to 4.53 C was observed after 
immersion for over a period of 30 days. However the Tg value of the gentamicin loaded 
microspheres decreased from 4.98 C before immersion to 4.62 C after immersion in SBF 
for over a period of 30 days (Figure 16). 
Changes in the other thermal properties such as the degree of crystallinity (%Xc) and 
melting temperature (Tm) were also observed in both the unloaded and gentamicin loaded 
P(3HB) microspheres  before and after immersion in SBF over a period of 30 days. The 
%Xc of the gentamicin loaded P(3HB) microsphere before immersion was 44.72%, 
however after immersion in SBF for 1 day the %Xc was reduced to 36.03%. The %Xc of 
the unloaded P(3HB) microspheres before immersion was 47.83% and after immersion it 
reduced to 46.67%. The %Xc of the gentamicin loaded P(3HB) microspheres on 
prolonged immersion in SBF for a period of 30 days was reduced from 36.03% to 34.4% 
and 27.06% on day 1, day 15 and day 30 respectively, when compared to the %Xc values 
of the unloaded P(3HB) microspheres which was 46.67 %, 46.26 % and 42.10%  on            
day 1, day 15 and day 30 respectively.   
The Tm values of the gentamicin loaded microspheres before immersion in SBF was 
174.46 C, which was reduced to 167.78 C after immersion in SBF for 1 day and 
continued to decrease to 167.73 C and 167.71 C over a period of 30 days.  The Tm values 
of the unloaded P(3HB) microspheres were 174.72 C before immersion in SBF and 
reduced to 174.33 C after immersion in SBF for 1 day and continued to decrease to 
173.61 C and 173.51 C over a  period of 30 days.     
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3.2.6 In vitro release studies 
The cumulative in vitro release of gentamicin from P(3HB) microspheres prepared using 
condition 4 (sample 4) is shown in  Figure 18. In this study the release profile is seen to 
be biphasic, where an initial burst release was observed followed by controlled release. 
Gentamicin released from the microspheres in the SBF solution at 37 C of pH 7.4, was 
measured after periods of 1 h, 5 h, 12 h and 20 h. During the initial burst release phase          
(0 minutes to 1 hour) the drug released was 90.56 g/mL, which was 60 % of the total 
encapsulated drug. This phase was followed by the controlled release period which was 
from 5 hours to 12 hours, where small amounts of the drug i.e 24.56 g/mL to 18 g/mL 
slowly diffused from the microspheres into the release buffer. Finally, after 20 h, the 
cumulative drug release was 95.33%.  
                                            
 
 
Figure 18:- In vitro gentamicin release profile from P(3HB) microspheres  (sample 4) (n = 3; error 
bars=±SD). 
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3.3 Discussions  
Biodegradable polymers have been used in a number of different forms such as tablets, 
films and rods; however the interest in microencapsulation of the drugs within the 
polymeric device such as microspheres for drug delivery has accelerated.  Thus, in this 
study a solid/oil/water emulsion (s/o/w) technique was used to fabricate the gentamicin 
loaded microspheres, so that a higher drug loading as well as higher encapsulation 
efficiency can be achieved. Three important factors such as the surfactant concentration, 
polymer concentration and the stirring rate were varied to study its effect on the 
microsphere structure.                  
3.3.1 The effect of polymer concentration on the microsphere size 
The amount of P(3HB) used per unit volume of the solvent in this study was varied from 
1g to 3g respectively. Microspheres prepared under conditions 1 and 2 had an average 
size of 1.7 m and 2 m, as shown in Figure 1A and B.  These microspheres were slightly 
larger than microspheres prepared under conditions 3 and 4 (Figure 1C and D) which 
were of mean size 1.58 m and 1.54 m respectively. The effect of varying the polymer 
concentration on the final microsphere structure was studied. The size of the 
microspheres prepared using lower concentrations of P(3HB) such as the microspheres 
prepared using conditions 1 were slightly smaller than the microspheres prepared using 
higher concentrations of P(3HB) (condition 2). It was observed that at higher 
concentrations of the polymer in the emulsion phase, the viscosity of the solution 
increases. At higher viscosities the solution is difficult to disperse due to which slightly 
larger microspheres are produced (Yang et al., 2001).  However the microspheres 
prepared using conditions 4 in this study with polymer concentrations of 3 g/L exhibited 
a smaller particle size when compared to the microspheres prepared using conditions 3. 
Although the increasing polymer concentration of 3 g/L in condition 4 had increased the 
viscosity of the emulsion phase other factors such as surfactant concentration and stirrer 
speed would have dominated contributing to the small size of the microspheres. 
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3.3.2 The effect of the surfactant concentration on the microsphere size 
In this study PVA was used as the surfactant and the concentrations of PVA in the first 
emulsion phase were varied to study its effect on the microsphere particle size.                 
The PVA concentration in the emulsion phase was varied from 0.5% w/v to 1% w/v.                     
An increase in the PVA concentration from 0.5% w/v to 1% w/v resulted in slight 
differences in the sizes of microspheres such as microspheres prepared under conditions 1 
and 2 had an average size of 1.7 m and 2 m and the microspheres prepared under 
conditions 3 and 4 which were of mean size 1.58 m and 1.54 m respectively. In 
addition, the microspheres had a smoother finish to the surface and were not coalesced 
together. An optimal viscosity of the emulsion phase is often required as this prevents the 
solids from precipitating out of the solution leading to the formation of smoother finished 
microspheres (Yang et al., 2001).  For e.g. in a study conducted by Yang et al.,  it was 
observed that at lower PVA concentrations such as 0.025% w/v, the water droplets inside 
the microspheres coalesced with each other, thereby forming interconnecting water 
channels which increased the release rate of BSA. These water channels then increased in 
size eventually leading to the collapse of the microspheres (Yang et al., 2001).  Higher 
concentrations of PVA on the other hand is known to increase the viscosity of the 
external phase, thus making it increasingly difficult to break the emulsion droplets into 
smaller sizes. Hence, larger microspheres are produced. However in this study only slight 
differences in the microsphere sizes were observed with increasing PVA concentrations 
as there is a maximum PVA concentration which influences the size of the microsphere 
beyond which an increase in the viscosity due to the PVA concentration does not have 
any further influence on the size of the microspheres and the stirrer speed was found to be 
the dominant factor.  
Once the microspheres were prepared they were washed three times with water to remove 
the presence of any residual PVA that was present on the surface of the microspheres. 
Residual PVA on the surface of the microspheres can have a significant effect on the 
physical properties of the microspheres such as the surface charge, surface 
hydrophobicity, in vitro drug release rate and rate of protein adsorption (Sahoo et al., 
2002). In this study despite the washings, residual PVA was still found associated with 
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the microspheres. Samples 1 and 2 (condition 1 and 2) exhibited a lower percentage of 
residual PVA which was 0.14% and 0.13% when compared to 0.6% and 0.54% of                
% residual PVA present in samples 3 and 4 (condition 3 and 4). After solvent 
evaporation, PVA is generally known to be bound irreversibly on the surface of the 
microspheres. The amount of PVA that binds to the curvature of the microspheres is 
again dependent on the microsphere size (Lee et al., 1999). It was observed that with the 
decrease in the microsphere size and an increase in the PVA concentration, the PVA 
transfer rate from the oil/water interface onto the newly formed curved interface of the 
microsphere would increase (Lee et al., 1999). This observation was in agreement with 
the results obtained in this study, where an increase in the PVA content on the surface of 
the microspheres was observed, when the PVA concentration in the external phase was 
increased. Lee et al., also observed that when PVA concentrations of 0.1% w/w, 1% w/w 
and 10% w/w were used, the PVA content on the surface of the PLGA microspheres 
varied from 7.4 mg/g, 15.2 mg/g, 23.7 mg/g, thus a higher concentration of PVA was 
observed on the microspheres prepared using 10% w/w of PVA (Lee et al., 1999). 
As expected, the surface area of the microspheres increased with a decrease in the 
average size of the microspheres. The microspheres with a higher specific surface area 
also exhibited an increase in the higher % residual PVA adsorbed on the surface. 
Researchers like Poletto et al., have also observed an increase in the specific surface area 
from 33m
2
/g to 120m
2
/g of the P(3HB-co-3HV) microspheres when the particle size was 
reduced from 360 m to 190 m (Poletto et al.,2007).  
3.3.3 The effect of stirring rate on the microsphere size 
In order to study the effect of stirring rate on microsphere size, the stirring rate was 
maintained at 300 rpm and 800 rpm in the final emulsification step under varying PVA 
and P(3HB) concentrations. The microsphere sizes were 1.7 m and 1.54 m when 
prepared under conditions 1 and 4 (sample 1 and 4, Table 1), with a stirrer speed of             
800 rpm. Similarly, the microspheres prepared under condition 2 and 3 (sample 2 and 3, 
Table 1), with a stirrer speed of 300 rpm exhibited an average size of 2 m and 1.58 m 
respectively. It has been previously observed that at an increased stirring rate of 800 rpm, 
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the microsphere size is significantly reduced (Kassab et al., 1997).  From the results 
obtained in this study, it can be concluded that the stirrer speed may have contributed to 
the small size of the microspheres. A highly viscous solution is difficult to disperse at a 
lower stirrer speed, due to which larger sized microspheres are produced. Martin et al., 
observed the formation of larger P(3HB) microspheres of 100 m to 250 m when the 
stirrer speed was reduced to 500 rpm when compared to the smaller microspheres              
(5 to 10 m) produced when the stirrer speed was increased to 800 rpm (Martin et al., 
2000). Similar observations were made in this study where at a higher stirrer speed of 800 
rpm smaller sized microspheres were produced when compared to those produced at 300 
rpm. Thus the stirrer speeds could have provided the required energy to disperse the oil 
phase in water producing smaller sized microspheres. It was also observed that the 
average microsphere size in this study varied from only 1 to 5 m despite the increasing 
viscosity of the emulsion phase in the presence of both PVA and polymer. In this study 
the effect of the stirrer speed had a dominant effect on the microsphere size as there is a 
maximum viscosity which influences the size of the microsphere beyond which an 
increase in the viscosity due to the PVA and polymer concentration does have any further 
influence on the size of the microspheres (Yang et al., 2001). 
 
3.4 Microsphere characteristics  
3.4.1 Surface morphology 
In this study, the surface morphology of the microspheres analysed using SEM revealed 
the presence of uniform spherical shaped microspheres, under the different preparation 
conditions used. The type of solvent and the volume used also influenced the surface 
morphology of the microspheres. In this study chloroform was chosen as the solvent as 
opposed to dichloromethane due to lesser miscibility of chloroform in water, which is 1 
in 200 parts when compared to dichloromethane, which is 1 in 50 parts (Sahoo et al., 
2002). An increased amount of PVA is known to partition into the polymer phase when 
the organic solvent exhibits an increased miscibility in water because of higher 
hydrophillicity (Sahoo et al., 2002). Thus in order to avoid a higher deposition of residual 
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PVA on the surface of the microspheres chloroform was used as the solvent. Although 
the presence of residual PVA was detected on the surface of the microspheres, the small 
amount of surface associated PVA may have not contributed to the changes in the surface 
morphology. The volume of chloroform used in this study however would have 
contributed to the production of uniform, spherical shaped microspheres. A decrease in 
the volume of the solvent is also known to affect the surface morphology of the 
microspheres thereby increasing the number of surface pores at a lower volume of the 
solvent. At a lower solvent volume the water droplets entrapped within the microspheres 
are known to evaporate leaving behind empty spaces both on the surface as well as within 
the microspheres thus contributing to a rough surface morphology. However in this study, 
since no surface associated pores were observed, the volume of the solvent may have 
been optimal for the production of smooth microspheres. Yang et al., observed a rough 
surface morphology with increased surface porosity when a low volume of methylene 
chloride was used as the solvent for the fabrication of PCL and PLGA (65:35) 
microspheres (Yang et al., 2001).  
3.4.2 Surface Hydrophobicity 
Microspheres fabricated with a higher PVA (1%) concentration appeared to be more 
hydrophilic in nature as compared to those that were formulated with 0.5% PVA, as seen 
from the lesser amounts of Rose Bengal Dye bound to their surfaces. In a relevant study 
Sahoo et al., observed a lower binding of 0.005µg/mL of Rose Bengal dye on the surface 
of nanoparticles which were formulated with 5% PVA when compared to 0.024µg/mL 
bound on nanoparticles formulated with a 0.5% PVA concentration. During microsphere 
preparation, hydrophobic ends of PVA penetrate into the organic phase and interact with 
P(3HB) microspheres due to which an irreversible binding of PVA occurs on the surface 
of microspheres when the solvent evaporates. An increased amount of PVA is known to 
partition into the polymer phase when the organic solvent exhibits an increased 
miscibility in water because of higher hydrophilicity. Since PVA is a hydrophilic 
polymer, therefore the higher amount of residual PVA on the surface of the microspheres 
would have accounted for the higher hydrophilicity (Sahoo et al., 2002).
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3.4.3 Zeta-potential analysis 
The zeta-potential values reflected the change in the surface charge due to the deposition 
of PVA on the surface of the microspheres (Wang et al., 2007). The COOH groups on the 
microspheres exhibited a negative charge at due to deprotonation (pH 7), however at a 
lower pH a charge reversal from negative to positive was observed. This phenomenon 
was observed for all microspheres prepared using different conditions. Similarly, 
decreases in positive zeta-potential values were observed when the concentration of 
residual PVA on the surface of microspheres was increased. Often non-ionic surfactants 
such as PVA are known to strongly adhere on the microsphere surface by anchoring the 
hydrophobic tail into the polymer only when it is hydrophobic, leaving the polar head 
protruded on the surface (Sahoo et al., 2002). During the microsphere preparation, 
hydrophobic ends penetrate into the organic phase and interact with P(3HB) microspheres 
due to which an irreversible binding of the PVA occurs on the surface of microspheres 
when the solvent evaporates. Thus, when P(3HB) is fabricated into microspheres, PVA 
used as a surfactant coats the surface thereby shielding the surface charge of PHB. Due to 
this, P(3HB) processed into microspheres carries a much less negative charge at neutral 
pH when compared to the negative charge of the neat P(3HB) (-40 mV at neutral pH). In 
acidic solutions such as pH <4.0, C═O of the ester present on the surface of microspheres 
gets protonated. As a result, at lower pH the negative surface charge is reversed to a 
positive surface charge. Similar observations were also made by Lee et al., [18] who 
showed that with an increase in PVA concentration from 0.5% to 5%, the zeta-potential 
values of the PLGA nanoparticles decreased from -15.4 mV to -08.0 mV at neutral pH. 
However in acidic solutions (pH<5.0), the zeta-potential values of microspheres with 
lower PVA concentration (0.5% w/v) showed a relatively high positive charge when 
compared to the lower surface charge of microspheres prepared with higher PVA 
concentration (1% w/v) (Lee et al., 2002).  
3.4.3.1 Effect of zeta-potential on protein adsorption 
 The changes in the surface properties of the microspheres can have a significant impact 
on their use for biological applications (Patil et al., 2007). Thus in this study the protein 
adsorption in the presence of varying surface charges were studied. In this study, a higher 
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amount of protein was adsorbed on microspheres with a lesser negative charge when 
compared to those with a higher negative charge. BSA adsorption on a surface of an 
adsorbent at a neutral pH occurs due to electrostatic interactions. Since BSA is negatively 
charged at neutral pH and the microspheres fabricated using different conditions also 
exhibited a negative surface charge at neutral pH, other interactive factors such as van der 
Waals, and steric interactions could have also contributed to the protein-adsorbent 
interaction (Robertson et al., 1990). Similar observations were made by Patil et al., where 
10 mg/mg (nanoparticles) of protein adsorption on the nanoparticles with a negative 
charge of -17.72 mV was observed. However 67.40 mg/mg (nanoparticles) of protein 
adsorbed on cerium oxide nanoparticles with a zeta-potential charge of 59.32 mV. The 
authors‟ had observed an increasing protein adsorption on nanoparticles with a positive 
zeta-potential charge, further confirming that the electrostatic interaction was the primary 
reason for the protein adsorption.  
3.4.4 Porosity 
In this study, the internal porosity within the microspheres measured using the liquid 
displacement technique showed no significant differences in the differently sized 
microspheres. During the formation of the microspheres after the solvent is removed, the 
water droplets within the microspheres are quickly trapped, which are later dried out 
leaving pores behind. The outer wall of the microspheres prevents further influx of water 
and the formation of large water droplets within the microspheres (Yang et al., 2001). 
The interpenetration of the surfactant at higher concentrations within the polymer matrix 
prevents the coalescing of the water droplets together and formation of one hollow core 
within. However at lower concentrations of PVA the water droplets are known to 
coalesce with each other forming interconnecting water channels eventually forming 
much non-uniform bigger pores. Yang et al., also observed the formation of much bigger 
pores when low PVA concentrations of 0.025% w/v was used. However, in the presence 
of 0.5% w/v of PVA the water droplets were stabilised preventing them from coalescing 
thus leading to uniform internal porosity. Thus in this study, the rapid solidification of the 
microspheres as well the PVA concentration from 0.5% w/v and 1% w/v was optimal and 
contributed to an even pore distribution throughout the polymer matrix. 
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3.4.5 Determination of the encapsulation efficiency of P(3HB) microspheres 
In another part of this study, the microspheres prepared under the different conditions 
were loaded with the drug gentamicin during microsphere formation to study the efficacy 
of these microspheres as drug delivery vehicles. Thus in order to achieve higher 
encapsulation efficiencies various factors such as drug/polymer ratio, type of solvent, and 
PVA concentrations on the encapsulation efficiencies were studied. In this study the drug 
concentration was kept constant at 2 mg/g (during microsphere preparation, Chapter 2 
section 5.3.1) and the polymer and PVA concentration varied. The microspheres prepared 
under condition 4, exhibited the highest encapsulation efficiency of 48% when compared 
to the microspheres produced using other conditions. In this study, the faster rate of 
solvent removal in the microspheres with a smaller size led to the rapid entrapment of the 
drug. Sendil et al., also observed an increase in the encapsulation efficiency with a 
decrease in microsphere size. P(3HB-co-3HV) microspheres with average size of 399 m 
in diameter exhibited lower encapsulation efficiency of 20.2% when compared to 30.1% 
encapsulation efficiency exhibited by the smaller microspheres (340 m) (Sendil et al., 
1999).  
Microspheres fabricated with higher concentrations of PVA are to known to yield stable 
emulsions which prevent the transfer of the encapsulated drugs into the surroundings; as a 
result the drug is more evenly distributed within the interior of the microspheres (Yang et 
al., 2001). This could also explain the higher encapsulation efficiency of gentamicin in 
the P(3HB) microspheres fabricated with a higher PVA concentration used in this study 
when compared to the lower encapsulation of 11% observed within the P(3HB) 
microspheres fabricated with a lower PVA concentration.  
 
Variations in the polymer/drug ratio influence the encapsulation efficiency (Wang et al., 
2007). In the presence of high concentrations of the polymer and fixed drug 
concentrations, higher concentrations of the drug are encapsulated within the 
microspheres thus exhibiting higher encapsulation efficiency (Wang et al., 2007). This 
could be another reason why higher encapsulation efficiency was observed in sample 4 
where an increased polymer content of 3g was used when compared to the microspheres 
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fabricated with a lower polymer content of 1g. In this study, the highest encapsulation 
efficiency of 48% was observed in microspheres that were prepared under condition 4 
(sample 4), were chosen for the in vitro drug release studies.  
3.4.6 Determination of drug-polymer interaction 
Other analyses such as XPS, FTIR and thermal analysis were also carried out on these 
particular microspheres to study the changes in the physicochemical properties of the 
polymer in the presence of the drug. 
3.4.6.1 Elemental composition of the surface of the microspheres 
The assessment of the gentamicin adsorption on the microsphere surface prepared under 
condition 4 (sample 4, Table1) was done on the basis of nitrogen content present on the 
samples since the nitrogen species is unique to the drug and is absent in the P(3HB) 
microspheres. From the XPS data a significant increase in the nitrogen content on the 
surface of the gentamicin loaded samples was observed when compared to the unloaded 
P(3HB) microspheres, where, as expected, only carbon and oxygen were seen. This result 
therefore indicated that apart from being encapsulated, some amount of gentamicin was 
bound onto the microsphere surface. Similar results were also observed by Naraharisetti 
et al.. They also observed the presence of surface bound drugs (gentamicin) on the 
microspheres made using poly-L-lactide (PLLA) and copolymers of DL-lactic-co-
glycolic acid (PLGA) (Naraharisetti et al., 2005). The microspheres with the highest 
encapsulation efficiency of 64.5% and largest particle size of 308 m in diameter 
exhibited the highest % of nitrogen on the surface, which was 2.01%. This indicated that 
gentamicin, in addition to being encapsulated within the microspheres, it was also found 
on the surface (Naraharisetti et al., 2005). 
3.4.6.2 Fourier Transform Infrared studies (FTIR)  
The drug and polymer interaction can play a very important role in the drug release 
characteristics. This chemical interaction between the drug/polymer is known to affect 
the in vitro release profile (Stephens et al., 2000). In this study Fourier Transform 
Infrared spectroscopy (FTIR) was used to analyse the possible interaction between the 
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drug gentamicin and P(3HB). From the FTIR results the characteristic bands of 
gentamicin at 1642cm
-1 
attributed to the secondary amide structure was not detected in 
the microsphere samples loaded with the gentamicin. The concentration of the drug 
present within the microspheres could have been too low to detect any interaction with 
the polymer using a not so sensitive technique such as FTIR. Some researchers such as 
Stephens et al., have used other techniques such as NMR and mass spectroscopic analysis 
to study the effect of the drug on the drug release rate. From the results the authors‟ 
observed that the drug release was retarded due to the amide formation between 
gentamicin sulphate and the polyanhydride matrix (Stephens et al., 2000). Although 
FTIR analysis revealed no possible bond formation in this study, more sensitive 
techniques such as NMR and mass spectroscopic analysis should be employed in the 
future. 
3.4.6.3 Thermal analysis of the microspheres (DSC) 
Differential Scanning Calorimetry is also another method of detecting the existence of a 
possible interaction between the drug and the polymer. In this study the thermal 
behaviour of the crude polymer, unloaded P(3HB) microspheres and the gentamicin 
loaded microspheres were compared to study the effect of the processing conditions and 
drug loading on the thermal properties of the polymer. From the thermograms of the 
crude polymer and the unloaded microspheres obtained from DSC, it was noticed that the 
glass transition temperature (Tg) of the unloaded polymer had increased from 4.35 C to                  
4.6 C. This indicated that the processing conditions of the polymer had increased the 
crystallinity of the polymer (Martin et al., 2000). Also, an increase in the Tg value 
(4.98 C) of the gentamicin loaded microspheres were also observed when compared to 
the unloaded P(3HB) microspheres. This difference in the Tg values between the 
gentamicin loaded and unloaded P(3HB) microspheres indicated that with an increase in 
the concentration of the emulsion in the presence of the drug, the mobility of the polymer 
chains is reducing the  Tg value of the polymer (Chang et al., 2006). The Tm of the 
gentamicin loaded microspheres of 174.46 C was also lower than that of the unloaded 
P(3HB) microspheres, indicating that the crystalline properties of the gentamicin loaded 
P(3HB) microspheres decreased in the presence of the drug, probably due to the
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 incorporation of the drug within the crystalline structure of the polymer hence disrupting 
the crystal structure. However, from the DSC thermograms of the gentamicin loaded 
P(3HB) microspheres in this study, the thermal properties of only the polymer dominated 
the thermogram and no thermal properties of the drug itself could be observed. The drug 
ratio of drug/polymer was too low to be detected as a result the thermal properties of the 
drug itself could not be detected. Researchers like Bidone et al., have also observed a 
decrease of 10 C in the Tm of ibuprofen loaded P(3HB) microspheres when compared to 
the unloaded P(3HB) microspheres. It was found that ibuprofen had coexisted as both a 
crystalline and molecular dispersion within the P(3HB) matrix thereby affecting the 
crystalline properties of the polymer in the microspheres. The thermal properties of 
ibuprofen were observed in the DSC thermograms due to the crystalline properties of the 
drug within the P(3HB) microspheres (Bidone et al., 2009). 
In this work the crystalline properties of the polymer were also altered after the solvent 
evaporation procedure as well as in the presence of the drugs. Shih et al. also conducted a 
study where P(3HB) and chitosan microspheres were synthesised using a single and 
double emulsion method and analysed by X-ray diffraction and FTIR techniques to 
identify the interaction of PVA used as a surfactant in the emulsion phase. From the 
results a minor phase indicative of PVA was observed in the XRD and FTIR data. This 
result indicated that the solvent evaporation techniques had an influence on the physical 
properties of the polymer (Shih et al., 2007). Thus for this study the presence of PVA 
used for the fabrication of the microspheres would have acted as an impurity thus 
influencing the crystalline properties of the P(3HB).  
3.4.7 In vitro degradation studies 
 In this study the water uptake and weight loss studies of the unloaded P(3HB) 
microspheres and the gentamicin loaded microspheres were carried out for a period of 30 
days to investigate the influence of the drug on the degradation properties of the 
microspheres. The gentamicin loaded microspheres exhibited a higher weight loss when 
compared to the unloaded P(3HB) microspheres. Similarly the water absorption by the 
gentamicin loaded microspheres also gradually increased exhibiting a simultaneous 
increase in the weight loss over a period of 30 days. For the gentamicin loaded P(3HB) 
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microspheres, the presence of the hydrophilic drug as well the % residual PVA on the 
surface of the microspheres would have also contributed to the increased water uptake 
when compared to the unloaded P(3HB) microspheres with just a coating of PVA. The 
water adsorption in the gentamicin loaded microsphere also increased due to the higher 
solubility or hydrophillicity of the drug (Frank et al., 2004). In this study, the rapid 
dissolution of the drug may have created additional pores leading to the increased water 
uptake and subsequent weight loss of the gentamicin loaded microspheres due to 
hydrolysis when compared to the unloaded P(3HB) microspheres. Bazzo et al., observed 
the rapid ingress of water within the P(3HB) microspheres due to the desorption of the 
drug crystals (Piroxicam) on the surface of the microspheres, this further led to the 
increased water uptake within the pores (sizes between 40 to 100Å) created due to the 
drug solubilisation in the dissolution medium (Bazzo et al., 2008). However the water 
adsorption in the unloaded microspheres in this study was relatively low when compared 
to the gentamicin loaded P(3HB) microspheres with no appreciable water uptake due to a 
physical properties of the polymer such as high crystallinity. 
3.4.7.1 Effect of water adsorption on the thermal properties of the gentamicin loaded and 
unloaded P(3HB) microspheres as a function of time 
In this study the thermal properties of the gentamicin loaded and unloaded P(3HB) 
microspheres were compared after the immersion studies in SBF, in order to investigate 
the effect of water adsorption and simultaneous degradation on the thermal properties as a 
function of time. The results from this study showed that no significant changes occurred 
in the Tg values of both the unloaded and gentamicin loaded P(3HB) microspheres after 
immersion in SBF on day 1 when compared to the microspheres before immersion. The 
high crystallinity of the polymer may have contributed to the insignificant changes in the 
Tg values on day 1 of both the gentamicin loaded and unloaded P(3HB) microspheres 
(Frank et al.,2004). However, with the increase in the immersion time (from day 1 to day 
15), the gentamicin loaded microspheres as well as the unloaded microspheres exhibited a 
reduction in the Tg value, which also coincided with the increased water uptake of the 
microspheres. A similar trend in the reduction of the Tg values of both the gentamicin 
loaded and unloaded P(3HB) microspheres were observed until day 30 with the highest 
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reduction in the Tg values observed for the 30 days immersion sample. This decrease in 
the Tg value occurred alongside an increase in the water uptake of the microspheres. 
Hence, the polymer chains must become more mobile due to the presence of water 
(Siepmann et al., 2001). Therefore, with the increase in the water uptake into the 
polymeric matrix, the Tg is reduced, causing the polymer chains to be more mobile 
(Siepmann et al., 2001).  Frank et al., made a similar observation when the Tg values of 
the lidosalt-loaded poly(lactide-co-glycolide) (PLGA) microspheres started to decrease 
after about 14 days of immersion in the buffer. During the initial lag phase the Tg value 
was 39 C after which the Tg value reached about 33 C after 30 days. A linear decrease in 
the Tg values along with the molecular weight was also observed (Frank et al., 2004). 
The degree of crystallinity (%Xc) and Tm values for the gentamicin loaded P(3HB) 
microspheres also exhibited a significant reduction (n=3,***p<0.001) from day 1 to day 
30 when compared to the unloaded P(3HB) microspheres over a period of 30 days. This 
change in the %Xc and Tm values of the gentamicin loaded microspheres was possibly 
due to the initial degradation that takes place in the amorphous region, followed by the 
degradation caused due to the chain scission in the crystalline domains, thus decreasing 
the overall crystallinity of the polymeric matrix.  
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3.4.8  In vitro release studies  
The in vitro drug release rate is largely dependent on the size of the microspheres (Edlund 
et al.,2002). Larger microspheres (100-300 m) tend to release the drug slowly and for a 
much longer time when compared to the smaller microspheres (Berkland et al., 2002).  
This slow release is due to the reduced drug diffusion path within microspheres and the 
decreased specific surface area of larger microspheres when compared to smaller 
microspheres. Thus in this study, drug release within a period of 24h was observed which 
can probably be attributed to the small size (1.54 m in diameter) of the microspheres.  
The in vitro drug release is also dependent on the drug distribution within the 
microspheres. The high initial burst release is often attributed to the presence of surface 
associated drugs (Kassab et al., 1997). In this study gentamicin, in addition to being 
encapsulated within the microspheres, was also adsorbed on the surface of the 
microspheres, as confirmed by the XPS analysis. As a result, an initial burst release of 
60% of the total encapsulated drug was recorded in this study. After an initial burst 
release, a slow and controlled release of the drug was observed.  
Often factors such as the type of encapsulated drug and polymer determine the rate of 
slow and sustained release (Poletto et al., 2007). In this study, a sustained release phase 
from 5 hours to 12 hours was observed where small amounts of the drug, slowly diffused 
from the microspheres into the release buffer. The length of the sustained release phase of 
polymeric matrices is largely dependent on the type of polymer used (Naraharisetti et al., 
2005). Polymers are known to undergo degradation either by surface erosion or bulk 
degradation or a combination of both. With the increase in the penetration of water 
molecules into the polymeric matrix, homogenous surface erosion starts to occur which is 
followed by bulk degradation.   
In this study, the total cumulative release of 95.33% was found to occur within a period 
of 20 hours, therefore drug release by either surface erosion or degradation was not 
considered due to the slow degradable nature of the polymer. The drug release in the final 
stage occurred most likely through the water channels that were created by the diffused 
drugs. Further in this study, it was observed that in the presence of the hydrophilic drug 
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and PVA, the water uptake rate of the polymer was accelerated, thereby having a 
significant impact on drug release. 
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3.5 Conclusions 
In this study, a solid-in-oil-water (s/o/w) technique was used in an attempt to produce 
tailored poly(3-hydroxybutyrate) P(3HB) microspheres. The effects of several parameters 
such as polymer precipitation, surfactant concentration and stirring rate were considered. 
The average size of the microspheres varied from 2µm to 1.54µm with specific surface 
areas from 9.60 m
2
/g to 6.05 m
2
/g. The microspheres produced using low stirring rates of 
300 rpm produced slightly larger microspheres when compared to the smaller 
microspheres produced when the stirring rate was increased to 800 rpm.                                
The solvent (chloroform) removal from the emulsion after microsphere fabrication did 
not produce any change in the surface morphology of the microspheres when observed 
under SEM. The presence of PVA used as a surfactant and the polymer concentration 
influenced the drug distribution within the microspheres. The presence of PVA in the 
internal water phase enhanced the stabilization of the inner water droplets and the surface 
associated PVA prevented the microspheres from coalescing. The presence of residual 
PVA on the surface of the microspheres affected factors such as zeta-potential, surface 
hydrophobicity, protein adsorption and the encapsulation efficiency of the microspheres. 
The surface and internal morphology, drug distribution and release kinetics of the 
microspheres exhibiting the highest encapsulation efficiency (48%), were investigated. 
The DSC analysis showed that the microsphere preparation process had influenced the 
thermal behaviour of the microspheres. The glass transition temperature Tg, of the 
microspheres had increased and the Tg and %Xc decreased in the presence of the drug 
(gentamicin). The hydrophilic nature of the drug also had an influence on the polymeric 
degradation as well as the drug release behaviour. The in vitro release of gentamicin was 
biphasic where an initial burst release was observed followed by a diffusion mediated 
sustained release.  
The knowledge gained in this work about the different factors influencing the drug 
release will have important implications for the controlled delivery of potent drugs in 
various therapeutic applications.  
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Chapter 4  
Multi-functional P(3HB) 
microsphere/45S5Bioglass
®
-based 
composite scaffolds for bone tissue 
engineering  
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4.1 Introduction  
There are several factors that make polyhydroxyalkanoates (PHAs) excellent candidate 
materials for use in TE and other biomedical applications, such as biocompatibility, 
ability to support cell growth, cell adhesion and biodegradability (Chen et al., 2005; Zhao 
et al., 2003). However, when used as scaffolds in bone TE, PHAs fail to actively bind to 
the living tissue by means of a biologically active apatite layer or meet the mechanical 
demands in load-bearing applications. Therefore, these polymers are combined with 
inorganic bioactive materials, such as bioactive glass or hydroxyapatite (HA), to increase 
their applicability in bone TE (Misra et al., 2006). The addition of bioceramics have also 
been observed to alter the degradation rate of the polymer composite by having an effect 
on certain parameters such as water absorption, weight loss and pH (Misra et al., 2010). 
The addition of bioactive ceramics in the composite polymeric system is also known to 
affect the biocompatibility of the composite systems due to the changes incorporated in 
the surface roughness, surface wettability and protein adsorption rate (Chen et al., 2006; 
Rainer et al., 2008). There is a growing need to make multifunctional scaffolds to include 
applications such as drug delivery. One of the major problems or complications 
associated with the use of implants or scaffolds for bone treatment is the occurrence of 
infections. Often, microorganisms adhere to the biomaterials used, forming a biofilm on 
the surface, which is a major contributor to the pathogenesis of implant-associated 
infections. These biofilms often exhibit a high antibiotic resistance. Osteomyelitis is one 
such bone infection, which is hard to treat (Korsatko et al., 1984).  The main causative 
agent for osteomyelitis is Staphylococcus aureus, Streptococcus and Haemophilus 
influenzae. To counteract bone infection following implantation, gentamicin is often 
used, an aminoglycoside antibiotic with a broad spectrum of activity against both Gram-
positive and Gram-negative bacteria (Brin et al., 2008; Solberg et al., 1999). Thus the 
need for functionalizing polymer/composite scaffolds with improved surface topography 
for cell attachment as well as a substrate for delivering drug is growing. 
  
In the present chapter, a series of experiments is designed to develop a multifunctional 
P(3HB)/Bioglass
®
 composite system with extra functionalities for tissue engineering 
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applications. The major tasks carried out are schematically represented in Figure 1. In 
this strategy, the drug is encapsulated in the polymer phase, which uniformly coats the  
3-D bioactive glass or ceramic scaffold. The goal is to deliver the drug at a controlled 
rate, while the rigid inorganic scaffold maintains the structural integrity of the construct. 
In the present investigation, novel scaffolds based on bioactive glass (45S5 Bioglass
®
) 
foams combined with P(3HB) microspheres as drug carriers have been developed for 
bone tissue engineering. The reason for using gentamicin, as the drug for this study was 
its broad spectrum of activity against both Gram-positive and Gram-negative bacteria. 
 
 
 
Figure 1: - Diagrammatic representation of the research methodologies used in this study.  
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4.2 Results 
4.2.1 P(3HB) microsphere-coated 45S5Bioglass
®
  composite scaffolds 
The first goal in the task of fabricating the microsphere-coating on the scaffold was to 
achieve a homogenous and structurally robust coating throughout the three-dimensional 
(3-D) structure of the scaffold. Therefore, methods such as agitation and sonication, 
described in Chapter 2 section 2.2.4.1 and 2.2.4.2 were used to coat 45S5Bioglass
®
 
scaffolds with P(3HB) microspheres. Besides using the slurry-dipping technique to coat 
the scaffold, the scaffolds were also immersed in the final PVA emulsion during 
microsphere production, as described in Chapter 2 section 2.2.4.3, and it was expected 
that the scaffolds would be well coated with the microspheres after the evaporation of the 
emulsion. In both the agitation and sonication methods similar results in terms of 
homogeneity of the coating were achieved, indicating that both techniques are in 
principle suitable for coating 3-D porous scaffold with P(3HB) microspheres. When the 
scaffolds were left in the final PVA emulsion, it was found that not only a non-
homogenous coating was observed, but also etching of the 45S5Bioglass
®
 surface had 
been initiated. The sonication technique, in which the scaffold was immersed in the 
microsphere slurry after sonication for different time periods, scaffolds were seen to 
acquire a microsphere coating both on the surface and within the crevices and scaffold 
pores, as seen in Figure 2. Therefore, after detailed investigation, the optimum condition 
chosen for coating was sonication of 1 wt% of aqueous microsphere suspension for 5 
mins followed by dip coating the scaffold for 5 minutes. 
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Figure 2:- SEM images of the 45S5Bioglass
® 
scaffolds immersed for (A) 2 mins, (B) 5 mins,                     
(C) 10 mins in the sonicated microsphere slurry. Uniform coatings of microspheres on the surface of 
the scaffold are seen in images (A) 800x, (B) 850x   C) 1500x. 
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The gentamicin-loaded microspheres were seen to attach both onto the 45S5Bioglass
®
 
scaffolds surface and within the crevices forming a fairly homogenous coating, as 
revealed by the SEM micrographs shown in Figure 3. The thickness of the coating varied 
from being a single-microsphere layer, and therefore 2 m thick, to a multi-microsphere 
layer with a thickness of 5–6 m.  
 
 
 
Figure 3:- SEM images of 45S5Bioglass
®
 scaffolds coated with gentamicin-loaded microspheres on 
the surface of the scaffold as seen in image A) 750 x and within the crevices of the scaffold B) 2500x. 
Arrows indicate a uniform coating of microspheres both on the surface and within the scaffolds. 
 
In order to determine the adhesion of the microspheres coating to the glass-ceramic 
surface, a 45S5Bioglass
®
-derived glass–ceramic tablet was fabricated (applying the same 
heat-treatment condition used to fabricate the scaffolds) and coated with microspheres 
(using the same coating condition as for the scaffolds). The coated tablet was dried 
overnight at room temperature. It was then gently washed with 30 mL of distilled water 
using a pipette. The weight of the tablet was recorded before and after washing. From the 
A B 
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SEM images of tablet surfaces, Figure 4A and 4B, no difference in the P(3HB) 
microsphere-coated 45S5Bioglass
®
 tablets (A) before and (B) after washing with water 
were observed.  SEM image of a P(3HB) microsphere-coated 45S5Bioglass
®
 composite 
scaffold after being in water for 28 days, Figure 4C also showed the high level of 
adhesion of the microspheres to the glass-ceramic surface. 
 
 
Figure 4:- SEM images of P(3HB) microsphere-coated 45S5Bioglass
®
 tablets (A) before and (B) after 
washing with water (C) SEM image of a microsphere-coated scaffold after being in water for 28 days 
showing the high level of adhesion of the microspheres to the glass-ceramic surface.
C 
A B 
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4.2.2 Mechanical properties 
The mechanical properties of scaffolds coated and uncoated with microspheres were 
investigated by the compressive strength test. Typical stress vs strain plots of both 
samples are shown in Figure 5.  The mean compressive strength of microsphere-coated 
scaffolds was determined to be 0.27MPa, which is double the value obtained for uncoated 
samples. The work of fracture is related to the total area under the stress vs strain curves. 
The larger the area, the higher is the fracture toughness of the material.  The area under 
the stress vs strain curve of the microsphere-coated scaffold sample was calculated to be 
4.83 mm
2
 (using Origin™ programme), and that of the uncoated scaffold, was 1.92 mm2. 
Hence the work of fracture of the microsphere-coated scaffolds was much higher than 
that of the uncoated scaffolds. 
 
Figure 5:- Stress-strain curves of the 45S5Bioglass
®
 porous scaffolds (A) with and (B) without the 
P(3HB) microsphere coatings, (n = 3; error bars=±SD).  
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4.2.2.1 Porosity  
The porosity of the P(3HB) microsphere-coated 45S5Bioglass
® 
scaffolds was calculated 
using equation 6, Chapter 2, section 2.8.3.1. After coating, the porosity reduced from the 
original 90% to 70%, as a result of which the compressive strength of the coated 
samples increased significantly as shown in Figure 6. Thus the P(3HB) microsphere 
coating decreased the overall porosity of the scaffolds somewhat and therefore the 
scaffold strength was predicted to increase.  
 
 
Figure 6:- The compressive strength values of the uncoated and coated 45S5Bioglass
®
 scaffold 
against the varying % porosity values is represented. The data (n = 3; error bars=±SD) were 
compared using ANOVA and the differences were considered significant at 
(F(1,4)=34.691),***ρ<0.0001.  
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4.2.3 In vitro bioactivity study of P(3HB) microsphere-coated 45S5Bioglass
®
  scaffolds  
As is common practice in the field of biomaterials (Hench et al 1998; Tanahashi et al 
1994), the bioactivity of the present P(3HB) microsphere-coated 45S5Bioglass
® 
 
scaffolds was assessed by measuring HA formation on the scaffolds‟ surface upon their 
immersion in SBF. It is therefore important to identify whether or not the P(3HB) 
microsphere-coating would affect the formation of HA on the scaffolds upon immersion 
in SBF. SEM was used to detect the presence of these HA crystals on the scaffold 
surfaces. The results of the SEM investigation carried out on scaffolds after immersion in 
SBF are presented in Figure 7. Figure 7A shows no formation of HA on a scaffold 
immersed for 24h in SBF. However, HA was seen to form by day 3, when a needle-like 
crystalline structure appeared on the surface of the scaffold, as illustrated in Figure 7B 
and C. By day 7, as seen in Figure 7D, the surface of the scaffold was almost fully 
covered by HA crystals (indicated by the arrow in the image). From the images in Figure 
7F1, it can be clearly seen that HA crystals have grown around the microspheres, the HA 
crystalline structures are indicated using arrows in these images. This observation 
provides good evidence to conclude that most of the microspheres were eventually 
embedded underneath a thick HA layer. This fact was established by the image in Figure 
7D1.  
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Figure 7:- SEM images of P(3HB) microsphere-coated 45S5Bioglass
®
 based glass–ceramic scaffolds immersed in SBF after (A) 24 h, 1,000 x, (B) 3 days, 
1000 x, (C) 7 days, 1000 x; (C1) 7 days 5,500 x (high magnification); (d) 14 days, 1000 x; (d1) 14 days 12,000 x (high magnification) and  (e) 30 days,        
1000 x; (F1) 30 days, 5000 x.  Arrows indicate the presence of hydroxyapatite (b, c, c1, d1) and arrows in figure e and e1 indicates the growth of 
hydroxyapatite on the surface of the microspheres. 
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4.2.4 X-Ray diffraction (XRD) analysis of the P(3HB) microsphere-coated 
45S5Bioglass
®
 scaffolds after immersion in SBF 
To further investigate HA formation on the material‟s surface after immersion in SBF, 
XRD analysis was conducted on P(3HB) microsphere-coated 45S5Bioglass
®
 composite 
scaffolds after immersion in SBF for 1 day, 3 days, 7 days, 2 weeks, 3 weeks and 4 
weeks. P(3HB) microspheres on their own and uncoated 45S5Bioglass
®
 scaffolds were 
also characterized by XRD to determine their crystalline phases, as shown in Figure 8. 
All scaffolds exhibit XRD patterns characteristic of a glass-ceramic structure, which has 
been discussed in detail elsewhere (Chen et al., 2006). Although a characteristic 
diffraction pattern was obtained on the P(3HB) microspheres (Figure 8), due to the 
relatively small quantity of the microspheres present on the coated scaffolds as compared 
to the amount of 45S5Bioglass
®
, the intensity of their diffraction pattern was too low and 
the pattern could not be distinguished from the spectrum of the sintered 45S5Bioglass
®
 
scaffold, which is dominated by the sodium calcium silicate phase, Na2Ca2Si3O9 (Chen et 
al., 2006).  
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Figure 8:- XRD patterns of A) P(3HB) microspheres only, B) uncoated 45S5Bioglass
®
  scaffold and C) P(3HB) microsphere-coated 45S5Bioglass
®
 
scaffolds after immersion in SBF for 24h, 3 days, 7 days, 2 weeks, 3 weeks and  4 weeks. HA; , Na2Ca2Si3O6.
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4.2.5 Surface topography studies 
In order to study the effect of P(3HB) microspheres on the topography of the scaffold 
surface, white light interferometry (Zygo
®
) was used. The root mean square (rms) values 
of all surfaces were measured and the sample coated by microspheres showed a 
significant increase in RMS value when compared to non-coated specimens as seen in 
Figure 9. White light interferometry (Zygo
®
) measures the surface roughness of a flat 
substrate; therefore, sintered 45S5Bioglass
®
 cylindrical tablets (diameter=10 mm, 
thickness =5 mm) were used as the substrate and coated with microspheres following the 
same procedure used to coat scaffolds. Figures 10A and B show the oblique plots of 
uncoated tablets before and after immersion in SBF for 7 days, while Figures 10C and d 
show the corresponding images for coated specimens. Individual P(3HB) microspheres 
on the coated sample surface were impossible to track by this technique, as the size of 
individual spheres is very close to the resolution limit of the instrument, which is not 
sensitive enough to generate the image of each microsphere on the surface; therefore, 
microspheres cannot be clearly identified in Figure 10C and D.  
 
Figure 9:- A comparison of the average rms roughness values of the indicated sample surfaces. The 
data (n = 3; error bars=±SD) were compared using t-test and the differences were considered 
significant at ***ρ<0.001. 
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Figure 10:- Schemes showing the oblique plots of the 45S5Bioglass
®
 tablet surfaces measured using white light interferometry: (A) plain 45S5Bioglass
®
 
tablet; (B) plain 45S5Bioglass
®
 tablet after immersion in SBF for 7 days; (C) P(3HB) microsphere-coated 45S5Bioglass
®
 tablet; (D) microsphere-coated 
45S5Bioglass
®
  tablet after immersion in SBF for 7 days. 
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4.2.6 In vitro drug release from P(3HB) microsphere-coated 45S5Bioglass
®
 composite 
scaffolds and uncoated 45S5Bioglass
®
 scaffolds 
Data on drug loading for both uncoated and microsphere coated scaffolds is shown in 
Table 1. The encapsulation efficiency was determined as described in Chapter 2 section 
2.4.1, equation 1. 
Table 1:- Drug loading in uncoated 45S5Bioglass
® 
scaffolds and P(3HB) microsphere coated 
45S5Bioglass
® 
 scaffolds. 
 
 
 
 
 
 
It was found that the encapsulation efficiency of the drug-loaded microspheres with a 
porosity of approximately 37% was 50%. In vitro drug release studies, the drug release 
profiles from uncoated 45S5Bioglass
®
 scaffolds and from free microspheres were used as 
a control to compare the release kinetics from the P(3HB) microsphere-coated 
45S5Bioglass
®
 scaffolds. Data of the release profiles of the controls and P(3HB) 
microsphere-coated 45S5Bioglass
®
 scaffolds clearly show their different behaviour, as 
presented in Figure 11. Compared to the initial burst release of 45% from the uncoated 
45S5Bioglass
®
 scaffold and from the free microspheres which was 60%, the 
P(3HB)/45S5Bioglass
®
 microspheres coated composite scaffolds showed a much lower 
initial release of 24%. The percentage cumulative gentamicin release was found to occur 
in a controlled manner over a period of 30 days from the composite scaffold which was 
83.91%, which is a more favourable result when compared to the uncoated scaffold, 
which exhibited 74.83% release over a period of 15 days and the much faster total drug 
release of 95.33% over a period of just 24h from the free microspheres, as shown in 
Figure 11. 
Samples 
 
Initial Drug 
added (mg/g) 
Drug loading 
(mg/g)  
 Uncoated 45S5Bioglass
® 
scaffolds 
2mg/g  1.8x10
-3
 
45S5Bioglass
® 
 scaffold 
coated with P(3HB) 
microspheres  
2mg/g 1x10
-2
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Figure 11:- Release of gentamicin from free microspheres, uncoated 45S5Bioglass
®
 scaffolds and 
P(3HB) microsphere-coated 45S5Bioglass
®
 composite scaffolds (n = 3; error bars=±SD). 
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4.2.7 In vitro degradation studies  
The water uptake and weight loss study for the 45S5Bioglass
®
 scaffolds (coated and 
uncoated with P(3HB) microspheres) were carried out using immersion tests in SBF over 
a period of 30 days. The in vitro degradation studies of the 45S5Bioglass
®
 scaffolds 
(coated and uncoated with P(3HB) microspheres) are depicted in Figure 12A and B.            
The water absorption/uptake (WA) of the 45S5Bioglass
®
 scaffolds increased on 
prolonged immersion in SBF. However, the water uptake of the P(3HB) microsphere-
coated 45S5Bioglass
® 
 composite scaffolds was 650%, which was higher when compared 
to 483% of the uncoated 45S5Bioglass
® 
 scaffolds over a period of 30 days. The weight 
loss (WL) of the P(3HB) microsphere-coated 45S5Bioglass
® 
 composite scaffolds also 
increased to 19.3% with the immersion time when compared to the uncoated                             
45S5Bioglass
®
 scaffolds which was only 8.3% over a period of 30 days.  
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Figure 12:- A) Water absorption and B) weight loss studies of uncoated 45S5Bioglass
®
 scaffolds and 
P(3HB) microsphere coated 45S5Bioglass
®
 composite scaffolds (n = 3; error bars=±SD). 
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4.2.8 Protein adsorption test  
The protein adsorption study was carried out on the samples, 45S5Bioglass
®
 scaffolds, 
P(3HB) microspheres coated 45S5Bioglass
®
 composite scaffolds and 45S5Bioglass
®
  
composite scaffolds covered with hydroxyapatite (immersed in SBF for a period of          
7 days). From the results, as seen in Figure 13, the total amount of protein adsorbed on 
the surface was significantly (***p<0.001) higher for composites covered with 
hydroxyapatite which was 16 g when compared to 12.9 g and 9.9 g on the P(3HB) 
microspheres coated 45S5Bioglass
®
 composite scaffolds  and 45S5Bioglass
®
 scaffolds. 
 
Figure 13:- Total protein adsorbed onto to uncoated porous 45S5Bioglass
®
 scaffolds,  P(3HB) 
microspheres coated 45S5Bioglass
®
 composite scaffolds, P(3HB) microspheres coated 45S5Bioglass
®
 
composite scaffolds covered with HA after immersion in SBF for 7 days were immersed in tissue 
culture medium (DMEM) at 37˚C for 1h and  24h. The data compared using ANOVA was 
significant, ***p<0.001, a Bonferroni Post Hoc was applied and significant differences at ***p<0.0001 
for 45S5Bioglass
®
 composite scaffolds covered with hydroxyapatite was observed when compared to 
45S5Bioglass
®
 scaffolds, P(3HB) microspheres coated 45S5Bioglass
®
 composite scaffolds.  
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4.2.8.1 Protein profile of the adsorbed proteins observed using SDS-PAGE 
After immersion of the samples in the biological medium, Dulbecco‟s Modified Eagle 
Medium (DMEM), the protein adsorbed from the medium onto the scaffold was extracted 
using 1% sodium dodecyl sulplate (SDS) and analysed using polyacrylamide gel 
electrophoresis (SDS-PAGE) to check for the structural integrity of the proteins 
adsorbed. As seen from the SDS-PAGE analysis shown in Figure 14, albumin appeared 
to the main protein adsorbed onto the scaffolds both at short (1h) and long (24h) exposure 
times. Again, the relative amount of proteins bound on the P(3HB) microspheres coated 
45S5Bioglass
®
 composite scaffolds covered with hydroxyapatite both at 1h and 24h were 
higher when compared to the 45S5Bioglass
® 
and P(3HB) microspheres coated 
45S5Bioglass
®
 composite scaffolds. The SDS-PAGE analysis of the protein eluted from 
the surface of the scaffolds showed a band at 62 kDa, the molecular weight of albumin. 
Although the serum protein adsorption was higher on the composite scaffold covered 
with hydroxyapatite, no difference in the kind of serum proteins adsorbed on the surface 
of the scaffolds was observed.  
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Figure 14:- A 12% SDS-PAGE showing the integrity of the proteins adsorbed on the 45S5Bioglass
®
 
samples. Following incubation with tissue culture/biological medium (DMEM) containing foetal calf 
serum (FCS) for 1h (A) and 24h (B) the protein bands were separated and visualised after staining. 
Lane 1:- Broad range molecular weight marker (10 kDa-200 kDa) from Lane 2: Protein adsorbed on 
tissue culture plate, Lane 3:-Proteins extracted from the uncoated porous Bioactive
®
 glass, Lane 4:- 
P(3HB) microspheres coated 45S5Bioglass
®
composite scaffolds,  Lane 5:- P(3HB) microspheres 
coated 45S5Bioglass
®
 composite scaffolds covered with HA after immersion in SBF for 7 days.  
Arrow indicating the presence of albumin (62kDa), the main protein adsorbed onto the scaffold.       
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4.3 Discussions 
4.3.1 45S5Bioglass
®
 Scaffold development 
In the present study, a drug-encapsulated P(3HB) microsphere coating on 3-D bioactive 
glass-ceramic scaffold surfaces was developed. A fairly uniform coating throughout the 
3-D scaffold structure was achieved by a simple slurry-dipping method, as assessed by 
SEM. The high level of bioactivity of the scaffolds given by the bioreactivity of 
45S5Bioglass
®
 was not negatively affected by the polymer coating, as determined by the 
SBF immersion study. Moreover, the nanoscale surface roughness of the scaffold struts 
was enhanced due to the presence of the microsphere coating. The coating added a drug 
delivery function with a controlled release rate to this multi-functional scaffold for bone 
TE application. 
In the present work relative encapsulation efficiency was followed by increasing the 
viscosity of the aqueous solution, preventing the diffusion of the drug from within the 
microsphere, thus a 50% encapsulation efficiency was achieved. (Pouton et al., 1996; 
Naraharisetti et al., 2006). Gentamicin is highly hydrophilic and hence difficult to 
encapsulate into a hydrophobic polymer from hydrophilic environment                 
(Lecaroz et al., 2006).  
In order to achieve a homogeneous and structurally robust coating of P(3HB) 
microspheres throughout the 3-D structure of the scaffold, a simple slurry-dipping 
technique was used. In the slurry-dipping technique well-dispersed microsphere 
suspensions were obtained when compared to the methods of coating agitation and 
immersion of scaffolds in the final PVA solutions. In addition a slurry of the drug-loaded 
microspheres was made using the highly non-polar solvent, hexane and then coated onto 
the 45S5Bioglass
®
 scaffolds. In the agitation method a reproducible homogenous coating 
could not be produced. Similarly when the scaffolds were immersed in the final PVA 
solution, the microspheres agglomerated on the scaffolds either due to the residual PVA 
or attractive Van der Waals forces between microspheres. Hence, a homogenous 
microsphere coating could not be achieved by this method. Therefore, the optimum 
condition chosen for coating was sonication of 1% wt. aqueous microsphere suspension 
for 5 min followed by dip-coating for 5 minutes. 
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4.3.2 Scaffold characterization and mechanical properties 
Compressive strength tests were carried out to determine the effect of microsphere 
coating on the mechanical strength of scaffolds. Both scaffolds (coated and uncoated) 
exhibited a typical failure mode for brittle foams, i.e. catastrophic failure after maximum 
stress and densification stages have been reached (Chen et al., 2006). As expected, the 
coated scaffold with lower porosity showed a higher maximum strength (0.27 MPa) than 
the uncoated scaffold (0.11 MPa). However the compression strength could be 
underestimated due to shearing. Shearing could occur during the compression strength 
test, mainly caused by the edge effects imposed on the specimen during the test. If the 
faces of the sample are not aligned well with the loading platen, large stress 
concentrations can occur, causing local buckling, which in turn can lead to shearing 
(Chen et al., 2006). Bretcanu et al., fabricated similar 45S5Bioglass
®
 scaffolds with 60 
pores per inch (ppi) polyurethane foams (PU) foams and sintering at 1100 C for 1h. The 
compressive strength of those samples was on average 0.22 MPa.  When similar scaffolds 
were coated with polymer by dipping them in a P(3HB) polymer solution, it was 
observed that the compressive strengths of coated samples were significantly higher than 
those of the uncoated scaffolds, with values of 0.6 MPa for 45 ppi samples and 1.5 MPa 
for 60 ppi samples (Bretcanu et al., 2007). This behaviour can be explained considering 
that the polymer coating acts as a ductile bridge holding the glass particles together as the 
foam struts start to break during the test (Zhang et al., 2002; Yunos et al., 2008; Bretcanu 
et al., 2007). Incorporation of a polymer coating thus introduces a toughening effect, as 
discussed in the literature (Zhang et al., 2002; Miao et al., 2008; Yunos et al., 2008). In 
the present work, however, the microsphere coating cannot provide such support as a 
toughening element, since these are individual spheres instead of a continuous polymer 
layer coating and infiltrating the foam struts. Moreover, the sphere-sphere interaction is 
weak, hence the spheres cannot act as a structural support during the fracture of foam 
struts. Nevertheless, a significant increase in the average compression strength was 
determined (0.27 vs. 0.11 MPa for coated and uncoated scaffolds, respectively), which is 
related to the reduction of porosity induced by the presence of the microspheres, as 
described above. 
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 4.3.3 In vitro bioactivity study of P(3HB) microsphere-coated 45S5Bioglass
®
  scaffolds 
The in vitro bioactivity of scaffolds was determined in simulated body fluid (SBF). The 
formation of hydroxyapatite (HA) on the surface of 45S5Bioglass
®
 scaffolds after 
immersion in SBF is normally used as a confirmation for the scaffold‟s bioactivity (Chen 
et al., 2006; Hench et al., 1998; Tanahashi et al., 1994). Although 45S5Bioglass
®
 is well 
known for its high bioactivity (Hench et al., 1998), it was important to study here the 
effect of the presence of biodegradable polymer microspheres on the bioactivity of the 
Bioglass
®
-derived glass-ceramic scaffolds. Experiments conducted by Chen et al., have 
shown that, after 3 days of immersion in SBF, the highly crystalline phase of 
45S5Bioglass
®
-derived glass-ceramic scaffolds, Na2Ca2SiO9, transforms into an 
amorphous calcium phosphate phase. Similarly, in the present study the formation of 
small but prominent X-Ray diffraction (XRD) peaks corresponding to an amorphous 
calcium phosphate phase was confirmed on the surface of scaffolds coated with P(3HB) 
microspheres after 3 days of immersion in SBF. The surface morphology of the scaffolds 
changed after 7 days of immersion in SBF, with a layer of HA particles of average 
thickness 2–5 m fully covering the microspheres on the scaffold surface. This fast 
growth rate of HA in SBF is due to the fact that, even though the scaffolds were coated 
with microspheres, there was still sufficient bioactive glass-ceramic surface in direct 
contact with the fluid to facilitate the ion-exchange process leading to HA formation 
(Bretcanu et al., 2007). It should be noted that, due to the uneven surface of the scaffolds, 
it is very difficult to produce a microsphere coating that fully covers the entire surface. 
SEM observations confirmed that some sharp edges of the scaffold had remained 
uncovered by the microspheres, thus providing sufficient bioactive surface to facilitate 
ion exchange and induce HA formation instead of preventing it. Moreover, during the 
process of HA formation, some microspheres could have detached as a consequence of 
the HA crystals growing on the surface of the scaffold. This effect would expose more 
surface of the scaffold to the SBF, therefore enhancing the HA formation rate. From the 
images seen in Figure 7 (e),(e1), it is possible to observe that HA crystals have grown 
around the microspheres, as indicated by arrows. This observation provides good 
evidence to conclude that most microspheres were eventually embedded underneath a 
relatively thick HA layer (Figure 7 (e1). As shown in Figure 7 (e1), a crack (formed when 
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the scaffold was drying after being extracted from the SBF solution) reveals that 
microspheres are embedded in the HA layer. The formation of microcracks on both the 
scaffold and dense tablet surfaces are caused by shrinkage of the surface layer upon 
drying after scaffolds (or tablets) have been taken out of the SBF solution. This is a 
common feature in this type of bioactive scaffolds (Bretcanu et al., 2007).  
4.3.4 Surface topography studies  
Another very important factor determining the success of a TE scaffold is its surface 
roughness, with rougher surfaces usually providing the ideal topography for cell 
attachment (Norman et al., 2006; Itala et al., 2002). It has also been shown that 
nanotopography results in enhanced osteoblast cells attachment, mobility and 
differentiation, exampleon nanostructured bioceramics (Webster et al., 1999). In this 
work, for the first time, we investigated the introduction of desirable nanotopography 
using the P(3HB) microsphere coating on scaffolds and the subsequent growth of HA 
crystals upon immersion in SBF (exampleafter 4 weeks of immersion), which provides a 
desired nanoscaled rough surface, as identified by SEM observation at high 
magnification. The average of nine rms roughness values obtained from white light 
interferometery was determined for each sample. The rms roughness values for uncoated 
and P(3HB) microsphere-coated samples were similar. The similarity of the values for 
uncoated and P(3HB) microsphere-coated samples could be due to the fact that the 
related valleys on the surface of the bioactive glass-ceramic tablets investigated which 
were filled up by the P(3HB) microspheres after the coating process. Therefore, they 
created a new flat surface and the surface roughness did not change significantly. Overall, 
the measured roughness value using white light interferometry on the microsphere-coated 
scaffold, after 7 days of immersion in SBF, was much higher in comparison to that of the 
uncoated scaffold. This increased roughness plays an important role in enhancing cell 
attachment, proliferation and bone matrix formation.  
In addition to SEM observations, XRD analysis were also carried out to confirm the 
bioactivity of the 45S5Bioglass
®
/P(3HB) microsphere coated composite scaffolds. XRD 
analysis as seen in Figure 8 enabled us to identify the presence of HA crystals on the 
scaffold surface, and also showed the steady decrease in the Na2Ca2SiO9 peaks with 
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increasing immersion time, in agreement with previous studies on similar scaffolds (Chen 
et al., 2006). XRD analysis indicates that, by week 4, HA has occupied the whole 
scaffold surface and the peaks corresponding to the sodium calcium silicate phase have 
almost all disappeared. The characteristic XRD pattern of P(3HB) (from the 
microspheres) could not be identified because of the relatively small amount present, 
which thus produced a low intensity diffraction pattern that could not be distinguished 
from the dominant patterns from the bioactive glass-ceramic scaffold and the newly 
formed HA. These combined results of SEM, EDX and XRD therefore indicate that 
P(3HB) microsphere coated 45S5Bioglass
®
-based scaffolds are bioactive, with respect to 
HA coatings. 
4.3.5 In vitro drug release from P(3HB) microsphere-coated 45S5Bioglass
®
 composite 
scaffolds and uncoated 45S5Bioglass
®
 scaffolds 
In vitro drug release studies from microsphere-coated scaffolds were carried out using 
LC-MS, as other derivatization techniques such as fluorimetric and colorimetric assays 
used by other researchers have been shown to have relatively low specificity and 
sensitivity (Lecaroz et al., 2006). For the purpose of comparison, the measurement of 
drug release kinetics from uncoated scaffolds and from P(3HB) microspheres was also 
carried out. It was observed that gentamicin encapsulated within microspheres fixed on 
scaffold surfaces was released in a controlled manner, as compared to the rapid release of 
the drug directly adsorbed onto the 45S5Bioglass
®
 scaffold or from P(3HB) microspheres 
on their own (Figure 11). A rapid burst release of 60% was seen from the free 
microspheres during the first few hours. This was followed by an almost total drug 
release of 95.33% over a period of 30h. This result is similar to the release profile 
observed by Naraharisetti et al., who showed that gentamicin was released from polymer 
microspheres in less than a day (Naraharisetti et al., 2005). The possible reason for this 
burst release could be due to the hydrophilic nature of the drug as well as the size of the 
microspheres used (1–2 m). For the uncoated 45S5Bioglass® scaffold, an initial burst 
release of 45% was followed by a gradual release for a period of 15 days. This dual 
release profile could be due to the drug being loosely bound to the surface of the scaffold, 
which should lead to the initial rapid drug release followed by the slower drug release of
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 the entrapped drug within the micropores present on the scaffold surface. Compared to 
the initial burst release in the uncoated scaffolds, the microsphere-coated scaffolds 
exhibited a much lower initial burst of 24% followed by continuous release over a period 
of 30 days, the appropriate timescale for a tissue engineered graft operation. The release 
of the drug during the first few hours of immersion could be due to the presence of a 
given quantity of the surface bonded drug, which diffuses out when in contact with water. 
The relatively slower gentamicin release from the composite scaffold indicates that the 
microspheres, once immobilized on the 45S5Bioglass
®
 scaffold, exhibit completely 
different drug release kinetics as compared to P(3HB) microspheres free to move in 
suspension. This result could be attributed to the decrease in the surface area exposed to 
the SBF environment in the immobilized microspheres. In addition, the apatite layer 
formed on the surface of the composite scaffold should also contribute to determining the 
kinetics of drug release. For example in the coated scaffolds at day 7, the surface of the 
scaffold was almost fully covered by HA crystals when compared to the uncoated 
scaffold, which was only unevenly covered by aggregated apatite spheres.  
4.3.6 Protein adsorption test  
Most mammalian cells adhere to a protein rich surface which promotes cell adhesion, 
migration and differentiation (Misra et al., 2008). During the first stage of cell adhesion, 
a layer of water and proteins are known to adhere onto the surface largely mediated by 
the surface properties of the biomaterial (Soderling et al., 1996). Surface roughness is one 
of the properties that are known to affect the amount of the proteins adsorbed. Therefore 
in this study, a higher amount of protein adsorption (n=3 ***p<0.001) was observed on 
the P(3HB) microsphere coated 45S5Bioglass
®
 composite scaffolds covered with 
hydroxyapatite when compared to the 45S5Bioglass
®
 and P(3HB) microsphere coated 
45S5Bioglass
®
 composite scaffolds. This may be attributed to the increased surface 
roughness of the 45S5Bioglass
®
 covered with hydroxyapatite which was confirmed in the 
surface topography studies when compared to the 45S5Bioglass
®
 and P(3HB) 
microsphere coated 45S5Bioglass
®
 composite scaffolds. Bioactive glass such as 
45S5Bioglass
®
 when immersed in bodily fluids are known to form an apatite or bioactive 
layer. Due to this bioactive layer an increased surface roughness as well as an increased 
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surface area is observed (Misra et al., 2008). Thus 45S5Bioglass
®
 samples with 
hydroxyapatite formation in this study also had an increased surface area when compared 
to the other samples which may have also contributed to an increase in the protein 
adsorption. In relation to the surface composition of the biomaterials, the surface charge 
is also known to influence amount of serum proteins adsorbed on the surface (Sahoo et 
al., 2002). The charged residues of albumin are also known to have a higher affinity to 
hydroxyapatite. For examplethe aspartic and glutamic acid residues are known to bind to 
the calcium site while lysine and arginine are known to bind to the phosphate groups. An 
increased protein adsorption was observed on the P(3HB) microsphere coated 
45S5Bioglass
®
 composite scaffolds covered with hydroxyapatite with an increased 
negative surface charge of -16.30 mV (Lu et al., 2001). 45S5Bioactive glass surface is 
also known to carry a negative surface charge of -14.72 mV. The surface charge of the 
major protein (albumin) present in the cell culture media is negative, which is dependent 
on the pH and ionic strength of the solution (Patil et al., 2007). Since the experiments in 
this study were carried out in DMEM media, pH 8.0, the surface charge of albumin 
present in DMEM would be negative. Also, in this study, an increased surface roughness 
and surface area of the P(3HB)/45S5Bioglass
®
 microsphere coated composite scaffolds 
covered with hydroxyapatite may have also favoured an increased protein adsorption 
when compared to the other scaffolds. The proteins such as BSA adsorbed on the 
P(3HB)/45S5Bioglass
®
 microsphere coated composite scaffolds covered with 
hydroxyapatite may have also established a strong molecule-molecule interaction when in 
contact with the HA surface. Due to the increased non-homogenous surface of the 
P(3HB)/45S5Bioglass
®
 microsphere coated composite scaffolds covered with 
hydroxyapatite, large aggregates of protein could have also been found on the surface due 
to which a higher amount of proteins were observed. 
A higher amount of protein adsorption was observed during the first hour of immersion 
on the surface of all the scaffolds after which a considerable decrease was observed with 
the increase in the immersion time (24h).  In general, proteins are known to form 
monolayers, sub-layers and multilayers and change their native conformation and 
orientation when they get initially adsorbed onto a surface (Wahlgren et al., 1991). 
However, over a period of time, protein conformational changes are known to occur 
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during which time the proteins flatten or spread in an attempt to optimize contact with the 
sorbent. Similarly the late arriving protein molecules are also observed to adsorb onto the 
monolayer of the proteins. Thus a structural heterogeneity in the protein adsorbed layer is 
observed. Proteins are also known to compete with each other for available binding sites 
on the sorbent, therefore during the time course of adsorption the proteins that were 
initially adsorbed onto the adsorbent surface could be displaced by the protein molecules 
that show a higher affinity for the surface. Therefore during the first hour of immersion, 
protein adsorption could have occurred in multilayers. However with the prolonged 
immersion (24h) in the biological media, the late-arriving protein molecules which were 
not bound to the adsorbent surface could have been readily desorbed due to which a 
lesser amount of proteins were recorded at 24h of immersion (Horbett et al., 1994).             
The surface composition of the biomaterial surface is also known to affect the binding 
characteristics as well as the conformation of the attached serum proteins (Gray et al., 
2004). Since proteins are often known to denature at the solid-liquid and vapour-liquid 
interface (Gray et al., 2004), the adsorbed proteins on the sample surfaces in this study 
were eluted and its stability checked on a SDS-PAGE. From the results, albumin was 
found to be the main protein that was bound onto the samples. The molecular weight of 
the albumin adsorbed on the samples which was 62 KDa was comparable to that of the 
albumin from the serum (used as control). This indicated that the proteins after adsorption 
on the scaffolds did not undergo any degradation. The 45S5Bioglass
®
/P(3HB) 
microsphere coated composite scaffolds covered with hydroxyapatite bound the highest 
amount of total protein when compared to the other samples. Thus apart from the 
difference in the quantity of the protein adsorbed, in this study there were no differences 
observed in the kind of proteins adsorbed. Ghannam et al., also similarly observed that 
there were no significant differences in the kind of serum protein adsorbed on the 
Bioactive glass surface with and without a HA layer. Thus it was concluded that the 
Bioactive glass surface with a HA layer had significantly affected the quantity of proteins 
adsorbed on the surface but the kind of proteins adsorbed remained unchanged (Ghannam 
et al., 1999).  
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4.3.7 In vitro degradation studies 
The P(3HB) microsphere coated 45S5Bioglass
®
 composite scaffolds and 45S5Bioglass
® 
scaffolds were immersed in SBF and the water uptake and weight loss studies  were 
carried out for a period 30 days. From the results it was observed that the 45S5Bioglass
®
 
composite scaffolds exhibited an increased rate of degradation when compared to the 
45S5Bioglass
® 
scaffolds. The presence of the hydroxyapatite on the surface of the 
P(3HB) microsphere coated 45S5Bioglass
®
 composite scaffolds with an increased 
surface area would have also improved the surface wettability of the scaffolds (data not 
shown) therefore exhibiting a higher water adsorption. The 45S5Bioglass
®
 scaffolds on 
the other hand however exhibited lower water absorption when compared to the 
composite scaffolds (coated with microspheres). Thus it could be concluded that a 
reduced HA formation in the absence of the microsphere coating could have led to a 
decreased surface area of the scaffolds as well as reduced surface wettability. Thus with 
added features of increased water adsorption and surface wettability, the P(3HB) 
microsphere coated 45S5Bioglass
®
 composite scaffolds covered with HA exhibited an 
increased rate of degradation or weight loss when compared to the uncoated                        
45S5Bioglass
®
 scaffolds.  
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4 Conclusions 
This work has led to the development of novel multi-functional 45S5Bioglass
®
-based 
glass–ceramic scaffolds for bone tissue engineering which exhibits topographical features 
to increase cell attachment and can also act as a carrier for controlled drug delivery via 
the immobilization of P(3HB) microspheres on the scaffold surfaces. Successful P(3HB) 
microsphere coating on the glass–ceramic scaffold was achieved using an optimized 
slurry dipping technique. The resulting composite scaffolds had increased compressive 
strength and ordered surface roughness (given by HA crystal formation on the 
microspheres in contact with SBF), and maintained the high bioactivity typical of a 
silicate glass–ceramic derived from Bioglass®. In vitro degradation studies confirmed that 
an improved surface wettability of the P(3HB) microsphere coated 45S5Bioglass
®
 
composite scaffolds due to the HA formation on an increased surface area had 
significantly increased the water uptake of scaffolds. Thus due to an increased water 
uptake, a higher weight loss was exhibited by the P(3HB) microsphere coated 
45S5Bioglass
®
 composite scaffolds. Similarly, the presence of HA on the P(3HB) 
microsphere coated 45S5Bioglass
®
 composite scaffolds also contributed to rough surface 
morphology which could also be related to an increased surface area available for protein 
adsorption. Therefore the P(3HB) microsphere coated 45S5Bioglass
®
 composite 
scaffolds exhibited upto 41% increase in protein adsorption when compared to the other 
scaffolds. The novel scaffolds were successfully tested for their gentamicin delivery 
capability. The encapsulated drug was released in a slow and sustained manner compared 
to the burst release of the drug measured from free P(3HB) microspheres and from the 
uncoated scaffold. Hence, the P(3HB) microsphere coated 45S5Bioglass
®
 composite 
scaffolds developed here is multifunctional in that it provides structural support, adequate 
surface roughness, bioactivity and controlled drug delivery function, being thus of high 
interest for bone tissue engineering. The present approach can be extended to other types 
of tissues due to its high versatility, given by the combination of different biomaterials 
and processing technologies used. 
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Chapter 5  
 
P(3HB/n-BG)composite films for 
wound healing applications 
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5.1 Introduction 
Recently a widespread need for the development of new biomaterials that can interface 
with soft biological tissue/fluid is emerging (Ostomel et al., 2006, Macneil et al., 2007). 
Several inorganic materials which were previously used only for applications such as 
bone and dental repair are now being considered for other applications such as wound 
healing. During a traumatic injury the body‟s skin barrier is breached which results in 
haemorrhage (Ostomel et al., 2006, Macneil et al., 2007). The lack of covering of the 
wound can result in infection leading to further complications. However, traditional 
dressings are insufficient to control the haemorrhage (Ostomel et al., 2006). Currently 
zeolite-based granular materials are used on the surface of wounds to induce rapid 
clotting. Zeolite is a haemostatic agent (HA), which has a high affinity for water; 
therefore it has a concentrating effect on the plasma by selectively dehydrating the blood. 
However, as a consequence of the affinity for water, energy release is very high during 
hydration; due to which they tend to burn the surrounding healthy tissues (Ostomel et al., 
2006, Eryilmaz et al., 2009). Therefore, efforts have now been focussed in developing 
new biocompatible materials to serve as scaffolds with an excellent efficacy for inducing 
haemostasis as well as promote tissue regeneration. Although bioactive glass ceramics 
were used largely for dental and bone applications, researchers like Ostomel et al., have 
focused on the use of these glasses for blood clotting applications. The authors‟ had 
formulated a high surface area bioactive glass and then tested  
its in vitro haemostatic efficacy. Haemostatic bioactive glass (BG) was considered as an 
ideal material for haemostatis as it is known to release Ca
2+
 ions upon hydration, which is 
required to support thrombosis (Ostomel et al., 2006). In another study Ostomel et al., 
suggested factors such as porosity, Si/Ca ratio and the spherical morphology of the 
bioactive glass microspheres (MBGMs) as important properties that affect the biological 
response required for wound healing scenarios. In addition, during clotting the intrinsic 
pathway of the blood clotting cascade is activated by the polar surfaces of the glasses. 
When blood is exposed to a foreign polar surface, blood-clotting factors such as Factors 
XII, XI, prekallikrein and high molecular weight kininogen are initiated. The activated 
factors are then responsible for the activation of the thrombin enzyme and polymerization 
reaction of fibrin. During haemostasis impermeable platelets are formed which act as a 
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plug at the site of injury, while the procoagulant substances activated in this process are 
localized at the site of injury (Hoffman et al., 2003). Therefore, haemostatic agents such 
as bioactive glass are known to produce the fastest haemostatic response by providing 
Ca
2+
 ions that act as cofactors that help in orienting proteins as well as enzymes that are 
responsible for fibrin production. Ostomel et al., also found that the high surface area of 
the bioactive glass could provide the support needed for thrombosis as well as provide an 
optimum ratio of SiO2 to Ca
2+
 ions required for the clotting cascade. The in vitro 
haemostatic efficacy is assayed using a thromboelastograph (TEG), which monitors the 
change in the viscoelasticity of blood in the presence of the haemostatic agent (HA) 
during thrombosis and thrombolysis (Ostomel et al., 2006).  
In this work, for applications in wound healing, the nanoscale bioactive glass particles       
(n-BGs) were incorporated within the P(3HB) matrix. The chemical composition of the 
n-BGs is not very different from microbioglass (m-BGs), however, they are known to be 
spherical in shape with a uniform surface morphology as compared to the m-BGs, which 
are irregular in size with large agglomerates (Misra et al., 2008). The spherical 
morphology of the ceramic particles with a high specific surface area is crucial for 
interface effects such as hydroxyapatite formation and contact activated coagulation 
(Misra et al., 2008; Ostomel et al., 2006).  The presence of nanoscale particles have been 
found to have an effect on the microstructural, mechanical and in vitro degradation 
behaviour of the composite systems used in tissue engineering applications (Pramanik et 
al., 2006).   
Cell response is affected by a number of physicochemical factors such as surface energy, 
surface charges and chemical composition of the biomaterials. Apart from these above-
mentioned factors, cell response is also affected by the surface topography (Teixeira et 
al., 2004). Surface topography is the most decisive physical cue for the cells, as the 
topography can be used to guide the cell orientation to achieve a functional tissue such as 
tendons and nerves. Researchers have focused their efforts on trying to mimic the 
nanoscale topographical features in the hope that these features can promote cellular 
functions such as cell adhesion, cell mobility and cell differentiation (Norman 2006).
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The nanoscale features are known to have both a direct influence and an indirect 
influence (an effect on the conformation of the adsorbed extracellular matrix 
components). The cell adhesion on the nanotopographical substratum is dependent on the 
integrin adhesion as well as the topographical nanofeatures. During cell adhesion, 
transmembrane proteins called integrins are recruited and activated. These integrins are 
known to establish the initial cell-matrix interactions. These integrin receptors are known 
to form adhesion plaques or focal adhesion sites on the substratum. Following the 
formation of focal adhesion sites, a series of temporospatial events are known to occur 
such as integrin clustering. Therefore for an increased cell adhesion, the lateral spacing in 
the nanofeatures of the matrix must be around 15-30nm (Biggs et al., 2010). 
Nanofeatures such as height, diameter and edge-edge spacing are also known to affect the 
intergrin clustering. Several polymeric substrates with nanotopographical features have 
shown an increase in the cell adhesion. For examplePoly (L-lactic acid) films with 
nanofeatures of 500-550 nm  in diameter and 250-300 nm in height displayed an increase 
in human foreskin fibroblast adhesion (Milner et al., 2007). However a disruption in the 
intergrin-substratum is known to occur when spacing between the nanofeatures is 
between 70-300 nm, the protein recruitment for focal adhesion is disrupted causing a 
decrease in the cell adhesion (Selhuber et al., 2008). For examplea reduced adhesion of 
human bone marrow stromal cells on polystyrene/poly(n-butyl methacrylate) blend was 
observed when the nanofeatures displayed dimensions of 0.99 µm in diameter and 90 nm 
in height (Berry et al., 2006).  
Microscale topography is also known to modulate cellular behaviour; however the sub 
cellular structures of the single cells such as cytoskeletal elements, transmembrane 
proteins and filipodia of the cells, tend more towards the nanoscale features (Biggs et al., 
2010). Several techniques such as electron beam lithography, photolithography have been 
used for creating ordered features and phase separation and colloidal lithography have 
been used to create unordered surface patterns. However apart from using these 
techniques other nanophase materials such as hydroxyapatite nanoparticles, bioactive 
glass nanoparticles and stimuli-sensitive polymeric nanoparticles have been used to 
produce nanometer features. These nanophase materials have displayed several 
advantages such as cell adhesion, proliferation and bioactivity (Webster et al., 1999).  
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Hence, the presence of nanoscale bioactive glass particles affects the microstructural, 
mechanical and biological properties of the composite films used for other tissue 
engineering applications. Therefore, the present study aims to depict the use of 
P(3HB)/nanoscale bioactive glass (n-BG) microspheres compressed to form films for 
applications in wound healing. For the first time, n-BG particles have been used to 
investigate its haemostatic efficacy, in wound healing applications. The reason for using 
n-BG particles was its spherical morphology, high surface area, increased bioactivity and 
its haemostatic efficacy higher protein adsorption capacity (Misra et al., 2008). In this 
chapter, the n-BG particles were mixed with the polymer solution, made into 
microspheres and compressed into films followed by a series of experimental techniques 
used to characterize the composite films. The results obtained from the characterization 
of the microsphere films can be categorized as (i) the effect of n-BG particles on the 
structural and thermal properties (ii) the effect of n-BG particles on the surface mediated 
phenomena such as haemostatic activity (iii) A comparative study on the in vitro 
biocompatibility of the P(3HB) and P(3HB)/n-BG microsphere films layer using the 
HaCaT keratinocyte cell line.  
In the second part of this study, the P(3HB)/(n-BG) microsphere films were immersed in 
SBF for a fixed time period to induce the formation of HA on the surface of the 
composite films leading to the formation of surface functionalized films. Thus by 
engineering nanotopography on the biomaterials, the adsorption and functionalities of the 
biochemical signaling molecules that direct cellular functions were modulated. These 
P(3HB)/n-BG composite films with HA deposition were also assessed in order to 
understand the effect of the biomaterial surface properties on the protein adsorption as 
well as keratinocyte function. The results from this study will give further information to 
design percutaneous implants with surface properties that can enhance the rate of skin 
regeneration.   
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5.2 Results 
5.2.1 Nanoscale bioactive glass and P(3HB)/nBG composite microsphere 
characterization  
The nanoscale bioactive glass (n-BG) particles used in this study had a spherical 
shape with relatively small agglomerate sizes as seen in Figure 1. These n-BG 
particles have a specific surface area (SSA) of 79 m
2
/g and with a diameter of 29 nm 
(Misra et al., 2008).  SEM images of the P(3HB)/nBG composite microspheres, 
Figure 1C, revealed the presence of both spherical and smooth surfaces as well as the 
presence of agglomerations of the n-BG particles present on the surface of the P(3HB) 
microspheres. SEM/EDX elemental mapping images on the P(3HB) microsphere 
cross-sections as seen in Figure 2 confirmed the presence of typical elements of 
bioglass i.e., silica (Si), calcium (Ca), phosphorous (P). This result further indicated 
that the n-BG particles were distributed throughout the polymeric matrix in addition 
to being present on the surface of the P(3HB) microspheres.  
 
Figure 1:- (A) SEM image of n-BG particles, (C) P(3HB)/n-BG composite microspheres. (Arrow 
indicating the presence of n-BG particles on the surface of the microspheres). 
 
A B 
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Figure 2:- An elemental X-Ray mapping of the cross section of the P(3HB)/n-BG microspheres. 
A) Cross section of the P(3HB)/n-BG composite microspheres. SEM/X-Ray mapping depicting 
the elements of n-BG, B) Si, C) Ca and D) P. 
5.2.1.1 Fourier Transform Infrared studies (FTIR) 
FTIR spectra of the P(3HB) and nanoscale bioactive glass (n-BG) and P(3HB)  
composite microspheres are represented in Figure 3. The FTIR spectra of the 
unloaded P(3HB) microspheres is shown in Figure 3A, where the bands with 
wavenumbers at 980 cm
-1
, 1226 cm
-1
, 1282 cm
-1
 and 1782 cm
-1
 were due to the 
crystalline phase of the polymer and bands at 1184 cm
-1
 and 1741 cm
-1
 were due to 
the amorphous phase of the polymer. The stretching vibrations of the amorphous and 
crystalline carbonyl groups are seen at 1741 cm
-1
 and 1728 cm
-1
 (Vallapil et al., 2007; 
Shih et al., 2007). FTIR analysis of n-BG particles (Figure 3B) before immersion in 
SBF revealed bands of silicate with wavenumbers at 1085 cm
-1
, 802 cm
-1
 and                  
472 cm
-1
. The bands with wavenumbers at 1085 cm
-1
 corresponded to the vibrational 
mode of the asymmetric stretch of Si-O-Si, similarly at 802 cm
-1
 it corresponded to 
the symmetric stretch of the Si-O and the band at 472 cm
-1
 corresponded to the 
vibrational bending of Si-O-Si (Barba et al., 1999). The FTIR spectra of the 
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P(3HB)/n-BG composite microspheres (Figure 3C) revealed the characteristic bands 
of P(3HB) with wavenumbers at  980 cm
-1
, 1282 cm
-1
 and 1782 cm
-1
. In addition, the 
characteristic bands of nanoscale bioactive glass particles with wavenumbers at            
1082 cm
-1
 and 805 cm
-1
 were also observed.  
 
 
Figure 3:- A) FTIR spectra of the P(3HB) microsphere films revealing the characteristic peak of 
P(3HB) at wavenumbers 1728 cm
-1
, 1282 cm
-1
, 1226 cm
-1  
and 980
-1 
cm 
-1
. B) FTIR spectra of the 
n-BG particles with the characteristic peak at wavenumbers 1085 cm
-1
 and 802 cm
-1
. C) FTIR 
spectra of the P(3HB)/n-BG composite microsphere films revealing the characteristic peak of 
P(3HB) at wavenumbers 1728 cm
-1
 and 1282 cm
-1
and the characteristics peaks of n-BG particles 
at 1082 cm
-1
and 805 cm
-1
. 
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5.2.1.2 Scanning Electron Micrographs/Energy Dispersive X-Ray (SEM/EDX) of 
microsphere films 
The P(3HB) microsphere films and the P(3HB)/nBG composite microsphere films 
were analyzed using SEM/EDX analysis (Figure 4 and 5). The P(3HB) microsphere 
films revealed the presence of carbon and oxygen as shown in Figure 4. The EDX 
analysis of the P(3HB)/nBG composite microsphere films revealed the presence of 
silica (Si), calcium (Ca) and phosphorous (P) in addition to C and O (Figure 5).  
 
Figure 4:- SEM/EDX micrographs of the P(3HB) microsphere films, revealing the presence of 
only carbon and oxygen was observed.  
 
Figure 5:- SEM/EDX micrographs of the P(3HB)/n-BG composite microsphere films depicting 
the presence of Si, Ca, P in addition to C and O. 
A 
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5.2.1.3 Thermal properties  
Differential Scanning Calorimetry (DSC) was used in order to determine the Tg, %Xc 
and Tm values of the P(3HB) microsphere films and P(3HB)/n-BG composite 
microsphere films. The results of the DSC thermograms are presented in Table 1. The 
DSC thermograms of the P(3HB) microsphere films and the P(3HB)/n-BG composite 
microsphere films are shown in Figure 6. There were no significant differences 
observed between the thermographs of the P(3HB) microsphere films (Figure 6A) and 
the P(3HB)/n-BG composite microsphere films (Figure 6B) during the first heating 
run. However, the emergence of a new melting peak in the second heating run was 
observed in the P(3HB)/n-BG composite microsphere films. The melting temperature 
and the crystallization temperature of the P(3HB) microsphere films were higher than 
the P(3HB)/n-BG composite microsphere films as seen in Table 1. The observations 
made from the thermal measurements for both the P(3HB) films and the P(3HB)/nBG 
composite microsphere films  can be summarized as follows : (i) The % crystallinity 
was less for the P(3HB)/nBG composite microsphere films as compared to the 
P(3HB) microsphere films (n=3 **p<0.01)  (ii) The melting temperature (Tm) was 
less for the P(3HB)/nBG composite films as compared to the P(3HB) microsphere 
films. The P(3HB)/n-BG microsphere films exhibited a decrease of  1.8% in the Tm 
values and 5.4% decrease in the %Xc values.  
 
Table 1:- A comparison of the thermal properties of the P(3HB) microsphere films and 
P(3HB)/n-BG composite microsphere films (n=3). 
Thermal Properties P(3HB) P(3HB)/n-BG 
Tm (°C) 173.15 170.46 
                 % Xc 47.66 40.03 
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Figure 6:- DSC thermograms of the A) P(3HB) microsphere film and B) P(3HB)/n-BG composite 
microsphere films.  
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5.2.1.4 Surface roughness (White light interferometry) 
White light interferometry was performed on the samples to analyse the change in the 
surface roughness induced by the presence of n-BG particles when compared to the 
P(3HB) microsphere films as seen in Figure 7. This technique measures the surface 
roughness of a flat substrate; therefore, P(3HB) microsphere films and P(3HB)/n-BG 
composite microsphere films (diameter = 12.87 mm, thickness = 0.87 mm) were 
measured for changes in surface roughness. The rms roughness value of the 
P(3HB)/n-BG composite microsphere films were 4.00µm (Figure 7B) which was 
significantly (n=3, **p<0.01) higher than 3.79µm of the P(3HB) microsphere films 
(Figure 7A).  
 
 
Figure 7:-2D and 3D plots of the P(3HB) microsphere film surfaces and P(3HB)/n-BG composite 
microsphere films as determined by white light interferometry. 2D plot (A) and 3D plot (A1) of 
the P(3HB) microsphere films. 2D plot (B) and 3D plot (B1) of the P(3HB)/n-BG composite 
microsphere films.  
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5.2.1.5 Surface wettability 
The static contact angle measurements of the P(3HB) microsphere films and 
P(3HB)/n-BG composite microsphere films were carried out to measure the surface 
wettability of the microsphere films as shown in Figure 8. The P(3HB) microsphere 
films had a  contact angle of 60.9  and the   composite P(3HB)/nBG microsphere 
films had a contact angle of 56.89  (n=3 ***p<0.001).   
 
 
Figure 8:- A comparison of the surface wettabilites of the P(3HB) microsphere films and 
P(3HB)/n-BG composite films. The data (n=3; error=±s.d) were compared using t-test and the 
differences were considered significant when ***p < 0.001.  
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5.2.1.6 Protein adsorption test  
Protein from the DMEM media containing FCS adsorbed on the surface of the 
P(3HB)/n-BG composite microsphere films before immersion in SBF was 323.5 g 
which was significantly (n=3 ***p<0.001) higher than 308 g of protein adsorbed on 
the P(3HB) microsphere films. The presence of the n-BG particles in the composite 
microsphere films resulted in higher protein binding when compared to the P(3HB) 
microsphere films, as is evident from the results in Figure 9. Thus, the composite 
microsphere films exhibited an increase of 4.8% when compared to the P(3HB) 
microsphere films  in total protein adsorption. 
 
 
Figure 9:-Total protein adsorption test carried out on the surface of P(3HB) microsphere films 
and P(3HB)/n-BG composites microsphere films. The data (n=3;error= s.d) were compared 
using t-test and the differences were considered significant when ***p<0.001. 
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5.2.1.7 Cell attachment tests  
Cell attachment tests were performed using Neutral red assay upon HaCaT cells 
grown for a period of three days, the keratinocyte cell line, on P(3HB) and P(3HB)/n-
BG composite microsphere films, proved the biocompatibility of the films.                    
The results are presented in Figure 10.  
 
 
 
Figure 10: - Cell attachment studies performed after 3 days, using Neutral Red assay, on P(3HB) 
microsphere films and P(3HB)/n-BG composite microsphere films. The cell attachment of all 
tested samples relative to the control (control set to 100%). The data (n=3; error=±s.d) were 
compared using t-test and the differences were considered significant when ***p < 0.001. 
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The cell viability of the P(3HB)/n-BG composite microsphere films was 100%  which 
was a significant increase (n=3, ***p<0.001) when compared to the cell viability on 
the P(3HB) microsphere films which was only 7%.  SEM images of the cells attached 
on day 3 on the P(3HB)/n-BG composite microsphere films showed cells appeared to 
be flat and  have confluent layer of cell growth on the surface of the films (Figure 
11B). In comparison, the cells attached on the P(3HB) microsphere films were not 
confluent and continuous as some cells appeared loosely bound as seen in Figure 11A.  
 
 
Figure 11:- SEM images of HaCaT cell attachment seen on day 3, on the surface of A) P(3HB) 
microsphere films and B) P(3HB)/n-BG composite microsphere films, (n=3; error=±s.d). 
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5.2.1.8 Haemostatic activity of n-BG 
Nanoscale bioactive glass particles (n-BG) are haemostatically active, promoting the 
rapid formation of blood clots (Ostomel et al., 2006). Therefore in this study, the in 
vitro haemostatic activity of varying amounts of n-BG particles (1mg, 2mg and 4mg) 
was evaluated using a thromoboelastograph (TEG) which is a clinical instrument that 
is used to monitor the change in the viscoelasticity of blood during clot formation 
(Ostomel et al., 2006) (Figure 12).  The initial detection of blood clot formation is 
referred to as R minutes. This is the time when the amplitude of bimodal symmetric 
viscoelasticity curve is 2mm.  For examplewhen 1mg of n-BG particles were used, the 
R value was 7.7 mins, for 2mg, the R value was 4.2 mins and for 4mg, the R value 
was 3.8 mins when compared to the control (in the absence of n-BG particles), which 
was 10.4 mins.  
      
 
Figure 12:- Thromboelastograph plot depicting the haemostatic activity of n-BG particles. The 
differences in the rate of coagulation in the presence of different amounts of n-BG particles is 
compared to the rate of coagulation in the control (absence of n-BG particles), (n=3; error=±s.d).  
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5.2.2  P(3HB)/n-BG composite microsphere films immersed in SBF  
5.2.2.1 Surface morphology 
In order to further enhance the nanoscale topographical features such as surface 
roughness on the P(3HB)/n-BG composite microsphere films, they were immersed in 
SBF for a period of 1, 3 and 7 days to induce the formation of crystalline 
hydroxyapatite (HA) needles. SEM images of the surface of the P(3HB)/n-BG 
composite microsphere films immersed in SBF for 1, 3 and 7 days are shown in 
Figure 13. The surface of the P(3HB)/n-BG composite microsphere films on day 3 
and day 7 (Figure 13C and D) revealed rough and uneven surface as compared to the 
films on day 1 which appeared fairly uniform and smooth (Figure 13B).  
 
Figure 13: - SEM images of the P(3HB)/n-BG composite microsphere films before immersion in 
SBF and after immersion in SBF. A) P(3HB)/n-BG composite microsphere film, B) P(3HB)/n-BG 
composite microsphere film immersed in SBF for 1 day. C) P(3HB)/n-BG composite microsphere 
films immersed in SBF for 3 days. D) P(3HB)/n-BG composite microsphere films immersed in 
SBF for 7 days. Numbers in the insets indicate magnification. 
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x5,500 x5,500 
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5.2.2.2 Fourier Transform Infrared studies (FTIR) 
The FTIR spectra of the nanoscale bioactive glass particles (n-BG) and the P(3HB)/n-
BG composite microsphere films after immersion in SBF  for a period of 1, 3 and 7 
days are represented in Figure 14. FTIR analysis of n-BG particles before immersion 
in SBF are mentioned in section 5.2.1.1. After immersion on day 1, P(3HB)/n-BG 
composite microsphere films revealed a P-O bending vibration between 600 cm
-1
 and 
500 cm
-1
 indicating the presence of a predominantly amorphous calcium phosphate 
layer.  However on day 3 and day 7, the P-O bending band became divided at                
1098 cm
-1
, 1046 cm
-1
, 950 cm
-1
, 606 cm
-1
, and 501 cm
-1
 indicating the presence of a 
crystalline Ca-P layer (Lu et al., 2001). 
 
 
Figure 14:- A) FTIR spectra of P(3HB)/n-BG composite microsphere films immersed in SBF for 
1 day, B) P(3HB)/n-BG composite microsphere films immersed in SBF for 3 days, C) P(3HB)/n-
BG composite microsphere films immersed in SBF for 7 days. 
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5.2.2.3 Scanning Electron Micrographs/Energy Dispersive X-Ray (SEM/EDX) and 
X-Ray diffraction (XRD) analysis of P(3HB)/nBG composite microsphere films  
The P(3HB)/nBG composite microsphere films when immersed in SBF for a period of        
1, 3 and 7 days were analyzed using SEM/EDX analysis to highlight the transition of 
the nanoscaled bioactive glass particles to a calcium phosphate layer (Figure 15). 
From the EDX analysis of the composite microsphere films, the presence of Ca and P 
peaks were observed after immersion in SBF for a period of 1, 3 and 7 days as seen in 
Figure 15 A, B, and C, although the Si peak was found on all the composite films, the 
intensity of the peak appeared to diminish after 3 days of immersion in SBF as seen in 
Figure 15B.  
 
 
Wavenumber cm
-1
 
A 
B 
P(3HB/n-BG 
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Figure 15:- SEM/EDX micrographs of the P(3HB)/n-BG composite microsphere films before and 
after immersion in SBF for a period of 1, 3 and 7 days. A) The P(3HB)/n-BG composite 
microsphere films before immersion depicting the presence of Si, Ca, P in addition to C and O. 
B) The presence of Si, Ca and P peaks are observed after immersion in SBF for  1 day. B) The 
relative intensity of the Si peaks appear increased on the surface of the P(3HB)/n-BG composite 
films after 3 days of immersion in SBF.  C) At day 7, a decrease in the Si peak was observed, 
followed by an increase in the Ca and P peak on the surface of P(3HB)/n-BG composite 
microsphere films. 
C 
D 
Day 3 
Day 7 
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The X-Ray diffraction peaks of the P(3HB)/n-BG composite microsphere films are 
represented in Figure 16. The growth of the characteristic crystalline hydroxyapatite 
peak between (2 ) 31º and 33º was observed on the P(3HB)/n-BG composite films 
when immersed in SBF for 1, 3 and 7 days as seen in Figure 16. Thus the 
observations made from the SEM/EDX and XRD analysis are summarized below (i) 
characteristic crystalline hydroxyapatite peak between (2 ) 31º and 33º was observed 
on the P(3HB)/n-BG composite microsphere films on 1, 3 and 7 days. (ii) the 
hydroxyapatite peak was shown to increase on prolonging the immersion time, 
indicating the transformation of amorphous (or weakly crystalline) hydroxyapatite to 
crystalline hydroxyapatite. 
 
 
 
Figure 16:- X-Ray diffractograms of the P(3HB)/n-BG composite microsphere films after 
immersion in SBF. The arrow shows the characteristic crystalline hydroxyapatite peak between 
(2 ) 31º and 33º. 
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5.2.2.4 Thermal properties of P(3HB)/nBG composite microsphere films 
Differential Scanning Calorimtery (DSC) was used in order to determine the % Xc and 
Tm values of the P(3HB)/n-BG composite microsphere films. The results of the DSC 
thermograms are presented in Table 2. The DSC thermograms of the P(3HB)/n-BG 
composite microsphere films immersed in SBF are shown in Figure 17. There were no 
significant differences observed between the thermographs of the P(3HB)/n-BG 
composite microsphere films  immersed in SBF for day 1, day 3 and day 7 during the 
first and second heating run. The emergence of a melting peak in the second heating 
run was observed in all the P(3HB)/n-BG composite microsphere films immersed in 
SBF. Thus the observations made from the thermal measurements of the P(3HB)/n-
BG composite microsphere films before and after immersion in SBF can be 
summarized as : (i) insignificant differences (n=3, p>0.05) in the thermal properties 
such as melting temperature and %Xc was observed when the P(3HB)/n-BG 
composite microsphere films were immersed in SBF for a period of 1, 3 and 7 days.  
 
Table 2:-Thermal properties of the P(3HB)/n-BG composite microsphere films before and after 
immersion in SBF, (n=3).  
 
   Thermal 
Properties 
P(3HB)/n-BG Day1  Day3  Day 7 
Tm (°C) 170.46 168 168.44 170.17 
% Xc 40 37.71 36.07 36.00 
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Figure 17:- DSC thermograms of the P(3HB)/nBG composite films (before and after immersion 
in SBF) A) P(3HB)/n-BG composite microsphere films before immersion in SBF used as control, 
B) P(3HB)/n-BG microsphere films immersed in SBF for a period of 1 day, C) P(3HB)/n-BG 
microsphere films immersed in SBF for a period of 3 days and D) P(3HB)/n-BG microsphere 
films immersed in SBF for a period of 7 days, n=3; error=±s.d. 
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5.2.2.5 Surface roughness (White light interferometry) 
White light interferometry was performed on the samples to analyze the change in the 
surface roughness of the P(3HB)/n-BG composite microsphere films induced by the 
presence of nanoscaled crystalline hydroxyapatite. The rms roughness value of the 
P(3HB)/n-BG composite microsphere films on day 1 of immersion in SBF was 
4.3 m, on day 3 was 5.99 m and on day 7 was 7.2 m (n=3 ***p<0.001) (Figure 18) 
as compared to much lower rms values of  4.04 m of the P(3HB)/n-BG composite 
microsphere films  before immersion in SBF. 
  
 
Figure 18:- Surface roughness of the P(3HB)/n-BG composite microsphere films after immersion 
in SBF for 1, 3 and 7 days measured using white light interferometry. The data (n=3; error=±s.d) 
compared using ANOVA was significant *** p<0.0001. A Bonferroni Post Hoc was applied and 
significant differences at ***p<0.0001 for P(3HB)/n-BG microsphere films immersed in SBF at 
day 3 and  day 7 were observed when compared to the control and P(3HB) microsphere films 
immersed for day 1. No significant differences (p>1.0) were observed between control and day 1. 
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A fairly homogenous surface roughness was observed on the P(3HB)/n-BG composite 
microsphere films immersed for 1 day in SBF as seen in the 2D and 3D plots (Figure 
19A  and A1) when compared to the surface roughness on the films immersed for 3 
days and 7 days where some areas on the films (3 days and 7 days) appeared to have a 
relatively higher surface roughness  as compared to the others (Figure 19 B, B1 and 
C, C1). 
 
Figure 19:-2D plot (A) and 3D plot (A1) of the P(3HB)/n-BG composite microsphere films after 
immersion in SBF for 1 day, 2D plot (B) and 3D plot (B1) after immersion in SBF for 3 days. 2D 
plot (C) and 3D plot (C1) after immersion in SBF for 7 days, (n=3; error=±s.d). 
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5.2.2.6  Surface wettability 
The static contact angle measurements of the P(3HB)/n-BG composite microsphere 
films before and after immersion in SBF were compared to monitor the changes in the 
surface wettability in the presence of the nanoscaled crystalline hydroxyapatite. The 
surface wettabilities of the P(3HB)/n-BG composite microsphere films after 
immersion in SBF increased significantly (n=3 ***p<0.001) as compared to the 
composite microsphere films before immersion as seen in Figure 20. A decrease in the 
water contact angle of the P(3HB)/n-BG composite microsphere films observed on            
1, 3 and 7 days were 12.60%, 19.29%, and 22.62% when compared to the P(3HB)/n-
BG composite microsphere films before immersion.  
 
 
Figure 20:- A comparison of the surface wettabilites of the P(3HB)/n-BG composite films before 
and after immersion in SBF on day 1, day 3 and day 7,  data (n=3; error=±s.d). The P(3HB)/n-
BG microsphere films after immersion in SBF had a significant (***p<0.0001) effect on surface 
wettability. Since the data compared using ANOVA was significant, a Bonferroni Post Hoc was 
applied and significant differences at ***p<0.0001 for P(3HB)/n-BG microsphere films immersed 
in SBF at day 3 and  day 7 were observed when compared to the control and P(3HB) 
microsphere films immersed for day 1. No significant differences (p>1.0) were observed between 
control and day 1. 
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5.2.2.7 Protein adsorption test  
In this study, the effect of the nanoscaled crystalline hydroxyapatite and its surface 
charge on protein adsorption was also investigated. The protein adsorption on the 
P(3HB)/n-BG composite microsphere films after immersion in SBF exhibited a lower 
amount of protein adsorption when compared to the composite microsphere films 
before immersion, as seen in Figure 21. For examplethe composite microsphere films 
exhibited a decrease of 28% on day 1. This was followed by a decrease of 90% on  
day 3 and 88% on day 7 as compared to the P(3HB)/n-BG composite microsphere 
films before immersion. 
 
 
Figure 21:- Total protein adsorption test carried out on the surface of P(3HB)/n-BG composites 
microsphere films (before and after immersion in SBF), data (n=3; error=±s.d).                                
The P(3HB)/n-BG microsphere films after immersion in SBF had a significant effect 
(***p<0.0001) on  protein adsorption. Since the data compared using ANOVA was significant, a 
Bonferroni Post Hoc was applied and significant differences at ***p<0.0001 for P(3HB)/n-BG 
microsphere films immersed in SBF at day 1 were observed when compared to the control and 
P(3HB) microsphere films immersed for day 3 and day 7. No significant differences (p>1.0) were 
observed between day 3 and day 7. 
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5.2.2.8 Cell attachment tests  
Cell attachment tests performed using HaCaT, the keratinocyte cell line, on 
P(3HB)/n-BG composite microsphere films before and after immersion in SBF 
proved the biocompatibility of the films. The results are presented in Figure 22.  
 
Figure 22:- Cell attachment studies performed on day 3, using Neutral Red assay, on P(3HB)/n-
BG composite films, (n=3; error=±s.d). The P(3HB)/n-BG microsphere films after immersion in 
SBF had a significant (***p<0.0001) effect on  cell attachment. Since the data compared using 
ANOVA was significant, a Bonferroni Post Hoc was applied and significant differences at 
***p<0.0001 for P(3HB)/n-BG microsphere films immersed in SBF at day 1 were observed when 
compared to the control and P(3HB) microsphere films immersed for day 3 and day 7. No 
significant differences (p>1.0) were observed between day 3 and day 7. 
 
SEM images of the  HaCaT cells attached on day 1 of the P(3HB)/n-BG composite 
microsphere films appeared to have a confluent layer of cell growth on the surface of 
the films comparable to the morphology of the cells attached on the P(3HB)/n-BG 
composite microsphere films before immersion in SBF (Figure 23A). Some cells were 
also seen growing on top of each other exhibiting limited spaces for them to spread. 
However on day 3 and 7, the cells attached on the films appeared raised due to the 
formation of the scattered hydroxyapatite crystals on the surface of the composite 
films as shown in Figure 23B and C. A significant increase in the cell viability, 
expressed as a percentage of cell growth on tissue culture plastics, was observed on 
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the P(3HB)/n-BG composite microsphere films after immersion in SBF when 
compared to the P(3HB)/n-BG composite microsphere films before immersion. The 
cell viability of the films immersed in SBF for day 1 had increased to 198% followed 
by a decrease of 116% on films immersed for 3 days and a 147% on films immersed 
for 7 days.  
 
Figure 23:- A) SEM images of HaCaT cell attachment seen on the surface of P(3HB)/n-BG 
composite microsphere films after immersion in SBF for 1 day. Similarly the HaCaT cell 
attachment is seen on the P(3HB)/n-BG microsphere films immersed in SBF on day 3 and day 7 
are represented in Figures B and C. (The arrow shows growth of HaCaT cells on the 
calcium/phosphate aggregates subsequent to NR assay). 
A B 
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5.3 Discussions  
In this study nanoscale bioactive glass particles were used in combination with 
P(3HB) due to the haemostatic efficacy. In addition this study allowed the 
investigation of the effect of the surface mediated phenomena such as in vitro 
hydroxyapatite deposition on cell attachment. The P(3HB)/n-BG composite 
microsphere films after immersion in SBF was also investigated in relation to 
microstructural, thermal properties, protein adsorption and the influence of varying 
surface properties such as nanotopography, surface chemistry and surface charge on 
the biocompatibility of the P(3HB)/n-BG composite microsphere films were also 
highlighted.  
5.3.1 Nanoscale bioactive glass and P(3HB)/nBG composite microsphere 
characterization 
5.3.1.1 Surface morphology of the n-BG particles and the P(3HB)/n-BG composite 
microspheres  
For this study nanoscale bioactive glass (n-BG) particles with a specific surface area 
of 79 m
2
g
-1
 were used, which was much higher than that of microbioglass (m-BG) 
(<1m
2
g
-1
) (Misra et al., 2008).  These particles were also smooth, spherical in shape 
and relatively small when compared to the irregularly shaped m-BG particles. The 
spherical morphology, with smooth regular shaped agglomerate sizes of the bioactive 
glass particles have been found to influence the rates of hydroxyapatite deposition as 
well as to improve its haemostatic efficacy (Ostomel et al., 2006). The spherical 
morphology, large pore volume and a higher surface area are thought to facilitate the 
cation release required for both hydroxyapatite depositions as well as contact 
activated coagulation (Ostomel et al., 2006). Ostomel et al., have also demonstrated 
the accelerated deposition rates of hydroxyapatite formation when mesoporous 
bioactive glass (MBGMs) particles with a high surface area were used (Ostomel et al., 
2006; Shih et al., 2006). The SEM images of the P(3HB)/n-BG composite 
microspheres revealed the presence of n-BG particles attached on the surface of the 
microspheres. In a similar study, Qiu et al., also encapsulated modified bioactive glass 
(MBG) powders into polylactic acid (PLA) microspheres using a solid-oil-in-water 
(s/o/w) technique. The surface morphology of the composite microspheres when 
analysed using SEM revealed the presence of MBG on the polymeric matrix (Qiu et 
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al., 2000). Thus apart from identifying the presence of n-BG particles on the surface 
of the microspheres, other characterization techniques such as FTIR and SEM/EDX 
analysis were employed to identify the presence of n-BG particles within the 
microspheres.  
5.3.1.2 FTIR analysis  
After the fabricating the P(3HB)/n-BG composite microspheres, FTIR analysis was 
done  to detect the presence of the n-BG particles in the composite microspheres. The 
characteristic peaks representative of P(3HB) and n-BG particles were detected in the 
FTIR spectra indicating the presence of n-BG particles in the P(3HB)/n-BG 
composite microspheres. In another relevant study Wang et al., incorporated 
hydroxyapatite nanoparticles (HA) within poly(3-hydrobutyrate-co-hydroxyvalerte) 
P(3HB-co-3HV) microspheres encapsulating gentamicin. In order to detect the 
presence of HA particles within the P(3HB-co-3HV) microspheres and on the surface, 
the authors‟ used characterization techniques such as FTIR. The FTIR spectra 
revealed sharp peaks with wavenumbers at 3570 cm
-1 
and 630 cm
-1 
characteristic of 
the HA molecules (Wang et al., 2007).  
5.3.1.3 Scanning electron microscopy /Energy dispersive X-Ray (SEM/EDX) 
A cross-section of the P(3HB)/n-BG composite microspheres was analysed using 
SEM/EDX analysis to identify the presence of n-BG particles embedded within the 
microspheres.  An elemental surface mapping of silica, calcium and phosphorous, the 
main components of n-BG in a fixed area on the cross-section of the P(3HB) 
microspheres, highlighted the presence of n-BG particles within the microspheres. 
This indicated that n-BG particles were successfully encapsulated within the P(3HB) 
microspheres during the microsphere preparation process. In another similar 
experiment Qiu et al., examined the cross-section of polylactic acid/modified 
mesoporous Bioglass composites (PLA/MBG) using SEM/EDX analysis. The 
presence of typical elements of MBG such as silica, calcium and phosphorous were 
detected in the EDX analysis which confirmed the presence of MBG within the 
composite microspheres (Qiu et al., 2000).  
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5.3.1.4 Effect of n-BG particles on the thermal properties of the P(3HB) microsphere 
films  
From the results of the thermal analysis it was observed that in the presence of n-BG 
particles, % crystallinity and the melting temperature of the P(3HB)/n-BG composite 
microsphere films were reduced when compared to the P(3HB) microsphere films. In 
the presence of n-BG particles, the crystallinity of the P(3HB)/n-BG composite films 
were reduced. The n-BG particles are known to hinder the growth of primary 
crystallites in P(3HB) due to which the crystallinity of the composite microspheres 
films are reduced. In this study the melting temperature of the P(3HB)/n-BG 
composite films reduced when compared to the P(3HB) films. The DSC thermograms 
of the P(3HB)/n-BG composite microsphere films in this study had also revealed the 
presence of a melting peak in the second heating run which was a significant 
observation. This indicated that the n-BG particles present in the P(3HB)/n-BG 
composite microsphere films did not retard the re-crystallization of P(3HB) during the 
cooling stage. Due to this, the presence of a crystallization peak in the P(3HB)/n-BG 
composite microsphere films was also observed. This observation was in agreement 
with the results obtained by Misra et al., where, in the presence of n-BG particles in 
the (3HB)/n-BG composite solvent cast films, the heat of fusion, an indicator of 
crystallinity was reduced to 55 J/g when compared to the P(3HB) solvent cast films 
which was 73 J/g. Here the presence of n-BG particles was observed to hinder the 
growth of the crystallites in the polymer (Misra et al., 2008).  In the study conducted 
by Misra et al., the increasing concentrations of microbioglass (m-BG) particles in the 
P(3HB)/m-BG composite films have been observed to prevent the re-crystallization of 
the polymer during the cooling stage. Due to this the prominent crystallization peak as 
well as a melting peak in the second heating run is not observed. However, the 
appearance of a small melting peak is also noticed when low concentrations of m-BG 
particles were used, indicating that the polymer was able to re-crystallize (Misra et al., 
2008). Thus from the above observation made by Misra et al., it can be concluded that 
the concentration of the n-BG particles used in this study was probably  relatively low 
and hence did not prohibit the recrystallization of the polymer due to which a melting 
peak in second heating run was observed. The DSC thermograms of the P(3HB) 
microsphere films exhibited prominent melting peaks both in the first and second  
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heating run. Misra et al., also observed no changes in the melting peaks of the P(3HB) 
microsphere films both in the first and second heating runs (Misra et al ., 2008). 
5.3.1.5 Surface morphology and roughness of the P(3HB) and P(3HB)/n-BG 
composite microsphere films  
The surface morphology of the P(3HB)/n-BG composite microsphere films when 
viewed under SEM revealed a fairly uniform surface morphology when compared to 
the P(3HB) microsphere films. However, when analysed for surface roughness using 
white light interferometery, the roughness of the P(3HB)/n-BG composite 
microsphere films was much higher than the P(3HB) microsphere films.  A fairly 
homogenous distribution of surface roughness was observed for the P(3HB)/n-BG 
composite microsphere films. A possible reason for the increase in the surface 
roughness of the P(3HB)/n-BG composite microsphere films could also be due to the 
presence of n-BG agglomerations on the surface of the microspheres. After the 
fabrication of the P(3HB)/n-BG composite microspheres, some amount of n-BG 
particles that were not encapsulated within the microspheres could have possibly 
settled down on the fabricated microspheres. These n-BG particles would have then 
bound to the surface of the composite microspheres due to the physical interlocking. 
In another relevant study Misra et al., examined the surface morphology of P(3HB)/n-
BG composite solvent cast films using SEM. The presence of the n-BG particles had 
changed the surface morphology of the P(3HB)/n-BG composite solvent cast  films 
inducing a rough topography to the films. The authors‟ had observed that despite 
sonicating the P(3HB)/n-BG mixture, the agglomerations of n-BG particles were 
evident. Thus a rapid solvent evaporation procedure was suggested (Misra et al., 
2009). For wound healing applications the presence of the n-BG particles on the 
surface would be advantageous as both biomineralization and blood clotting are 
surface-mediated phenomenon. Also, the presence of the n-BG particles on the 
surface of the microspheres would induce nanoscale topographies which can guide the 
cells required for wound healing.  
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5.3.1.6 Factors affecting the biocompatibility of the microsphere films  
The water contact angle measurements (also an indication of surface wettability) was 
carried out to study the influence of the n-BG particles on surface wettability of the 
P(3HB)/n-BG composite microsphere films. From the results, the surface wettability 
of the films had increased in the P(3HB)/n-BG composite microsphere films when 
compared to the P(3HB) microsphere films.   The presence of the n-BG particles on 
the surface had increased the hydrophillicity the P(3HB)/n-BG composite 
microsphere films due to which the water adsorption of the films had also increased 
(Misra et al., 2008). In a similar observation made by Misra et al., the presence of n-
BG particles in the P(3HB)/n-BG composite microsphere films had improved the 
surface wettability of the films considerably due to its hydrophillicity (Misra et al., 
2008). The P(3HB) microsphere films on the other hand exhibited a higher water 
contact angle as compared to the P(3HB)/n-BG composite microsphere films, due to 
its lower water adsorption, further confirming the hydrophobic nature of the polymer. 
The water contact angle determined in this study for the P(3HB) films was however 
lower than the reported value of 70 ±5º (Wang et al., 2006), here the presence of the 
hydrophilic PVA used to fabricate the microspheres would have made them relatively 
hydrophilic, hence influencing the surface wettability of the P(3HB) films.  
The adsorption of proteins on the surface of biomaterials is important as this will 
permit the cells to attach, spread, proliferate and differentiate (Misra et al., 2010).  In 
the present study, the total serum protein adsorbed on the P(3HB)/n-BG composite 
microsphere films was significantly (n=3, ***p<0.001) higher, when compared to the 
P(3HB) microsphere films before immersion in SBF. This difference was attributed to 
the effect of surface roughness on the P(3HB)/n-BG composite microsphere films 
caused by the presence of n-BG particles when compared to the P(3HB) microsphere 
films. This result was in agreement with the observation made by Misra et al., where 
the total protein adsorption was significantly higher (171µg) on P(3HB/n-BG) 
composite films  when compared to the neat P(3HB) films. This difference in the 
protein adsorption was attributed to the marked differences in surface morphology 
and surface area available for protein adsorption (Misra et al., 2008).  
The presence of proteins on the surface of a biomaterial is also known to promote the 
subsequent adhesion of cells on the biomaterial surface (Ghannam et al., 1999).  
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The % cell viability results in this study revealed a higher cell attachment on the 
P(3HB)/n-BG composite microsphere films when compared to the P(3HB) 
microsphere films. In this study, the presence of a nanotopography induced by the 
presence of n-BG particles as well an increased protein adsorption had contributed to 
the higher cell attachment on the P(3HB)/n-BG microsphere films as compared to the 
P(3HB) microsphere films. Misra et al., observed an increase of 65% in the 
proliferation rate of MG-63 osteoblast cell line when compared to the control (tissue 
culture plastic) (Misra et al., 2008). The nanoprotrusions formed on the P(3HB)/n-BG 
composite microsphere films in this study had also increased the surface area for cell-
substratum contact and at this protrusion height, the focal adhesion was not perturbed, 
as they were also able to trap the proteins that were necessary to increase cell 
adhesion. This also establishes the fact that the height of the nanotopographical 
feature is very critical; as this determined whether the adherent cells were exclusively 
located on the apex of the nanotopographical feature or if they were able to establish 
contact with the basal substrate and the other cells (Biggs et al., 2010). Thus the 
protein adsorption results along with the cell proliferation data indicated that the 
P(3HB)/n-BG composite microsphere films exhibited good biocompatibility. The 
P(3HB) microsphere films on the other hand exhibited a hydrophobic surface with 
reduced protein adsorption due to which the cell adhesion was lower. Generally the 
cells when added to a hydrophobic surface form few filaments due to which they do 
not adhere onto the surface, thus resulting in a loose attachment (Peschel et al., 2007).  
5.3.1.7 Haemostatic activity  
Apart from favouring the formation of silanol groups on the surface of Bioglass
®
 and 
inducing the formation of hydroxyapatite, Ca
2+
 ions are responsible for a cascade of 
reactions that lead to fibrin polymerization and clot stabilization (Hoffman et al., 
2003). Bioactive glasses are also known to be a rapid acting haemostatic agent as they 
release Ca
2+
 ions upon hydration (Ostomel et al., 2006). Therefore in order investigate 
the haemostatic efficacy of n-BG particles and determine its suitability as a wound 
healing agent, a thromboelastograph test was done to measure the change in the 
viscoelasticity of blood during clot formation in the presence of the n-BG particles. 
From the results it was observed that the time for clot detection had decreased linearly 
with the increase in the concentration of n-BG particles. These results were similar to 
the observation made by Ostomel et al., where a decrease in the clot detection time 
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had decreased linearly when the concentration of mesoporous bioactive glass (MBGM 
80) was increased. In this study, the time for the clot formation, in the presence of n-
BG particles, was much less when compared to those of the m-BG particles. The n-
BG particles as mentioned earlier have a higher specific surface area of 79 m
2
g
-1
 when 
compared to m-BG <1m
2
g
-1
. Hence, a reduced time for clot detection was observed in 
the presence of nBG.  
5.3.2 P(3HB)/n-BG composite microsphere films immersed in SBF  
A composite film containing bioactive glass is considered to be bioactive largely due 
to its ability to nucleate new layers of hydroxyapatite (HA) at the implant-tissue 
interface (Misra et al., 2008). The presence of an apatite layer on a biomaterial is also 
known to induce nanotopography. In addition, the surface chemistry of the apatite 
layer immersed for different time periods is known to vary. These variations in the 
biomaterial surface properties are known to have a significant effect on protein 
adsorption and the subsequent cellular interactions. Therefore for this study, the 
P(3HB)/n-BG composite microsphere films were immersed in SBF for a period of 1, 
3 and 7 days to induce the formation of an apatite layer. The in vitro bioactivity tests 
were performed in a simulated body fluid, SBF, which is known to have an ionic 
composition similar to that of blood plasma. This bioactive layer was characterized 
using a range of techniques such as FTIR, SEM/EDX and XRD analysis.  Finally, the 
total protein adsorption on the surface of these composite films and the effect of this 
nanotopography on the keratinocyte attachment, morphology and proliferation was 
investigated. In another relevant study Ostomel et al., immersed mesoporous 
bioactive glass microspheres (MBGMs) in SBF to monitor the formation of 
hydroxyapatite on the surface of the microspheres. Since Ca is an important parameter 
to accelerate coagulation response, the authors‟ wanted to determine the 
bioavailability of these Ca ions for coagulation (Ostomel et al., 2006). 
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5.3.2.1 Surface morphology of the P(3HB)/n-BG composite microsphere films 
As seen from the SEM images in Figure 13, the surface morphology of the P(3HB)/n-
BG composite microsphere films before immersion in SBF was fairly uniform in 
appearance. The surface morphology of the films immersed in SBF for 1 day was also 
comparable to films before immersion. However the nucleation of hydroxyapatite 
from the n-BG particles was evident from the SEM micrographs of the films 
immersed for 3 and 7 days. The presence of spherical nodules scattered over the 
surface was observed on the films immersed for 3 days. However, a more or less 
homogenous layer of HA crystals were observed on day 7. In a study conducted by 
Misra et al., the formation of scattered HA crystals were observed on the P(3HB)/n-
BG composite films only after 5 days of immersion and a homogenous distribution of 
HA crystals were observed on the entire surface after 30 days of immersion in SBF. 
The formation of HA crystals is qualitatively proportional to the concentration of n-
BG particles used to fabricate the films and its availability on the surface of the films. 
Therefore the formation of HA crystals was much earlier in this study, at 3 days when 
compared to 7 days as observed by Misra et al., probably due to the presence of 
higher amount of n-BG particles on the surface (Misra et al., 2008). 
5.3.2.2 FTIR analysis  
The P(3HB)/n-BG composite microsphere films after immersion in SBF for a period 
of 1, 3 and 7 days were characterized using FTIR to detect the presence of Ca and P 
formation on the surface. In the FTIR spectrum of the P(3HB)/n-BG composite 
microsphere films before soaking in SBF, the absorption bands of silica were 
observed. The P(3HB)/n-BG composite microsphere films after 1 day of immersion 
revealed the presence of two new absorption bands with wavenumbers at 500 cm
-1
 
and 600 cm
-1
 corresponding to the formation of an amorphous calcium phosphate 
layer. The FTIR spectra of the P(3HB)/n-BG composite microsphere films after 3 and 
7 days of immersion in SBF revealed bands that were analogous to that of apatite. The 
presence of absorption bands with wavenumbers at 601 cm
-1
 and 568 cm
-1
 further 
confirmed the formation of a crystalline calcium phosphate layer. When the 
biomaterial is immersed in SBF a sequence of reactions are involved in the formation 
of hydroxyapatite. Initially there is a rapid exchange of Na
+
 and Ca
+ 
ions followed by 
an increase in the hydroxide ion concentration and the loss of soluble silica (Si
+
) due
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to the formation of SiOH. The formation of a Si-O-Si group is observed after the 
condensation and repolymerisation of a SiO2 rich layer. Finally, the absorption of 
Ca
2+
 ions and PO4
2-
 takes place, leading to the formation of an amorphous calcium 
phosphate layer. This amorphous layer further undergoes crystallization leading to the 
formation of a hydroxyapatite layer.  The results obtained in this study were also in 
agreement with the above observations where on day 1, two new absorption bands 
corresponding to the formation of an amorphous calcium phosphate layer was 
observed. With the increase in the immersion time the transformation of these bands 
to a crystalline HA layer was observed. These results were similar to the observations 
made Lu et al., when 45S5Bioglass particles where immersed in an electrolyte 
solution for 1, 3 and 7 days and then analysed using FTIR.  The presence of an 
amorphous calcium phosphate layer was observed on day 1 of immersion which was 
followed by the appearance of P-O bending vibration band between 500 cm
-1
 and         
600 cm
-1
, indicating the formation of an amorphous calcium phosphate layer. The 
crystallization of this Ca-P layer was observed on day 3 and day 7 when the P-O 
bending band became divided (Lu et al., 2001).  
5.3.2.3 SEM/EDX and XRD analysis  
SEM/EDX analysis of the P(3HB)/n-BG composite microsphere films immersed in 
SBF were carried out to highlight the transition of the bioactive glass particles to 
calcium phosphate layer. The results of the EDX analysis of this study revealed the 
presence of Ca and P deposits on the films on day 1. These surface deposits contained 
high concentrations of Ca and Si initially but were low in P concentrations. All the 
samples were initially high in Si concentrations but began to diminish after 3 days. 
Simililarly an increase in the P concentrations were also observed with the increase in 
the immersion time. These results were also similar to observation made by Lu et al., 
where the results of the EDX analysis revealed the presence of Ca, P and Si initially 
on day 1 of immersion followed by decrease in the Si concentrations and an increase 
in the P concentrations with prolonged immersion time (Lu et al., 2001). The early 
levels of bioactivity although confirmed using FTIR and SEM/EDX analysis, the X-
Ray diffraction studies were carried out to identify the presence of a prominent 
hydroxyapatite peak. The results of the XRD studies in this study, confirmed the 
presence of HA where the corresponding peaks at 2  of 32º was found to increase 
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with the immersion time. Misra et al., also observed an increase in the HA peaks at 2  
of 32º in the X-Ray diffractograms of P(3HB)/n-BG composite films with the increase 
in the immersion time (Misra et al., 2008). Thus from the results of the 
characterizations (FTIR, SEM/EDX and FTIR) done in this study it can be concluded 
that the P(3HB)/n-BG composite microsphere films when immersed in SBF exhibited 
bioactivity. These immersion experiments in SBF showed that the n-BG particles had 
significantly enhanced the surface reactivity of the P(3HB)/n-BG composite 
microsphere films. The higher exposure of the n-BG particles on the film surface 
could have also contributed towards the bioactivity of the P(3HB)/n-BG composite 
microsphere films thus transforming the polymeric surface into a highly bioactive 
surface.   
5.3.2.4 Thermal properties  
The thermal properties of the P(3HB)/n-BG microsphere films such as melting 
temperature and %Xc after immersion in SBF for 1, 3 and 7 days did not exhibit 
significant changes when compared to the films before immersion. The thermal 
properties of a biomaterial are known to have an effect on the in vitro degradation 
rate. For examplepolymer films with a combination of high molecular weight, high 
crystallinity and relatively hydrophobic nature prevents any appreciable water uptake. 
However initial degradation in biomaterials which are not highly crystalline exhibit 
initial degradation in the amorphous regions followed by a second round of 
degradation through a chain scission in the crystalline domains, thus exhibiting an 
overall reduction in the crystallinity of the matrix with the increase in the water 
uptake.  P(3HB)/n-BG films have been observed to exhibit a rapid increase in the 
water uptake  (33%) within the first 10 days of immersion in SBF (Misra et al., 2008), 
However in this study, the increased water uptake in the presence of the n-BG 
particles as well the formation of HA did not seem to have a significant effect on the 
thermal properties. Since the thermal properties were measured only for a period of 7 
days, significant changes in the thermal properties would have probably occurred on 
prolonged immersion.  
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5.3.2.5 Surface roughness  
The surface roughness of the P(3HB)/n-BG composite microspheres immersed in SBF 
for 1, 3 and 7 days were analysed using white light interferometery to study the 
changes induced in the roughness due to the formation of crystalline hydroxyapatite 
(HA). The surface roughness of the films on day 1 was comparable to the rms 
roughness values of the films before immersion in SBF. SEM images also verify this 
observation where fairly uniform and smooth surfaces were observed. However, films 
immersed in SBF for 3 and 7 days, revealed an increasing surface roughness when 
compared to the films before immersion. As observed from the SEM images, the 
presence of the spherical nodules on day 3 and a non-uniform layer of HA on day 7 
had contributed to the changes in the surface roughness. The surface roughness maps 
along with the 2D plots of P(3HB)/n-BG composite microspheres films immersed in 
SBF for 3 days and 7 days did not reveal a homogenous roughness and there were 
some areas which exhibited higher relative roughness than the others. This non-
homogenous surface roughness was again contributed by the lack of a uniform HA 
layer formed on day 3 and day 7. Similar results were observed in a study conducted 
previously, where the measured surface roughness values on day 7 for bioactive glass-
ceramic tablets coated with microspheres after immersion in SBF was much higher as 
compared to just the bioactive glass-ceramic tablets. The growth of HA crystals upon 
immersion in SBF was known to be responsible for inducing changes in the surface 
roughness of the bioactive glass-ceramic tablets coated with microspheres (Francis et 
al., 2010).  
5.3.2.6 Surface wettability  
Static contact angle measurements were done to study the effect of HA crystals on the 
surface wettability of the P(3HB)/n-BG microsphere films. The presence of the HA 
crystals on the surface of the P(3HB)/n-BG composite microsphere films led to a 
significant increase in the wettability of the composite films by lowering the water 
contact angle. The presence of the amorphous calcium phosphate deposition on day 1 
and nanoscale sized HA crystals on day 3 and day 7 of the P(3HB)/n-BG composite 
microsphere films had improved the surface wettability of the films due to the 
increased hydrophillicity. 
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5.3.2.7 Protein adsorption  
P(3HB)/n-BG composite microsphere films with enhanced surface roughness induced 
by the formation of HA were tested for their biocompatibility. Surface roughness is 
known to increase the potential surface area for cell attachment and biomaterial-cell 
interactions (Itala et al., 2002). Thus for this study, the influence of HA formation on 
the total protein adsorption were investigated. From the results, the P(3HB)/n-BG 
composite microsphere films before immersion in SBF had exhibited the highest 
amount of protein adsorption as compared to the films after adsorption. The total 
protein adsorption on the P(3HB)/n-BG composite microsphere films after adsorption 
was recorded highest on day 1 and a small amount of protein adsorption was observed 
on day 7 and on day 3. This difference in the protein adsorption between the 
P(3HB)/n-BG composite microsphere films before and after immersion in SBF could 
be attributed to the surface charge, surface area, surface roughness and hydrophilicity 
variations induced by the formation of HA on the surface composite microsphere 
films.  Bioactive glass surface is known to carry an intrinsically negative surface 
charge (Lu et al., 2001). However, after immersion in SBF, the negative charge of the 
bioactive glass surface is neutralized by the adsorbed proteins (Lu et al., 2001). On 
day 1 of immersion in SBF, the formation of an amorphous Ca-P layer is observed to 
induce a charge reversal from a negative to a positive surface charge (Lu et al., 2001). 
However, when an amorphous Ca-P layer is converted to a crystalline Ca-P layer with 
a prolonged immersion in SBF (3 days and 7 days), a second charge reversal from a 
positive to negative charge between -13 mV to -16.30 mV is observed to occur. This 
second sign reversal from a positive to negative charge occurs due to the precipitation 
of phosphate ions from the solution (Lu et al., 2001). The nature of the zeta-potential 
charge of a material surface affects both the amount as well as the orientation of the 
proteins adsorbed (Lu et al., 2001). Thus based on these observations, on day 1 of 
immersion in SBF the amorphous calcium phosphate layer carries a positive surface 
charge of 7.47 mV, therefore negatively charged protein molecules such as albumin, 
fibronectin and vitronectin present in Dulbecco‟s Modified Eagle medium (DMEM) 
bound to the surface, hence a higher amount of protein adsorption was observed when 
compared to the P(3HB)/n-BG  composite films immersed in SBF for 3 and 7 days. 
On day 3 of immersion in SBF, the crystalline HA layer exhibited a surface charge of                    
-13mV, which was higher than the negative charge of the P(3HB)/n-BG composite 
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microsphere films before immersion, due to which less  protein adsorption was 
observed. On day 7 of immersion in SBF, the films exhibited a higher negative 
surface charge of -16.30 mV when compared to the films on day 3. Nevertheless a 
small amount of protein adsorption was also observed. Ghannam et al., also observed 
a significant decrease from 1000µg to 800µg in the serum protein adsorbed onto 
bioactive glass when the negativity of the material increased. The negatively charged 
serum proteins were inhibited from adsorbing onto the surface due to which a 
decrease in the protein adsorption was observed (Ghannam et al., 1999). BSA carries 
a negative charge at neutral pH; however the net charges of three domains of BSA (I, 
II, III) are not uniformly distributed. For examplethe net charge of domain I and II are 
-16.8mV whereas the domain III carries a net charge of -1.3mV at pH 7. An 
imbalanced charge distribution is also observed where some amino acids are 
negatively charged at pH 7 and some amino acids are hydrophobic with no charge at 
any pH. As a result only 36% of the negatively charged groups of the BSA molecule 
are neutralised in an electrostatic interaction with a positively charged surface 
(Rezwan et al., 2004). Therefore in this study other factors such as increased surface 
roughness and surface area would have contributed to the protein adsorption on the 
negatively charged surfaces, where an increasing surface roughness as well a higher 
surface area is known to affect the amount of proteins adsorbed on the scaffolds 
(Misra et al., 2008). 
 
5.3.2.8 Cell adhesion  
The presence of proteins on the surface of a biomaterial is known to promote the 
subsequent adhesion of cells on the biomaterial surface (Ghannam et al., 1999). 
Similarly a rough surface of a biomaterial is also known to not only provide an 
optimal surface topography for cell attachment but it could also provide a larger 
surface area for biomaterial-cell interactions (Itala et al., 2002).  Thus in the present 
study, the effect of biomaterial surface properties and protein adsorption on the 
subsequent cellular attachments was evaluated. The biocompatibility of the P(3HB)/n-
BG composite microsphere films after immersion in SBF was demonstrated using the 
HaCaT keratinocyte cell line, the cell proliferation rate was determined using Neutral 
Red assay and the cell attachment and distribution of HaCaT on the P(3HB)/n-BG 
composite microsphere films were examined through SEM. From the results obtained,
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 highest % cell viability was observed on the P(3HB)/n-BG composite microsphere 
films immersed in SBF for 1 day when compared to the % cell viability on the 
P(3HB)/n-BG composite microsphere films before immersion. The enhanced surface 
topography as well as an increased amount of protein adsorption might be one of the 
reasons why a significant increase in the % cell viability on the P(3HB)/n-BG 
composite microsphere films after immersion in SBF was observed. These results 
were similar to the observations made by Ghannam et al., where the highest adhesion 
of osteoblast (MC3T3-E1) cells were observed on the bioactive glass surface covered 
both by a layer of amorphous Ca/P and adsorbed serum protein when compared to 
other surfaces such as (hydroxyapatite (HA) and bioactive glass (BG) with only 
protein and no amorphous Ca/P layer (Ghannam et al., 1999). In this study the films 
immersed in SBF for 3 days and 7 days also exhibited a significant increase in the % 
cell viability when compared to the % cell viability observed on the P(3HB)/n-BG 
composite microsphere films before immersion in SBF. The enhanced surface 
roughness as well as available surface area may have contributed to an increase in the 
protein adsorption. In another relevant study Itala et al., compared the osteoblast cell 
surface response on a microroughened bioactive glass surface with a surface 
roughness of 0.35µm and 0.52µm and a smooth surface with a surface roughness 
between 0.1µm to 0.15µm. The cell proliferation assay analysed using a non-
radioactive cell proliferation assay and in situ staining and laser confocal microscopy 
revealed an enhanced cell attachment on the microrough surface when compared to 
the smooth surface (Itala et al., 2002).  
When the % cell viability of the P(3HB)/n-BG composite microsphere films after 
immersion in SBF were compared , the highest % cell viability were observed on the 
films immersed in SBF for 1 day when compared to the films immersed for 3 and 7 
days. Although a small-scale surface roughness between 10 nm to 10µm is known to 
influence biomaterial-cell interactions, an increase in the surface roughness beyond an 
optimum point is known to affect the cell interactions (Itala et al., 2002). Thus the 
increased surface roughness of the films on day 3 and day 7 might have affected the 
% cell viability. The lesser amount of proteins adsorbed as well as the changes in the 
conformation of the adsorbed proteins on different surface roughness observed on the 
day 3 and day 7 films may have contributed to the lower cell adhesion when 
compared to the cell adhesion on day 1. 
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A qualitative analysis of cell adhesion and distribution on the P(3HB)/n-BG 
composite microsphere films were carried out using SEM. The SEM images of the 
cells attached on the films immersed in SBF on day 1 revealed a well-spread uniform 
surface morphology comparable to the cell attachment on the P(3HB)/n-BG 
microsphere films before immersion in SBF. The morphology of the cells attached on 
the P(3HB)/n-BG composite microsphere films immersed for 3 days and 7 days 
appeared raised due to the presence of HA crystals present beneath. The cells 
appeared to spread and form a non-uniform layer on the films. The surface 
irregularities of the films also seem to interfere with the cell attachment where a 
continuous uniform layer was not observed. Therefore, these results indicated that due 
to increased surface roughness or nanotopography, the cell attachment was affected 
due to which lower cell viability was recorded. Although nanoscale protrusions act as 
mediators for cellular adhesions, protein kinetics and cellular differentiation, an 
increase in the nanoprotrusion height such as 90 nm for some cells such as human 
bone marrow stromal cells is known to cause a reduction in cellular adhesion                 
(Biggs et al., 2010). The cytoskeletal organization and the filipodia formation initially 
increase in the presence of an increased nanoscale protrusion when compared to the 
cells on a flat substrate. However, this attachment phase does not last for long and the 
cells adhered on this protrusion undergo dedifferentiation or adhesion mediated 
apoptosis. Due to this a reduced cell adhesion or cell spreading is observed. Thus the 
results in this study were indicative of an increased nanoscaled protrusion (diameter 
and height) seen on the films immersed in SBF for 3 days and 7 days. Thus it can also 
be inferred that the nanoscaled feature of the films immersed in SBF for 1 day was 
probably less than 60-70 nm in pillar height, which facilitated integrin clustering, and 
focal adhesion formation due to which a higher cell adhesion and enhanced cellular 
spreading by providing tactile stimuli. Thus from these results of the cell viability 
tests, the P(3HB)/n-BG composite microsphere films immersed in SBF exhibited 
biocompatibility and no measureable toxicity towards the HaCaT keratinocyte cell 
line. However, this study also revealed that there is an optimal point for increased 
surface roughness beyond which a negative effect on the cell-biomaterial interaction 
would be observed. The influence of varying surface properties such as surface 
chemistry and surface charge on the biocompatibility of the P(3HB)/n-BG composite 
microsphere films were also highlighted.  
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5.4 Conclusions 
In this chapter P(3HB)/n-BG composite microsphere were studied as potential wound 
healing patches. Detailed structural, thermal and biocompatibility studies were carried 
out. The nanoscaled bioactive glass with a high surface area was also tested for its in 
vitro haemostatic efficacy and was able to successfully reduce the clot detection time. 
This feature would add an additional desirable property to the wound healing patches. 
The presence of n-BG particles in the P(3HB)/nBG composite microspheres films 
resulted in a uniform surface roughness on the P(3HB)/n-BG composite microsphere 
films which increased by 5% when compared to the P(3HB) microsphere films. 
Similarly, an increase of 6.5% was observed in the surface wettability of the 
P(3HB)/n-BG composite microsphere films when compared to the P(3HB) 
microsphere films. The presence of the n-BG particles on the surface had increased 
the hydrophilicity of the P(3HB)/n-BG composite microsphere films due to which the 
water adsorption of the films had also increased. The effects of nanotopography on 
the biocompatibility such as protein adsorption and HaCaT keratinocyte cell 
attachment were also highlighted. The total serum protein adsorbed and the cell 
proliferation rate on the P(3HB)/n-BG composite microsphere films was significantly 
(n=3, ***p<0.001) higher, when compared to the P(3HB) microsphere films. This 
difference can most likely be attributed to the effect of surface roughness. The 
addition of the n-BG particles had also affected the thermal properties of the 
P(3HB)/n-BG composite microsphere films, where the heat of fusion was 
significantly (n=3 ***p<0.001) reduced when compared to the P(3HB) microsphere 
films. However, the presence of the n-BG particles had not completely prevented the 
re-crystallization of the polymer, as was evident by the presence of the melting peak 
in the second heating run.  
For the second part of this study, the surface roughness of the P(3HB)/n-BG 
composite microsphere films were further enhanced by immersion in SBF for a period 
of 1, 3 and 7 days. The films were immersed in SBF, in an effort to study the effect of 
the roughness induced by the formation of HA on the cellular functions such as cell 
adhesion. From the SEM images the surface of the P(3HB)/n-BG composite 
microsphere films appeared fairly uniform and smooth on day 1, however on day 3 
and day 7 a rough and uneven surface was observed. The presence of HA on the 
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P(3HB)/n-BG composite microsphere films on day 3 and day 7 had increased the 
surface roughness of the films. HA formation on the surface of the P(3HB)/n-BG 
composite microsphere films was confirmed using FT-IR, SEM/EDX and XRD 
analysis.  
The presence of the amorphous calcium phosphate deposition on day 1 and nanoscale 
sized HA crystals on day 3 and day 7 of the P(3HB)/n-BG composite microsphere 
films had also improved the surface wettability of the films due to an increased 
hydrophillicity. The total protein adsorption on the P(3HB)/n-BG composite 
microsphere films after adsorption was recorded highest on day 1 and a small amount 
of protein adsorption was observed on  day 3 and day 7. Similarly, the highest % cell 
viability was observed on the P(3HB)/n-BG composite microsphere films immersed 
in SBF for 1 day. The morphology of the cells attached on the P(3HB)/n-BG 
composite microsphere films after immersion in SBF for 1 day appeared well-spread 
with a flattened morphology. On the other hand, the cell morphology on the films 
immersed for day 3 and day 7 did not reveal a flattened morphology, the cells 
appeared raised due to the presence of the crystalline calcium-phosphate layer found 
beneath. Thus the rough surface morphology of the films on day 3 and day 7 appeared 
to interfere with cell adhesion where the cells appeared scattered without the 
formation of a continuous thick layer.  
Thus from this study, the advantages of incorporating n-BG particles in the P(3HB) 
microsphere films were understood. The presence of n-BG in the P(3HB) microsphere 
films was able to induce a nanotopography, which in turn had an effect on the surface 
wettability of the films as well protein adsorption. The %cell viability was also 
significantly increased in the presence of the n-BG particles. However when the 
P(3HB)/n-BG composite microsphere with enhanced surface roughness were tested 
for biocompatibility, reduced amount of protein adsorption and cell adhesion were 
observed. This study further indicated that there is an optimal surface roughness for 
increased cell adhesion beyond which it would be deleterious for cell adhesion.
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Chapter 6 
Tetracycline encapsulated poly(3-
hydroxybutyrate) for wound healing 
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6.1 Introduction  
The skin is the largest organ of the body which represents one-tenth of the body mass.       
It is composed of three layers, the epidermis, dermis and the hypodermis                      
(Metcalfe et al., 2007). The main function of these layers is to protect the skin from 
any mechanical damage such as wounding. The epidermis, a thin and cellular layer is 
known primarily to provide vital barrier function and maintain homeostasis by 
constant recycling of the basal layer. The common cell type forming a barrier layer in 
the epidermis is the keratinocytes (Metcalfe et al., 2007).  Since the skin contributes 
to the major part of the body, any damage due to injury, burns and disease can have a 
major consequence. Therefore, several tissue engineered skin substitutes are being 
designed to treat acute and chronic and skin wounds (Metcalfe et al., 2007).  In tissue 
engineering, a biomaterial is designed that can be used to replace the damaged organ 
or tissue. However, for skin tissue regeneration or wound healing the biomaterial 
should possess the strength to promote the growth of skin cells such as keratinocytes, 
melanocytes and fibroblasts. They should be non-toxic, non-antigenic and facilitate 
angiogenesis while being incorporated with minimal scarring and pain. In addition to 
this, biomaterials are also required to act as an artificial extracellular matrix (ECM) 
for the cells to attach.  
Apart from providing adequate mechanical stability and providing a desired cellular 
response, there is a growing need to functionalise these biodegradable polymeric 
scaffolds by adding either growth factors or drugs. Thus biodegradable scaffolds can 
be multi-facteted where, the improved surface characteristics can promote cell 
attachment, while acting as a drug delivery vehicle for a controlled release of drugs or 
growth factors. In the present chapter compressed P(3HB) microsphere films 
encapsulating tetracycline were developed for wound healing applications. 
Tetracycline is one of the most abundantly used drug, since it is a broad spectrum 
antibiotic. It is also known to exhibit anti-inflammatory action and the ability to 
promote fibroblast attachment (Domingues et al., 2004). 
In previous studies, films made of polysaccharides; -hydroxy acids and their 
copolymers have been used as dermal tissue patches. However, due to some 
disadvantages such as prolonged healing times and limited tissue functionality, 
alternative biodegradable polymers have been considered (Metcalf et al., 2007). 
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Although polyhydroxyalkanoates (PHAs) have been used for a number of biomedical 
applications, polymers such as P(3HB), P(3HB-co-HV) and P(3HB-co-3HHx) have 
not yet been fully investigated for skin tissue engineering due to their crystallinity and 
poor flexibility, which have been considered limiting (Peschel et al., 2008; Luo et al., 
2009).  Nevertheless, P(3HB-co-4HB-co-3HHx) films were made in an attempt to 
improve the mechanical and biocompatible properties of the films for use as an 
implant for wound healing applications. L929 mouse fibroblasts and human 
keratinocytes,  (HaCaT) cells were seeded on these films to test their biocompatibility 
in comparison to films made of poly(lactic acid)(PLA), P(3HB-co-3HHx) films and 
polylysine-coated plates used as a control (Liu et al., 2008). From the SEM images a 
well spread cell shape with large number of pseudopods indicating strong cell-to-cell 
and cell to material interactions were identified. Thus from this study it was proven 
that films made of P(3HB-co-4HB-co-3HHx) exhibited favourable biocompatible and 
biodegradable properties when compared to  poly(lactic acid)(PLA) and P(3HB-co-
3HHx) films (Liu et al., 2008).  Other novel terpolyesters of poly(3-hydroxybutyrate-
co-3-hydroxyvalerate-co- hydroxyhexanoate),(P(3HB-co-3HV-co-3HHx), produced 
from recombinant  microorganisms were made into films and tested for their 
mechanical and biocompatible properties for possible use in skin tissue engineering 
(Ji et al., 2008). These films exhibited the flexibility that was required for skin tissue 
engineering. Similarly, P(3HB-co-3HV-co-3HHx) films seeded with HaCaT cells 
exhibited the highest cell density and viability when compared to films made of other 
polyhydroxyalkanoates such as P(3HB), P(3HB-co-3HV), P(3HB-co-4HB), P(3HB-
co-3HHx) (Ji et al., 2008).  
For research related to skin graft or wound healing one of the most commonly used 
cell types is the HaCaT cell line. These cell lines were isolated from the periphery of a 
melanoma of human adult skin (Metcalf et al., 2007). These differentiated 
keratinocytes appear to be similar to normal human keratinocytes. When the skin is 
subjected to injury, the keratinoyctes present near the wound site respond to the 
biochemical signalling by migrating and adhering to the site. The adherence of the 
cells is mediated by integrins. These integrins have receptor sites, which exhibit 
domains for the specific proteins in the extracellular matrix (ECM) to bind (Wozniak 
et al., 2004).  After adhering, the cells aggregate to form clusters or focal adhesion 
(FA) sites/complexes. Following this, a series of multiple signalling complexes are 
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formed which initiate the re-epithelisation of a wound site (Miyamoto et al., 1995; 
Wozniak et al., 2004). The adherence of keratinocytes onto PHAs depends on a 
number of factors such as the adsorption of proteins on the surface the surface 
chemistry which influences the hydrophobicity or hydrophillicity, surface energy and 
the pH (Nebe et al., 2002, Patil et al., 2007). The extent and quality of protein 
adsorption on the biomaterial/scaffold is dependent on the nano/microstructural 
morphology and on the wettability of the films. Wang et al., have demonstrated the 
preference of different cell lines on various surfaces and observed that with the 
changes in the topography and roughness of the surfaces, the protein conformation 
also changes. Due to this, the ligand binding for specific cells is affected
 
(Wang et al., 
2007). Misra et al., 2009 incorporated vitamin E in P(3HB) films and studied the 
effect of vitamin E incorporation on the hydrophillicity and total protein adsorption on 
the films. The incorporation of vitamin E introduced some nano/microstructural 
changes on the surface, which, in addition to increasing the hydrophillicity of the 
surface, also increased the protein adsorption (Misra et al., 2009). 
This chapter describes work related to the combined applications of PHAs for 
scaffolds and drug delivery. The chosen drug for this work was tetracycline. 
Tetracycline were encapsulated in P(3HB) microspheres which was then compressed 
to form films. The effect of tetracycline addition on the surface roughness, wettability, 
thermal and crystalline properties of P(3HB) microsphere films were studied in detail. 
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6.2 Results 
6.2.1 Tetracycline loaded P(3HB) microsphere films characterizations 
6.2.1.1 Surface morphology of the P(3HB) microsphere films  
SEM images of the surface of the tetracycline loaded and unloaded P(3HB) 
microsphere films are shown in Figures 1 and 2. The surface of the unloaded P(3HB) 
microsphere films appear fairly uniform and smooth as seen in Figure 1A when 
compared to the tetracycline loaded films which were rough and uneven in 
appearance. The films with the highest drug loading of 4wt% appeared increasingly 
uneven and rough as seen in Figure 2 A3 when compared to the films with lower 
amount of the drug (0.5 wt% and 2 wt%) as seen in Figure 1 A1 and Figure 2 A2. The 
former also had an increased number of pores on the surface. Although the 
microspheres on the surface of the tetracycline loaded and unloaded films lost their 
identity when compressed into discs as seen in Figures 1B, 1B1, 2B2 and 2B3, the 
microspheres within the disc remained unaffected by the pressure applied and retained 
their shape, as seen in the cross-section images seen in Figures 1C, 1C1, 2C2 and 
2C3. 
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Figure 1:- Scanning electron micrographs of the surface of the P(3HB) microsphere films A) unloaded/blank P(3HB) microsphere films A1) P(3HB) microsphere 
films loaded with 0.5 wt% of tetracycline, B) Cross-section view of unloaded P(3HB) microsphere films, B1)  cross-section view of 0.5 wt% tetracycline loaded 
microsphere films and Side view of the C) unloaded P(3HB) microsphere films and C1) 0.5 wt% tetracycline loaded microsphere films.
B C A 
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Figure 2:- Scanning electron micrographs of the surface of the P(3HB) microsphere films with tetracycline loadings of A2) 2 wt%,   A3) 4 wt%.  Cross-section view 
P(3HB) microsphere films with tetracycline loadings of B2) 2 wt%, B3) 4 wt% and Side view of the P(3HB) microsphere films with tetracycline loadings of C2) 
2wt% and C3) 4wt%. 
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6.2.1.2 XPS evaluation  
The surface chemistry of the microspheres was analysed using XPS, enabling the 
examination of carbon, nitrogen and oxygen content using a soft X-Ray excitation, as 
shown in Figure 3 A, B, C. Since nitrogen species is unique to the drug and absent in 
the P(3HB) microspheres it was was used to estimate the amount of drug entrapped 
during the microsphere fabrication procedure. The surface chemical composition of 
the tested samples listed in Table 1 showed an increase in the nitrogen content with 
the increase in the tetracycline loading ratio.  The binding energy of nitrogen (N) was 
399.5eV which corresponds to the single bonded nitrogen. The binding energy of the 
tetracycline loaded microspheres was found to be 402.2 eV, quite close to the value 
for singly bonded nitrogen. 
Table 1: XPS data for the P(3HB) microspheres loaded with different amounts of tetracycline        
0.5 wt%, 2wt% and 4wt%. The relative mass percentages of each compound are presented (n=3). 
Tetracycline loaded 
P(3HB) microsphere 
films  
% Carbon % Oxygen % Nitrogen 
0.5 wt% 70.69 26.76 2.56 
2 wt% 71.53 25.46 2.60 
4 wt% 72.36 23.39 4.08 
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Figure 3:- The surface chemistry of the microspheres was analysed using XPS as nitrogen species 
is unique to the drug and absent in the P(3HB) microspheres   A) Nitrogen (N1s) XPS spectra of  
P(3HB) microsphere film  B) The nitrogen peak with a binding energy  of  402.2 eV with a 
tetracycline  loading of 0.5 wt%. B) Nitrogen (N1s) XPS spectra of P(3HB) microsphere film  
with a tetracycline  loading of 2wt%  B1) The nitrogen peak with a binding energy  of 402.2 eV. 
C) Nitrogen (N1s) XPS spectra of P(3HB) microsphere film  with a tetracycline loading of 4wt% 
C1) The nitrogen peak with a binding energy of   402.2 eV. 
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6.2.1.3 Surface topography studies  
In order to study the effect of tetracycline loading on the compressed P(3HB) 
microsphere film surface roughness, white light interferometry was used as shown in 
Figure 4. A comparison of the surface roughness quantified as rms of roughness (for 
the unloaded and loaded P(3HB) microsphere films represented in Figure 4 revealed 
that the maximum surface roughness was exhibited by the surface of the P(3HB) 
microsphere films with the highest drug loading.  
 
Figure 4:- A comparison of the surface roughness quantified as root mean square of roughness 
(rms), for the unloaded and loaded microsphere films, data (n=3; error=±s.d).  The tetracycline 
loaded P(3HB) microsphere films had a significant (***p<0.0001) effect on the surface roughness. 
Since the data compared using ANOVA was significant, a Bonferroni Post Hoc test was applied 
and significantly greater effect at ***p<0.0001 on the surface roughness for 4wt% tetracycline 
loaded P(3HB) microsphere films were observed when compared to the control and other 
tetracycline loaded films.  
The rms roughness value of the unloaded P(3HB) microsphere film of 4.2 m (Figure 
5A) was slightly lower than the film with a drug loading of 0.5 wt% as seen in Figure 
5B, thus indicating no significant difference in the surface roughness in the presence 
of the lower amount of drug. However, significant increases (n=3, ***p<0.001), in the 
rms roughness values were observed when the drug loading in the films were 
increased. The P(3HB) microsphere films with 2 wt% of the drug had a rms 
roughness value of  5.98 m, Figure 5C and films with  4 wt% had a rms roughness 
value of 6.74 m (n=3, ***p<0.001), Figure 5D, thus indicating a higher surface 
roughness with an increase in the drug loading. 
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Figure 5: The 2D and 3D plots of the P(3HB) microsphere film surfaces (with and without the 
drug) as determined by white light interferometry.  2D plot (A) and 3D plot (A1) of the unloaded 
P(3HB) microsphere films.  2D plot (B) and 3D plot (B1) of the P(3HB) microsphere films with 
0.5 wt% of tetracycline loading. 2D plot (C) and 3D plot (C1) of the P(3HB) microsphere films 
with 2 wt% of tetracycline loading. 2D plot (D) and 3D plot (D1) of the P(3HB) microsphere films 
with 4 wt% of tetracycline loading, (n=3; error=±s.d). 
A A1 
B B1
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C1 C 
D D1 
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6.2.1.4 Fourier Transform Infrared studies (FTIR) 
FTIR spectra of the unloaded P(3HB) microsphere films and tetracycline loaded 
P(3HB) microsphere films with different tetracycline loadings were carried out to 
identify any possible chemical drug-polymer interaction. The FTIR spectra of the 
tetracycline loaded P(3HB) microspheres as shown in Figure 6 revealed absorption 
bands with characteristic wavenumbers at 980 cm
-1
, 1230cm
-1
, 1282cm
-1
  and 
1782cm
-1
 due to the crystalline phase of P(3HB) and wavenumbers at 1184 cm
-1
 and 
1741cm
-1
 due to the amorphous phase of P(3HB). The stretching vibrations of the 
amorphous and crystalline carbonyl groups are seen at 1741cm
-1
 and 1728cm
-1 
respectively (Vallapil et al., 2007; Shih et al., 2006). The characteristic peaks for the 
tetracycline hydrochloride is seen between the wavenumbers 1200 cm
-1
 and 1800 cm
-1
 
as shown in Figure 6A. The carbonyl and amino groups of the amide group in ring A 
are assigned at wavenumbers 1673cm
-1 
and 1537cm
-1
 and the carbonyl groups were 
assigned to the wavenumbers at 1619cm
-1
 and 1586cm
-1 
 (Gu et al., 2005). The 
tetracycline loaded P(3HB) microsphere films with different drug loadings showed no 
additional chemical shifts in the FTIR spectra.  
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Figure 6:- FTIR spectrum of the P(3HB) microsphere films (with and without tetracycline). (A) Tetracycline, P(3HB) microsphere films loaded with 0.5wt% (B),                       
2 wt%  (C) and  4wt% (D)
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6.2.1.5 X-Ray diffraction analysis (XRD) 
X-ray diffraction analysis was carried out to evaluate the effect of tetracycline on the 
crystallinity of P(3HB). The X-ray diffraction pattern of tetracycline hydrochloride 
could be observed at diffraction angles of 2  with characteristics peaks at 11.2 , 
13.88 , 16.04 , 20 , 24.48  and 28.76 , as seen in Figure 7A. The X-ray diffraction 
peaks obtained for P(3HB) at 2  were 13.48 , 16.88 , 21.72 , 22.64  and 25.64  as 
shown in Figure 7E, which are comparable to those, observed in literature (Bidone                  
et al., 2009), thus reflecting its semi-crystalline nature. The X-ray diffraction patterns 
of the P(3HB) microspheres loaded with tetracycline such as 0.5 wt%; 2wt%; 4wt% 
are represented in the diffractograms 7C, D and E. The intensity of the X-ray 
diffraction peaks of the tetracycline loaded P(3HB) microsphere films with different 
drug loading ratios were not significantly changed in comparison to the unloaded 
P(3HB) microspheres.  
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Figure 7:- X-Ray diffractograms of the P(3HB) microsphere films (with and without the drug). X-Ray diffractogram of A) Tetracycline. B) Unloaded P(3HB) 
microsphere films and P(3HB) microsphere films loaded C) with 0.5 wt% of tetracycline, D) with 2 wt% of tetracycline and E) with 4 wt% of tetracycline.  
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6.2.1.6 Thermal analysis  
Differential scanning calorimetry (DSC) was used to determine the changes in the 
thermal behaviour of the P(3HB) microspheres during solvent evaporation, as well as to 
determine the possible interaction between the drug and the polymer (Figure 8). The Tm 
of the unloaded P(3HB) microspheres and the drug loaded P(3HB) microspheres were 
lower than that of the crude polymer. A decrease in the degree of crystallinity (%Xc) of 
the P(3HB) loaded microspheres with 0.5wt%, 2wt% and 4wt%  of tetracycline was 
observed when compared to the crude and unloaded P(3HB) microspheres (Figure 8). 
However, the glass transition temperature (Tg) of the tetracycline loaded P(3HB) 
microspheres were higher than that of the crude polymer and the unloaded P(3HB) 
microspheres, where the highest Tg value was exhibited by the microspheres with highest 
tetracycline loading  (Figure  9). 
 
Figure 8:- A comparison of the %Xc and Tm of the crude polymer and the P(3HB) microspheres 
(with and without the drug), data (n=3; error=±s.d). The tetracycline loaded P(3HB) microsphere 
films had a significant (*** p<0.0001) effect on the %Xc. Since the data compared using ANOVA was 
significant, a Bonferroni Post Hoc test was applied and significantly greater effect at ***p<0.0001 on 
the %Xc values for 4wt% tetracycline loaded P(3HB) microsphere films were observed when 
compared to the control and 0.5 wt% tetracycline loaded films. No significant differences (p>1.0) 
were observed in the Tm values of the tetracycline loaded P(3HB) microsphere films when compared 
to the control. 
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Figure 9:- A comparison of the Tg values of the crude polymer and the P(3HB) microspheres (with 
and without the drug), (n=3; error=±s.d). The tetracycline loaded P(3HB) microsphere films had a 
significant (***p<0.0001) effect on Tg. Since the data compared using ANOVA was significant, a 
Bonferroni Post Hoc test was applied and  significantly greater effect at ***p<0.0001 on the Tg values 
for 4wt% tetracycline loaded P(3HB) microsphere films were observed when compared to the 
control and other tetracycline loaded films.  
6.2.2 In vitro degradation studies of the tetracycline loaded P(3HB) microsphere films  
The water uptake (WA) and weight loss (WL) study for the tetracycline loaded 
microsphere films with different drug loadings such as 0.5 wt%, 2wt%, 4wt%, were 
conducted using immersion tests in 0.1M phosphate buffered saline solution (PBS) for a 
period of 30 days. The results from the in vitro degradation studies are depicted in Figure 
10.  
The unloaded P(3HB) microsphere films exhibited a %WA of 180% to 250% over a 
period of 30 days. The %WL was 5% to 8% over a period of 30 days.  
Tetracycline loaded P(3HB) films with 0.5 wt% of the drug showed an increase in the 
%WA from 237% to 300% from day 1 to day 30, where insignificant differences  (n=3, 
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p>0.5) were observed on day 1 when compared to the %WA of the unloaded P(3HB) 
microsphere films but significant changes (n=3, ***p<0.001) in the %WA were observed 
from 15 days to 30 days when compared to the unloaded P(3HB) microsphere films. The 
%WL was 12% over a period of 30 days. This change in the %WL was significant (n=3, 
**p<0.01) when compared to the unloaded P(3HB) microspheres films which exhibited a 
%WL of  8% over a period of 30 days. No significant differences (n=3, p>0.2) in the % 
WL were observed from day 1 to day 15 when compared to the unloaded P(3HB) 
microsphere films.  
Films with 2 wt% of tetracycline also showed no significant increase (n=3, p>0.2) in the 
%WA on day 1 when compared to the unloaded P(3HB) microsphere films. However 
with an increase in the immersion time from day 15 day 30, a significant (n=3, 
***p<0.001) increase in the %WA of 388% (a 25% increase) was observed when 
compared to the %WA of the unloaded P(3HB) microsphere films. The P(3HB) 
microsphere films with 2wt% of tetracycline exhibited a significant(n=3, ***p<0.001) in 
%WL of 9% to 33% when compared to the unloaded P(3HB) microsphere films which 
was 5% to 8% over a period of 30 days.  
Finally, the %WA for the tetracycline loaded films with the highest drug loading of                
4 wt% was 488% over a period of 30 days which was higher than that of the other 
tetracycline loaded films. When compared to the %WA of the unloaded P(3HB) 
microsphere films,  a significant (n=3, ***p<0.001) increase of 49% was observed. As 
expected, the highest %WL from day 1 to day 30, of 13% to 35%, was exhibited by these 
microsphere films when compared to the unloaded P(3HB) microsphere films (n=3, 
***p<0.001).
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Figure 10: - In vitro degradation study of the P(3HB) microsphere films (with and without 
tetracycline) in phosphate buffered saline solution (PBS). The tetracycline loaded P(3HB) 
microsphere films had a significant (*** p<0.0001) effect on A) % water absorption (WA) and B) % 
weight loss (WL). A Bonferroni Post Hoc was applied and significant differences at ***p<0.0001 for 
2wt% and 4wt% tetracycline loaded P(3HB) microsphere films were observed when compared to the 
control and 0.5wt% tetracycline loaded P(3HB) microsphere films on day 15 and day 30.                         
No significant (p>2.0) differences in the %WA and %WL of the tetracycline loaded P(3HB) 
microspheres films on day 1 when compared to the control.  
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A gradual change in the pH of PBS (7.4) with the increase in the immersion time of the 
unloaded and tetracycline loaded P(3HB) microsphere films were also observed, as 
shown in Figure 11. The pH of the unloaded P(3HB) microsphere films changed from 
7.25 to 7.24 over a period of 30 days. The pH of the media with 0.5 wt% tetracycline 
loaded films remained also from 7.24 to 7.23 over a period of 30 days. The pH of the 
media with the 2 wt% tetracycline loaded P(3HB)  microsphere films changed from 7.24 
to 7.22 over a period of 30 days but no significant changes were observed when 
compared to the pH of the unloaded P(3HB) microsphere films. However a significant 
(n=3, ***p<0.0001) and (n=3, **p<0.001)  pH change from 7.24 to 7.19, occurred from 
day 15 to day 30 in media with the films loaded with the highest drug loading 4 wt% 
tetracycline when compared to the control and other tetracycline loaded microsphere 
films as seen in Figure 11. 
 
Figure 11:- Changes in the pH of the 0.1 M PBS solution over a period of 30 days in the presence of 
the tetracycline loaded P(3HB) microspheres films is represented, (n=3; error=±s.d). Tetracycline 
loaded P(3HB) microsphere films had a significant (**p<0.001) effect on pH . Since the data 
compared using ANOVA was significant, a Bonferroni Post Hoc was applied and significant 
differences at ***p<0.0001 for 4wt% tetracycline loaded P(3HB) microsphere films were observed 
when compared to the control and  0.5 wt%, 2 wt% tetracycline loaded films on day 15 and day 30. 
No significant (p>2.0) differences between 0.5 wt% and 2 wt% tetracycline loaded films were 
observed. 
7.14
7.16
7.18
7.2
7.22
7.24
7.26
7.28
p
H
Time in Days 
0.5 wt% 2 wt% 4 wt% Unloaded P(3HB) microsphere films 
Day 1                Day 15               Day 30 
 Chapter 6:Results 
 
228 
 
6.2.2.1 Thermal analysis after in vitro degradation studies of the P(3HB) microsphere 
films (with and without the drug) 
Thermal analysis of the P(3HB) microsphere films (with and without the drug) were 
carried out to identify the possible changes in the thermal properties after in vitro 
degradation studies (Figure 12).  
The Tm and %Xc values of the 0.5wt% tetracycline loaded P(3HB) microsphere films, 
when compared to the unloaded P(3HB) microsphere films, did not exhibit any 
significant changes over a period of 30 days (Figure 11A). However, the Tg values on day 
15 and day 30 were significantly reduced (n=3, ***p<0.001) when compared to the Tg 
values of 4.56 C and 4.41 C on day 15 and day 30 of the unloaded P(3HB) microsphere 
films (Figure 13).  
The Tm and the % Xc values of the P(3HB) microsphere films loaded with 2wt% 
tetracycline, after immersion in PBS, continued to remain insignificantly different (n=3, 
p>0.2) when compared to unloaded P(3HB) microsphere films immersed in PBS over a 
period of 30 days (Figure 12B), but a significant reduction (n=3, ***p<0.001) in the Tg 
values of 3.75 C and 3.54 C on day 15 and day 30 were observed when compared to the 
Tg values of the unloaded P(3HB) microsphere films on day 15 and day 30 (Figure 13). 
The Tm of the P(3HB) microsphere films loaded with 4wt% tetracycline after immersion 
in PBS, continued to remain insignificant (n=3, p>0.2) when compared to unloaded 
P(3HB) microsphere films over a period of 30 days (Figure 12C), but significant 
reduction (n=3, ***p<0.01)  in the % Xc and Tg  values were observed when compared to 
the unloaded P(3HB) microsphere films on day 1, day 15 and day 30 (Figure 13).  
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Figure 12:- A comparison of the thermal properties of the P(3HB) microsphere films (with and 
without the drug) measured on day1, day 15 and day 30 using  DSC.  A) The thermal properties of 
the P(3HB) microsphere films loaded with 0.5 wt% of tetracycline. B) The thermal properties of the 
P(3HB) microsphere films loaded with 2 wt% of tetracycline and C) the thermal properties of the 
P(3HB) microsphere films loaded with 4 wt% of tetracycline.  The tetracycline loaded P(3HB) 
microsphere films had a significant (***p<0.001) effect on the %Xc. Since the data compared using 
ANOVA was significant, a Bonferroni Post Hoc was applied and significant differences at 
***p<0.0001 for 4wt% tetracycline loaded P(3HB) microsphere films were observed when compared 
to the control and  other tetracycline loaded films on day1,  15 and day 30. No significant differences 
(p>2.0) were observed in the Tm values of the tetracycline loaded P(3HB) microsphere films when 
compared to the control. 
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Figure 13:- A comparison of the glass transition properties (Tg) of the P(3HB) microsphere films 
(with and without the drug) measured on day 1, day 15 and  day 30 using  DSC. The tetracycline 
loaded P(3HB) microsphere films had a significant (*** p<0.0001) effect on the Tg values. Since the 
data compared using ANOVA was significant, a Bonferroni Post Hoc was applied and  significant 
differences at ***p<0.0001 for 2 wt% and 4wt% tetracycline loaded P(3HB) microsphere films were 
observed when compared to the control and 0.5wt% tetracycline loaded films on day 15 and day 30. 
 
The DSC thermograms of P(3HB) microsphere films (with and without the drug) after 
the in vitro degradation studies in PBS over a period of 30 days are shown in Figure 14. 
The DSC thermograms of the tetracycline loaded microsphere films as seen on day 1, day 
15 and day 30 showed no characteristic endothermic peak at 234 C for tetracycline 
(Govender et al., 2005). The thermograms also appeared similar to those of unloaded 
P(3HB) microsphere films.  
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Figure 14:- A comparison of the DSC thermograms of the P(3HB) microsphere films (with and 
without the drug) measured at  day 1, day 15 and  day 30 to identify the possible drug-polymer 
interaction.  A1) The DSC thermograms of the unloaded P(3HB) microsphere films and the P(3HB) 
microspheres loaded B1) with 0.5 wt% of tetracycline, C1) with 2 wt% of tetracycline and D1) with          
4 wt% of tetracycline. (n=3; error=±s.d). 
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6.2.3 In vitro drug release studies 
The cumulative in vitro release of tetracycline from microsphere films with different drug 
loading ratios 0.5 wt%, 2 wt% and 4 wt% are represented in Figure 15. The encapsulation 
efficiencies of the tetracycline loaded microsphere films were determined as described in 
Chapter 2 section 8.1.1, shown in Table 2. The tetracycline loaded microspheres with the 
lowest drug loading ratio of 0.5 wt% exhibited the highest encapsulation efficiency of 
25% when compared to the P(3HB) microspheres with 15% and 11% for 2wt% and                        
4 wt% of tetracycline respectively.  
Table 2:- The encapsulation efficiency of the P(3HB) microspheres loaded with different drug 
loadings (n=3). 
Sample Initial Drug Loading (w/w) (%) Encapsulation 
Efficiency 
0.5 wt% 0.5 mg drug/100 mg P(3HB) 25% 
2 wt% 2 mg drug /100 mg P(3HB) 15% 
4 wt% 4 mg drug /100 mg P(3HB) 11% 
 
From the results a biphasic release profile was observed, an initial burst release followed 
by a sustained release in the medium. The tetracycline loaded film with 0.5 wt% of the 
drug exhibited an initial burst release of 13.49% from 0 to 1 hour of the actual drug 
loading. Similarly, microsphere films with 2 wt% and 4 wt% tetracycline exhibited a 
burst release of 6.4% and 14% of the actual drug loading of from 0 to 1 h of immersion in 
the release buffer. 
Following the initial phase of burst release, 48% of sustained phase of controlled drug 
release was observed in films loaded with 0.5 wt% tetracycline between 24 h to 48 h. 
Similarly, tetracycline films loaded with 2 wt% of the drug exhibited a controlled release 
of 33% the drug between 24 h and 168 h. Finally, the tetracycline film loaded with 4 wt% 
of the drug exhibited a controlled release of 31% between 24 h and 48 h. As expected, the 
highest % cumulative release of 100% was observed from the films with the highest drug 
loading when compared to 99% from films with 2 wt% and 99% from films with 0.5 wt%
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 of tetracycline. Although a cumlative release of 100% was achieved by all the films the 
intermediate drug release rates were different due to the different drug loadings. 
 
 
 
Figure 15:- In vitro kinetic profiles of tetracycline release from P(3HB) microsphere films containing 
microspheres with different drug loading ratios of 0.5 wt%, 2 wt% and 4 wt% in phosphate buffer at 
37 C, (n=3; error=±s.d). 
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6.2.4 Factors affecting the biocompatibility of the biodegradable polymers used as 
scaffolds 
6.2.4.1 Surface wettability (before protein adsorption) 
The effect of drug loading on the surface wettability of films was investigated.             
The water contact angle values of both the tetracycline loaded and unloaded microsphere 
films are shown in Figure 16. The water contact angle of the tetracycline loaded film with 
4 wt% was reduced to 54.39  from 64.67  (16% decrease), 2 wt% was reduced to 57.13  
(11.65% decrease) and 0.5 wt% the water contact angle was reduced to 62.13  (not 
significant) when compared to the control value of 64.67 . The surface wettability of 
tetracycline films loaded with 2wt% and 4 wt% was significantly reduced (*** p<0.0001) 
when compared to the control and 0.5 wt% tetracycline loaded films. 
 
Figure 16:- A comparison of the surface wettabilites of the P(3HB) microsphere films (with and 
without the drug). The P(3HB) microsphere films tetracycline loadings had a significant                          
(*** p<0.0001) effect on the surface wettability. Since the data compared using ANOVA was 
significant, a Bonferroni Post Hoc was applied and  significant differences at ***p<0.0001 for 2 wt% 
and 4wt% tetracycline loaded P(3HB) microsphere films were observed when compared to the 
control and 0.5wt% tetracycline loaded films.  
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6.2.4.2 Protein adsorption study in DMEM media  
The protein adsorption test carried out after a period of 3 days on the tetracycline loaded 
P(3HB) microsphere films with different drug loadings were compared to the unloaded 
P(3HB) films. As shown in Figure 17, a higher adsorption of protein was observed on the 
drug loaded P(3HB) microsphere films when compared to the unloaded P(3HB) 
microsphere films. As expected, a higher adsorption of protein was observed on the 
P(3HB) microsphere films with the highest drug loading ratio of 4 wt% when compared 
to the films with a drug loading ratio of  2wt% and 0.5%. The unloaded P(3HB) films had 
308.5 g/cm
2
 of adsorbed protein where as the tetracycline loaded P(3HB) films with 
0.5wt% of tetracycline had 331.4 g/cm
2
 of adsorbed protein, those with 2wt% 
tetracycline had 385.6 g/cm
2
 and with 4wt% of drug had 581.4 g/cm
2
 of adsorbed 
protein. Hence, in the presence of the highest concentration of tetracycline (4 wt%), a 
significant increase (n=3, ***p<0.001) of 88% in the protein adsorption was observed, 
when compared to 25% of 2 wt% and 7.5% of 0.5 wt% tetracycline loaded microsphere 
P(3HB) films, with respect to the unloaded P(3HB) films.  
 
Figure 17:- Total protein adsorption carried out on the surface of the P(3HB) microsphere films 
(with and without the drug) (n=3; data=±s.d). The P(3HB) microsphere films with tetracycline 
loadings has a significant *** p<0.0001 effect on protein adsorption. Since the data compared using 
ANOVA was significant, a Bonferroni Post Hoc was applied and a significantly greater difference at 
***p<0.0001 for 4wt% tetracycline loaded P(3HB) microsphere films were observed when compared 
to the control and other tetracycline loaded films. 
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6.2.4.3 Surface wettability tests (after protein adsorption) 
The water contact angle of the tetracycline loaded and unloaded P(3HB) microsphere 
films after the protein adsorption test for a period of 3 days were compared as shown in 
Figure 18. It was observed that with higher protein adsorption, there was an increase in 
the wettability of the samples. The water contact angle of the unloaded P(3HB) 
microsphere films reduced from 64.67  to 58.94 , a decrease of 9%, (n=3 **p<0.01). In 
the 4wt% tetracycline loaded film, after protein adsorption, the water contact angle 
reduced from 54.39  to 52.6 , a 3% reduction, (n=3, **p<0.01).  Similarly, a reduction in 
the water contact angle from 57.13  to 56.1  a decrease of 2% (n=3, **p<0.01) was 
observed with tetracycline films loaded with 2 wt% and that of  films with 0.5 wt% of 
tetracycline reduced from 62.13  to 57.4 ,  a decrease of 7% (n=3, **p<0.01).  
 
 
 
Figure 18:- A comparison of the surface wettabilites of the P(3HB) microsphere films (with and 
without the drug) after protein adsorption (after 3 days). The data (n=3; error=±s.d) were compared 
using t-test and the differences were considered significant when, **p < 0.001. 
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6.2.4.4 Cell attachment tests  
Cell attachment tests performed using HaCaT cells, the keratinocyte cell line, on both 
unloaded and drug loaded P(3HB) films, proved the biocompatibility of the films.                     
A significant increase in the cell viability, expressed as a percentage of cell growth on 
tissue culture plastics (Figure 19), was observed on the tetracycline loaded P(3HB) films 
containing 0.5 wt% of the drug, 48% (n=3, ***p<0.0001) when compared to the films 
with 2 wt%, 32 % (n=3, ***p<0.0001), 4 wt%, 24%, (n=3, ***p<0.0001) and even the 
unloaded films 5.99%, (n=3, ***p<0.0001). 
 
Figure 19:- Cell attachment study performed on day 3, using Neutral Red assay, on P(3HB) 
microsphere films (with and without the drug). All tested samples were relative to the control 
expressed as a percentage of cell growth on tissue culture plastics. The P(3HB) microsphere films 
with tetracycline loadings has a significant effect  on cell attachment. Since the data (n=3; data=±s.d) 
compared using ANOVA was significant *** p<0.0001,  a Bonferroni Post Hoc was applied and a 
significant differences at ***p<0.0001 for 2 wt% and 4wt% tetracycline loaded P(3HB) microsphere 
films were observed when compared to the control and 0.5wt% tetracycline loaded films.  
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SEM images of the cells attached on day 1 of the tetracycline loaded microsphere films 
containing 0.5 wt% and 2 wt% of the drug appeared flat and uniformly spread (Figure 20 
A2, A3). Whereas the cells attached on the tetracycline films with 4wt% of the drug 
appeared rounded in morphology and less confluent (Figure 21A4). After 3 days of 
incubation in the cell culture media, all the tetracycline loaded films appeared to have a 
confluent layer of cell growth on the surface (Figure 21B2, B3, B4) when compared to 
the cell growth on the unloaded films where the growth was less confluent (Figure 20B1).  
                                                               
 
Figure 20: - Scanning electron micrographs (SEM) of HaCaT cell attachment on day 1 and day 3 on 
the surface of the control (tissue culture plastic) A and B respectively. Unloaded P(3HB) microsphere 
films A1 and B1 respectively. 
A B 
A1 B1 
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Figure 21:- The HaCaT cell attachment seen on day 1 and day 3  on the P(3HB) microsphere films 
loaded with 0.5 wt% tetracycline (A2 and B2), 2 wt% tetracycline (A3 and B3) and 4 wt% 
tetracycline (A4 and B4). 
A2 B2 
B3 A3 
A4 B4 
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6.3 Discussions 
6.3.1 Tetracycline loaded P(3HB) microsphere films characterizations 
In this study tetracycline was incorporated in the newly developed and novel P(3HB) 
microsphere films in order to serve a dual purpose, improving surface properties and 
biocompatibility and as a source of the antibiotic in order to prevent bacterial infection. 
With the incorporation of tetracycline, the surface roughness, surface wettability and 
surface morphology/topography were all improved significantly.  
6.3.1.1 Surface morphology 
The surface morphology of the tetracycline loaded compressed microsphere films with 
different drug loadings were compared to the surface morphology of the unloaded 
P(3HB) microsphere films used as controls. The SEM images of the P(3HB) microsphere 
films after drug loading appeared to have a porous structure and an uneven surface 
morphology when compared to the smooth surface of the unloaded P(3HB) microsphere 
films. The microsphere films with the highest tetracycline loading of 4 wt% appeared 
more irregular and rougher when compared to the films loaded with lower tetracycline 
such as 0.5wt% and 2 wt%. The rough surface of the microsphere films is most likely to 
be due to the presence of the drug molecules adsorbed on the surface of the microsphere 
and the change in the surface morphology of the microspheres when formed in the 
presence of the drug. Thus, with the increase in drug loading the surface morphology of 
the films appeared uneven and irregular. In a study conducted by Misra et al., a smooth 
surface morphology of the P(3HB) solvent cast films were observed after the 
incorporation of vitamin E. The vitamin E added to the polymer solution was 
incorporated within the microstructure of the film during the solvent cast film synthesis, 
due to which a homogenous distribution of the vitamin E was achieved (Misra et al., 
2006). However, in another relevant study Chee et al., used a similar technique as in 
Misra et al., 2006, for the incorporation of the Mitragynine in poly(3-hydroxybutyrate-
co-4-hydroxybutyrate), P(3HB-co-4HB) solvent cast films. The drug and the polymer 
were dissolved in the chloroform solution and then cast into films. The surface 
morphology of the films initially appeared smooth and even, however, with the increase 
in the drug concentration from 10 wt% to 40 wt% a coarse and rough surface morphology
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 was observed (Chee et al., 2008). Thus apart from the different techniques used to 
fabricate the films, the increasing concentrations of the drug are also known to influence 
the surface morphology of the films.   
Due to the encapsulation and adsorption of the drug, a topographical change on the 
surface was observed leading to an increased roughness of the P(3HB) microsphere films. 
The quantification of surface roughness using white light interferometery confirmed that 
the drug loaded microsphere films had a rougher surface when compared to the unloaded 
microsphere films. The tetracycline loaded P(3HB) microsphere films with the highest 
drug loading exhibited a surface roughness of 6.74 m which was significantly higher 
than those with a lower drug loading. Thus it can be concluded that with the increase in 
the concentration of the drug loading an increase in the surface roughness of the 
microsphere films were also observed. Researchers like Lu et al., have also made similar 
observations with the emergence of a rougher surface morphology in the presence of an 
increasing concentration of the drug (Lu et al., 2001).  Bazzo et al., also confirmed that 
the presence of the drug crystals on the surface of the P(3HB) microspheres contributed 
to the rough morphology of the drug loaded microspheres. SEM images had revealed the 
presence of crystalline needles of the drug piroxicam (PXC) on the surface of the P(3HB) 
microspheres (Bazzo et al., 2008). 
6.3.1.2 X-Ray photoelectron spectroscopy (XPS)  
The assessment of the tetracycline adsorption on the microsphere surface was done on the 
basis of nitrogen content present on the samples since the nitrogen species is unique to 
the drug and is absent in the P(3HB) microspheres. From the XPS data, a significant 
increase in the nitrogen content of the drug loaded samples was observed when compared 
to the unloaded P(3HB) microsphere films, where, as expected, only carbon and oxygen 
were seen. Similarly, with an increase in the tetracycline loading, an increase in the 
nitrogen species on the surface of the microspheres was observed. Therefore, from this 
data it was deduced that in addition to being encapsulated within the microspheres, 
tetracycline was also adsorbed on the surface. Studies by Gangrade et al., also revealed 
an increase of drug crystals on the surface of poly(hydroxybutyrate) P(3HB) and poly(3-
hydroxybutyrate-co-3-hydroxyvalerate),P(3HB-co-3HV), microspheres when the 
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concentration of the drug progesterone was increased from 1 wt% to 5 wt% (Gangrade et 
al., 1991). 
It has been observed by Bazzo et al., that in the solid-oil-water emulsion technique used 
to fabricate the drug loaded microspheres, the aqueous solution of the drug added into the 
polymer solution in addition to being encapsulated within the P(3HB) microspheres could 
also diffuse out and remain on the outer surface of the microspheres during solvent 
evaporation. The increasing viscosity of the second emulsion phase prevents the drug 
from diffusing out into the aqueous phase; as a result they get adsorbed on the surface of 
the microspheres (Bazzo et al., 2008). Thus in this study due to the increasing viscosity 
of the second emulsion in the presence of the increasing concentration of the drug, 
tetracycline could have got adsorbed on the surface of the microspheres.  
6.3.1.3 Thermal analysis of the P(3HB) microspheres (with and without the drug) 
The Tg values of the microspheres with different tetracycline loadings before immersion 
in PBS and fabrication into films were carried out in order to investigate the changes in 
the thermal properties of the polymer, in the presence of the drug as well as the 
fabrication techniques used.  From the results it was observed that the Tg values of the 
unloaded microspheres after fabrication was slightly higher than those compared to the 
crude polymer. This increase in the Tg value could indicate that the mobility of the 
polymer chains in the microspheres after the fabrication was restricted. Similarly the Tg 
values of the P(3HB) microspheres loaded with tetracycline also increased further when 
compared to the crude polymer and the unloaded P(3HB) microspheres. The 
microspheres with the highest drug loading of 4 wt% exhibited an increased Tg value of 
4.9°C when compared to the films with lower loading of tetracycline. Numerous factors 
like structural change in molecules, cooling rate and incorporation of additives alter the 
Tg. For examplethe insertion of bulky, inflexible side group increases T g of the polymer 
due to decrease in mobility of the polymer chains. Thus in this study the presence of the 
drug could have acted as an impurity thus affecting the Tg of P(3HB) microspheres.  
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6.3.2 In vitro degradation studies of the P(3HB) microsphere films (with and without the 
drug) in PBS  
The degradation rates of the microsphere films (with and without the drug) were 
evaluated based on the water absorption and weight loss studies after time bound 
degradation in PBS (pH 7.4) at 37 C.  The results of the 30 day degradation study 
indicated that the tetracycline films with the highest drug loading underwent a maximum 
weight loss over a period of 30 days when compared to the films with a lower drug 
loading. This result suggested that the tetracycline films with the highest drug loading 
were more sensitive to degradation when compared to the other films. This increase in 
the degradation rate was most likely due to the presence of a higher amount of the 
hydrophilic drug (tetracycline) present both on the surface and encapsulated within the 
P(3HB) matrix, allowing access to water from the PBS, leading to faster degradation via 
hydrolytic cleavage. The surface morphology of all the tetracycline loaded films appeared 
uneven and exhibited porosity. However, the tetracycline films with the highest drug 
loading appeared to have an increased porosity when compared to the films with lower 
tetracycline loading and the tetracycline particles were found entrapped within the pores.  
The initial dissolution of the drugs, upon immersion in the PBS buffer, leads to the 
formation of aqueous channels on the surfaces which were filled with the aqueous 
medium. Water penetration in the polymer matrix results in hydrolytic scission of the 
ester linkages in the polymer backbone, thus accelerating the polymer degradation due to 
which the drug mobility and the release rates are also affected (Chee et al., 2008). A 
similar observation was made by Chee et al., where the P(3HB-co-4HB) films exhibited 
higher pore size and porosity when the concentration of the drug was increased from 10 
wt% to 40 wt%. The authors‟ observed that before drug loading the polymer pores were 
present closer to each other, however after drug loading the pores got entrapped with the 
drug therefore increasing in size. Films with a higher drug loading also appeared coarser 
with the increased drug entrapment within the pores. As a result, the large amount of 
drugs present on the surface and entrapped within the pores underwent rapid dissolution 
when immersed in the release buffer thereby increasing the water channels in the films. 
Due to this, the polymer degradation rate by hydrolytic scission was accelerated (Chee et 
al., 2008). The crystallinity of the tetracycline loaded and unloaded P(3HB) microsphere
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 films are also shown to influence the rate of in vitro degradation. In this study, the 
tetracycline loaded films with a lower % Xc exhibited an increased degradation rate when 
compared to the films with a higher degree of crystallinity. As suggested in literature, 
with the prolonged immersion in the aqueous medium, the Tg value also decreases, 
causing an increase in the polymer chain mobility, thus allowing more water to penetrate, 
hence increasing hydrolytic degradation (Chee et al., 2008).  
6.3.3 Differential Scanning Calorimetry (DSC) and X-Ray Diffraction (XRD) analysis  
DSC and XRD analysis were carried out to verify the changes in the thermal properties 
and crystallinity of the drug loaded microspheres during the in vitro degradation study. 
The representative DSC thermograms of the tetracycline loaded and unloaded P(3HB) 
microsphere films at different time points were analysed to study the possible changes in 
the melting temperature (Tm), the glass transition temperature (Tg) and the degree of 
crystallinity (% Xc) in the presence of the drug tetracycline. 
 In this study the endothermic events corresponding to the melting temperature (Tm) of all 
the tetracycline loaded microsphere films at day 1, day 15 and day 30 exhibited only one 
melting peak in the range of 171ºC to 173ºC when compared the unloaded P(3HB) 
microsphere films. Similarly, no separate peak for tetracycline was seen in the 
tetracycline loaded microsphere films, this indicated that the peak corresponding to the 
melting of the drug was probably not revealed, as it melted with the polymer while 
heating. The DSC thermograms of the poly(3-hydroxybutyrate), P(3HB) and poly(3-
hydroxybutyrate-co-3-hydroxyvalerate) P(3HB-co-3HV) microspheres loaded with the       
5 wt% of the drug progesterone also did not reveal a separate peak in a study conducted 
by Gangrade et al. The authors‟ also observed that the peak corresponding to the melting 
of the drug had merged with the polymer melting peak (Gangrade et al., 1991).  
The tetracycline films with the highest drug loading also exhibited significant changes 
(n=3, ***p<0.001) both in the % Xc and Tg over a period of 30 days when compared to 
the unloaded P(3HB) microsphere films. However the films with a lower loading of 
tetracycline such as 0.5 wt% and 2wt% exhibited no such changes in the %Xc over a 
period of 30 days when compared to the unloaded P(3HB) microspheres. The change in 
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the %Xc of the tetracycline loaded microsphere films with the highest drug loading 
indicated that the tetracycline might have acted as an impurity thereby hindering the 
crystallization of the polymer.  Due to this, a reduction in the %Xc values of the highest 
drug loaded films were observed when compared to the films with lower drug loadings. 
In the P(3HB) microsphere films with the lower drug loading, the amount of drug present 
was too low to have an effect on the crystalline properties of the polymer, due to which 
no changes were observed in the %Xc values. Freiberg et al., have also observed that at 
higher concentrations, the drugs are known to exist in a particulate form rather than a 
dispersion within the microspheres possibly due to its lack of solubility in the polymer 
matrix thereby affecting the crystallinity of the polymer (Freiberg et al., 2004).  
Palau et al., also observed similar changes in the crystallinity of the two new copolyesters 
consisting of an alternating disposition of glycolic acid units and 4-hydroxybutyric or               
6-hydroxyhexanoic acid, named as poly(4HB-alt-Glc) and poly(6HHx-alt-Glc) in the 
presence of the drug triclosan. The crystallinity of the drug loaded polymer reduced to 
13% when compared to the crystallinity of the unloaded polymer which was 17%. This 
indicated that triclosan hindered the crystallization of the polymer and that some amount 
of drug molecules were incorporated into the crystalline phase (Palau et al., 2008). 
Significant changes in the Tg values of all the drug loaded microsphere films over a 
period of time indicated that an increase in the polymer chain mobility over time allowed 
the PBS solution to penetrate within the films, thereby increasing the degradation 
process. Although, in this study the DSC thermograms indicated that the presence of the 
drug may have hindered the crystallinity of the polymer more reliable measurements can 
however be obtained from X-ray diffraction analysis. 
X-ray diffraction (XRD) analysis of tetracycline loaded microspheres were carried out to 
confirm the dispersion of the tetracycline particles within the P(3HB) microspheres.          
The diffraction patterns of both tetracycline and P(3HB) measured separately and used as 
controls exhibited intense peaks confirming their high crystallinity. However, the 
diffraction patterns of the tetracycline loaded microspheres with 0.5 wt%, 2 wt% and         
4 wt% were identical to those of the unloaded P(3HB) microspheres. Although 
tetracycline rendered a well-defined diffraction pattern with intense peaks, they could not 
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be detected in the tetracycline loaded microspheres. This result could possibly suggest 
that tetracycline was too low in concentration to be detected, due to which no separate 
diffraction peaks of tetracycline could be detected.  However other analysis such as 
small-angle diffraction analysis (SAXD) could be carried out to get additional 
information on the lamellar structures such as the thickness, the organization between the 
crystalline and amorphous domains in the presence and the absence of the drug (Palau et 
al., 2008).  
6.3.4 Factors affecting the in vitro drug release  
A number of factors are known to affect the drug release rate such as the microsphere 
size, drug distribution within the microsphere and porosity, which are all related to the 
matrix processing condition used to fabricate the microspheres. In this study the 
microsphere films with the highest drug loading (4wt%) exhibited the lowest 
encapsulation efficiency of 11% when compared to 15% and 25% of the films loaded 
with 2 wt% and 0.5 wt% of tetracycline. Often factors such as drug/polymer ratio, 
affinity of the drug for the aqueous or organic phase and the microsphere size play an 
important role in the affecting the encapsulation efficiency of the microspheres (Wang et 
al., 2007). In this study the polymer ratio was kept constant and the drug concentration in 
the drug/polymer ratio varied. Thus, with the increase in the drug loading, the viscosity of 
the emulsion phase appeared to increase due to which the diffusion of the drug back into 
the emulsion phase was prevented, hence getting adsorbed onto the microsphere surface. 
This was further confirmed in the XPS analysis by the increase in the nitrogen species on 
the surface with the increase in the tetracycline loading. Another possible reason for the 
low encapsulation efficiency in the microspheres with a high drug loading is the presence 
of insufficient amount of polymer to encapsulate drug completely (Wang et al., 2007).    
Since in this study the polymer ratio in the drug/polymer ratio was kept constant and as 
the drug concentration increased lower encapsulation efficiency was observed due to the 
increased leakage of the drug into the buffer. Wang et al., also observed a decrease in the 
encapsulation efficiency from 59% to 45% in P(3HB-co-3HV) microspheres when the 
drug loading (ibuprofen) was increased from 9.8 wt% to 16.9 wt% (Wang et al., 2007).  
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The average microsphere size is also found to have an effect on the encapsulation 
efficiency and the drug distribution within the microspheres (Sahoo et al., 2002;              
Bidone et al., 2009). However, in this study, all the microspheres appeared similar in size 
Therefore, from the in vitro release profile a biphasic release was seen where all the films 
exhibited an initial burst release followed a slow sustained release of the drug.                   
As expected, the films with the highest drug loading ratio exhibited a higher burst release 
within the first hour when compared to the other films. Wang et al., also made similar 
observations, when the drug/polymer ratio was increased from 10/50 (mg/mg) to 30/50 
(mg/mg) where a burst release of 70%, 84% and 88% were observed in the first 2 hours 
of immersion (Wang et al., 2007). Therefore, in this study, once the films were immersed 
in the release buffer the drug particles present close to the surface underwent a rapid 
dissolution thus creating large openings/pores for the faster buffer penetration into the 
microsphere films.  
SEM analysis demonstrated the difference in the surface morphology and porosity of the 
films with different drug concentrations. The films with the highest drug loading ratio 
appeared less porous in appearance before immersion in the release buffer. After 
immersion in the release buffer the dissolution of the drugs created a diffusion path, 
which was filled with water and this facilitated the drug release initially from amorphous 
region. Chee et al., also made a similar observation in porous structures of the amorphous 
films when the drug (Mitragynine) loading was increased from (10 wt% to 40 wt%).     
The drug appeared to be entrapped within the polymer pores due to which a higher initial 
release was observed (Chee et al., 2008). Similarly, the number of pores on the polymer 
matrix also appeared to increase after drug dissolution. This had further created a number 
of open water filled channels for the drugs to diffuse (Chee et al., 2008).  
Often polymeric matrices are known to swell and expand in size when the water uptake 
within the microspheres/films increases (Naraharisetti et al., 2006). Following the initial 
diffusion of the drugs, a slower release or lag phase is observed in films with different 
drug loadings. During the lag phase the remaining drug entrapped deep within the 
microsphere films was released gradually. In the films with the lowest drug loading such 
as 0.5 wt% of tetracycline, the lag phase was observed only for a period of 48 hours when 
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compared to 48 hours and 168 hours of the films with 2 wt% and 4 wt% of tetracycline 
respectively. The films with lower drug loading had less surface associated drugs, the 
drug release from the microspheres was attributed to a small-scale diffusion from the 
surface of the microspheres. Thus, with an increase in the drug loading the dissolution of 
a large amount of surface associated drugs continued for a period of 48 hours followed by 
a considerably longer lag phase. With the increase in the water uptake a simultaneous 
decrease in the Tg value was also observed. A decrease in the Tg value, as mentioned 
earlier, indicated that the polymer chain mobility was more restricted, as a result an 
increase in the drug release from deep within the films were observed with rapid uptake 
of water.   
6.3.5 Factors affecting the biocompatibility of the tetracycline loaded microsphere films  
In this study the change in the wettability of the films in the presence of tetracycline and 
the adsorbed proteins were measured. The surface wettability of the tetracycline loaded 
films with different drug loading ratios were measured and compared with the unloaded 
P(3HB) films used as controls. With the increase in the tetracycline concentration a 
significant increase in the wettability of films was observed when compared to the 
controls. A significant increase in the wettability of P(3HB) films was also observed by 
Misra et al., when vitamin E was incorporated in the films (a decrease of 27%).                            
In another relevant study, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) solvent cast 
films were treated by exposing the films to oxygen plasma glow discharge and 
polymerised using acrylic acid and then coupled with insulin (Kang et al., 2001). The 
presence of insulin on the surface significantly decreased the water contact angle of the 
P(3HB-co-3HV) microsphere films from 75º to 31  (Kang et al., 2001).  
The role of the extracellular matrix proteins (ECM) is to direct the function of the cells 
(such as keratinocytes) attached on the surface of a biomaterial towards                                           
re-epithelialisation phase of wound healing. Other factors such as the biomaterial surface 
properties also play an important role in protein adhesion, conformation and subsequent 
protein mediated keratinocyte functions (Bush et al., 2008). In the present study, a 
statistically higher level of protein adsorption was observed on the surface of the 
tetracycline loaded microsphere films in comparison to the unloaded P(3HB) microsphere 
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film. Similarly, the tetracycline loaded film of 4 wt% exhibited the highest amount of 
protein adsorbed on the surface when compared to the films with lower tetracycline 
loading.  Often, the most abundant protein that binds to the biomaterial surface when 
exposed to serum is albumin. Albumin adsorption particularly increases when there is an 
increase in the surface wettability and surface roughness of the sample. This observation 
correlates with the results obtained in this work, where the increase of hydrophillicity and 
surface roughness of the tetracycline loaded films led to a higher level of protein 
adsorption when compared to the unloaded P(3HB) microsphere films. Similarly an 
increase in the tetracycline loading also contributed an increase in hydrophillicity and 
surface roughness due to which an increased protein adsorption was observed. For 
example 4 wt% tetracycline loaded P(3HB) microsphere films exhibited higher 
hydrophillicity and surface roughness and increased protein adsorption when compared to 
the 0.5 wt% and 2 wt% tetracycline loaded P(3HB) microsphere films. This result was in 
agreement with the observation made by Misra et al., where the total protein adsorption 
was significantly higher (171µg) on P(3HB/n-BG) composite films when compared to the 
neat P(3HB) films. This difference in the protein adsorption was attributed to the marked 
differences in surface morphology and surface area available for protein adsorption 
(Misra et al., 2008). 
Cell adhesion on the surface of biomaterials are initiated in two stages, where in at the 
first stage the water and a layer of proteins are selectively adsorbed on the surface this is 
followed by the adhesion of the cells on the layer of proteins which is mediated by the 
ECM, cell membrane and the cytoskeletal proteins (Misra et al., 2009). Thus, the surface 
properties of the biomaterial such as wettability, roughness, and porosity influence cell 
adhesion and cell proliferation (Peschel et al., 2007; Liu et al., 2008). In this study the 
effect of the hydrophilic drug and the layer of adsorbed protein on cell adhesion were 
studied. SEM images of the cells adherence after 3 days of incubation in biological media 
such as Dulbecco‟s Modified Eagle Medium (DMEM) appeared to have a difference in 
cell morphology, shape and degree of attachment on all the films. The tetracycline loaded 
films with a lower drug loading of 0.5 wt% and 2 wt% appeared to have layers of cells as 
seen from the cross section images when compared to the unloaded P(3HB) films and the 
P(3HB) films loaded with  4 wt% of tetracycline where a less confluent single layer was
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formed indicating loose attachment or poor adherence. The unloaded P(3HB) films 
exhibited poor cell adherence and proliferation kinetics due to their higher surface 
hydrophobicity when compared to the tetracycline loaded P(3HB) microsphere films. 
Peschel et al., have also observed loose adherence of keratinocytes (HaCaT) on P(3HB) 
films. It was observed that the cells grew in the form of clusters on the surface of the 
films with few filaments that resulted in a loose attachment when compared to films 
made of other PHAs such as P(4HB) where the maximum cell number amounted to about 
50% of the control (Peschel et al., 2007). Similarly in this study, the rounded morphology 
and the less confluent growth of the cells on the P(3HB) loaded films with 4 wt% of 
tetracycline was due to the high concentration of the drug that was released from the 
films which affected the cell viability and growth. Although the films with the highest 
tetracycline loading had exhibited increased surface wettability and protein adsorption, 
the higher drug concentration appeared to have a profound effect on the cell viability and 
morphology on the surface of materials thereby affecting the cell growth. Chee et al., also 
observed a decrease in the cell growth (L929 fibroblast) from 12% to 9.4% when the drug 
loading (mitragynine) was increased from 10 wt% to 40 wt% in the poly(3-
hydroxybutyrate-co-45%-4hydroxybutyrate) P(3HB-co- 45% 4HB) films. In this study, 
the effects of high concentrations of the drug and surface morphology were studied (Chee 
et al., 2008). 
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6.4 Conclusions 
The efficacy of using films made from compressed P(3HB) microspheres encapsulating 
tetracycline as a patch for drug delivery and wound healing purposes was studied. In this 
study the incorporation of the drug successfully improved the surface properties of the 
biomaterial such as surface morphology, wettability, and roughness thereby promoting 
cell adhesion on the microsphere films. The presence of tetracycline on the surface of the 
microspheres, as detected by XPS, and possible structural changes within the 
microsphere, in the presence of tetracycline, resulted in changes in the surface properties 
of these films. The results from the water contact angle study showed a significant 
improvement in the hydrophilicity of the microsphere films with the addition of 
tetracycline which was further complemented by the increase in the total protein 
adsorption. These alterations in film surface properties resulted in an improved patch for 
keratinocyte adhesion and growth as indicated by the increased numbers of viable cells 
on the drug loaded microsphere films compared to those on the unloaded microsphere 
films. 
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Chapter 7  
Polyhydroxyalkanoate microsphere-
based protein encapsulation for 
biomedical applications  
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7.1 Introduction  
Proteins constitute very important therapeutic drugs in the recent years. They have been 
used in the form of vaccines, cytokines, enzymes, hormones and growth factors, for 
exampleproteins such as human growth hormone, erythropoietin, interferon, and 
lyzozymes have been increasingly used for a number of different biomedical applications 
(Morita et al., 2000). However the major disadvantage faced in using proteins is the 
requirement of recurrent injections in order to maintain adequate therapeutic 
concentrations due to short half-lives in vivo. Some proteins are also not completely 
absorbed in the gastrointestinal tract due to their high molecular weight. Thus efforts are 
now being focussed on the use of successful long term controlled release devices (Morita 
et al., 2000). In the recent years implantable biodegradable polymers such as 
poly(lactide-co-glycolide, poly(vinyl alcohols) and polyanhydrides have been used as an 
alternative to the traditional methods of protein delivery (Morita et al., 2000). The protein 
stability is however known to be preserved when other techniques such as 
microencapsulation are used. For examplea solid-in-oil-water (s/o/w) double emulsion 
has been known to be suitable for protein drugs as the activity of the proteins can 
sometimes be retained in organic solutions. Thus microencapsulation techniques have 
now been commonly used for the encapsulation of proteins and peptide based drugs into 
the polymeric microspheres. Yang et al., successfully used the double emulsion 
solvent/evaporation method for the encapsulation of BSA into PCL (polycaprolactone) 
and PLGA (poly(DL-lactic-co-glycolic acid)) 65 : 35 microspheres (Yang et al., 2001). 
Microspheres can also be used to target specific sites in the body thereby optimising the 
therapeutic response and eliminating the inconvenience of repeated injections. Integrins, 
lipoproteins and monoclonal antibodies have been encapsulated within microspheres for 
targeted protein release. However, drug release in target specific sites will depend on the 
microsphere size (Yang et al., 2001). For examplemicrospheres used to deliver drugs in 
the lungs should be around 10µm as this will allow the lung‟s capillaries to capture the 
microspheres. Ophthalmic drug delivery is also another application where the 
microspheres encapsulated with the drug can be used for the slow/gradual release of the 
drug, owing to their small size. Macular degeneration is often age related and the most 
common cause for vision loss. This condition occurs when the arteries that supply oxygen 
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and nutrients to the retina harden. As a result, the central vision of the affected individual 
deteriorates. There are two main types of macular degeneration, dry and wet. The dry 
form occurs by the deposition of yellow spots in the macula and does not cause any loss 
of vision. Wet macular degeneration is a more serious condition causing permanent 
central vision loss. In this condition the newly formed blood vessels under the macula 
become thin and tend to rupture causing bleeding and damage to the surrounding tissues. 
It causes significant vision problems in the affected eye and can progress very rapidly, 
causing permanent central vision loss. Currently the most common treatment for the wet 
macular degeneration is the drug Lucentis®, produced by Genentech, USA. Lucentis® 
contains a protein ranibizumab, a humanised monoclonal antibody fragment which is 
produced in Escherichia coli. This antibody is targeted against human vascular 
endothelial growth factor A (VEGF A) which is responsible for endothelial cell 
proliferation, neovascularisation and vascular leaks. The binding of ranibizumab to 
VEGF A prevents the interaction of VEGF A to its receptors, vascular endothelial growth 
factor receptor 1 and 2 (VEGFR 1 and 2) thereby preventing the progression of wet form 
of age-related macular degeneration (Sanharawi et al., 2010). Lucentis® however needs to 
be administered through monthly intraocular injections, a requirement extremely 
distressing to the patient. In addition, it can lead to conjunctival haemorrhage, 
inflammation of the eye, retinal tear, traumatic cataract and retinal detachment. Also, the 
cost of Lucentis®, used every month i.e. 12 injections per year is £14,000 at the currently 
proposed selling price. Hence, there is a need for the development of improved methods 
of delivery of this drug. An ideal solution would be the introduction of the drug in such a 
manner that it is released slowly over a long period of time (for example6 months), hence 
decreasing the number of intraocular injections required by the patients.  
PHAs are biocompatible and degrade in the human body. In work described in this 
chapter we aimed to produce PHA microspheres and to use them as drug delivery 
vehicles in the intraocular environment. Bovine serum albumin (BSA) with a molecular 
mass of 66,200 Da was used as the model protein to study the in vitro release rate in 
phosphate buffer saline and contact lens solution (representative of an intraocular 
environment). The stability of BSA within the P(3HB) microspheres and in the in vitro 
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release medium was studied using sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE). The results obtained from this study were then used for 
planning the encapsulation of the expensive drug Lucentis® in P(3HB) microspheres. 
These microspheres can then be injected into the patient‟s eye leading to a gradual release 
of the drug, hence eliminating the need for monthly injections. The in vitro release rate in 
phosphate buffer saline and contact lens solution (representative of an intraocular 
environment) was carried out.  
In order to enhance the tissue development, tissue-engineering scaffolds are loaded with 
growth factors. Often the simplest method of incorporating the growth factors is by the 
direct addition of growth factors in the scaffolds (Sokolsky et al., 2007). Both natural and 
synthetic scaffolds have been used for the delivery of these growth factors. One of the 
major challenges faced in the direct incorporation of the growth factor in the scaffold, is 
the denaturation of these growth factors during the fabrication process. Hydrogels used to 
encapsulate bone morphogenic proteins (rh-BMP) during the fabrication process have 
proven to be effective in promoting bone and cartilage formation; however the main 
disadvantage is the inhibition of complete release of proteins from the hydrogels. The 
release kinetics from hydrogels is largely diffusion controlled through numerous aqueous 
channels within the hydrogel, as a result the extended release of the proteins do not occur 
(Sokolsky et al., 2007). Microencapsulation is another common method for the delivery 
of growth factors. Both double emulsion and single emulsion techniques have been used 
for the encapsulation of the growth factors, where the growth factors have been dissolved 
in the organic polymer solution during microsphere fabrication. Patrick et al., 
successfully encapsulated vascular endothelial growth factor (VEGF) within poly(DL-
lactic-co-glycolic acid)/poly(ethylene glycol) microspheres. These microspheres were 
used to stimulate angiogenesis of the tissues by a slow and sustained release of VEGF 
over a period of 28 days (Patrick et al.,1999)  Platelet derived growth factors have also 
been successfully encapsulated within microspheres and loaded onto 3-D nano fibrous 
materials leading to a sustained release of this growth factor for days to months (Wei et 
al.,2004). However, during microencapsulation of proteins into biodegradable 
microspheres, the exposure of protein molecule to the organic solvents and physical
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stresses such as agitation can cause undesirable changes to the three-dimensional 
structure of the protein leading to loss of its activity (Nellore et al., 1996). Therefore 
Ribonuclease A (RNase A), a monomeric enzyme with a molecular mass of 13,700 Da, 
similar in size to that of BMP-2 growth factor (too expensive to be used for initial 
experiments) was chosen as a model protein to study the effects of microencapsulation on 
the structural integrity and activity of the protein. The primary, secondary and tertiary 
structures of RNase A have been well characterized and it is also easy to monitor for 
bioactivity. Therefore the aim of this study was to identify whether the RNaseA activity 
and structural integrity is maintained during the encapsulation process. The results could 
then be extrapolated to BMP-2.  
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7.2  Results  
7.2.1 Characterization of Bovine serum album (BSA) encapsulated P(3HB) microspheres 
7.2.1.1 Production of BSA encapsulated P(3HB) microspheres  
A solid-oil-in-water encapsulation method was optimised to entrap different 
concentrations of BSA within the P(3HB) microspheres as shown in Table 1. 
Table 1:-The different BSA loadings entrapped within P(3HB) microspheres  
Sample Initial Drug Loading (w/w) 
 0.75 wt% 0.75mg BSA/100 mg P3HB 
1.5 wt% 1.5mg BSA/100 mg P3HB 
5 wt% 5mg BSA//100 mg P3HB 
 
The optical micrographs of the first emulsion (w1/o) (mentioned in Chapter 2, section 
2.2.2) and second emulsion (w1/o/w2) (mentioned in Chapter 2, section 2.2.2) are shown 
in Figure 1A and 1B respectively. The formation of microdroplets of water within the 
microspheres is observed in the second emulsion. After solvent evaporation the 
microspheres formed were washed with water and dried. 
 
Figure 1:- The optical micrographs of the A) first emulsion (w1/o) and B) second emulsion (w1/o/w2) 
during the P(3HB) microsphere formation loaded with 0.75 wt%, 1.5 wt% and 5 wt% of BSA. Arrow 
indicating the formation of microdroplets of the water within the P(3HB) microspheres.  
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7.2.1.2 Bulk shape and structure of the BSA loaded P(3HB) microspheres  
The bulk shape and structure of the BSA loaded microspheres were observed using 
scanning electron microscopy (SEM), Figure 2.  The surface morphology of P(3HB) 
microspheres loaded with 0.75 wt% of BSA appeared smooth and more or less spherical. 
The P(3HB) microspheres loaded with 1.5wt% and 5wt% of BSA also appeared spherical 
but the surface morphology of the microspheres were less smooth.  
 
Figure 2:- SEM image of P(3HB) microspheres loaded with A) 0.75 wt%, B) 1.5 wt% and C) 5 wt% 
of BSA. SEM images of the surface morphology of BSA-loaded P(3HB) microspheres at high 
magnification (x22,000) A1) 0. 75wt%, B1) 1.5 wt% and C1) 5 wt% of BSA. 
 
A A1
B B1
C1C
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7.2.1.3 Microsphere size and its distribution 
The particle size distribution curve of the P(3HB) microspheres loaded with                   
0.75 wt%, 1.5 wt% and 5 wt% of BSA are shown in Figure 3A, B and C respectively. 
The particle size distribution curve of the P(3HB) microspheres loaded with 0.75 wt% of 
BSA shown in Figure 3A revealed that more than 50% of the measured particles had a 
mean particle size ranging from 1.5µm-2µm and 90% were below 5µm in size range.  
Figure 3B shows that the size range for the microspheres loaded with 1.5 wt% of BSA 
were around 1-15 m, where 50% of the measured particles had a mean particle size 
ranging from 1.5 µm to 2.0 m and 90% of the microspheres had diameters below 5 m. 
Figure 3C shows that the size range for the microspheres loaded with 5 wt% of BSA 
which were around 1-10 m, where 90% of the measured particles had a mean particle 
size ranging from 1.5µm to 2.0 m and 80% of the microspheres had diameters below 
5 m. 
 
Figure 3:- Size distribution analysis of P(3HB) microspheres loaded with  A) 0.75 wt%, B) 1.5 wt% 
C) 5 wt% of BSA.  
The % porosity of the microspheres loaded with 0.75 wt%, 1.5 wt% and 5 wt% BSA was 
calculated using equation 6 from Chapter 2, section 2.8.1.3, and found to be 32%, 39% 
and 24%. The % residual PVA of 0.28%, 0.39% and 0.54% were found bound on the 
surface of the microspheres loaded with 0.75 wt%, 1.5 wt% and 5 wt% of BSA.  
D 
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7.2.1.4 Encapsulation efficiency 
The encapsulation efficiencies, surface associated proteins and the total amount of BSA 
remaining in the PVA solution for the different loadings of BSA in the microspheres are 
represented in Figure 4. The encapsulation efficiencies were calculated using equation 1, 
Chapter 2, section 2.4.1. The encapsulation efficiency of the P(3HB) microspheres loaded 
with 0.75 wt%, 1.5 wt% and 5 wt% of BSA were 58.1%, 50% and 69.4% respectively. 
The surface associated proteins bound onto the microspheres were 9%, 13.93% and 
8.36% for 0.75 wt%, 1.5 wt% and 5 wt% of BSA respectively. The total amount of BSA 
remaining in the final PVA solution of the microspheres fabricated with 0.75 wt%,       
1.5 wt% and 5 wt% were 32.58%, 29.63% and 18.64% respectively.  
 
 
 
Figure 4:- Encapsulation efficiency, % of surface associated BSA and % of BSA present in the PVA 
solution for different BSA loadings, (n=3; error=±s.d). 
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7.2.1.5 In vitro release kinetics of BSA  
In vitro BSA release from the P(3HB) microspheres with different BSA loadings were 
carried out in PBS solution and contact lens solution. The contact lens solution was used 
to mimic the ocular environment. A biphasic release prolife was observed, as shown in 
Figure 5. The BSA loaded P(3HB) microspheres in the PBS solution exhibited a higher a 
initial burst release of the actual BSA loading when compared to the P(3HB) 
microspheres in contact lens solution (Figure 6). 
 
Figure 5:-The 24 hour burst release of BSA in PBS and contact lens solution, (n=3; error=±s.d). 
The P(3HB) microspheres loaded with  0.75 wt%, 1.5 wt% and 5 wt% of BSA exhibited 
an initial burst release of 1%, 1.08% and 0.9% whereas the initial burst exhibited by the 
BSA loaded P(3HB) microspheres in contact lens solution was 0.1%, 0.05% and 0.04% 
respectively. A maximum cumulative percentage release observed for the 0.75 wt%, 1.5 
wt% and 5 wt%  BSA loaded microspheres in PBS, were 15.87%, 59.83%, and slightly 
higher than 100% (indicating slight overestimation of the protein) BSA respectively, as 
shown in Figure 6A. Similarly a maximum cumulative percentage release of 5.4%, 
14.60%, and 52.46% was observed for the 0.75 wt%, 1.5 wt% and 5 wt% BSA loaded 
microspheres in the contact lens solution as shown in Figure 6B. 
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Figure 6:-A) In vitro cumulative release profiles of BSA loaded P(3HB) microspheres in  PBS and B) 
contact lens solution (the initial amount of BSA loaded is indicated on the graph), (n=3; error=±s.d). 
 A 
 B 
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7.2.1.6 In vitro degradation studies  
The in vitro degradation of the P(3HB) microspheres were carried out in contact lens 
solution and PBS solution at 37ºC under static conditions for a period of 30 days. The 
parameters measured in order to assess the degradation behaviour of P(3HB) 
microspheres were, the water uptake (%WA) and weight loss (%WL) studies, pH 
changes and SEM to observe changes in the surface morphology. As seen in Figure 7A, 
the %WA of the P(3HB) microspheres in the PBS solution increased from 148.4% on  
day 1 to 250% over a period of 30 days. The %WL of the P(3HB) microspheres on day 1 
was 13% followed by an increase to 45.16%  over a period of 30 days. The %WA of the 
P(3HB) microspheres in the contact lens solution from day 1 to day 30 increased from 
105% to 156.9%. Similarly, an increase in the %WL of the P(3HB) microspheres from 
8% to 30.23% from day 1 to day 30 was observed (Figure 7B). 
 
Figure 7:- Water adsorption and weight loss measurements after immersion in A) PBS and B) 
contact lens solution, (n=3; error=±s.d).  
A 
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 7.2.1.6.1 Changes in pH  
The pH of PBS solution as well the contact lens solution was monitored for a period of 30 
days to analyse the changes in the surrounding medium induced by the immersion of 
P(3HB) microspheres. The pH of the PBS solution exhibited a gradual decrease in the pH 
of the solution from 7.28 to 6.8, from day 1 to day 30, as seen in Figure 8A. Similarly the 
pH of the contact lens solution also exhibited a gradual decrease from 7.35 to 7.0 over a 
period of 30 days (Figure 8B).  
 
Figure 8:- A) Changes in the pH of PBS over a period of 30 days was significant (F(2,6)=3.23), 
**p<0.001. A Bonferroni Post Hoc was applied and significant differences at ***p<0.0001 on day 30 
was observed when compared to day 1, day 7 and day 15. No significant differences between day 1, 
day 7 and day 15 were observed. B) Changes in the pH of the Contact lens solution containing 
P(3HB) microspheres was significant *** p<0.0001.  (n=3; error=±s.d). A Bonferroni Post Hoc was 
applied and significant differences at ***p<0.0001 on day 30 was observed when compared to day 1, 
day 7 and day 15. No significant differences between day 1, day 7 and day 15 were observed.
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7.2.1.6.2 Examination of surface morphology after in vitro degradation 
The surface morphology of the P(3HB) microspheres after in vitro degradation studies 
carried out both in PBS (Figure 9A) and contact lens solution (Figure 9B) for a period of 
30 days, as examined by SEM, remained smooth and spherical with no changes to its 
surface morphology. However in the contact lens solution traces of degradation was 
observed in the 30 day sample. The contact lens solution should be more representative of 
the intraocular environment. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9:- (A) Scanning electron 
micrographs of BSA-loaded PHA 
microspheres during in vitro 
degradation in PBS and (B) in 
contact lens solution. Numbers in the 
insets indicate days of sample 
incubation and the size. 
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7.2.1.7 Protein profile of the BSA entrapped in the microspheres and released into PBS 
and contact lens solution observed using SDS-PAGE 
The protein profile of the microsphere entrapped BSA and released was studied using 
SDS-PAGE as shown in Figure 10. From the gel, a single band corresponding to the Mw 
of BSA (66,200 Da), identical to that found in the control lanes were observed at all time 
points. 
 
 
     Figure 10:- SDS-PAGE results of BSA samples taken after different time points.   
Lane 1, Mw marker, Lane 2, 5, normal BSA solution used as controls. Lanes 3&4, BSA released from 
microspheres into PBS and contact lens solution respectively, on day 1. Lanes 6&7, BSA released 
from microspheres into PBS and contact lens solution respectively, on day 14 and Lane 8 & 9, BSA 
released from microspheres into PBS and contact lens solution on day 28 of the in vitro release study.  
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7.2.2 Lucentis
®
 encapsulation studies  
7.2.2.1 Characterization of P(3HB) microspheres entrapped with Lucentis
®
 
The bulk shape and structure of the 5 wt% Lucentis
®
 loaded microspheres were observed 
using scanning electron microscopy (SEM) (Figure 11A). Figure 11B shows spherical 
microspheres with a more or less uniform shape and structure. From the particle size 
distribution curve as shown in Figure 11C, revealed that more than 50% of the measured 
particles had a mean particle size ranging from 1.5µm-2µm and 90% were below 5µm in 
size range. The measured sizes were compared with the SEM photomicrographs to verify 
accuracy. The % porosity calculated using equation 6 from Chapter 2, section 2.8.1.3 was 
17.4% and the % residual PVA bound onto the surface of the P(3HB) microspheres was 
0.56%.  
 
 
Figure 11:- A) SEM image of Lucentis
®
 loaded P(3HB) microspheres. B) SEM images of the surface 
morphology of Lucentis
®
 loaded P(3HB) microspheres at high magnification (x22,000) C) Particle 
size distribution analysis of P(3HB) microspheres loaded with Lucentis
®
. 
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7.2.2.2 Encapsulation efficiency 
The encapsulation efficiencies (%EE), surface associated Lucentis
®
 and the total amount 
Lucentis
®
 present in the PVA solution is represented in Figure 12. The encapsulation 
efficiency (%EE) of the P(3HB) microspheres loaded with Lucentis
®
 were calculated 
using equation 1, Chapter 2, section 2.4.1. The % EE of the P(3HB) microspheres loaded 
with  5 wt% (5mg/100mg) of Lucentis
®
 was 48%. The total amount of Lucentis
®
 present 
in the final PVA solution was 38% and the surface associated proteins bound to the 
microspheres were 13%  
 
 
Figure 12:- The percentage encapsulation efficiency, percentage of surface associated protein and 
percentage of Lucentis
®
  present in the PVA solution of the Lucentis
®
  loaded microspheres, (n=3; 
error=±s.d). 
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7.2.2.3 In vitro release kinetics of Lucentis
®
     
In vitro Lucentis
®
 release from the P(3HB) microspheres were carried out in PBS 
solution and contact lens solution. The contact lens solution was used to mimic the ocular 
environment. A triphasic release prolife was observed, as shown in Figure 13. The 
Lucentis
®
 loaded P(3HB) microspheres in the PBS solution exhibited a higher initial 
burst release of 12% when compared to 9% in the contact lens solution after 24 hours of 
immersion. Following an initial burst release, a gradual increase in the release was 
observed until 40 days after which a steady sustained release was observed for a period 
75 days. A maximum cumulative percentage release of 57% was observed for the 
Lucentis
®
 loaded microspheres in PBS and a maximum cumulative percentage release of 
39% was observed for the Lucentis
®
 loaded microspheres in contact lens solution after a 
period of 75 days, as shown in Figure 13.   
 
 
      Figure 13:-In vitro release profile of Lucentis
®
 from P(3HB) microspheres, (n=3; error=±s.d).  
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7.2.2.4 Protein profile of Lucentis
® 
entrapped in the P(3HB) microspheres and released 
into PBS and contact lens solution observed using SDS-PAGE 
The protein profile of the microsphere entrapped Lucentis
®
 and released was studied 
using SDS-PAGE as shown in Figure 14. From the gel, a single band corresponding to 
the heavy and light chain of Lucentis
®
 (23,00 Da and 25,000 Da), identical to that found 
in the control lanes were observed at all time points. 
 
 Figure 14:- SDS-PAGE results of Lucentis® samples released from P(3HB) microspheres after 
different time points.   
A) Lane 1, Mw marker, Lane 2, Lucentis
®
 solution used as control, Lanes 3, 4, & 5, Lucentis
®
 
released from microspheres into PBS on day 1, day 15 and day 30 respectively of the in vitro 
release study. 
B) Lane 1, Mw marker, Lane 2, 3, & 4 Lucentis
®
 released from microspheres into PBS on day 
45, day 60 and day 75 respectively of the in vitro release study. 
C) Lane 1, Mw marker, Lane 2 Lucentis
®
 solution used as control. Lanes 3, 4, & 5 Lucentis
®
 
released from microspheres into contact lens solution on day 1, day 15 and day 30 
respectively of the in vitro release study. 
D) Lane 1, Mw marker, Lane 2, 3, & 4 Lucentis
®
 released from microspheres into contact lens 
solution on day 45, day 60 and day 75 of the in vitro release study. 
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7.2.3 RNase A encapsulation studies 
7.2.3.1 Characterization of P(3HB) microspheres entrapped with RNase A 
The bulk shape and structure of the 50 wt% RNase A loaded microspheres were observed 
using scanning electron microscopy (SEM) (Figure 15A). Figure 15B shows spherical 
microspheres with a more or less uniform shape and structure. 
7.2.3.2 Microsphere size and size distribution 
From the particle size distribution curve as shown in Figure 15C, more than 80% of the 
measured particles had a mean particle size ranging from 1.5µm-2µm and 20% were 
below 5µm in size range. The measured sizes were compared with the SEM 
photomicrographs to verify accuracy. The average % porosity calculated using equation 6 
from Chapter 2, section 2.8.1.3 was 12.34% was and the % residual PVA bound onto the 
surface of the P(3HB) microspheres was 0.6%.  
  
 
Figure 15:- A) SEM image of P(3HB) microspheres. B) SEM images of the surface morphology of 
RNase A loaded P(3HB) microspheres at high magnification (x22,000) C) Particle size distribution 
analysis of P(3HB) microspheres. 
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7.2.3.3 Encapsulation efficiency 
The encapsulation efficiencies (%EE), surface associated RNase A and the total amount 
of RNase A present in the PVA solution is represented in Figure 16. The encapsulation 
efficiencies of the P(3HB) microspheres loaded with RNase A were calculated using 
equation 1, Chapter 2, section 2.4.1. The % EE of the P(3HB) microspheres loaded with 
50 mg of RNase A was 48%. The surface associated proteins bound to the microspheres 
were 8.6% and the total amount of RNase A present in the final PVA solution was 43%. 
 
 
Figure 16:- The percentage encapsulation efficiency, percentage of surface associated protein and 
percentage of protein present in the PVA solution of the RNase A loaded microspheres, (n=3; 
error=±s.d). 
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7.2.3.4 In vitro release kinetics of RNase A  
In vitro release studies were performed by monitoring the release of RNase A in pH 7.4, 
PBS solution at 37ºC. The amount of RNase A released at each sampling point, 
determined by the BCA assay, was plotted as a function of time in Figure 17. The in vitro 
release was characterised by an initial burst release of 8.4% in 24 hours followed by a 
slower release profile. The % cumulative release achieved at the end of 30 days was 
68.7%. 
 
 
      Figure 17:-In vitro release profile of RNase A from P(3HB) microspheres, (n=3; error=±s.d).   
 
0
10
20
30
40
50
60
70
80
0 5 10 15 20 25 30 35
%
 C
u
m
u
la
ti
v
e 
re
le
as
e 
Time in Days 
 Chapter 7:Results 
 
274 
 
7.2.3.5 Stability of RNase A entrapped in the microspheres  
7.2.3.5.1 Fluorescence studies  
Fluorescence emission scans were used to determine the changes in tyrosine residues 
present in the RNase A structure, which has a maximum emission spectra around 303 nm. 
The fluorescence emission scans of the control and RNase A entrapped within the 
P(3HB) microspheres after chloroform treatment is represented in Figure 18. From the 
results both the spectra appear to be super imposable with maximum emission observed 
at 303 nm.  
 
 
 
Figure 18:-Fluorescence spectra of chloroform-treated RNase A as compared to the untreated RNase 
A. 
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7.2.3.5.2 Protein profile of the RNase A entrapped microspheres observed using SDS-
PAGE 
The protein profile of the solvent treated RNase A entrapped within P(3HB) 
microspheres was determined using a 15% gel, (Figure 19). From the gel, the band 
corresponding to the Mw of RNase A (13,700 Da) was found to be identical to that found 
in the control lanes 2, lane 3 (free RNase A placed in contact with unloaded microspheres 
and subjected to the same release medium and temperature) and lane 4 (chloroform 
treated RNase A). Thus the structural integrity of RNase A was confirmed during the 
extended release periods.  
 
 
Figure 19:- SDS-PAGE results of RNase A samples. 
Lane 1, Mw marker, Lane 2, Control, Lane 3, free RNase A placed in contact with the placebo 
microspheres and subjected to the same release medium and temperature and Lane 4, chloroform 
treated RNase A.  
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7.2.3.6 Enzyme activity of RNase A using methylene blue assay 
The Ribonuclease (RNase A) released from the P(3HB) microspheres and the RNase A 
(used as a control not subjected to the microsphere fabrication conditions) were assayed 
for a period of 30 days by monitoring the shift in the absorbance maximum of methylene 
blue (688 nm) upon intercalation into intact RNA. From the results, the specific enzyme 
activity of RNase A released from the P(3HB) microspheres was 12 EU/mg on day 0 
when compared to 24.4 EU/ g of the RNAse A not subjected to the microsphere 
fabrication conditions. The enzyme activity continued to decrease from day 1 to day 30. 
For example on day 30 the specific enzyme activity of RNase A released from the 
P(3HB) microspheres had reduced to 0.13 EU/ g when compared to the control which 
had reduced to 0.22 EU/ g (Figure 20). % decline in the enzyme activity of the control 
and release samples expressed over a period of 30 days is represented in Figure 21. 
 
 
 
Figure 20:- A decline in the intercalation of methylene blue by RNase A was observed over a period 
of 30 days, (n=3; error=±s.d). 
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Figure 21:- % enzyme activity of the control and release samples expressed over a period of 30 days, 
(n=3;error=±s.d). 
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7. 3 Discussions 
7.3.1 Protein loaded P(3HB) microsphere characterizations 
7.3.1.1 Bulk shape and structure of the protein loaded microspheres 
The bulk shape and structure of the bovine serum albumin (BSA), Lucentis
®
 and 
ribonuclease A (RNase A) loaded microspheres when observed under SEM appeared 
more or less spherical with uniform shape and structure and did not appear to be 
aggregated. The results from the optical micrographs revealed microspheres with a 
hollow inner core during the first emulsion phase (w/o). However, in the second emulsion 
phase, micro droplets of water with a honeycomb structure within the emulsion droplets 
were observed. The volume of the oil-phase, i.e 50mL and the solvent evaporation rate 
used in this study had a significant effect on the internal morphology of microspheres. At 
a lower oil-phase volume, the polymer is known to be concentrated and viscous; as a 
result it is difficult to break the internal water into smaller droplets during the first 
emulsion phase. Thus at a rapid solvent evaporation rate and polymer precipitation, large 
hollow spaces are formed. However, at a higher oil phase volume and rapid solvent 
evaporation rate the microspheres solidify quickly. As a result the water droplets that 
diffuses into the microspheres forming honeycomb structures. These solidified 
microspheres then prevent further influx of water into the microspheres thereby 
preventing them from coalescing together and forming large hollow spaces (Jayanthi et 
al., 1996). In a similar study conducted by Yang et al., uniform honeycomb structures 
within the PLGA microspheres were observed when 250 mL of the second oil phase 
volume was used. However when 9 mL was used in the first oil phase, microspheres with 
a hollow inner core was observed (Yang et al., 2001). Thus in this study the second oil 
phase volume of 250 mL during microsphere fabrication could have contributed to the 
formation of small spherical porous microspheres. This is desirable for controlled drug 
delivery applications as the drugs can be entrapped within these porous structures, 
thereby contributing to a controlled release 
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7.3.1.2 Particle size analysis 
For controlled release applications microsphere particle size plays an important role. For 
examplefor ophthalmic delivery, an increase in size to 10µm is known to cause patient 
discomfort and blurring of vision. In this study, the size of the P(3HB) microspheres 
encapsulating BSA, as revealed by the particle size analyser, was of an average size of 
1.5µm to 2.0µm. Similarly the Lucentis
®
 loaded P(3HB) microspheres were also of an 
average size of 1.5µm to 2.0µm which is ideal for use in intraocular drug delivery. The 
RNase A loaded P(3HB) microspheres also exhibited 80% of the mean particle size 
ranging from 1.5µm-2µm and 20% below 5µm in size range. Although the molecular 
weights of the proteins encapsulated, i.e. BSA (66.2 kDa) Lucentis
®
 (48 kDa) and 
RNaseA (13.7 kDa), were different, the microsphere size was not affected by this. Sandor 
et al., made similar observations, where no differences in the average poly(lactic-co-
glycolic acid), PLGA, microsphere size was seen when encapsulated with different 
molecular weight proteins such as BSA (66.2kDa) and lysozyme (14.3kDa).                       
The average sizes of the microspheres observed were in the range of 2.23 m (Sandor et 
al., 2001). The size of the microspheres is known to be affected by a number of 
processing factors such as viscosity of the polymer solution, stirrer speed and the PVA 
concentration used in the external phase, as mentioned in Chapter 3, section 3.3.1. For 
BSA, Lucentis
®
 and RNase A encapsulation, in this study, the stirrer speed could have 
contributed to the formation of 2µm sized microspheres. The stirrer speed of 800 rpm 
was probably high enough to disperse the second emulsion into small droplets due to 
which smaller sized microspheres were produced. Igartua et al., observed the formation 
of uniform sized PLGA microspheres with an average size of 1.32µm when a stirrer 
speed of 9500 rpm was used (Igartua et al., 1998). As mentioned in earlier in Chapter 3, 
section 3.3.1 and 3.3.2, an increase in the PVA and polymer concentration is known to 
increase the viscosity in the emulsion phase, which in turn leads to the production of 
larger sized microspheres. However there is a maximum PVA and polymer concentration 
which influences the size of the microsphere beyond which an increase in the viscosity 
does not have any further influence on the size of the microspheres and the stirrer speed 
dominates (Lee et al., 1999). For exampleLee et al., observed that at a polymer 
concentration of 6 wt%, an increase in the PVA concentration from 0.1% w/v to 1% w/v
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and an increase in the stirrer speed from 2500 rpm to 5000 rpm, the microspheres sizes 
appeared similar at 2.0µm and 2.1µm. The authors‟ observed that although the PVA and 
polymer concentration is important up to maximum concentration, the stirrer speed had 
dominated leading to the formation of small sized microspheres (Lee et al., 1999). The 
results from this study also further indicate that microspheres sizes were influenced by 
the stirrer speed which had contributed to the formation of small sized microspheres. 
7.3.1.3 Surface morphology 
The BSA, Lucentis
®
 and RNase A loaded P(3HB) microspheres when examined under 
SEM appeared smooth and spherical. The type of protein loading did not affect the 
morphology of the microspheres. However the P(3HB) microspheres with the higher 
BSA loading of 1.5wt% and 5wt% and the Lucentis
®
 loaded microspheres appeared 
slightly rough due to the presence of surface associated proteins. In a study conducted by 
Bouissou et al., the surface morphologies of the poly(lactic-co-glycolic acid) PLGA 
microspheres encapsulated with fibronectin prepared using different surfactants such as 
PVA, Igepal and Triton X-100 were compared. The PLGA microspheres prepared using 
PVA appeared smooth and uniform when compared to the rough surface morphology of 
the microspheres prepared with other surfactants such as Igepal and Triton X-100.  The 
authors‟ had observed that the reduced surfactant viscosity while using PVA was 
responsible for the production of a smooth surface morphology when compared to the 
other surfactants used (Bouissou et al., 2004). In this study PVA used as surfactant in the 
emulsion could have also contributed to the formation of a smooth microsphere surface. 
The microsphere wall is also known to vary in both thickness and porosity depending on 
the varying temperatures during solvent evaporation (Yang et al., 2001). At higher 
temperatures, microspheres with highly porous outer walls are formed due to the rapid 
solvent evaporation. Since the solvent evaporation was carried out at room temperature in 
this study, smooth surfaced microspheres were produced in most cases.  
7.3.1.4 Porosity 
The BSA (66.2kDa) loaded P(3HB) microspheres with different loadings exhibited an 
internal porosity of 32%, 39% and 24%, while Lucentis
® 
(48kDa) and RNase A
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 (13.7kDa) loaded microspheres had exhibited a lower internal porosity of 17% and 12%. 
Thus the % porosity of the P(3HB) microspheres in this study varied with the type of 
protein encapsulated. Often the microspheres encapsulating smaller molecular weight 
proteins are known to have reduced number of pores within the microspheres. On the 
other hand, the microspheres encapsulating larger molecular weight proteins such as BSA 
are known to have an increased number of pores (Sandor et al., 2001). These 
observations correlated with the results obtained in this study where P(3HB) 
microspheres encapsulating the high molecular weight proteins such as BSA and 
Lucentis
®
 exhibited higher porosity when compared to the microspheres encapsulating 
lower molecular weight protein such as RNase A.  
7.3.1.5 Protein encapsulation efficiency 
The highest encapsulation efficiency of 70% was observed in microspheres that were 
loaded with 5 wt% of BSA when compared to the microspheres loaded with lower 
concentrations of BSA. As expected, in this case the amount of microsphere surface 
associated protein was relatively low and the amount of protein that was lost in the PVA 
solution was also the lowest. The viscosity of the outer emulsion phase with the 
increasing BSA concentration would have increased, which would have further inhibited 
the BSA diffusion from the microspheres into the outer oily phase comprising of PVA, 
solvent and water. As a result, a higher BSA distribution within the microspheres with 5 
wt% BSA was observed when compared to the P(3HB) microspheres with lower BSA 
loadings.  
P(3HB) microspheres loaded with 5wt% of Lucentis
® 
exhibited an encapsulation 
efficiency of 48% and a surface associated protein of 13%.  The average microsphere 
pore size is affected by the molecular weight of the proteins. Therefore, with an increase 
in the molecular weight of the proteins, an increase in the average pore size of the 
microsphere is observed. For exampleSandor et al., observed an average pore size of 
40nm for microspheres encapsulating larger proteins such as BSA (66.2kDa) and an 
average pore size of 20nm for microspheres encapsulating lyzozyme (13.4kDa) (Sandor 
et al.,2001). The molecular weight of Lucentis
®
 (48kDa) encapsulated within P(3HB) 
microspheres in this study was slightly smaller than the molecular weight of BSA, 
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therefore the average pore size of the microspheres may be similar. However, a non-
denaturing PAGE, which is known to preserve the covalently and non-covalently bonded 
aggregates, should be carried out in the future to confirm the absence of protein 
aggregates. Higher molecular weight proteins are known to be compact in nature thus 
getting entangled within the polymeric device and affecting the in vitro drug release 
kinetics (Pouton et al., 1996). Nevertheless during microsphere fabrication, Lucentis
® 
may have diffused from within the microspheres due to its lower molecular weight in 
comparision to the molecular weight of BSA and got bound onto the surface of the 
microspheres. This could probably explain the higher percentage of surface associated 
protein (13%) and lower encapsulation efficiency (48%) when compared to 8% of surface 
associated protein and 70% encapsulation efficiency on the 5wt% BSA loaded P(3HB) 
microspheres.  
RNase A loaded P(3HB) microspheres in this study exhibited an encapsulation efficiency 
of 48%. The encapsulation efficiency is also influenced by the distribution of pores 
within the microspheres, which in turn is affected by the molecular weight of the 
proteins. For examplemicrospheres encapsulating larger molecular proteins are known to 
exhibit large open pores at the surface of the microspheres and dense layers within the 
microspheres. Due to this the encapsulation of the large molecular weight proteins within 
the microspheres is reduced. However, by increasing the microsphere size a higher 
encapsulation of larger molecular weight proteins could be achieved, as these proteins 
will largely be present within the core of the microspheres. On the other hand 
microspheres encapsulating proteins with smaller molecular weight have a uniform pore 
distribution where the proteins are entrapped largely within the microspheres thus 
exhibiting higher encapsulation efficiency. For exampleSandor et al., observed that 
microspheres encapsulating smaller molecular weight proteins such as Lyzozyme 
(13.4kDa) exhibited uniformly distributed open branched network of pores within the 
microspheres. These microspheres exhibited a higher encapsulation efficiency of 80% 
when compared to the lower encapsulation efficiency of 45% when BSA (66.2 kDa) used 
which exhibited large open pores at the surface of the microspheres. Thus in this study an 
encapsulation efficiency of 48% of RNase A (13.7 kDa) was observed probably due to 
the encapsulation of the protein within the core of the microspheres. In another relevant 
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study Murata et al., also observed an encapsulation efficiency of 48% of small interfering 
RNA (siRNA) within PLGA microspheres with an average size of 35-45µm. However, in 
order to increase the encapsulation efficiencies, they used carriers such as arginine. Due 
to the ionic interaction between the terminal carboxylic anions of PLGA and the basic 
amino acid groups of the arginine, a rigid structure of the PLGA microspheres were 
formed resulting in an increased encapsulation efficiency of 64.3% (Murata et al., 2008). 
7.3.2 In vitro release studies 
7.3.2.1 BSA in vitro release studies 
 In vitro release studies of BSA were conducted both in contact lens solution as well PBS 
solution to measure the amount of BSA that was released from the microspheres with 
different BSA loadings. An in vitro release study in contact lens solution was chosen, as 
it was more representative of the intraocular environment. From the results, a relatively 
higher initial burst release was observed, after 24 hours, in the microspheres immersed in 
PBS solution, when compared to those immersed in contact lens solution. The very small 
burst release observed in the contact lens solution was a positive result as this could 
indicate that there will be minimal burst release of the drug when the microspheres are 
used for intraocular delivery.  
Within the first few hours, the BSA that was bound loosely to the surface of the 
microspheres could have contributed to the initial burst release. The initial burst release 
was however not dependent on the BSA loadings. The P(3HB) microspheres with a 
higher BSA loading exhibited a lower burst release due to the lower surface associated 
proteins when compared to the microspheres with a lower BSA loading and higher 
surface associated proteins. Following the initial burst release of BSA, a diffusion 
controlled release phase for microspheres with different BSA loading conditions both in 
PBS and contact lens were observed. However the microspheres loaded with 5 wt% of 
BSA exhibited a higher diffusion controlled release both in PBS as well in the contact 
lens solution when compared to the microspheres with lower BSA loadings. Due to the 
higher amount of BSA encapsulated in the 5 wt% microspheres, the concentration 
gradient between the microspheres and the outer emulsion phase would have been higher
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 when compared to the microspheres with lower BSA loadings. This difference in the 
concentration gradient would have initiated the higher release of protein from within the 
microspheres. The solvation of the protein molecules would have further created 
interconnecting channels and pores providing increased access for the surrounding 
medium. As a result, the additional protein molecules embedded within the microspheres 
would have migrated and a faster release rate would have occurred when compared to the 
microspheres with lower BSA loadings. Similarly researchers like Yang et al., have also 
observed that PLGA microspheres with the highest BSA loading of 2.64% had exhibited 
a higher release rate when compared to the microspheres loaded with 0.66% and 0.45% 
of BSA.(Yang et al., 2001).  
7.3.2.2 Lucentis
®
 in vitro release studies  
In vitro release study of Lucentis
®
 (48kDa) was also conducted both in contact lens 
solution as well PBS solution to measure the amount of Lucentis
®
 that was released from 
the microspheres. From the results, as seen a relatively higher initial burst release of 12% 
was observed after 24 hours in the microspheres immersed in PBS solution, when 
compared to 9% of those immersed in contact lens solution. This difference in the initial 
burst release observed between PBS and contact lens solution could be due to the higher 
solubility of Lucentis
®
 in PBS when compared to the contact lens solution. Following an 
initial burst release, again a higher diffusion controlled release rate was observed in PBS 
when compared to the contact lens solution. This was due to the initial solvation of the 
protein molecules on the surface of the microspheres into the PBS solution. This could 
have created interconnecting channels providing access to the surrounding medium. The 
buffer penetration into the microspheres would have further initiated subsequent 
dissolution of Lucentis
®
 embedded within the matrix. The % cumulative release of 
Lucentis
®
 from both PBS and contact lens solution was 57% and 39% respectively for an 
extended period of 75 days. This slow release of Lucentis
®
 could be attributed to the low 
porosity of the microspheres. For example Lucentis
®
 loaded P(3HB) microspheres 
exhibited a porosity of 17% when compared to 24% porosity exhibited by the 5wt% BSA 
loaded microspheres which contributed to a release rate of 100% and 52% in PBS and 
contact lens solution respectively, within a period of 30 days. 
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7.3.2.3 RNase A in vitro release studies 
The RNase A in vitro release profiles were also characterised by a biphasic release 
profile. An initial burst release of 8.45% was observed in 24 hours followed by a slower 
release over a period 30 days. The burst release from the microspheres was attributed to 
the surface associated proteins. Nellore et al., observed a burst release of 50-70% in PBS 
solution due to the presence of surface associated RNase A. Following an initial burst 
release a gradual increase in the release rate was observed due to the higher amount of 
protein that is entrapped within the uniform open branched network of pores within 
microspheres.  Sandor et al., also observed a higher initial phase of release from PLGA 
microspheres encapsulating proteins such as lyzozyme, which was followed by a gradual 
increase in the release phase. The authors‟ also observed a small amount of protein 
release in the final stages (4 weeks) which was largely attributed to the degradation of the 
PLGA microspheres (Sandor et al., 2001). Although polymer erosion is known to 
contribute to final stages of drug delivery, in this study however it is probable that the 
RNase A release was complete before the polymer erosion could play a significant role. 
This is the major difference between PLGA and PHAs; the latter are very slow 
degrading, so in this study the degradation would contribute really minimally to drug 
elution.  
7.3.3 In vitro microsphere degradation study of P(3HB) microspheres  
In order to study the in vitro degradation of the P(3HB) microspheres; they were 
immersed in PBS and contact lens solution for different time periods. The water uptake 
(%WA) and weight loss (%WL) exhibited by the P(3HB) microspheres in the PBS 
solution were higher when compared to that of the  contact lens solution. This indicated 
that the P(3HB) microspheres exhibited a much slower degradation rate in contact lens 
solution when compared to the degradation rate in PBS. The different rates of BSA 
release in PBS and contact lens solution from the P(3HB) microspheres could also 
influence the %WA of the P(3HB) microspheres. Since the BSA release rate was higher 
in PBS when compared to the release rate in contact lens solution, the empty voids 
steadily forming in the P(3HB) microsphere due to BSA release may increase the 
network of water channels for water penetration, thereby accelerating the weight loss of 
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the P(3HB) microspheres in PBS. P(3HB) undergoes random chain scission by ester 
hydrolysis, auto-catalysed by the generation of carboxylic acid end groups (Knowles et 
al.,1992). The surface morphology of the P(3HB) microspheres after in vitro degradation 
studies carried out both in PBS and contact lens solution for a period of 30 days, 
remained smooth and spherical. This indicated minimal surface degradation. In vitro 
degradation of P(3HB) in buffer solutions is observed to show no visible bulk mass loss 
after 180 days indicating that P(3HB) undergoes slow in vitro degradation. However, a 
decrease in the molecular weight of the polymer is observed after 80 days of incubation 
(Doi et al., 1989). The degradation of P(3HB) is observed to take place though random 
scission in both the amorphous and crystalline regions of the polymer matrix (Freier et 
al., 2002b).  
7.3.4 Protein stability tests 
7.3.4.1 Protein profile of the BSA entrapped in the microspheres and released in to PBS 
and contact lens solution 
From the gel, a single band corresponding to the Mw of BSA (66, 200Da), identical to that 
found in the control lanes was observed at all time points. Proteins are known to possess 
a complex internal structure, which provides its unique biological activity. These proteins 
can become inactive by denaturation and aggregation when exposed to surfactants or 
elevated temperatures. Similarly, reduction in the pH during incubation in the release 
medium is known to cause protein inactivation. Thus, in order to develop a successful 
protein-microsphere based delivery system; the structural integrity of the protein needs to 
be retained throughout the encapsulation and release period. However this result does not 
completely rule out the presence of protein aggregates linked by either covalent or non-
covalent bonding. Therefore a non-denaturing PAGE, which is known to preserve the 
covalently and non-covalently bonded aggregates, should be carried out in the future to 
confirm the absence of protein aggregates. In another relevant study, Igartua et al., 
confirmed the structural integrity of BSA using SDS-PAGE analysis which encapsulated 
in PLGA microspheres prepared using a w/o/w technique. The structural integrity of the 
protein released in phosphate buffered saline (PBS) during the in vitro assays was 
confirmed with a single band that corresponded to its molecular weight.  The authors‟
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 had also carried out a non-denaturing PAGE which did not reveal any aggregates of the 
protein further confirming that the structural integrity of BSA was retained even under 
the unfavourable encapsulation conditions (Igartua et al., 1998).  
7.3.4.2 Protein profile of the Lucentis
®
 entrapped in the microspheres and released into 
PBS and contact lens solution 
From the gel, a single band identical to that found in the control lanes (25,000Da) was 
observed at all time points. The molecular weight of Lucentis
®
 is 48,000Da (23,000Da 
and 25,000Da for the light and heavy chain, respectively). The reducing agent β-
surfactant 
SDS is known to cause the complete unfolding of the native protein structure by binding 
to the hydrophobic residues and to the peptide backbone. Therefore, during SDS-PAGE 
analysis both the short and long chains (23 kDa, 25kDa) would have appeared as a single 
band after reduction of the disulphide linkage. A non-denaturing PAGE could also be 
carried out in future to preserve the covalently and non-covalently bonded aggregates.  
 
7.3.4.3 RNase A stability evaluation 
Damaging effects on the enzymatic activity of the protein is known to occur when they 
come in contact with organic solutions (Nellore et al., 1996). In order to monitor the 
stability of RNase A before and after in vitro release studies, fluorescence tests, SDS-
PAGE and Methylene blue activity tests were performed. 
7.3.4.3.1 Fluorescence tests 
 The fluorescence emission spectra for RNase A placed in contact with the microsphere 
solution and not subjected to agitation was used as a control. Chloroform treated RNase 
A were conducted to investigate the possible changes in the three-dimensional structure 
of the protein in the presence of the organic solvent. From the results, the fluorescence 
emission spectra of the control and chloroform treated microspheres were super 
imposable with a maximum emission spectra at 303nm. A slight difference in the 
fluorescence intensity was observed which could be due to the difference in the protein 
concentration of the samples. During denaturation, the hydrogen bonds of RNase A are 
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disrupted leading to changes in the tryptophan fluorescence, leading to an increase in the 
fluorescence emission (Nellore et al.,1996). Unfolding of the tryptophan and tyrosine 
containing proteins such as RNase A is known to shift the fluorescence maximum to 
longer wavelengths such as 350 nm. Since the maximum fluorescence emission spectra 
of the control and chloroform treated RNase A were at 303nm in this study, this indicated 
that the RNase A loaded in the microspheres, after chloroform treatment, was not 
affected by the microsphere fabrication methods used (Nellore et al.,1996). In a similar 
study conducted by Nellore et al., the fluorescence emission spectra of the acetonotrile 
treated RNase A, seen at 303 nm was super imposable with the emission spectra of the 
control, thus confirming that the acetonitrile treatment did not lead to any significant 
changes in the tyrosine and tryptophan residues of the RNase A molecules (Nellore et al., 
1996).  
7.3.4.3.2 Protein profile of the RNase A entrapped in the microspheres and released into 
PBS solution 
In the SDS-PAGE, a single band corresponding to the Mw of RNase A (13,700 Da), 
identical to that found in the control lanes were observed with the solvent treated RNase 
A. This treatment should be analogous to the conditions used during microsphere 
manufacture. However a non-denaturing PAGE, which is known to preserve the 
covalently and non-covalently bonded aggregates, should be carried out in the future to 
confirm the absence of protein aggregates. Nellore et al., also observed no changes in the 
molecular weight of the RNase A after solvent treatment. They observed that the relative 
mobility (Rf), a function of the logarithm of the molecular weight, was similar to that of 
the untreated RNase A, used as a control, indicating that there was no gross aggregation 
(Nellore et al., 1996).   
7.3.4.3.3 Methylene Blue RNAse Enzyme Assay 
The enzyme activities of the control RNase A (free RNase A placed in contact with the 
placebo microspheres and subjected to the same release medium and temperature) was 
compared with the specific activity of the RNase A released in the PBS solution. From 
the results it was observed that about 56% of the initial activity of the microencapsulated 
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RNase A was retained when compared to the control RNase A on  
day1. Nellore et al.,  also observed loss of enzymatic activity when RNase A 
encapsulated within PLGA microspheres was compared with RNase A placed in contact 
with the placebo microspheres (controls) at 37°C and pH 7.4. The authors‟ observed a 
loss of 17% of the RNase A enzyme activity of the controls over a period of 7 days when 
compared to 70% loss of enzyme activity of the in vitro released samples. During 
microencapsulation the protein comes in contact with the organic solvent and then is 
released into the medium when the buffer penetrates further into the microspheres. This 
process may be unfavourable for the protein due to which it gets inactivated. A change in 
pH, such as reduction in the pH during incubation in the release medium would have also 
caused protein inactivation. 
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7.4 Conclusions 
Protein delivery using biodegradable polymers is becoming increasingly common. The 
conventional method of encapsulating drugs in microspheres has also been applied to 
proteins. Often during microencapsulation, the surface and internal morphology, protein 
distribution and release kinetics are affected by a number of factors such as the type of 
protein encapsulated, polymer used and the methods of microsphere fabrication used. In 
this study an initial development of a microsphere-based protein delivery system using 
the biodegradable and biocompatible polyhydroxyalkanoates was developed. The 
microspheres were encapsulated with three model proteins BSA, Lucentis
®
 and RNase A 
to understand the effect of morphology, drug distribution on the in vitro release profiles. 
The effects of solvent treatment and physical stresses encountered during 
microencapsulation into polymeric matrices were also examined using SDS-PAGE and 
fluorometric analysis. The microspheres produced were of an average size of 2µm. For 
the first part of this study where microsphere-based intraocular drug delivery was 
developed, this size would be advantageous, as it will allow their use in an ophthalmic 
context. Once injected intraocularly, they would allow the gradual release of the relevant 
drug in the intraocular chamber. The microspheres were encapsulated with different BSA 
loadings, 0.75wt%, 1.5wt% and 5wt%. The microspheres with the highest BSA loading 
yielded a larger concentration gradient between the emulsion droplet and the continuous 
phase, due to which a higher amount of BSA was released when compared to the 
microspheres with a lower BSA loading. The initial burst release was attributed to the 
surface associated BSA rather than the actual loadings, nevertheless the microspheres 
with the highest BSA loading exhibited a higher burst release due to the higher amount of 
surface associated BSA. The microencapsulation process also did not lead to any 
degradation of BSA and hence can be assumed to be equally gentle to any protein drug. 
The microspheres encapsulated with 5wt% of the second model protein Lucentis
® 
exhibited an encapsulation efficiency of 48% and a surface associated protein of 13%. A 
higher percentage of surface associated protein (13%) was observed when compared to 
8% of the 5 wt% BSA loaded microspheres. The lower molecular weight of Lucentis
® 
may have diffused from within the microspheres and got bound onto the surface of the 
microspheres thereby increasing the percentage of surface associated proteins.
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A relatively higher initial burst release was observed after 24 hours in the microspheres 
immersed in PBS solution, when compared to those immersed in contact lens solution. 
The initial burst release was attributed to the surface associated Lucentis
®
 on the 
microsphere surface as well as the higher solubility of Lucentis
®
 in PBS when compared 
to the contact lens solution may have contributed to the initial burst release. The % 
cumulative release of Lucentis
®
 from both PBS and contact lens solution was slower for 
an extended period of 75 days when compared to the higher release exhibited by the 5 
wt% BSA loaded microspheres within a period of 30 days. This slow release of Lucentis
®
 
could be attributed to its lower porosity when compared to the porosity exhibited by the 
5wt% BSA loaded microspheres. The microencapsulation process also did not lead to any 
degradation of Lucentis
®
. However a non-denaturing PAGE, which is known to preserve 
the covalently and non-covalently bonded aggregates, should be carried out in the future 
to confirm the absence of protein aggregates. Hence in the context of wet macular 
degeneration, this drug delivery system would work very well as a controlled delivery 
can be achieved. Its use would decrease the frequency of injections required by the 
patients, a major achievement both in terms of the cost of treatment (for NHS in the UK) 
and the physical and emotional well being of the patients.  
The third model protein used in this study was RNase A. RNase A has the same 
molecular weight as other functional agents such as bone morphogenic proteins (BMP-2). 
Therefore, the aim of this study was to identify whether the RNase A activity and 
structural integrity is maintained during the encapsulation process. The in vitro release 
study of RNase A in PBS revealed an initial burst release within the first 24 hours 
followed by a gradual increase a period of 30 days. The stability of RNase A following 
exposure to organic solvents was evaluated using a variety of analytical techniques such 
as fluorescence emission spectra, SDS-PAGE and methylene blue enzyme activity test. 
The fluorescence emission spectra revealed that the solvent treatment did not perturb the 
structure of RNase A. In the SDS-PAGE, a single band corresponding to the Mw of 
RNase A (13,700 Da), identical to that found in the control lanes were observed with the 
solvent treated RNase A. This treatment should be analogous to the conditions used 
during microsphere manufacture. As mentioned above a non-denaturing PAGE, which is 
known to preserve the covalently and non-covalently bonded aggregates, should be
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carried out in the future to confirm the absence of protein aggregates. During 
microencapsulation the protein comes in contact with the organic solvent and then is 
released into the medium when the buffer penetrates further into the microspheres. This 
process may be unfavourable for the protein due to which it gets inactivated. As a result a 
gradual decrease in the enzyme activity of RNase A was observed over a period of time.
 Chapter 8:Conclusions 
 
293 
 
Chapter 8 
Conclusions
 Chapter 8:Conclusions 
 
294 
 
8.1 Conclusions 
The biodegradable P(3HB) microspheres system developed in this research has shown 
the potential to be used in various biomedical applications. Poly(3-hydroxybutyrate) 
P(3HB), was used to produce microspheres using a solid-in-oil-water (s/o/w) technique. 
For this study, several parameters namely as polymer concentration, surfactant and 
stirring rates were considered. The average dimensions of the microspheres were 2µm to 
1.54µm with specific surface areas from 9.60 m
2
/g to 6.05 m
2
/g was produced. The 
microspheres produced using low stirring speed of 300 rpm produced slightly larger 
microspheres when compared to the smaller microspheres produced when the stirring rate 
was increased to 800 rpm. The surface morphology of the microspheres after solvent 
evaporation appeared smooth when observed under SEM. Gentamicin was also 
encapsulated within these P(3HB) microspheres and the release kinetics of the 
microspheres exhibiting the highest encapsulation efficiency, 48%, was investigated. The 
DSC analysis showed that the microsphere preparation process as well as the drug had 
influenced the thermal behaviour of the microspheres. The hydrophilic nature of the drug 
also had an influence on the polymeric degradation as well as the drug release behaviour. 
The in vitro release of gentamicin was biphasic where an initial burst release was 
observed followed by a diffusion mediated sustained release. 
 P(3HB) microspheres have been used in combination with 45S5Bioglass
® 
(micro and 
nanoscale bioactive glass). The P(3HB) microspheres were coated onto the                          
3-D 45S5Bioglass
® 
scaffolds. Successful microsphere coating on the 45S5Bioglass
®
 
scaffold was achieved using an optimized oil/water emulsion. The resultant composite 
scaffold had increased compressive strength, surface nanotopography and high 
bioactivity. The multifunctional scaffold was also successfully used as a drug delivery 
vehicle. The encapsulated drug within the coated scaffolds was released in a slow and 
sustained manner compared to the burst release of the drug from the P(3HB) 
microspheres on their own and the uncoated scaffold. Hence, this multifunctional 
scaffold can potentially be used to deliver drugs, proteins or growth factors to treat bone 
related diseases. 
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P(3HB) compositions were also used to prepare composite films with a combination of 
nanoscale bioactive glass (n-BG) (10 wt%) for wound healing applications. With the 
incorporation of n-BG particles, the changes in the thermal and surface properties such as 
surface roughness and protein adsorption were investigated. The various analyses 
performed/undertaken showed that the addition of n-BG particles had increased the 
surface roughness of the films, improved the surface wettability and reduced the heat of 
fusion by 19%. Surface mediated reactions such as clot formation was also investigated. 
By using n-BG particles the time until clot detection was found to decrease linearly with 
the increase in the amount of n-BG particles. An increase in the rate of coagulation was 
also observed when the amounts of n-BG particles were increased. Although 
45S5Bioglass
®
 has been previously reported as a haemostatic agent, this is the first time 
that n-BG particles have been reported for its applicability as a haemostatic agent. For the 
second part of this study, P(3HB)/n-BG composite microsphere films were immersed in 
SBF for a period of 1, 3 and 7 days and the effect of surface roughness of the cell 
adhesion was studied. The presence of the amorphous calcium phosphate deposition on 
day 1 and nanoscale sized HA crystals on day 3 and day 7 of the composite microsphere 
films had improved the surface wettability of the films due to its increased 
hydrophillicity. However due to the variations in the surface charge of the films after 
immersion in SBF, the protein adsorption was affected. This difference in the protein 
adsorption was attributed to the variations in the surface charge of the HA. The % cell 
viabilities on the composite microsphere films after immersion in SBF for 3 and 7 days 
were however affected by the rough surface morphology of the films. The cells on these 
films appeared scattered without the formation of a continuous thick layer due to which a 
lower cell adhesion was observed. Thus, in this study an optimal surface roughness for 
increased cell adhesion was observed beyond which it would be deleterious for cell 
adhesion and differentiation.  
The efficacy of using films made from compressed P(3HB) microspheres encapsulating 
tetracycline as a scaffold for drug delivery and wound healing purposes was also studied. 
In this study the incorporation of the drug successfully improved the surface properties of 
the biomaterial such as surface morphology, wettability, roughness and porosity thereby 
promoting cell adhesion on the microsphere films. The presence of tetracycline on the 
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surface of the microspheres, as detected by XPS, resulted in changes in the surface 
properties of these films. The results from the water contact angle study showed a 
significant improvement in the hydrophillicity of the microsphere films with the addition 
of tetracycline that was further complemented by the increase in the total protein 
adsorption. These alterations in film surface properties resulted in an improved scaffold 
for keratinocyte adhesion and growth as indicated by the increased numbers of viable 
cells on the drug loaded microsphere films compared to those on the unloaded 
microsphere films.  Finally the P(3HB) degradation was dependant on the  crystallinity, 
thermal properties and water permeability. The different drug loading ratio, which led to, 
surface morphology changes also had an effect on polymer degradation.  
 
P(3HB) microspheres were also investigated for use as drug delivery vehicles in the 
intraocular environment. These drug-loaded microspheres would then be injected into the 
vitreous humor of the patient‟s eye leading to gradual release of the drug, hence 
eliminating the need for monthly injections. Thus for this study the P(3HB) microspheres 
were entrapped with BSA and the release kinetics of BSA from the loaded microspheres 
were investigated. Finally, the degradation studies on the BSA loaded P(3HB) 
microspheres were carried out.  The results from this preliminary study had confirmed 
that the BSA entrapped in the microspheres was released slowly and thus this system, 
when optimised, has the potential to be used for long-term intraocular drug delivery. The 
release rate of the drug, after optimisation, should allow release of the relevant drug for at 
least six months. The process did not lead to any degradation of BSA and hence can be 
assumed to be equally gentle to any protein drug. This is in fact the most positive result 
obtained in this project indicating the feasibility of the use of this system in the context of 
wet macular degeneration. 
 
The results obtained from BSA encapsulation were then used for planning the 
encapsulation of the Lucentis
®
, currently the most common treatment for the wet macular 
degeneration produced by Genentech USA. These microspheres can then be injected into 
the patient‟s eye leading to gradual release of the drug, hence eliminating the need for 
monthly injections. The in vitro release rate in phosphate buffered saline and contact lens 
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solution (representative of an intraocular environment) was carried out. The % 
cumulative release of Lucentis
®
 from both PBS and contact lens solution was slower for 
an extended period of 75 days when compared to the higher release exhibited by the                
5 wt% BSA loaded microspheres within a period of 30 days. This slow release of 
Lucentis
®
 could be attributed to its lower porosity when compared to the porosity 
exhibited by the 5wt% BSA loaded microspheres. The microencapsulation process also 
did not lead to any degradation of Lucentis
®
. However a non-denaturing PAGE, which is 
known to preserve the covalently and non-covalently bonded aggregates, should be 
carried out in the future to confirm the absence of protein aggregates.  
Finally the effects of solvent treatment encountered by the model protein Ribonuclease A 
(RNase A) during microencapsulation in P(3HB) microspheres were investigated. Thus 
from these preliminary results the same encapsulation technique can be used for the 
encapsulation of BMP-2 and the typical response of cells C2C12 in the presence of   
BMP-2 from the release media can be studied. The stability of RNase A during the 
microencapsulation procedure was monitored using fluorspectrophometric studies and 
SDS-PAGE. The biological activity of the protein present in the release samples was 
determined by the Methylene Blue assay. The microspheres were characterised for 
surface morphology and encapsulation efficiency protein release profiles and protein 
activity. From the results, structural integrity of RNase A was maintained. Uniformly 
spherical sized microspheres in the size range of 2 µm were prepared. The fluorescence 
emission spectra revealed that the solvent treatment did not perturb the structure of 
RNase A. In the SDS-PAGE, a single band corresponding to the Mw of RNase A (13,700 
Da), identical to that found in the control lanes were observed with the solvent treated 
RNase A. During microencapsulation the protein comes in contact with the organic 
solvent and then is released into the medium when the buffer penetrates further into the 
microspheres. This process may be unfavourable for the protein due to which it gets 
inactivated. As a result, a gradual decrease in the enzyme activity of RNase A was 
observed over a period of time. 
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9.1 Future work  
On the basis of the results achieved there are potential areas of further research that will 
provide a better understanding of the applicability of P(3HB) and P(3HB)/n-BG 
composite systems 
 P(3HB) microsphere  production:- Surface properties of the microspheres have 
been known to have a significant influence on the host response system. The cells 
of the mononuclear phagocyte system rapidly clear most of the microspheres once 
injected in the body. However if the microspheres are internalised it could be 
advantageous, as these microspheres can be targeted to specific locations such as 
the spleen, liver and bone marrow to achieve a sustained release of the drug. 
Therefore drugs that would become effective only after internalization by the 
phagocytic cells should be chosen. The physico-chemical properties of the 
microspheres such as surface charge, surface hydrophobicity and size should be 
controlled and the intracellular microspheres uptake should be carried. The              
in vitro experiments can provide useful information of the fate of the drugs once 
injected into the body.  
 The P(3HB) microspheres coated 45S5Bioglass® composite scaffolds:- GFP 
transfected MG63 cells can be used to assess cell viability/proliferation in order to 
measure biocompatibility and bioactivity, the number of cells will be determined 
by means of Cyquant and Alamar Blue assays, both of which are quantitative, 
reproducible assays. It can also be determined if osteoblastic growth is indeed 
induced and maintained by these composites by evaluating the expression of 
important bone-associated proteins namely, core binding factor 1 (cbfa1), alkaline 
phosphatase (AP), osteopontin (OP), osteocalcin (OC) and type I collagen (Col I) 
using a combination of biochemical assays, immunocytochemistry and 
quantitative Real Time Polymerase chain reaction (RT-PCR).  Furthermore, bone 
mineralization; a strong indicator of bioactivity, on these composites will be 
assessed using Alizarin Red staining. Implantation of these scaffolds in bone 
defects and the bone formation and effects on angiogenesis and vascularization of 
these scaffolds can be monitored. 
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 P(3HB) microspheres/n-BG (10 wt%) composite microsphere films :- These films 
could be further characterised with respect to porosity and mechanical properties. 
The surface energy of the composite microsphere films and its effect on cell 
proliferation should be identified. Foreign body reactions should also be 
monitored when used as subcutaneous implants for in vivo experiments. Based on 
several factors of the microsphere films such as surface hydrophobicity, surface 
morphology and crystallinity the platelet adhesion and activation tests such as a 
lactate dehydrogenase (LDH) assay should be carried out to characterize the 
haemostasis of the materials and further confirm their applicability in wound 
healing.  
 Polyhydroxyalkanoate microsphere-based systems for intraocular drug delivery: -
Since the preliminary data from this study indicated that the BSA and Lucentis
®
 
entrapped in the microspheres was released slowly, this system can now be used 
for long-term intraocular drug delivery of other drugs such as  Avastin, produced 
by Genentech USA. The drug needs to be administered through monthly 
intraocular injections Hence, P(3HB) microspheres can be used to encapsulate the 
drugs and it‟s in vitro release kinetics measured over a long period of time (for 
example3 months). The degradation studies of Lucentis
® 
and Avastin as well as 
the structural integrity of the drug using non-denaturing PAGE should be 
monitored. The release of Lucentis
®
 and Avastin from the P(3HB) microspheres 
should be  studied in vitro.  
 Polyhydroxyalkanoate microsphere-based systems for encapsulating Bone 
morphogenic proteins (BMP-2):- The use of solid-oil-in-water emulsion technique 
for the encapsulation of BMP-2 should be carried out. The growth factor 
encapsulated microspheres can be incorporated into the 3-D scaffolds and the in 
vitro release of BMP-2 can be assayed using alkaline phosphatase (AP) assay.  
The cell line C2C12 cells which when stimulated with BMP-2 is known to induce 
an increase in alkaline phosphatase activity. This can be measured by staining. 
Therefore, the typical response of cells C2C12 in the presence of BMP-2 from the 
release media should be studied. Further studies on cell attachment, 
cytoskeleton/focal contacts and signal transduction should be investigated. This 
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long term in vitro release system of BMP-2 could be used to induce bone 
formation.  
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